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Abstract 
Aims: 
The aim of this thesis was firstly, to prospectively examine cognitive function 
in relation to epilepsy, with event-related potential (ERP) and neuropsychological 
assessments, over a one year period. Secondly, to investigate whether 
electrophysiological measures have some predictive value for behavioural outcomes. 
Methods: 
A methodology development study investigated optimal stimulus and 
recording parameters for the mismatch negativity (MMN). 
A prospective epilepsy study included investigation of a healthy control 
group, groups of patients with: primary generalised seizures (PGS), focal with 
secondary generalised seizures (FSG) or focal seizures (FS) and a chronic pain group 
undergoing anti-epileptic drug (AED) therapy. Assessments were conducted over the 
course of 12 months: at baseline (session 1), 6-months follow-up (session 2) and 12- 
months follow-up (session 3). ERP measures included the MMN, P3b and P3a. 
Neuropsychology measures were obtained using visual reaction time, spatial working 
memory, planning, word list learning, perseverative function, story recall memory 
and word list learning tests. 
Cross-sectional analyses of data obtained at sessions 1 and 2 were carried out 
to investigate group differences at the different time points. Longitudinal analyses 
were carried out to investigate the effect of time on behavioural and ERP changes in 
relation to the different groups. Finally, the predictive value of baseline ERPs for 
behavioural outcomes at one year follow-up was explored. 
Results: 
The methodology development study demonstrated that a reading task with 
duration increment tones yielded the most replicable MMNs in healthy controls. 
The clinical study demonstrated significant changes in some ERP 
components obtained from standard oddball, dual target oddball and novel sounds 
tasks, between controls and seizure groups -some of which were only apparent at 
session 3. Although the seizure groups showed evidence of significant impairments 
in aspects of behavioural performance, there was no significant progressive 
deterioration over time. Moreover, although the pain group showed similar 
behavioural impairments, in contrast to the seizure groups, they showed significant 
improvements in some aspects of performance over time. 
Conclusion: An MMN recording protocol was established for use with the 
subsequent prospective clinical study. The prospective epilepsy study revealed 
functional cognitive changes that may be linked to the nature of pathophysiology 
underlying different seizure types. 
-2- 
Acknowledgements 
I would like to thank the Barts and The London Joint Research Board for providing 
the studentship that assisted with the resources used to carry out this research. 
Many thanks to Dr Geoff Barrett for his guidance with this work, for sharing his 
expert advice and for his overall encouragement and support. I would also like to 
thank Dr Howard Ring for his supervision and feedback during this research. 
The work included in this thesis would not have been possible without the volunteers 
who took part in the experiments. I am very grateful to everyone who kindly 
dedicated their time and efforts. 
I would like to thank Dr Charlie Cockerell for letting me impose on his epilepsy 
clinics, at the Royal London Hospital, for many months. Many thanks to Dr Joanna 
Zarkrewska, who kindly helped me recruit volunteers through the facial pain clinics 
at the Barts and the London Dental Institute, and at the Trigeminal Neuralgia AGM 
2002. Thanks also to Dr Jane Gallagher for her help with recruitment from her pain 
clinics, at St. Bartholomew's Hospital, and for her advice during the early stages of 
patient recruitment. 
Many thanks to Dr R. Blunden, at the Royal London Hospital, and Drs P. Thompson 
and D. Upton, at the Institute of Neurology, for their much appreciated help with 
obtaining the story recall tests. 
Thanks to the staff at the Department of Psychiatry, at Queen Mary's, for their 
general support. Also, to all the staff at the EEG Department, at the Royal Free 
Hospital, for all their support over the past few months, in particular Dr Bryan Youl 
and Liz Sims. I would also like to thank Dr Sara Montagnese and Dr Marsha 
Morgan, at the Royal Free Hospital Hepatology Department, for all their advice and 
encouragement during the final stages of this thesis. 
I am indebted to my brilliant friends, colleagues and family who have provided me 
with heaps of motivation and support - especially during the plentiful crises over the 
past few years. In particular, a big thank you to: Alison, Dan, Neil, Nuri, Mary- 
Anne, Rachel, Sara, Soamesh, Skippy, Sushma and Yogesh. 
Finally, a big thank you to my parents, for their unlimited support, love and 
encouragement. 
-3- 
Table of contents 
Table of Contents 
Section Page 
number 
Abstract ............................................................................................... 
2 
Acknowledgements ............................................................................ 3 
List of tables ....................................................................................... 
11 
List of figures ...................................................................................... 
16 
List of abbreviations .......................................................................... 22 
1 Chapter I 23 
Neuropsychology and epilepsy: Background and review of the 
literature 
1.1. Historical overview of epilepsy ........................................................... 
23 
1.2. Epidemiology of epilepsy .................................................................... 
24 
1.3. Classification of seizure types ............................................................. 
24 
1.3.1. Partial seizures ..................................................................................... 
25 
1.3.2. Primary generalised seizures ............................................................... 
25 
1.3.3. Limitations of seizure classification .................................................... 
26 
1.4. Classification of epilepsies and epilepsy syndromes ..................... 
26 
1.4.1. Localisation-related epilepsy ................................................ 
28 
1.4.2. Outline of the pathophysiology of localisation-related seizures........ 29 
1.4.3. Idiopathic generalized epilepsy (IGE) .................... ......... 
30 
1.4.4. Outline of the pathophysiology of generalized seizures ................. 
30 
1.5. Functional localisation of neuropsychological processes .................... 
31 
1.5.1. Memory ........................................................................ 31 
1.5.1.1. Registration .................................................................... 31 
1.5.1.2. Immediate memory ........................................................... 32 
1.5.1.3. Rehearsal ....................................................................... 32 
1.5.1.4. Long-term memory (LTM) .................................................. 33 
1.5.1.5. Procedural memory ........................................................... 33 
1.5.1.6. Declarative memory .......................................................... 34 
1.5.2. Attention ..................................................................... 35 
1.5.3. The anatomy of neuropsychological functions ........................... 36 
1.6. Studies investigating cognitive function in relation to epilepsy using 
neuropsychological assessment ........................................................... 37 
-4- 
Table of contents 
1.6.1. Effects of duration of epilepsy and seizure frequency on 
neuropsychological function ................................................ 38 
1.6.2. Effects of epilepsy and seizure type on neuropsychological function 39 
1.6.3. Effects of anti-epileptic drug therapy on neuropsychological 
function ........................................................................ 41 
1.6.4. Effects of psychosocial factors on cognitive function ................... 43 
1.6.5. Summary ....................................................................... 43 
2 Chapter II 44 
Cognitive event-related potentials: A technical overview and 
review of the literature 
2.1. The electroencephalogram ................................................................... 44 
2.2. Event-related potentials ....................................................................... 45 
2.2.1. Obtaining cognitive ERPs .................................................................... 46 
2.2.2. Technical aspects relating to cognitive ERP acquisition ..................... 
47 
2.2.2.1. Amplifier and filter settings for optimal ERP acquisition ................... 
47 
2.2.2.2. ERP extraction from the EEG .............................................................. 
48 
2.2.2.3. Influence of ocular artefacts on ERPs .................................................. 
48 
2.2.2.4. Summary of optimal ERP acquisition techniques ............................... 
49 
2.3. Auditory event-related potentials ......................................................... 
49 
2.3.1. N1, negative difference wave (Nd) and processing negativity......... 49 
2.3.2. Mismatch negativity ........................................................................... 
51 
2.3.3. The "basic" N2, N2b and N2c ............................................................. 52 
2.3.4. P3 (P3a and P3b) ................................................................................. 52 
2.4. Cognitive ERP and epilepsy studies .................................................... 54 
2.4.1. Effects of epilepsy on the MMN .......................................................... 54 
2.4.2. Effects of partial epilepsy on the P3 .................................................... 55 
2.4.3. Effects of generalised epilepsy on cognitive ERPs ............................. 59 
2.4.4. Effects of AED therapy on cognitive ERPs ......................................... 64 
2.4.5. Summary of the effects of epilepsy on cognitive ERPs .................. 66 
3.0. Introduction to the investigations in this thesis .................. 
3 Chapter III 67 
Repeatability of the mismatch negativity recorded with different 
stimulus and attention conditions 
-5- 
Table of contents 
3.1. Introduction .......................................................................................... 
67 
3.2. Method ................................................................................................. 
70 
3.2.1. Subjects ........................................................................ 
70 
3.2.2. Recording conditions and stimulus parameters ................................... 70 
3.2.2.1. Reading task ......................................................................................... 
71 
3.2.2.2. Visual vigilance task ............................................................................ 71 
3.2.3. Procedure ............................................................................................. 72 
3.2.4. ERP recording ...................................................................................... 72 
3.2.5. Data analysis ........................................................................................ 73 
3.3. Results .................................................................................................. 74 
3.3.1. Within-session MMN repeatability ..................................................... 
74 
3.3.2. Inter-session MMN repeatability ......................................................... 
75 
3.4. Discussion 
............................................................................................ 81 
4 Chapter IV 84 
Baseline study: 
Electrophysiological and neuropsychological comparisons of 
different seizure type groups with healthy controls 
4.1. Introduction 
...................... .......................................................... 
84 
4.2. Method 
................................................................................................. 
89 
4.2.1. Subjects 
................................................................................................ 
89 
4.2.2. Neuropsychological tests ..................................................................... 
90 
4.2.3. ERP tests and stimulus parameters ...................................................... 
90 
4.2.3.1. Mismatch negativity (MMN) recording .............................................. 91 
4.2.3.2. P3b standard oddball recording ........................................................... 91 
4.2.3.3. P3a novel sounds task recording .......................................................... 92 
4.2.3.4. Dual target oddball (DTO) task recording ........................................... 92 
4.2.4. ERP recording procedures ................................................................... 93 
4.2.5. ERP data analysis ............................ 
4.2.5.1. MMN analysis ........................................... 
4.2.5.2. P3b standard oddball task analysis ...................................................... 94 
4.2.5.3. P3a novel sounds task analysis ........................................... 
4.2.5.4. DTO task analysis ................................................................................ 94 
4.2.6. Statistical analyses ............................................................................... 95 
-6- 
Table of contents 
4.3. Results .................................................................................................. 
95 
4.3.1. Demographic measures ........................................................................ 
95 
4.3.2. Clinical and neuropsychological measures .......................................... 
95 
4.3.2.1. HAD results ......................................................................................... 
95 
4.3.2.2. WCST results ....................................................................................... 
97 
4.3.2.3. Visual reaction time results .................................................................. 
99 
4.3.2.4. SWM results ........................................................................................ 100 
4.3.2.5. Planning (Stockings of Cambridge/Tower of London) test results.... 101 
4.3.2.6. RAVLT results ..................................................................................... 102 
4.3.2.7 Story recall results ............................................................................... 105 
4.3.3. ERP behavioural results ....................................................................... 
108 
4.3.4. ERP results ........................................................................................... 109 
4.3.4.1. MMN results ........................................................................................ 109 
4.3.4.2. P3b standard oddball task results ......................................................... 
113 
4.3.4.3. P3a novel sounds task results .............................................................. 
117 
4.3.4.4. DTO task results - auditory targets ..................................................... 
121 
4.3.4.5. DTO task results - visual targets ......................................................... 
126 
4.4. Discussion 
............................................................................................ 
131 
5 Chapter V 138 
12-month follow-up cross-sectional study: electrophysiological 
and neuropsychological comparisons of different seizure type 
groups with healthy controls. 
5.1. Introduction 
.................................................................... 138 
5.2. Method ................................................................................................. 138 
5.2.1. Subjects ................................................................................................ 138 
5.2.2. Neuropsychological tests ..................................................................... 139 
5.2.3. ERP tests and stimulus parameters ...................................................... 140 
5.2.3.1. MMN recording ................................................................................... 140 
5.2.3.2. P3b standard oddball recording ........................................................... 140 
5.2.3.3. P3a "novel sounds" recording .............................................................. 140 
5.2.3.4. Dual target oddball (DTO) task recording ........................................... 140 
5.2.4. ERP recording procedures ................................................... 140 
5.2.5. ERP data analysis ................................................................................. 140 
-7- 
Table of contents 
5.2.6.1 Statistical analyses ............................................................................... 
140 
5.3. Results -12-month follow-up cross-sectional results .................... 141 
5.3.1. Demographic measures ........................................................................ 
141 
5.3.2. Clinical and neuropsychological measures .......................................... 
141 
5.3.2.1. HAD results ......................................................................................... 
141 
5.3.2.2. WCST results ....................................................................................... 
143 
5.3.2.3. Visual reaction-time results ................................................................. 
146 
5.3.2.4. Spatial working memory (SWM) results ............................................. 
147 
5.3.2.5. Planning (Stockings of Cambridge/Tower of London) test results.... 148 
5.3.2.6. RAVLT results ..................................................................................... 
148 
5.3.2.7. Story recall results ............................................................................... 153 
5.3.3. ERP behavioural results ....................................................................... 156 
5.3.4. ERP results at 12-month follow-up ............................................................... 
158 
5.3.4.1. MMN results ........................................................................................ 
158 
5.3.4.2. P3b standard oddball task results ......................................................... 
163 
5.3.4.3. P3a novel sounds task results ............................................................... 
169 
5.3.4.4. DTO task results - auditory targets ..................................................... 
175 
5.3.4.5. DTO task results - visual targets ......................................................... 
181 
5.4. Discussion 
............................................................................................ 
186 
6 Chapter VI 193 
Longitudinal study: 
Electrophysiological and neuropsychological comparisons of 
different seizure type groups with healthy controls 
6.1. Introduction 
.......................................................................................... 193 
6.2. Method ................................................................................................. 193 
6.2.1. Subjects ................................................................................................ 193 
6.2.2. Neuropsychological tests ........................................................ ............. 194 
6.2.3. ERP tests and stimulus parameters ...................................................... 195 
6.2.3.1. MMN recording ................................................................................... 195 
6.2.3.2. P3b standard oddball recording ........................................................... 195 
6.2.3.3. P3a "novel sounds" recording .............................................................. 195 
6.2.3.4. Dual target oddball (DTO) task recording ........................................... 195 
6.2.4. ERP recording procedures ................................................................... 195 
-8- 
Table of contents 
6.2.5. ERP data analysis ................................................................................ 
196 
6.2.6. Statistical analyses ............................................................................... 
196 
6.3. Results .................................................................................................. 
196 
6.3.1. Demographic measures ........................................................................ 
196 
6.3.2. Clinical and neuropsychological measures ................................. 
6.3.2.1. HAD results ......................................................................................... 
198 
6.3.2.2. WCST results ....................................................................................... 
200 
6.3.2.3. Visual reaction time results .................................................................. 204 
6.3.2.4. Spatial working memory results .......................................................... 207 
6.3.2.5. Planning (Tower of London/Stockings of Cambridge) test results..... 209 
6.3.2.6 RAVLT results ..................................................................................... 
210 
6.3.2.7. Story recall results ............................................................................... 215 
6.3.3. ERP behavioural results ....................................................................... 
219 
6.3.3.1. P3b oddball task behavioural results ................................................... 
219 
6.3.3.2. P3a novel sounds task behavioural results ................................. 
220 
6.3.3.3. DTO task behavioural results ............................................... 
220 
6.3.4. ERP results ..................................................................... 
225 
6.3.4.1. MMN results ........................................................................................ 
225 
6.3.4.2. P3b standard oddball task results ......................................................... 
232 
5.3.4.3. P3a novel sounds task results ................................................ 
241 
6.4.4.4. DTO task -auditory targets .................................................................. 
251 
6.4.4.5. DTO task - visual targets ..................................................................... 
261 
6.5. Discussion 
........................................................................................ 269 
7 Chapter VII 279 
Relationship between baseline electrophysiology and 12-month 
follow-up neuropsychology results from patients with epilepsy. 
7.1. Introduction .......................................................................................... 279 
7.2. Method ................................................................................................. 279 
7.2.1. Subjects ................................................................................................ 279 
7.2.2. Procedure ............................................................................................. 279 
7.2.3. ...................................... Statistical analysis .......................................... 280 
7.3. Results .................................................................................................. 280 
7.4. Discussion ............................................................................................ 283 
-9- 
Table of contents 
8 Chapter VIII 286 
Overall Discussion and Conclusions 
8.1. Limitations of the methodology .......................................................... 286 
8.1.1. Sample size ............................................... 
8.1.2. Lack of neuroimaging data .................................................................. 286 
8.1.3. Correlative anti-epileptic drug (AED) levels ....................................... 287 
8.1.4. Seizure frequency data ......................................................................... 287 
8.1.5. Duration of epilepsy data ..................................................................... 287 
8.1.6. Statistical correction for multiple comparisons ................................... 287 
8.1.7. Sensitivity of the neuropsychology tests ............................................. 288 
8.1.8. Technical aspects ................................................................................. 288 
8.2. Synthesis of main findings ................................................................... 288 
8.2.1. Mismatch Negativity (MMN) repeatability study ............................... 288 
8.2.2. Prospective epilepsy study: baseline cross-sectional study ................. 
288 
8.2.3. Prospective epilepsy study: 12-month follow-up cross-sectional 
study ..................................................................................................... 289 
8.2.4. Prospective epilepsy study: 12-month follow-up longitudinal study 290 
8.2.5. Prospective epilepsy study: predictive value of ERPs on behavioural 
outcomes .............................................................................................. 295 
8.3. Overall conclusions ............................................................................. 
296 
List of appendices ............................................................................... 297 
Appendix I: Participant details ........................................................ 298 
Appendix II: Medication details ....................................................... 303 
Appendix III: Neuropsychology tests ............................................... 306 
Appendix IV: ERP data .................................................................... 311 
Appendix V: ERP waveforms averaged sweeps data ..................... 365 
References ........................................................................................... 370 
-10- 
List of tables 
List of tables 
No. Title Page 
1.1 The ILAE classification of the e ile Sies and epilepsy syndromes. 27 
1.2 Outline classification of e ile to enic lesions. 29 
2.1 Summary of studies examining the P3 in relation to partial and generalized 62- 
epilepsy. 63 
3.1 Recording conditions and stimulus parameters used for investigating MMN 70 
repeatability. 
3.2 Details of participants in the within-session MMN repeatability study. 71 
3.3 Details of participants in the test-retest MMN repeatability study. 71 
3.4 CV values (%) for within-session MMN mean peak amplitude repeatability 75 
(between set 1 and set 2) obtained in each initial test condition. 
3.5 CV values (%) for within-session MMN peak latency repeatability (between 75 
set 1 and set 2) obtained in each initial test condition. 
3.6 CV values (%) for within-session MMN mean peak amplitude repeatability 76 
(between set 1, set 2 and set 3) obtained in each retest condition. 
3.7 CV values (%) for inter-session MMN peak latency repeatability (between set 76 
1, set 2 and set 3) obtained in each retest condition. 
4.1 Summary of demographic data for the epilepsy, pain and healthy control 89 
groups. 
4.2 Summary of demographic data for epilepsy seizure-type groups. 90 
4.3a Seizure groups vs. control group: WCST baseline summary of group effects 97 
with <_ 0.1 from one-way ANOVA analysis. 
4.3b Seizure groups vs. control group: WCST baseline summary of post-hoc 97 
Dunnett's test results with p: 5 0.1. 
4.4a Seizure groups vs. control group: visual RT test baseline summary of group 99 
effects with p: 5 0.1 from one-way ANOVA analysis. 
4.4b Seizure groups vs. control group: visual RT test baseline summary of post- 100 
hoc Dunnett's test results with <_ 0.1. 
4.5a Seizure groups vs. control group: Tower of London (planning) test baseline 102 
summary of group effects with p: 5 0.1 from one-way ANOVA analysis. 
4.5b Seizure groups vs. control group: Tower of London (planning) test baseline 102 
summary of post-hoc Dunnett's test results with <_ 0.1. 
4.6a Seizure groups vs. control group: RAVLT test baseline summary of group 103 
effects with p: 5 0.1 from one-way ANOVA analysis. 
4.6b Seizure groups vs. control group: RAVLT test baseline summary of post-hoc 103 
Dunnett's test results with 5 0.1. 
4.7a Seizure groups vs. control group: story recall test baseline summary of group 106 
effects with <_ 0.1 from one-way ANOVA analysis. 
4.7b Seizure groups vs. control group: story recall test baseline summary of post- 106 
hoc Dunnett's test results with p: 5 0.1. 
4.8 Button press latency values in response to correctly detected auditory targets 108 
in the standard P3b oddball test, the P3a novel sounds test and the DTO task, 
obtained at baseline. 
4.9 Target detection accuracy scores in the standard P3b oddball test, the Pia 109 
novel sounds test and the DTO task, obtained at baseline. 
4.10 MMN peak latency, onset, offset and duration values obtained at baseline. 110 
4.11 MMN m pa values, at electrodes Fz, Cz, Pz, F3 and F4, obtained at baseline. 110 
-11- 
List of tables 
4.12a Seizure groups vs. control group: MMN baseline summary of group effects 110 
with <_ 0.1 from one-way ANOVA analysis. 
4.12b Seizure groups vs. control group: MMN baseline summary of post-hoc 110 
Dunnett's test results with p5 0.1. 
4.13 Peak latency values for Ni, N2 and P3b components, measured at Pz, 113 
obtained with the standard oddball task at baseline. 
4.14 Peak amplitude values for Ni, N2 and P3b components, measured at Pz, 114 
obtained with the standard oddball task at baseline. 
4.15a Seizure groups vs. control group: standard oddball task baseline summary of 114 
group effects with p: 5 0.1 from one-way ANOVA analysis. 
4.15b Seizure groups vs. control group: standard oddball task baseline summary of 114 
post-hoc Dunnett's test results with <_ 0.1. 
4.66 Peak latency values for Ni, N2 and P3a components, measured at Cz, 117 
obtained with the novel sounds task at baseline. 
4.17 Peak amplitude values for N 1, N2 and P3a components, measured at Cz, 118 
obtained with the novel sounds task at baseline. 
4.18a Seizure groups vs. control group: novel sounds task baseline summary of 118 
group effects with <_ 0.1from one-way ANOVA analysis. 
4.18b Seizure groups vs. control group: novel sounds task baseline summary of 118 
post-hoc Dunnett's test analysis with <_ 0.1. 
4.19 Peak latency values for N 1, N2 and P3b components, measured at Pz, 122 
obtained with auditory targets in the DTO task at baseline. 
4.20 Peak amplitude values for Ni, N2 and P3b components, measured at Pz, 122 
obtained with auditory targets in the DTO task at baseline. 
4.21a Seizure groups vs. control group: DTO task (responses to auditory targets) 122 
baseline summary of group effects with p<_ 0.1 from one-way ANOVA 
analysis. 
4.21b Seizure groups vs. control group: DTO task (responses to auditory targets) 123 
baseline summary of post-hoc Dunnett's test results with _< 
0.1. 
4.22 Peak latency values for N 1, N2 and P3b components, measured at Pz, 127 
obtained with visual targets in the DTO task at baseline 
4.23 Peak amplitude values for Ni, N2 and P3b components, measured at Pz, 127 
obtained with visual targets in the DTO task at baseline. 
4.24a Seizure groups vs. control group: DTO task (responses to visual targets) 127 
baseline summary of group effects with p<_ 0.1 from one-way ANOVA 
analysis. 
4.24b Seizure groups vs. control group: DTO task (responses to visual targets) 128 
baseline summary of post-hoc Dunnett's test results with p: 5 0.1. 
5.1. Summary of demographic data for the epilepsy, pain and healthy control 139 
groups participating in the 12-month follow-up session. 
5.2. Summary of demographic data for epilepsy seizure-type groups participating 139 
in the 12-month follow-up session. 
5.3a Seizure groups vs. control group: WCST 12-month follow-up results 143 
summary of group effects with <_ 0.1 from one-way ANOVA analysis. 
5.3b Seizure groups vs. control group: WCST 12-month follow-up summary of 144 
post-hoc Dunnett's test results with p: 5 0.1. 
5.4a Seizure groups vs. control group: visual RT test 12-month follow-up 146 
summary of group effects with p<_ 0.1 from one-way ANOVA analysis. 
- 12 - 
List of tables 
5.4b Seizure groups vs. control group: visual RT test 12-month follow-up 147 
summary of post-hoc Dunnett's test results with <_ 0.1. 
5.5a Seizure groups vs. control group: RAVLT 12-month follow-up summary of 149 
group effects with <_ 0.1 from one-way ANOVA analysis. 
5.5b Seizure groups vs. control group: RAVLT 12-month follow-up summary of 150 
post-hoc Dunnett's test results with p: 5 0.1. 
5.6a. Seizure groups vs. control group: story recall test 12-month follow-up 154 
summary of group effects with <_ 0.1 from one-way ANOVA analysis. 
5.6b. Seizure groups vs. control group: story recall test 12-month follow-up 154 
summary of post-hoc Dunnett's test results with <_ 0.1. 
5.7. Button press latency values in response to correctly detected auditory targets 157 
in the standard P3b oddball test, the P3a novel sounds test and the DTO task 
at 12-month follow-up. 
5.8. Target detection accuracy scores in the standard P3b oddball test, the P3a 157 
novel sounds test and the DTO task at 12-month follow-up. 
5.9. MMN peak latency, onset, offset and duration values obtained at 12-month 159 
follow-up. 
5.10. MMN mpa values, at electrodes Fz, Cz, Pz, F3 and F4, obtained at 12-month 159 
follow-up. 
5.1 la Seizure groups vs. control group: MMN 12-month follow-up summary of 159 
group effects with p: 5 0.1 from one-way ANOVA analysis. 
5.1 lb Seizure groups vs. control group: MMN 12-month follow-up summary of 160 
post-hoc Dunnett's test results with <_ 0.1. 
5.12 Peak latency values for Ni, N2 and P3b components, measured at Pz, 164 
obtained from the standard oddball task at 12-month follow-up. 
5.13 Peak amplitude values for Ni, N2 and P3b components (standard oddball 164 
test) measured at Pz, obtained from the standard oddball task at 12-month 
follow-up. 
5.14a Seizure groups vs. control group: standard oddball task 12-month follow-up 165 
summ of group effects with <_ 0.1 from one-way ANOVA analysis. 
5.14b Seizure groups vs. control group: standard oddball task 12-month follow-up 165- 
results summary of post-hoc Dunnett's test results with p: 5 0.1. 166 
5.15 Peak latency values for Ni, N2 and Pia components, measured at Fz, 170 
obtained from the novel sounds task at 12-month follow-up. 
5.16 Peak amplitude values for Ni, N2 and P3a components, measured at Fz, 170 
obtained from the novel sounds task at 12-month follow-up. 
5.17a Seizure groups vs. control group: novel sounds task 12-month follow-up 171 
summary of group effects with p! 5 0.1 from one-way ANOVA analysis. 
5.17b Seizure groups vs. control group: novel sounds task 12-month follow-up 171- 
summary of post-hoc Dunnett's test results with p: 5 0.1. 172 
5.18 Peak latency values for Ni, N2 and P3b components, measured at Pz, 176 
obtained with auditory targets in the DTO task at 12-month follow-up. 
5.19 Peak amplitude values for Ni, N2 and P3b components, measured at Pz, 176 
obtained with auditory targets in the DTO task at 12 month follow-up. 
5.20a Seizure groups vs. control group: DTO task (auditory targets) 12-month 176 
follow-up summary of group effects with p<_ 0.1 from one-way ANOVA 
analysis. 
5.20b Seizure groups vs. control group: DTO task (auditory targets) 12-month 177- 
follow-up summary of post-hoc Dunnett's test results with <_ 0.1. 178 
-13- 
List of tables 
5.21 Peak latency values for N1, N2 and P6 components measured at Cz, obtained 182 
with visual targets in the DTO at 12-month follow-up. 
5.22 Peak amplitude values for Ni, N2 and P6 components, measured at Cz, 182 
obtained with visual targets in the DTO at 12-month follow-up. 
5.23a Seizure groups vs. control group: DTO task (visual targets) 12-month follow- 182 
up summary of group effects with <_ 0.1 from one-way ANOVA analysis. 
5.23b Seizure groups vs. control group: DTO task (visual targets) 12-month follow- 183 
up summary of post-hoc Dunnett's test results with :50.1. 
6.1 Summary of demographic data for the epilepsy, pain and healthy control 194 
groups participating in the baseline, 6-month and 12 month follow-up 
sessions. 
6.2 Summary of demographic data for the seizure-type groups participating in the 194 
baseline, 6-month and 12 month follow-up sessions. 
6.3 Seizure frequency relating to the month prior to the 3 sessions. 197 
6.4 Control vs. seizure groups: statistical summary of results with p: 50.1 from 201 
repeated measures ANOVA of WCST scores obtained at all 3 test sessions. 
6.5 Control vs. pain group: statistical summary of results with p<_0.1 from 201 
repeated measures ANOVA of WCST scores obtained at all 3 sessions. 
6.6 Controls vs. seizure groups: statistical summary of results with p<_0.1 from 204 
repeated measures ANOVA of visual RT test scores obtained at all 3 sessions. 
6.7 Controls vs. pain group: statistical summary of results with p<_0.1 from 205 
repeated measures ANOVA of visual RT test scores obtained at all 3 sessions. 
6.8 Controls vs. seizure groups: statistical summary of results with p<_0.1 from 208 
repeated measures ANOVA of SWM test scores obtained at all 3 sessions. 
6.9 Controls vs. pain group: statistical summary of results with p<_0.1 from 208 
repeated measures ANOVA of SWM test scores obtained at all 3 sessions. 
6.10 Controls vs. seizure groups: statistical summary of results with p<_0.1 from 209 
repeated measures ANOVA of planning test scores obtained at all 3 sessions. 
6.11 Controls vs. pain group: statistical summary of results with p50.1 from 209 
repeated measures ANOVA of planning test scores obtained at all 3 sessions. 
6.12 Controls vs. seizure groups: statistical summary of results with p50.1 from 211 
repeated measures ANOVA of RAVLT test scores obtained at all 3 sessions. 
6.13 Controls vs. pain group: statistical summary of results with p<_0.1 from 212 
repeated measures ANOVA of RAVLT test scores obtained at all 3 sessions. 
6.14 Controls vs. seizure groups: statistical summary of results with p<_0.1 from 216 
repeated measures ANOVA of story recall test scores obtained at all 3 
sessions. 
6.15 Controls vs. pain group: statistical summary of results with p<_0.1 from 216 
repeated measures ANOVA of story recall test scores obtained groups at all 3 
sessions. 
6.16 Controls vs. seizure groups: statistical summary of results with p50.1 from 219 
repeated measures ANOVA of ERP RT results obtained at all 3 sessions. 
6.17 Controls vs. pain group: statistical summary of results with p<_0.1 from 219 
repeated measures ANOVA of ERP RT results obtained at all 3 sessions. 
6.18 Controls vs. seizure groups: summary of results with p: 50.1 from repeated 226 
measures ANOVA of MMN results obtained all 3 sessions. 
6.19 Controls vs. pain group: summary of significant statistical results with p<_0.1 226 
repeated measures ANOVA of MMN results obtained at all 3 sessions. 
- 14 - 
List of tables 
6.20 Controls vs. seizure groups: summary of results with p<_0.1 from repeated 234 
measures ANOVA of responses to auditory targets in the P3b oddball task 
obtained at all 3 sessions. 
6.21 Controls vs. pain group: summary of results with p<_0.1 from repeated 234 
measures ANOVA of responses to auditory targets in the P3b oddball task 
obtained at all 3 sessions. 
6.22 Controls vs. seizure groups: summary of results with p<_0.1 from repeated 243 
measures ANOVA of responses to auditory targets in the P3a novel sounds 
task obtained at all 3 sessions. 
6.23 Controls vs. pain group: summary of results with p<_0.1 from repeated 243 
measures ANOVA of responses to auditory targets in the P3a novel sounds 
task obtained at all 3 sessions. 
6.24 Controls vs. seizure groups: summary of results with p<_0. Ifrom repeated 252 
measures ANOVA of responses to auditory targets in the DTO task obtained 
at all 3 sessions. 
6.25 Controls vs. pain group: summary of results with p<_0.1 from repeated 253 
measures ANOVA of responses to auditory DTO task obtained at all 3 
sessions. 
6.26 Controls vs. seizure groups: summary of results with p<_0. Ifrom repeated 262 
measures ANOVA of responses to visual targets in the DTO task obtained at 
all 3 sessions. 
6.27 Controls vs. pain group: summary of results with p<_0.1 from repeated 262 
measures ANOVA of responses to visual targets in the DTO task obtained at 
all 3 sessions. 
7.1. Relationship between baseline ERP measures and neuropsychology measures 282 
at 12-month follow up obtained from the PGS group. 
7.2. Relationship between baseline ERP measures and neuropsychology measures 283 
at 12-month follow up obtained from the FSG group. 
7.3. Relationship between baseline ERP measures and neuropsychology measures 283 
at 12-month follow up obtained from the FS group. 
-15- 
List of figures 
List of figures 
No. Title Page 
2.1. The 10-20 system of electrode placement 45 
2.2. The effect of averaging on ERP identification. 46 
3.1. Individual MMN waveforms at Fz superimposed for each set obtained within- 77 
session in each recording condition. 
3.2. Individual MMN 1,2 (within-session sets) and 3 (retest set) difference 78 
waveforms at electrode Fz in condition DDR. 
3.3. Individual MMN 1,2 (within-session sets) and 3 (retest set) difference 79 
waveforms at electrode Fz in condition DIR. 
3.4. Individual MMN 1,2 (within-session sets) and 3 (retest set) difference 80 
waveforms at electrode Fz in condition FIR. 
4.1a HAD anxiety scores for healthy control, pain and seizure groups at baseline. 96 
4.1b HAD depression scores for healthy control, pain and seizure groups at 96 
baseline. 
4.2a WCST total error scores for healthy control, pain and seizure groups at 98 
baseline. 
4.2b WCST perseverative error scores for healthy control, pain and seizure groups 98 
at baseline. 
4.3a RAVLT trial 1 scores for healthy control, pain and seizure groups at baseline. 104 
4.3b RAVLT trial 5 scores for healthy control, pain and seizure groups at baseline. 104 
4.3c RAVLT trial 6 scores for healthy control, pain and seizure groups at baseline. 105 
4.3d RAVLT trial 7 scores for healthy control, pain and seizure groups at baseline. 105 
4.4a Immediate story recall scores for healthy control, pain and seizure groups at 107 
baseline. 
4.4b Delayed story recall scores for healthy control, pain and seizure groups at 107 
baseline. 
4.5a Group averaged MMN difference waveforms, obtained at baseline, from the 111 
seizure groups and the healthy control group. 
4.5b Group averaged MMN waveforms, obtained at baseline, from the pain group 112 
and the healthy control group. 
4.6a Group averaged waveforms obtained at baseline, in response to target tones in 115 
the standard oddball task, from the seizure groups and the healthy control 
group. 
4.6b Group averaged waveforms, obtained at baseline in response to target tones in 116 
the standard oddball task, from the pain group and the healthy control group. 
4.7a Group averaged waveforms obtained at baseline, in response to non-target 119 
sounds in the P3a novel sounds task, from the seizure groups and the healthy 
control group. 
4.7b Group averaged waveforms obtained at baseline, in response to non-target 120 
sounds in the P3a novel sounds task, from the pain group and the healthy 
control group. 
4.8a Group averaged waveforms obtained at baseline, in response to auditory 124 
targets in the DTO task, from the seizure groups and the healthy control 
group. 
4.8b Group averaged waveforms obtained at baseline, in response to auditory 125 
targets in the DTO task, from the pain group and the healthy control group. 
- 16 - 
List of figures 
4.9a Group averaged waveforms obtained at baseline, in response to visual targets 129 
in the DTO task, from the seizure groups and the healthy control group. 
4.9b Group averaged waveforms obtained at baseline, in response to visual targets 130 
in the DTO task, from the pain group and the healthy control group. 
5.1a HAD anxiety scores for healthy control, pain and seizure groups at 12 month 142 
follow-up. 
5.1b HAD depression scores for healthy control, pain and seizure groups at 12 142 
month follow-up. 
5.2a WCST total error scores for healthy control, pain and seizure groups at 12 144 
month follow-up. 
5.2b WCST non-perseverative error scores for healthy control, pain and seizure 145 
groups at 12 month follow-up. 
5.2c WCST trial administered scores for healthy control, pain and seizure groups 145 
at 12 month follow-up. 
5.3. SWM strategy scores for healthy control, pain and seizure groups at 12 month 148 
follow-up. 
5.4a RAVLT trial 1 scores for healthy control, pain and seizure groups at 12 month 151 
follow-up. 
5.4b RAVLT trial 5 scores for healthy control, pain and seizure groups at 12 151 
month follow-up. 
5.4c RAVLT trial 6 scores for healthy control, pain and seizure groups at 12 152 
month follow-ti . 5.4d RAVLT trial 7 scores for healthy control, pain and seizure groups at 12 152 
month follow-up. 
5.5a Story recall immediate scores for healthy control, pain and seizure groups at 12 155 
month follow-up. 
5.5b Story recall delayed scores for healthy control, pain and seizure groups at 12 155 
month follow-up. 
5.5c Story recall retention scores for healthy control, pain and seizure groups at 12 156 
month follow-up- 
5.6a Group averaged MMN difference waveforms, obtained at 12-month follow- 161 
up, from the seizure groups and the healthy control group. 
5.6b Group averaged MMN difference waveforms, obtained at 12-month follow- 162 
up, from the pain rou and the health control group. 
5.7a Group averaged waveforms, obtained at 12-month follow-up in response to 167 
target tones in the standard oddball task, from the seizure groups and the 
healthy control group. 
5.7b Group averaged waveforms, obtained at 12-month follow-up in response to 168 
target tones in the standard oddball task, from the pain group and the healthy 
control group. 
5.8a Group averaged waveforms obtained at 12-month follow-up, in response to 173 
non-target sounds in the Pia novel sounds task, from the seizure groups and 
the healthy control group. 
5.8b Group averaged waveforms, obtained at 12-month follow-up, in response to 174 
non-target sounds in the P3a novel sounds task, from the pain group and the 
healthy control group. 
5.9a Group averaged waveforms obtained at 12-month follow-up, in response to 179 
auditory targets in the DTO task, from the seizure groups and the healthy 
control group. 
-17- 
List of figures 
5.9b Group averaged waveforms obtained at 12-month follow-up, in response to 180 
auditory targets in the DTO task, from the pain group and the healthy control 
group. 
5.10a Group averaged waveforms obtained at 12-month follow-up, in response to 184 
visual targets in the DTO task, from the seizure groups and the healthy 
control group. 
5.10b Group averaged waveforms obtained at 12-month follow-up, in response to 185 
visual targets in the DTO task, from the pain group and the healthy control 
group. 
6. la HAD anxiety scores for all groups at baseline (session 1), 6-month follow-up 199 
(session 2) & 12-month follow-up (session 3). 
6. lb HAD depression scores for all groups at baseline (session 1), 6-month follow- 199 
up (session 2) & 12-month follow-up (session 3). 
6.2a WCST non-perseverative error scores for all groups at baseline (session 1), 6- 202 
month follow-up (session 2) & 12-month follow-up (session 3). 
6.2b WCST categories completed scores for all groups at baseline (session 1), 6- 202 
month follow-up (session 2) & 12-month follow-up (session 3). 
6.2c WCST total error and scores for all groups at baseline (session 1), 6-month 203 
follow-up (session 2) & 12-month follow-up (session 3). 
6.2d WCST perseverative error scores for all groups at baseline (session 1), 6- 203 
month follow-up (session 2) & 12-month follow-up (session 3). 
6.3a Simple RT scores for all groups at baseline (session 1), 6-month follow-up 205 
(session 2) & 12-month follow-up (session 3). 
6.3b Simple MT scores for all groups at baseline (session 1), 6-month follow-up 206 
(session 2) & 12-month follow-up (session 3). 
6.3c Choice RT scores for all groups at baseline (session 1), 6-month follow-up 206 
(session 2) & 12-month follow-up (session 3). 
6.3d Choice MT scores for all groups at baseline (session 1), 6-month follow-up 207 
(session 2) & 12-month follow-up (session 3). 
6.4 SWM test strategy scores for all groups at baseline (session 1), 6-month 208 
follow-up (session 2) & 12-month follow-up (session 3). 
6.5 Interaction effects of session and group on PSMM for controls vs. seizure 210 
groups at baseline (session 1), 6-month follow-up (session 2) & 12-month 
follow-up (session 3). 
6.6a RAVLT scores for trial 1 recall for all groups at baseline (session 1), 6-month 212 
follow-up (session 2) & 12-month follow-up (session 3). 
6.6b RAVLT scores for trial 5 recall for all groups at baseline (session 1), 6-month 213 
follow-up (session 2) & 12-month follow-up (session 3). 
6.6c RAVLT scores for trial 6 recall for all groups at baseline (session 1), 6-month 213 
follow-up (session 2) & 12-month follow-up (session 3). 
6.6d RAVLT scores for trial 7 recall for all groups at baseline (session 1), 6-month 214 
follow-up (session 2) & 12-month follow-up (session 3). 
6.6e interaction effects of session and group on RAVLT trial 1 recall for the pain 214 
group and control group at baseline (session 1), 6-month follow-up (session 
2) & 12-month follow-up (session 3). 
6.7a Story recall test scores of immediate recall for all groups at baseline (session 217 
1), 6-month follow-up (session 2) & 12-month follow-up (session 3). 
6.7b Story recall test scores of 30-minute delayed recall for all groups at baseline 217 
(session 1), 6-month follow-up (session 2) & 12-month follow-up (session 3). 
-18- 
List of figures 
6.7c Story recall test scores of retention for all groups at baseline (session 1), 6- 218 
month follow-up (session 2) & 12-month follow-up (session 3). 
6.7d Interaction effects of session and group on story recall retention score for the 218 
seizure groups and control group at baseline (session 1), 6-month follow-up 
(session 2) & 12-month follow-up (session 3). 
6.8a RT for correctly detected targets the oddball task for all groups at baseline 220 
(session 1), 6-month follow-up (session 2) & 12-month follow-up (session 3). 
6.8b Accuracy of target detection in the oddball task for all groups at baseline 221 
(session 1), 6-month follow-up (session 2) & 12-month follow-up (session 3). 
6.8c RT for correctly detected targets in the P3a novel sounds task for all groups at 221 
baseline (session 1), 6-month follow-up (session 2) & 12-month follow-up 
(session 3). 
6.8d Accuracy of target detection in the P3a novel sounds task for all groups at 222 
baseline (session 1), 6-month follow-up (session 2) & 12-month follow-up 
(session 3). 
6.8e RT for correctly detected auditory targets in the DTO task for all groups at 222 
baseline (session 1), 6-month follow-up (session 2) & 12-month follow-up 
(session 3). 
6.8f Accuracy of auditory target detection in the DTO task for all groups at 223 
baseline (session 1), 6-month follow-up (session 2) & 12-month follow-up 
(session 3). 
6.8g Accuracy of visual target detection in the DTO task for all groups at baseline 223 
(session 1), 6-month follow-up (session 2) & 12-month follow-up (session 3). 
6.8h Interaction effects of session and group on accuracy of auditory target 224 
detection in the oddball task for pain and control groups at baseline (session 
1), 6-month follow-up (session 2) & 12-month follow-up (session 3). - 
6.8i Interaction effects of session and group on RT for correctly detected auditory 224 
targets in the DTO task for pain and control groups at baseline (session 1), 6- 
month follow-up (session 2) & 12-month follow-up (session 3). 
6.9a Group averaged MMN difference waveforms obtained at the 3 test sessions 227 
for the control group. 
6.9b Group averaged MMN difference waveforms obtained at the 3 test sessions 228 
for the PGS group. 
6.9c Group averaged MMN difference waveforms obtained at the 3 test sessions 229 
for the FSG group. 
6.9d Group averaged MMN difference waveforms obtained at the 3 test sessions 230 
for the FS group. 
6.9e Group averaged MMN difference waveforms obtained at the 3 test sessions 231 
for the pain group. 
6.9f Interaction effect of electrode and group on MMN mpa for seizure and 232 
control groups. 
6.10a Group averaged P3b waveforms obtained in response to auditory target tones 235 
in the standard oddball task at the 3 test sessions for the control group. 
6.10b Group averaged P3b waveforms obtained in response to auditory target tones 236 
in the standard oddball task at the 3 test sessions for the PGS group. 
6.10c Group averaged P3b waveforms obtained in response to auditory target tones 237 
in the standard oddball task at the 3 test sessions for the FSG group. 
6.10d Group averaged P3b waveforms obtained in response to auditory target tones 238 
in the standard oddball task at the 3 test sessions for the FS group. 
-19- 
List of figures 
6. l0e Group averaged P3b waveforms obtained in response to auditory target tones 239 
in the standard oddball task at the 3 test sessions for the pain group. 
6.10f Interaction effect of electrode and group on N1 amplitude for seizure and 240 
control groups. 
6.10g Interaction effect of electrode and group on N2 amplitude for seizure and 240 
control groups. 
6.10h Interaction effect of session and group on P3b latency for seizure and control 241 
groups at baseline (session 1), 6-month follow-up (session 2) and 12-month 
follow-up (session 3). 
6.11 a Group averaged Pia waveforms obtained in response to novel non-target 244 
sounds in the P3a novel sounds task at the 3 test sessions for the control 
group. 
6.1 lb Group averaged P3a waveforms obtained in response to novel non-target 245 
sounds in the P3a novel sounds task at the 3 test sessions for the PGS group. 
6.11c Group averaged P3a waveforms obtained in response to novel non-target 246 
sounds in the P3a novel sounds task at the 3 test sessions for the FSG group. 
6.1 ld Group averaged P3a waveforms obtained in response to novel non-target 247 
sounds in the P3a novel sounds task at the 3 test sessions for the FS group. 
6.1 le Group averaged P3a waveforms obtained in response to novel non-target 248 
sounds in the Pia novel sounds task at the 3 test sessions for the pain group. 
6.11 If Interaction effect of electrode and group on Ni amplitude for seizure and 249 
control groups. 
6.11 g Interaction effect of session and group on N2 latency for seizure and control 249 
groups at baseline (session 1), 6-month follow-up (session 2) and 12-month 
follow-up (session 3). 
6.1 Ih Interaction effect of session and group on N2 latency for pain and control 250 
groups at baseline (session 1), 6-month follow-up (session 2) and 12-month 
follow-up (session 3). 
6.1 li Interaction effect of session and group on P3a latency for seizure and control 250 
groups at baseline (session 1), 6-month follow-up (session 2) and 12-month 
follow-up (session 3). 
6.12a Group averaged P3b waveforms obtained in response to the auditory target 254 
tones in the DTO task at the 3 test sessions for the control group. 
6.12b Group averaged P3b waveforms obtained in response to the auditory target 255 
tones in the DTO task at the 3 test sessions for the PGS group. 
6.12c Group averaged P3b waveforms obtained in response to the auditory target 256 
tones in the DTO task at the 3 test sessions for the FSG group. 
6.12d Group averaged P3b waveforms obtained in response to the auditory target 257 
tones in the DTO task at the 3 test sessions for the FS group. 
6.12e Group averaged P3b waveforms obtained in response to the auditory target 258 
tones in the DTO task at the 3 test sessions for the pain group. 
6.12f Interaction effect of session and group on N1 latency for seizure and control 259 
groups at baseline (session 1). 
6.12g Interaction effect of session and group on N1 latency for seizure and control 259 
groups at 6-month follow-up (session 2). 
6.12h Interaction effect of session and group on Ni latency for seizure and control 260 
groups at 12-month follow-up (session 3). 
-20- 
List of figures 
6.12i Interaction effect of session and group on P3 latency for seizure and control 260 
groups at baseline (session 1), 6-month follow-up (session 2) and 12-month 
follow-up (session 3). 
6.13a Group averaged P6 waveforms obtained in response to the visual targets in 263 
the DTO task at the 3 test sessions for the control group. 
6.13b Group averaged P6 waveforms obtained in response to the visual targets in 264 
the DTO task at the 3 test sessions for the PGS group. 
6.13c Group averaged P6 waveforms obtained in response to the visual targets in 265 
the DTO task at the 3 test sessions for the FSG group. 
6.13d Group averaged P6 waveforms obtained in response to the visual targets in 266 
the DTO task at the 3 test sessions for the FS group. 
6.13e Group averaged P6 waveforms obtained in response to the visual targets in 267 
the DTO task at the 3 test sessions for the pain group. 
6.13f Interaction effect of session and group on P6 latency for seizure and control 268 
groups at baseline (session 1), 6-month follow-up (session 2) and 12-month 
follow-up (session 3). 
6.13g Interaction effect of session and group on P6 latency for pain and control 268 
groups at baseline (session 1), 6-month follow-up (session 2) and 12-month 
follow-up (session 3). 
7.1. Relationship between Ni amplitude (at P3) at baseline and story recall test 281 
immediate recall score at 12-month follow-up for the PGS group. 
7.2. Relationship between MMN offset at baseline and SWM strategy score at 12- 281 
month follow-up for the PGS group. 
- 21 - 
List of abbreviations 
List of abbreviations 
AED anti-epileptic drug 
AMIPB adult memory and information processing test battery 
CANTAB Cambridge Neuro s cholo ical Test Automated Battery 
CBZ carbamazepine 
CLRE c to enic localisation-related epilepsy 
CPE c to enic partial epilepsy 
CPS complex partial seizure 
CV co-efficient of variation 
DAT delayed alternation task 
DDR duration decrease deviant tone with the reading task 
DDV duration decrase devinat tone with the visual task 
DIR duration increase deviant tone with the reading task 
DIV duration increase deviant tone with the visual task 
DTO dual target oddball 
EEG electroencephalogram 
EOG electro-oculogram 
ERP event-related potential 
ExTLE extra-temporal lobe epilepsy 
FIR frequency increase deviant tone with the reading task 
FIV frequency increase deviant tone with the visual task 
FSG focal with secondary generalised. (seizure) 
FS focal seizure 
GBT gabapentin 
GTCS generalised tonic-clonic seizure 
HAD hospital anxiety and depression scale 
HS hi ocam al sclerosis 
IGE idiopathic generalised epilepsy 
ILAE International League Against Epilepsy 
JME juvenile myoclonic epilepsy 
NART National Adult Reading Test 
LRE localisation-related epilepsy 
LTM long-term memory 
MEG ma netoence halo ra hic 
MMN mismatch negativity 
MPA mean peak amplitude 
MTS mesial temporal lobe sclerosis 
MWCST modified Wisconsin card sorting test 
PHB phenobarbital 
PGS primary generalised seizure 
PHT phenytoin 
RT reaction time 
RAVLT Re 's auditory verbal learning test 
SLRE symptomatic localisation-related epilepsy 
SOC Stockings of Cambridge 
STM short-term memory 
SWM spatial working memory 
TLE temporal lobe epilepsy 
VPA valproate 
WCST Wisconsin card sorting test 
-22- 
Chapter I 
Chapter I 
NEUROPSYCHOLOGY AND EPILEPSY: BACKGROUND AND REVIEW 
OF THE LITERATURE 
1.1. Historical overview of epilepsy 
Epilepsy is defined as "a condition characterised by recurrent (two or more) 
epileptic seizures, unprovoked by any immediate identified cause" (International 
League Against Epilepsy, 1989). 
The earliest documentation of a seizure dates back to the time of the earliest written 
language around 3000 years ago (Goldensohn, 1997). At the time, the reported 
seizure was attributed to the effects of supernatural forces on events and individual 
behaviour. This notion persisted until the 16`h century and superstitions and magic 
prevailed as attempted prophylactics and cures for epilepsy. Around 2400 years ago, 
the "Hippocratic school" put forward the view that epilepsy may in fact be caused by 
changes in physical brain consistency and that diet and drugs may be beneficial 
treatments (Hippocrates, 1839). However, it was not until about 1000 years later that 
these Hippocratic works were rendered useful to European physicians following their 
translation into English and Latin. 
In the 16th century Paracelsus, a prominent Swiss physician, introduced the use of 
chemicals, albeit substances such as opium, copper, iron and alcoholic extracts, into 
the treatment of epilepsy (Goldensohn, 1997). Advances in the understanding of 
processes underlying epilepsy were initiated in the 17`h century by William Gilbert 
who's magnetic and electric studies formed a foundation for ensuing progress in the 
field of electrophysiology. It was the monumental discovery of intrinsic nerve and 
muscle electricity, in animals, by Luigi Galvani that paved the way for further 
understanding of electrophysiology. However, for political reasons Galvani's work 
remained dormant for three decades after his death. Between the mid 19`h and 20th 
century, the greatest rate of progression in the field of epilepsy, up until that, time 
occurred. Richard Caton, using a mirror galvanometer, described the existence of 
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electrical currents in animal brains. J. Hughlings Jackson, William Gowers and 
David Ferrier shed further light on the clinical understanding of partial seizures. 
Furthermore, Jackson went on to establish the fundamental dichotomy of seizure 
classification into generalised and partial that persists in current day practice. 
1.2. Epidemiology of epilepsy 
Due to a lack of definitive studies, the true incidence of the different epileptic 
syndromes seems somewhat uncertain. However, the general consensus from 
epidemiological studies is that epilepsy is a common disorder with an annual 
incidence of 40-50 per 100 000 persons in the developed world (Crombie et al., 
1960; Cockerell et al., 1995; Sander & Shorvon, 1996). In the United Kingdom 
alone, around 35 000 individuals are reported to be diagnosed with this condition 
(Cockerell et al., 1995). 
Over the years, many different seizure disorders and epilepsy syndromes have been 
recognised, this review mainly emphasises the partial epilepsies and their effects on 
cognitive functions. 
1.3. Classification of seizure types 
An epileptic seizure is defined as "Manifestation(s) of epileptic (excessive and/or 
hypersynchronous) usually self-limited activity of neurones in the brain" (Blume et 
al., 2001). An epileptic seizure type is defined as "An ictal event believed to 
represent a unique pathophysiological mechanism and anatomic substrate. This is a 
diagnostic entity with aetiological, therapeutic and prognostic implications (new 
concept" (Engel, J., 2001). 
The fundamental classification of epileptic seizures is based on the dichotomy 
between partial and generalised seizures. In 1989 the International League Against 
Epilepsy (ILAE) defined two main seizure types based on clinical and 
electroencephalogram (EEG) features: partial, subdivided into simple and complex 
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according to whether or not consciousness is preserved or impaired and generalised, 
subdivided into convulsive and non-convulsive. A recent reconsideration of the 
ILAE scheme introduced the term focal to replace partial and localisation-related 
seizures. This revised scheme also abandons the classification of partial seizures into 
simple or complex, to avoid the implication that impaired consciousness relates to 
limbic system involvement, and also to correct the misuse of complex partial 
seizures as a synonym of temporal lobe epilepsy. 
1.3.1. Partial seizures 
Partial, or focal, seizures involve clinical and electrographic changes that reflect the 
initial activation of a system of neurones confined to one part of the cerebral 
hemisphere (ILAE's Commission on Classification, 1981). Clinical manifestations of 
the seizures are dependent on the part of the brain affected. A simple partial seizure 
(SPS) involves no change in consciousness although it may be impaired if the seizure 
evolves into a complex partial seizure (CPS). SPSs are usually brief in duration 
(lasting a few seconds) and may have clinical manifestations in terms of motor, 
somatosensory/special sensory, autonomic or psychic disturbances. 
CPSs involve altered consciousness, which may be preceded by an aura, 
accompanied by oro-alimentary, mimicry, gestural, ambulatory, verbal or responsive 
automatisms. They vary in duration from a few seconds to several minutes. CPSs 
arise from the temporal lobe in approximately 60% of cases and the frontal lobe in 
about 30% of cases (Duncan, Shorvon & Fish, 1995). CPSs are often followed by 
post-ictal features which may present in the form of confusion, headache or 
emotional disturbance. 
Both types of partial seizure may evolve to become generalised seizures if the 
cortical electrical disturbance spreads widely from its focus. 
1.3.2. Primary generalised seizures 
Generalised seizures incorporate electrical disturbances involving wide areas of both 
cerebral hemispheres with no apparent anatomic or functional focus. Consciousness 
is impaired as a result of extensive cortical and subcortical involvement. The EEG 
shows sudden onset, generalised epileptiform discharges. Generalised seizures 
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include absence, tonic-clonic, myoclonic and atonic attacks. The ictal phase of 
generalised seizures is usually about 10 to 30 seconds in duration, followed by the 
post-ictal phase consisting of drowsiness, confusion and muscle soreness which may 
last for up to several hours. 
1.3.3. Limitations of seizure classification 
Seizure classifications are confounded by a number of problems. A large number of 
seizures do not fulfil all the criteria in any one category of classification. Many 
seizures with focal underlying cause are not always associated with clinical or EEG 
evidence of focal onset. Another problem is that the EEG may also show great 
variation in the same patient on different occasions and in different patients with the 
same seizure type. Despite these limitations, this seizure classification system is 
widely used for its clinical simplicity. 
1.4. Classification of epilepsies and epilepsy syndromes 
A comprehensive classification system was introduced by the Commission on 
Classification and Terminology of the ILAE in 1989. This system sought to 
incorporate anatomical, EEG, aetiological, seizure type, precipitation and syndromic 
features. Again, the generalised or focal nature of seizures is used as the main basis 
of this classification system. Table 1.1 details this classification system. 
Idiopathic epilepsy refers to certain generalised or partial epileptic syndromes, which 
display particular clinical and EEG features and have a genetic component. The term 
cryptogenic epilepsy defines unprovoked recurrent generalised seizures, or 
unprovoked partial seizures that have no identifiable factor known to be associated 
with an increased risk of seizures. Recurrent seizures associated with known risk 
factors fall under the description of symptomatic epilepsy. 
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1. Generalised 
Idiopathic generalised epilepsies with age-related onset 
Benign neonatal familial convulsions 
Benign neonatal convulsions 
Benign myoclonic epilepsy in infancy 
Childhood absence epilepsy 
Juvenile myoclonic epilepsy 
Epilepsy with generalised tonic-clonic seizures on awakening 
Other idiopathic generalised epilepsies not defined above 
Epilepsies with seizures precipitated by specific modes of activation 
Crvnto2enic or symptomatic eeneralised enilensies 
West's syndrome 
Lennox-Gestaut syndrome 
Epilepsy with myoclonic-astatic seizures 
Epilepsy with myoclonic absences 
Symptomatic Qeneralised enilensies 
Non-specific aetiolovv 
Early myoclonic aetiology 
Early infantile encephalopathy with burst-suppression 
Other symptomatic epilepsies not defined above 
Specific syndromes 
Epilepsies in other disease states 
2. Localisation-related 
Localisation-related enilensies - idiopathic with age related onset 
Benign epilepsy with centrotemporal spikes 
Childhood epilepsy with temporal paroxysms 
Primary reading epilepsy 
Localisation-related epilepsie - symptomatic 
Epilepsia partialis continua 
Syndromes characterised by specific modes of precipitation 
Temporal lobe epilepsies 
Frontal lobe epilepsies 
Parietal lobe epilepsies 
Occipital lobe epilepsies 
Localisation-related epilepsies - idiopathic 
3. Epilepsies and syndromes undetermined as to whether focal or generalised 
With both generalised and focal seizures 
Neonatal seizures 
Severe myoclonic epilepsy in infancy 
Electrical status epilepticus in slow wave sleep 
Acquired epileptic aphasia 
Other undetermined epilepsies (not defined above) with unequivocal generalised or focal features 
4. Special syndromes 
Febrile convulsions 
Isolated seizures 
Seizures occurring only when there is an acute metabolic or toxic event due to factors such 
as alcohol, drugs, eclampsia, non-ketotic hyperglycaemia 
Table 1.1. The ILAE classification of the epilepsies and epilepsy syndromes 
(adapted from Duncan, Shorvon & Fish, 1995) 
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1.4.1. Localisation-related epilepsy 
Partial (localisation-related) epilepsy is termed symptomatic (SLRE) if there is an 
identifiable underlying pathology or cryptogenic if the underlying pathology is 
undetectable with current neuroimaging techniques. A wide range of aetiologies may 
underlie SLRE (Table 1.2). Temporal lobe epilepsy (TLE) is the most common form 
of partial epilepsy. TLE is most commonly associated with mesial temporal lobe 
sclerosis (MTS) which describes characteristic pathological changes seen in the 
microscopic and macroscopic structure. The mesial temporal region is comprised of 
the hippocampus, the entorhinal, perirhinal and piriform cortices and the amygdala. 
The first studies which identified this pathology were carried out by Bouchet and 
Cazauvielh in 1825 who ascribed the term hippocampal sclerosis (HS) to the gross 
features of a hard, shrunken hippocampus. Microscopic features of MTS include 
specific patterns of neuronal loss particularly in the region known as CAI (also 
referred to as Sommer's sector). Sommer also identified a pathologic relationship 
between hippocampal damage and clinical seizure symptoms. He postulated that the 
hippocampus was probably the initial site for seizures involving prodromes and 
abnormal sensory phenomena or illusions. Bratz (1899) expanded on Sommer's 
microscopic observations by noting that hippocampal sclerosis incorporates severe 
pyramidal neurone loss and gliosis throughout the hippcampus, particularly in 
Sommer's sector and also severe damage in the end folium. 
More recent studies have observed reductions in dendritic spine density and 
increased dendritic swellings, with simplifications of dendritic architecture, in 
patients with partial epilepsy. Such changes are thought to contribute to alterations in 
interictal behaviour and cognitive function. However, these studies also acknowledge 
the fact that these changes may well occur as a consequence of the seizures rather 
than being the primary cause (Multani et al., 1994). Patients with MTS have been 
found to have a correlation between the severity of their epilepsy and the extent of 
focal cognitive impairment (Chelune, 1994). 
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Outline classification of epileptogenic lesions 
Lesions originating during intrauterine life Inflammatory lesions and their residua 
Lesions associated with childbirth Neoplasms including DNET 
Lesions resulting from childhood febrile convulsions Neuronal migration disorders 
Lesions resulting from head injury Infectious lesions 
Acquired vascular lesions Metabolic encephalopathies of extra-cerebral origin 
Cerebral vascular malformations Endogenous metabolic encephalopathies 
Table 1.2. Outline classification of epileptogenic lesions 
(adapted from Mathieson, 1982) 
Approximately 30% of patients with chronic refractory epilepsy are comprised of 
those with cryptogenic localisation- related epilepsy (CLRE) (Li et al, 1995). In 
some cases of CLRE, there will be a degree of mesial temporal sclerosis (MTS) or 
other subtle focal cortical pathology which is undetectable with current investigative 
tools. However, in the majority of cases, the basis of the underlying pathophysiology 
of CLRE is unclear with current diagnostic imaging techniques (Koepp, 2000). 
Interestingly, the severity of epilepsy in these patients may be the same as that in 
patients with definitive lesions (Koepp, 2000). 
1.4.2. Outline of the pathophysiology of localisation-related seizures 
At the cellular level, focal seizures are associated with regional intermittent 
paroxysmal depolarising shifts (PDS) which can cause "bursts" of electrical impulses 
in resting neurones. These interictal changes correspond to the characteristic spike or 
spike and wave discharge seen in the scalp recorded EEG. The generation of these 
PDS seems to involve intrinsic neurones, known as burster cells, which generate all- 
or-nothing unitary depolarisations with superimposed trains of action potentials 
(Connors & Guttnick, 1984). Normal, non-epileptic cortical neurones include an 
approximate 5% population of burster cells, however, they form a much larger 
population in epileptogenic tissue (Connors, 1984). These burster cells have the 
ability to recruit surrounding "follower cells" into the interictal discharges. 
The development of a seizure involves a positive feedback mechanism which is 
usually in the form of the epileptiform discharging neurones firing synchronously 
and projecting back into the site of generation of the interictal discharges, which 
perpetuates a reverberating circuit (Jones & Lambert, 1990). However, the presence 
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of "filter" mechanisms in the brain helps to curtail these circuits. As an example, 
epileptiform discharges starting in the entorhinal cortex (EC) do not necessarily 
recruit the rest of the hippocampus due to inhibitory input from the dentate gyrus 
(DG) which suppresses the spread of excitatory activity (Rausche et al., 1991). 
1.4.3. Idiopathic generalised epilepsy (IGE) 
IGE refers to a number of syndromes which include one or more generalised seizure 
type e. g. absences, tonic-clonic seizures or myoclonic jerks with no apparent clinical 
or imaging evidence of focal pathology. IGE syndromes include childhood absence 
epilepsy (CAE), juvenile absence epilepsy (JAE), juvenile myoclonic epilepsy 
(JME), epilepsy with grand mal seizures on awakening and eyelid myoclonia with 
absences. Individuals often have some degree of overlap in the IGE syndromes that 
they experience. 
1.4.4. Outline of the pathophysiology of generalised seizures 
It is thought that disruption of interactions between cortical and subcortical pathways 
with reticular origin form the basis of generalised epilepsies (Gloor, 1968). The type 
of disruption that causes a predisposition to generalised seizures remains largely 
speculative. Primary generalised seizures can be elicited experimentally by systemic 
administration of agents that alter the balance between neuronal excitation and 
inhibition. Therefore, inherent abnormalities in excitatory or inhibitory mechanisms 
are thought to contribute to mechanisms underlying generalised seizures. The voltage 
sensitive excitatory NMDA glutamatergic receptor has been implicated as its 
antagonists prevent or suppress induced seizures in animal models (Croucher et al., 
1982 and Herron et al., 1986). The NMDA receptor is involved in intermittent 
depolarising shifts and neuronal burst-firing patterns that promote hypersynchronous 
discharges. Abnormal inhibitory mechanisms may also underlie the initiation of 
generalised seizure activity. In particular, the initial hyperpolarisation mediated by 
the GABAB receptor and subsequent depolarisation also contributes to neuronal 
hypersynchrony. The occurrence of this in thalamocortical pathways may underlie 
the rapid, widespread abnormal neuronal firing patterns. Reticular thalamic nuclei 
have the potential to act as pacemakers and indirectly influence the cortex thereby 
over-ruling normal electrophysiological processes (McCormick, 1992). 
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1.5. Functional localisation of neuropsychological processes 
To help put into context the functional changes that occur in association with 
epilepsy, the following section details how anatomical organisation within the 
normal healthy cortex relates to various cognitive processes and the consequences of 
disruption of these processes. 
Cognitive functions can be classified into four main subgroups: (1) receptive 
functions, which involve the processes of selecting, acquiring, classifying and 
integrating information; (2) memory and learning, which refer to information storage 
and retrieval; (3) thinking, which involves the mental organisation and reorganisation 
of information. It also incorporates problem solving; and (4) expressive functions, 
which refer to the means through which information is communicated or reacted to. 
Although each of these categories constitutes a distinct aspect of behaviour, they are 
normally closely related and interdependent. Within each class of cognitive 
functions, a further division may be made to help distinguish between those functions 
that mediate verbal/symbolic information and those that deal with data that cannot be 
communicated in words or symbols, for example visual or sound patterns. These 
subclasses of functions differ from each other in their neuroanatomical organisation. 
On the other hand, they share other basic neuroanatomical and psychometric 
relationships within the functional system described in subsequent sections with 
focus on memory. 
1.5.1. Memory 
The ability to learn about and remember information, objects and events is generally 
known as declarative memory. In clinical terms, there are three recognisable stages 
of declarative memory which allow understanding of dysfunctional memory (Wilson, 
1986). The first two are successive stages of short term storage, known as 
registration and immediate memory, and the third is long-term storage. 
1.5.1.1. Registration 
The first stage, registration, or sensory memory, holds large amounts of incoming 
information in sensory store for brief periods of time (1 or maximally 2 seconds) 
(Zaidel, 1990). The first traces of an incoming stimulus may be perceived as a 
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transient visual image (iconic memory), which may last up to 200 milliseconds 
(msec), or auditory "replay" (echoic memory), which may last up to 2000 msec. This 
is an indication of early stage memory processing with regard to sensory modality 
(de Sonnerville & Njiokiktjien, 1988). The attention-focusing aspect of perception 
plays an integral role in the registration process. Information being registered is 
either processed further as short-term memory or it is quickly discarded (Pribram, 
1969). 
1.5.1.2. Immediate memory 
Registration is followed by short term memory (STM) or immediate memory and this 
involves the storage of information that has been retained temporarily during the 
registration process. The STM store acts as a limited capacity store, from which 
information is transferred to a more permanent store, and also as a limited capacity 
retrieval system (Watkins, 1974). The time span for immediate memory ranges from 
30 seconds to several minutes. Baddeley (1986) suggests a set of subsystems of 
immediate memory which are referred to as working memory. There are two further 
subcategories of working memory, one for processing language (the phonological 
loop) and one for visuospatial information (the visuospatial sketchpad). Working 
memory serves to "hold information in mind, to internalise information and to use 
that information to guide behaviour without the aid of external cues" (Goldman- 
Rakic, 1993). Primary memory is another component of short-term storage, which 
differs from working memory in that it is attention dependent and diminishes rapidly 
with distraction. 
There is evidence to suggest that information in immediate memory is temporarily 
maintained in self-contained neural networks that sustain a nerve impulse by 
channeling it repeatedly through the same network. These networks are referred to as 
reverberating neural circuits. 
1.5.1.3. Rehearsal 
Any repetitive mental process that serves to lengthen the duration of a memory trace 
is referred to as rehearsal. A memory trace may be retained for several hours with 
rehearsal. This increases the likelihood that a given bit of information will be 
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permanently stored. In some cases, short-term memory is stored for several hours, 
sometimes for up to one or two days. This time span far exceeds that which a 
reverberating circuit could maintain. The memory trace does not necessarily become 
permanently fixed as long term storage. There is some debate as to whether this 
short-term memory is simply information transferred to long-term memory but is so 
newly laid down that it is still relatively vulnerable to interference effects. Therefore, 
it lacks the stability associated with long-term memory. 
1.2.1.4. Long-term memory (LTM) 
LTM, also known as secondary memory, refers to the ability to store information. 
Consolidation occurs to allow storage of information as long-term memory. This can 
occur rapidly or continually over a long period of time. Learning refers to the 
requirement of attention to acquire new information. However, information may also 
be acquired without directed effort, by means of incidental learning. Information 
stored in the LTM system tends to be organised according to meaning, whereas in the 
STM system it is organised in terms of contiguity or sensory properties such as 
similar sound, shapes or colours. 
1.5.1.5. Procedural memory 
Procedural memory can be thought of as a "habit system" in the way that it refers to, 
for example, the retention of ability to walk, talk, dress and eat etc. in patients whose 
memory of past history and ongoing events is impaired (Mishkin & Petri, 1984). 
Comparatively little is known about the processes underlying procedural memory, 
although further insight may provide hope for memory-impaired patients. Procedural 
memory has been sub-divided into three main categories: (1) skill memory, which 
refers to motor and cognitive skill learning; (2) priming, which concerns the 
facilitation of a required response with previous exposure but without conscious 
awareness; and (3) classical conditioning. A number of studies have shown that these 
different aspects of memory are all preserved in patients with amnesia (Ewert et al, 
1989; Parkin, 1982) and are acquired or utilised without awareness or conscious 
effort (Graf et al, 1984). 
Implicit memory can be used as a broad definition of the subdivisions of procedural 
memory. This type of memory may involve processes that tap into episodic and 
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semantic memory systems but not necessarily operating in the same way. Explicit 
memory can be used to describe intentional recollection requiring conscious effort 
that is available to awareness. 
1.5.1.6. Declarative memory 
The process of information retrieval is known as remembering, which may occur 
through recall involving an active, complex search process. The process of 
recognition occurs when a like stimulus triggers remembering. Retrieval by 
recognition is much easier than retrieval by remembering even with the healthy 
brain. 
The diversity of pathological conditions affecting memory also enables the 
distinction of material specific memory problems. This is seen when patients show 
deficits that are specific to the nature of the information to be processed. Such 
deficits are specific to sensory modality - verbalised or non-verbalised information, 
or motor skill learning. Moreover, stored memories involving different sensory 
modalities, knowledge categories and output mechanisms, are all differentially 
affected by brain disease (Farah et al., 1989). For example, recognition of printed 
words may be impaired while speech comprehension and picture recognition remain 
unaffected. In some cases, the ability to access information in one category may be 
intact e. g. memory for landmarks, whereas the ability to access information in a 
similar category may be impaired e. g. recalling routes (Schachter & Nadel, 1991). 
Episodic or event memory refers to memories of personal experience and therefore 
can be localised in time and space. Semantic memory refers to information learned as 
knowledge, for example the alphabet. The distinction between these two is illustrated 
in patients with severe retrograde amnesia who still manage to retain general 
knowledge, language use and practical knowledge (Warrington & McCarthy, 1988). 
When the process of learning requires active, effortful processing it can be 
distinguished from automatic memory, which involves the passive acquisition of 
information (automatic memory). The difference between these two becomes 
apparent when patients with disorders such as head trauma or Alzheimer's disease 
have no problems with immediate recall of digits but impaired ability to recite a 
string of digits in reverse order (Hasher & Zacks, 1979). 
-34- 
Chapter I 
Other types of declarative memory such as source (or contextual) memory and 
prospective memory become apparent in certain clinical cases. Source memory refers 
to knowledge of where or when something was learned. In other words, the 
contextual information surrounding the learning experience which may be 
assimilated as part of incidental memory. Prospective memory refers to the ability to 
remember to do something at a particular time i. e. carry out previously decided 
activities at a particular time. The clinical significance of this type of memory is 
illustrated in patients with frontal lobe dysfunction who manage to retain most 
standard memory abilities and yet fail to keep appointments unless reminded. 
1.5.2. Attention 
Attention can be thought of as a collective of related capacities and processes that 
enable an organism to be receptive to stimuli and allow it to begin processing this 
incoming information. In general, attention is thought to be a system in which 
processing occurs sequentially, or in a series of stages, within different systems of 
the brain. Only a limited amount of processing activity can be done at any one time, 
therefore the attentional system has limited capacity (Gazzaniga, 1987). For example, 
it may be difficult for an individual to concentrate on a news report on the radio 
while at the same time watching a programme on the television, but on the other 
hand, the same individual would have no difficultly performing an automatic 
attention task such as driving while listening to the radio. Attentional capacity can 
vary between individuals and also within an individual under different conditions. 
For example, it may be temporarily reduced in association with depression or fatigue, 
and old age or traumatic head injury may reduce attentional capacity more 
permanently (Hasher & Zacks, 1979). 
Focussed or selective attention can be described as the ability to deal with 
information while suppressing competing distractions. It is also commonly described 
as concentration. Sustained attention or vigilance describes the ability to maintain 
attention over a period of time. Divided attention refers to the ability to respond to 
more than one task at a time or to multiple aspects within a task. These different 
varieties of attention may be altered by discrete damage affecting part of the 
attentional system. 
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Having defined how structural organization within the cortex ties in with functional 
processes, the following section goes on to explore the consequence of interruptions, 
arising from epilepsy, to the inter-relationship between cerebral structure and 
function. 
1.5.3. The anatomy of neuropsychologicalfunctions 
From human clinical studies and animal models, it is known that damage to the 
hippocampus and thalamus impairs the formation of long-term declarative memories. 
Although memories are not stored in the hippocampus itself, damage to this area 
makes it difficult to store new memories but does not impair old memories. The 
amygdala and hippocampus are involved in the formation of memory traces. In 
particular, the amygdala is involved in the laying down of emotionally influenced 
memories and their reinforcement for LTM. The following studies highlight how 
damage to various cortical structures leads to impairment of different aspects of 
cognitive function, assessed using neuropsychological tests that are relevant to this 
thesis. 
Damage to the prefrontal cortex produces effects similar to those seen with 
hippocampal damage. The hippocampus and amygdala send part of their output to 
the prefrontal cortex. Humans with prefrontal cortex damage show perseverative 
impairments in performance on a delayed alternation task (DAT) and the Wisconsin 
Card-Sorting Test (WCST). With the DAT, patients are required to alternate between 
picking up an object on their left and, after a delay, picking it up on their right 
(Freedman & Oscar-Berman, 1986). This task requires memory for what has just 
been done and suppression of a previous response to enable substitution with a new 
one. The WCST requires the patient to sort cards displaying symbols, which vary in 
type, colour and number, into stacks according to one rule, e. g. shape, then reshuffle 
them and sort them by a different rule, e. g. colour. Patients with prefrontal damage 
generally have little trouble detecting and sorting according to the first rule but have 
difficulty shifting to a new rule (Janowsky et al., 1989). 
Owen et al. (1995) examined the effects of temporal, frontal or amygdalo- 
hippocampectomy excisions on short-term recognition memory and learning. This 
study employed a spatial working memory test from the Cambridge 
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Neuropsychological Test Automated Battery (CANTAB). Significant deficits in 
spatial working memory performance were found in both frontal lobe and amygdalo- 
hippocampectomy excision groups, the latter group being impaired only at most 
difficult task levels. The effects of laterality of the frontal lobe lesions were not 
significant and patients with bi-frontal lesions performed equivalent to or better than 
those with either left- or right- sided lesions. The same group of patients also 
underwent the "Tower of London" test of planning also from CANTAB. The frontal 
lobe group showed significant impairments in both accuracy and latency of planning 
but the temporal lobe excision and amygdalo-hippocampectomy patients showed no 
deficits in planning performance (Owen, 1990). 
Miotto et al. (1996) investigated the importance of strategy formation in spatial 
working memory function in patients who had unilateral surgical excisions of the 
frontal cortex (UFL), either with left sided lesions (LFL) or with right sided lesions 
(RFL). The results of this study showed that poor strategy formation was associated 
with RFL patients. The authors suggest that this is consistent with the tendency for 
spatial tasks, which are more "frontally sensitive", to be more affected by right 
frontal lesions. However, as spatial memory deficits are also associated with 
temporal lobe lesions, it is thought that there may be reciprocal connections, to 
facilitate spatial memory processing, between the pre-frontal cortex and the 
hippocampus (Goldman-Rakic, 1990). 
1.6. Studies investigating cognitive function in relation to epilepsy using 
neuropsychological assessment 
The following section provides an overview of neuropsychological changes in 
cognitive function that have been reported to occur in association with epilepsy, 
focussing mainly on studies that include tests of memory function. 
Epilepsy involves ictal, and often inter-ictal, cerebral electrical dysfunction and 
therefore the manifestation of cognitive impairment as a secondary symptom is 
considered to be very likely (Aldenkamp, 1997). Most early studies in this field 
measured changes in IQ over a period of time but generally failed to provide any 
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convincing evidence of cognitive deterioration linked directly to epilepsy alone 
(Paskind, 1932; Barnes et al., 1938; Kugelmass et al., 1938). Recent studies have 
employed more sophisticated neuropsychological tests to demonstrate cognitive 
dysfunction in patients with epilepsy. Cognitive impairment may be caused by a 
number of factors related to epilepsy, for example, anti-epileptic drug (AED) 
treatment may have detrimental effects on cognitive performance (e. g. Duncan et al., 
1990). Factors such as the cumulative effects of epileptiform discharges in the brain 
(Aarts et al., 1984 and Binnie & Marston, 1992) and the actual localisation of the 
epileptogenic focus in specific areas of the brain may also contribute to aberrations in 
cognitive performance (Hermann et al., 1987; Blake et al., 2000 and Giovagnoli, 
2001). However, the differential contribution of these different factors remains 
unclear. 
1.6.1. Effects of duration of epilepsy and seizure frequency on neuropsychological 
function 
Decline in cognitive ability, in patients with epilepsy, is thought to be associated with 
the extent of cerebral electrical dysfunction (Dodrill & Wilkus, 1976). Dikmen et al., 
(1977) examined a large group of patients with generalised tonic-clonic seizures 
(GTCS) and found that longer duration of epilepsy, earlier age of onset and high 
seizure frequency were the most significant correlates of neuropsychological 
impairment. A more recent study by Dodrill (1986) found that a large number of 
tonic-clonic seizures over the course of several years was likely to lead to "mental 
dulling, " which was independent from the effects of medication and demographic 
variables. The most significant factor for determining neuropsychological 
impairment was seizure history. Greater incidence of status epilepticus and a lifetime 
incidence of more than one hundred GTCSs related to poorer cognitive functioning. 
However, it is difficult to draw firm conclusions as to whether cognitive impairments 
are the result of seizures themselves or whether they reflect the underlying brain 
disruption causing the seizures in the first place. Bergin et al. (2000) investigated the 
effects of different epilepsy type on remote memory function (detailed below) which 
incidentally revealed that all patient groups showed impaired performance in relation 
to a greater number of reported generalised seizures. 
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Some investigators hold the view that intractable partial seizures cause no significant 
change in global cognitive function over a period of time. Holmes et al. (1998) 
carried out a 10-year follow up study investigating IQ and neuropsychological 
functioning in a group of un-operated patients with intractable CPSs. The authors 
found that global measures of intelligence and neuropsychological function did not 
deteriorate over a decade even in patients with secondary generalised seizures. 
Incidentally, a significant decline in seizure frequency was reported, probably due to 
improvements in AED therapy over the course of 10 years, so it can be argued that 
cognitive abilities remained stable over the time course because of better seizure 
control. Other investigations do however provide direct evidence which links 
cognitive decline to the prevalence of partial epilepsy. Jokeit and Ebner (1999) 
investigated how psychometric intelligence is affected by the duration of refractory 
TLE. Their findings demonstrate that the longer the duration of epilepsy, the greater 
the severity of psychometric intelligence impairment. This supports the notion that 
noxious factors related to epilepsy, for example pathological inter-ictal brain activity, 
chronic and transient metabolic disturbances and chronic AED therapy, contribute to 
secondary neurophysiological and structural changes. This theory is substantiated by 
evidence from quantitative magnetic resonance imaging (MRI) studies. There are 
reports of significant neuronal loss in the hippocampus with recurrent cryptogenic 
TLE seizures (Lencz et al., 1992) and reductions in hippocampal neuronal density 
(Sass et al., 1990; Kalviainen et al., 1998; Zaidel et al., 1995) in cases of 
symptomatic TLE. This may help explain impairment of cognitive function reported 
in this group of patients. 
1.6.2. Effects of epilepsy and seizure type on neuropsychological function 
Hirtz and Nelson (1983) state that greater, and more diffuse, cognitive problems are 
seen in patients with generalised seizures as compared to those seen in patients with 
focal seizure activity. Therefore, it can be postulated that more specific and focal 
cognitive impairment may be the consequence of focal seizures. Hermann et al. 
(1987) carried out a range of neuropsychological assessments to investigate the 
nature of deficits associated with the localisation of epileptic foci. Patients with left 
temporal foci were mainly impaired in verbal memory ability, showed some deficits 
in abstract reasoning and had slowed right hand finger tapping. Conversely, patients 
with right temporal foci had slower left hand finger tapping and also showed deficits 
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in visuoperceptual and mental flexibility, as assessed by the WCST which gauges 
perseverative function. A more recent study by Giovagnoli (2001) examined patients 
with frontal lobe epilepsy (FLE) who had unilateral left or right sided hippocampal 
lesions. Left FLE patients were found to be significantly impaired on the modified 
WCST (mWCST), short term memory and word learning. Giovagnoli (1999) 
compared verbal semantic memory function in patients with lateralised TLE to those 
with extra-temporal lobe epilepsy (exTLE) and healthy controls. Significant 
impairment of semantic memory was found in patients with left TLE compared to the 
healthy control group. Episodic memory was significantly impaired in both TLE and 
exTLE groups. This study concludes that left TLE contributes significantly to verbal 
semantic memory deficits and claims that this may be due to impairment of access to 
the semantic-lexical storage mechanism. 
Comparisons of the effects of different types of epilepsy on remote memory have 
been carried out by Bergin et al. (2000). This group investigated remote memory 
function in patients with TLE, exTLE and primary generalised epilepsy PGE. 
Patients with TLE performed significantly worse than the other patient groups and a 
healthy control group. The PGE and exTLE groups did not differ significantly from 
the healthy control group. Performance in all groups was found to be unrelated to 
verbal IQ, educational achievement, and social class or drug treatment. The authors 
conclude that their findings provide evidence for weak memory for past events in 
patients with TLE and point towards broader memory disturbance in this group than 
has been previously highlighted. 
Aikia et al. (1995) investigated verbal learning and memory function in a group of 
patients with newly diagnosed cryptogenic partial epilepsy in comparison to a group 
of healthy controls. The patients and controls did not differ significantly in tests of 
immediate and delayed (90 minute) story recall. However, the 52% of the patient 
group, compared with 15% of the controls group, had at least mild impairment of 
delayed recall, assessed with a modified version of the Rey Auditory Verbal 
Learning Test (RAVLT) which incorporated a 90 minute delayed recall of a list of 15 
semantically unrelated words. The authors conclude by posing the question of 
whether patients with memory deficits at the time of diagnosis are those who are 
likely to go on to develop intractable chronic epilepsy and whether such patients are 
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also more vulnerable to the cognitive side-effects of AEDs. Later work by Aikia et 
al. (1999) examined variables that predicted 2-year seizure outcome in patients with 
newly diagnosed partial epilepsy. This study concludes that the presence of verbal 
memory impairment at the time of diagnosis of partial epilepsy is a significant 
predictor of seizure outcome. The authors report that this variable, in association 
with clinical and EEG variables, could correctly predict prognosis in 94% of newly 
diagnosed patients. 
Another study investigating verbal memory performance in patients with epilepsy 
was carried out by Blake et al. (2000). This study prospectively examined long-term 
retention of memory in patients with TLE and healthy controls, over an 8 week 
period, which exceeds the recall time often employed in conventional tests 
investigating delayed memory recall. Stories comprising 26 to 30 idea units from the 
Adult Memory and Information Processing Battery (AMIPB) were administered for 
the assessment of immediate, short delay and long delay recall. Interestingly, the 
results of this study showed that despite normal learning and retention over a shorter 
30 minute period, patients with epileptic foci in the left temporal lobe performed 
poorly on the 8 week recall test compared with patients with right temporal foci and 
with healthy controls. The study concludes that there is evidence for an extended 
period of memory consolidation which is disrupted when there is functional 
impairment of hippocampal-cortical interactions. Moreover, the authors conclude 
that the critical region for this process is, at least for verbal memory, situated in the 
left temporal lobe. 
1.6.3. Effects of anti-epileptic drug therapy on neuropsychological function 
Many studies have been carried out to investigate the effect of AEDs on cognition. 
However, limitations in study design, methodology and analysis of these 
investigations means there is no clear consensus in this field (Vermeulen & 
Aldenkamp, 1995). It is not easy to assess the contributions of AEDs to cognitive 
decline in epilepsy as, for ethical reasons, it is a factor which is difficult to purposely 
manipulate. Moreover, seizures themselves and their underlying aetiology often 
confound conclusions drawn from clinical studies. 
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There is some evidence, as discussed earlier, to suggest that cognitive deficits may 
arise in relation to different seizure types, even prior to the onset of AED therapy. 
Prevey et al. (1998) investigated cognitive function in patients with CPSs and 
compared it to patients with secondary generalised seizures before the onset of AED 
treatment. Both groups were found to have impaired motor function and reduced 
verbal memory function. Little difference was found between epileptic patients and 
healthy controls in immediate memory span tests. However, both seizure groups 
showed reduced ability to acquire new information over repeated learning trials and 
less capacity to retain information over distraction-filled delay intervals. Ogunrin et 
al. (2000) reported significant impairment of short-term memory, psychomotor 
speed/alertness and sustained attention in a sample of 60 newly diagnosed, non- 
medicated patients compared to a matched healthy control group. 
However, there is some evidence pointing towards AEDs contributing to detrimental 
effects on cognition. The effects of AED removal on cognitive function were studied 
by Duncan et al. (1990). Patients on polytherapy were subjected to a drug reduction 
regime and assessed prior to the reduction, at the end of the reduction period and 
finally 4 weeks after the end of the reduction. Patients were grouped according to 
reduction of phenytoin (PHT), carbamazepine (CBZ) or valproate (VPA) and a 
control group who maintained their original drug regime was also included. Removal 
of PHT led to significant improvements in attention and concentration in patients 
with intractable seizures. Significant improvements in motor performance were seen 
in all the AED reduction groups. However, the results of Duncan et al's study are 
confounded by a reported increase in seizure frequency for the CBZ withdrawal 
group, and complicated by the fact that all drug-withdrawal patients were still taking 
at least one other AED. Furthermore, conclusions of the study were drawn from 
cross-sectional sample comparisons, whereas a repeated-measures study design 
provides a more valid means of investigating AED effects (Vermeulen & 
Aldenkamp, 1995). 
There is also some evidence to suggest that there is no positive link between AED 
therapy and cognitive function. In 1992, Dodrill and Wilensky conducted an 
extensive study in which patients were grouped according to whether they were on 
PHT monotherapy, PHT with other AEDs or drug regimens exclusive of PHT. The 
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results of this study failed to reveal any significant loss in cognitive function 
associated with sustained PHT or other AED administration over a 5-year period. 
Good seizure control was maintained during the follow-up interval and the authors 
suggest that previous studies citing the detrimental affects of PHT were confounded 
by poor seizure control. 
Vermeulin and Aldenkamp (1995) suggest that definitive knowledge about the 
effects of individual AEDs can only be assessed adequately by examining the effects 
of monotherapy in patients with well-controlled seizures, using repeated measure 
design studies with a no-treatment comparison group to measure absolute effects. 
1.3.4. Effects of psychosocial factors on cognitive function. 
The impact of psychosocial factors on mental ability is often neglected in studies of 
patients with epilepsy. Nonetheless, the significant prevalence of factors such as 
depression (Mendez et al., 1986) and anxiety (Currie et al., 1971), reported in 
association with epilepsy, may well influence cognitive performance. Lesser et al., 
(1986) suggest that performance at work and school is affected by attitudes of peers 
and self-perception in epileptic patients. A more extensive study by Dodrill (1986) 
revealed that factors such as depression, anxiety, fear of the possibility of a seizure 
and fear of the possibility of peers witnessing a seizure, had important implications 
in the day-to-day lives of patients with epilepsy. However, there is also some 
evidence to suggest that mood states do not affect cognitive impairments in patients 
with epilepsy but these findings are limited to patients with newly diagnosed 
epilepsy (Kalviainen et al., 1998; Aikia et al., 1995 and Pulliainen et al., 2000). This 
variation of findings between different studies may be due to differences in methods 
of assessing mood and cognitive function. 
1.3.5. Summary 
Overall, the literature to date suggests that there is good evidence to support the 
conclusion that epilepsy, particularly if it arises from the temporal lobe, is associated 
with impaired memory function when assessed with neuropsychological techniques. 
Factors such as seizure type, duration of epilepsy, age of onset, AED treatment and 
psychosocial issues all seem to play a variable but definite role in the 
neuropsychological performance of patients. 
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COGNITIVE EVENT RELATED POTENTIALS: A TECHNICAL 
OVERVIEW AND REVIEW OF THE LITERATURE 
2.1. The electroencephalogram 
The electroencephalogram (EEG), recorded from the scalp surface, reflects 
summated electrical post-synaptic potentials generated by synchronously active 
neurones in the brain. The electrical potentials are generated mainly from cortical 
layers I and II, in particular from pyramidal cells, which are arranged in vertical 
columnar alignments that lie perpendicular to the cortical surface (Fourment et al., 
1965; Jami et al., 1968). The EEG recorded from the scalp surface represents activity 
picked up from the subjacent cortex. The electrical state of the cortex is regulated by 
diffuse neuronal projections from deeper structures within the brainstem. In 
particular, the reticular thalamic nucleus is thought to serve as a pacemaker by 
imposing rhythmicity on other thalamic nuclei with cortical projections (Cooper, 
Binnie & Fowler, 1995). Desynchronisation of the EEG (increased frequency and 
reduced amplitude) is brought about by brainstem projections to the thalamus by 
modifying or suppressing the rhythmic activity. Hence EEG characteristics, in terms 
of frequency and amplitude, change in accordance with different levels and states of 
consciousness. 
The 10-20 electrode placement system, as shown in Figure 2.1, described by Jasper 
(1958) is used internationally for clinical and research investigations. The EEG can 
be analysed in frequency and temporal domains. In the former, the EEG is divided 
into frequency bands (e. g. alpha, theta, delta) and information is obtained with 
reference to change in the prevalence of one frequency or another and their relative 
amplitudes. In the temporal domain, information is derived from the timing of 
potential peaks and their relative amplitudes. These potentials may be obtained in 
response to given sensory stimuli (evoked potentials) and cognitive stimuli (event- 
related potentials). 
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Figure 2.1. The 10-20 system of electrode placement 
(reproduced from Jasper, 1958) 
2.2. Event-related potentials (ERPs) 
2 
RI(MI 
Recordings of electrical brain activity enable the flow of sensory-perceptual 
information, in afferent pathways and cortical sensory areas, to be traced with a high 
temporal resolution. Since the 1960s, studies have demonstrated that attended stimuli 
during visual and auditory selective attention tasks evoke short latency sensory 
responses in modality-specific cortex. Stimulus information travelling through 
cortical sensory pathways leads to the generation of negative and positive field 
potentials from synchronous neuronal activity at different sites in afferent neuronal 
pathways. Those voltage deflections that are time locked to sensory, cognitive or 
motor events are referred to as event-related potentials (ERPs). These potentials 
represent not only the registration of a stimulus but also its "higher level evaluation" 
within the brain (McCallum, 1997). ERPs are named according to their polarity at the 
scalp (P being positive and N being negative) and the latency, following stimulus 
delivery, at which they have been observed in healthy volunteers. 
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2.2.1. Obtaining cognitive ERPs 
When recorded from the scalp, sensitive amplifying equipment and the use of the 
averaging technique (Dawson, 1954) are required to detect these tiny potentials 
which range from approximately 0.5 to 30 microvolts (µV), or more, and usually 
occur within less than 1 second after stimulus presentation. This is critical to enable 
detection of these potentials which are often recorded from a site at considerable 
distance from the generator source and need to be distinguished from other, often 
much larger, potentials of biological and environmental origin with which they are 
intermixed. Figure 2.2 shows an example of how the process of averaging a different 
number of EEG sweeps (epochs) helps clarify the component of interest. This makes 
evaluation of peak latency and amplitude much easier and more reliable. ERP 
waveforms are usually defined and evaluated using latency and amplitude 
measurements in the order of milliseconds (msec) and tV respectively. 
Figure 2.2. The effect of averaging on ERP identification. 
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2.2.2. Technical aspects relating to cognitive ERP acquisition 
Suitable recording parameters are essential to avoid any artefactual distortion of the 
signals of interest. Electrical potentials at the surface of the scalp are usually 
recorded using metal electrodes and transferred through conducting leads to 
recording amplifiers which relay the signals to a memory store from which they are 
displayed on a visual output device. The most commonly used type of electrode is 
the stick-on silver disc electrode, 1 cm in diameter, with a silver chloride coating 
(Ag/Ag-Cl electrode). This type of electrode is non-polarisable and therefore well 
suited to recording surface potentials. A conducting medium acts as a transmission 
bridge between the scalp and the electrode. ERPs are obtained by recording the 
difference in voltage between two electrode locations. The "active" recording 
electrodes are placed at locations of interest, according to the 10-20 system, and 
record activity with respect to difference of potential at "active" sites and that at a 
"common reference" electrode, placed at a site which is relatively free from the 
activity of experimental interest. The common reference may consist of a single 
electrode or a pair of linked electrodes for example as in the case of linked mastoid 
electrodes. 
2.2.2.1. Amplifier and filter settings for optimal ERP acquisition 
Recent acquisition systems designed for recording ERPs allow manipulation of 
amplifier filter settings to attenuate signal frequencies outside the band-width of 
interest. Usually, ERPs are embedded among high frequency and higher amplitude 
signals from various sources - most commonly the EEG, electromyographic activity 
from the neck and jaw muscles and external electrical mains (50 Hz) activity. 
Therefore altering the low-pass (high frequency) filter can minimise these extraneous 
signals and help clarify the signal of interest. Similarly, high pass (low frequency) 
filter settings determine how much slow potential contamination is seen in the ERP 
of interest. Most cognitive ERPs such as the mismatch negativity (MMN) and P3 are 
low frequency components and therefore require adequate high pass filtering to allow 
accurate latency characterisation. High pass filters ranging from D. C., if the amplifier 
allows, to 0.15 Hz and low pass filters ranging from 70 to 100 Hz are commonly 
employed for optimal ERP acquisition. The high frequency cut-off is often 
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manipulated offline, using phase-free digital filtering to avoid latency distortion, to 
values down to 30 Hz to attenuate high frequency contamination. 
2.2.2.2. ERP extraction from the EEG 
ERPs occur within the EEG as responses that are time-locked to experimental 
stimuli. They are derived from the EEG by a process of averaging a number of 
epochs associated with a particular stimulus type. The process of averaging, first 
employed by Dawson in 1954 to obtain evoked potentials, serves to attenuate the 
EEG signals which vary randomly in relation to the delivered stimulus and 
emphasise the ERP of interest which bears a time-locked relationship to the stimulus. 
2.2.2.3. Influence of ocular artefacts on ERPs 
The electrical potential difference between the front and back of the eyeball causes 
large voltage deflections which fluctuate in association with eye blinks or lateral eye 
movements. This oculographic potential contaminates the comparatively tiny EEG 
and even smaller ERP signals of interest and poses a considerable problem in ERP 
acquisition. A number of possible methods may be employed to overcome this 
problem. It is essential to simultaneously record the electro-oculogram (EOG) during 
ERP procedures to monitor both vertical and lateral eye movements. One method of 
minimising EOG artefact is by instructing the subject to fixate at a point central to 
their direct line of vision and to avoid blinking during the experimental procedure. 
However, this can be a tiresome task and places extra demand on the subject, which 
may distract them from the experimental task, particularly in patients who may not 
have the ability to comply as well as healthy individuals due to their clinical state. 
Another method for minimising EOG artefact is to exclude EEG epochs that coincide 
with EOG activity if it exceeds a pre-set voltage such as 50 or 100 µV for at least 15 
msec. A limitation of this method is that occasional smaller voltage deflections, 
produced by more subtle eye movements, included in the averaged ERP, may distort 
the latency and amplitude of the component of interest. Also, anxious subjects often 
make large numbers of eye movements during experimental tests so excluding a 
large number of trials may lead to an inadequate number of epochs for the ERP 
average. Another approach is to mathematically assess the relative contribution of 
the EOG signal to each scalp electrode. The relative amount of EOG signal can then 
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be subtracted from EEG activity recorded at each electrode site to derive the signal 
of interest. 
2.2.2.4. Summary of optimal ERP acquisition techniques 
In summary, it is essential to consider characteristics of the ERPs of interest before 
setting up a recording procedure in order to optimise recording parameters for 
obtaining the signal of interest. This is crucial in order to obtain representative ERPs 
that are minimally contaminated by extraneous signals unrelated to the experimental 
task. Filter settings from D. C. to 100 Hz with choice of off-line filtering is desirable. 
Simultaneous EOG recording with a robust method of compensating for ocular 
artefact contributions to the signal of interest is also desirable. 
2.3. Auditory event-related potentials 
The following sections provide an overview of the ERPs associated with auditory 
stimuli, including the role of attention and stimulus novelty in determining the 
waveforms. With the exception of the mismatch negativity (MMN), most of the 
potentials detailed below are modality non-specific, i. e. they may be elicited in 
response to visual, auditory or somatosensory stimuli. 
2.3.1. Ni, negative difference wave (Nd) and processing negativity 
The Nd first described by Naatanen et al. (1978) is derived by taking the difference 
between two ERP waveforms that are elicited in response to the same physical 
stimulus when it is attended compared to when it is unattended. The NI waveform is 
a negative potential with a latency of about 100 msec elicited in response to any 
auditory stimulus and most other sensory modalities. It is modulated by intensity, 
inter-stimulus interval and novelty (Polich et al., 1988). Processing negativity as 
described by Naatanen et al. (1978), detailed further below, refers to the same 
component but differs in functional significance in that it is related to extra 
processing activity associated with a selection process preceding attended events. 
The paradigm for eliciting "processing negativity" typically involves presentation of 
randomised tone sequences with inter-stimulus intervals varying between 250-1250 
ms (e. g. Hillyard et al., 1973). A small fraction of the tones (10%) vary slightly in 
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duration or intensity from the frequent, standard tones. The subject's task is to attend 
to the rare, infrequent stimuli in one ear only. This high-load dichotic auditory 
paradigm elicits a negative ERP deflection that begins from 60-100 ms post- 
stimulus. 
Hillyard et al. (1973) suggest that modulation of the Ni component results from the 
effect of attention with the inference that sensory input, when unattended, is 
excluded from further processing. This view relates to the idea of the existence of a 
sensory gain control mechanism. However, according to Naatanen et al. (1978) the 
effect of attention is to add negativity to the unattended ERP and this negativity is 
not necessarily time-locked to the Ni component. This processing negativity is 
thought to represent the process of matching incoming stimuli with the short-term 
memory trace of the factors that define the attended stimulus. This view is suggestive 
of a specialised processing system for attended stimuli. However, further studies 
revealed that both the Ni and Nd are composed of multiple subcomponents that arise 
from common generator sources in the auditory cortex, which makes it difficult to 
resolve the issue of the existence of a sensory gain control mechanism (Naatanen and 
Picton, 1987; Woldorff & Hillyard, 1991). 
However, there is some evidence to support the existence of a sensory gain control 
mechanism. Studies have shown that the early phase of the Nd coincides in time with 
the evoked Nl and that the early Nd and N1 show similar patterns of lateralised 
asymmetry depending on the ear of stimulation (reviewed in Woldorff & Hillyard, 
1991). Also, neuromagnetic studies have investigated effects of the dichotic 
listening task on the magnetic equivalent of the Ni known as the M100 (Rif et al, 
1991; Woldorff et al, 1993). The auditory cortex of the supratemporal plane is 
thought to contain the neural generators of the M 100 to unattended tones, the 
enlarged M 100 to attended tones, and the differential attention effect (Woldorff et al., 
1993). 
The N2 component consists of subcomponents known as the mismatch negativity 
(MMN), the basic N2, N2b and N2c - the classifaction of which is based on 
automatic vs. controlled mechanisms of generation (Naatanen & Picton, 1986). 
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2.3.2. Mismatch negativity 
The MMN is the earliest measurable brain response that distinguishes between usual 
and unusual auditory stimuli. This potential is modality specific as it has only been 
clearly demonstrated with auditory stimuli. It was first identified by Naatanen et al. 
in 1978 and in the laboratory it can be elicited in response to infrequent "deviant" 
sounds in a sequence of repetitive "standard" sounds. Stimulus deviance may be 
presented in the form of changes in tone frequency, duration or intensity. The MMN 
has a peak latency of 150-200 ms and can be elicited in the absence of attention. In 
contrast to the N1, the MMN component is thought to reflect automatic, pre-attentive 
processing involved in auditory discrimination and perception (Alho, 1995). The 
MMN is thought to be contaminated with other ERP components such as the Ni and 
N2 (Naatanen, 1990) and so is usually obtained by creating a "difference" waveform 
by subtracting the responses to the standard stimuli from those to the deviant stimuli. 
The MMN is thought to be generated by an automatic comparison mechanism which 
detects the physical characteristics of a deviant stimulus and compares them with a 
sensory memory trace of the standard repetitive tones (Naatanen et al., 1978). Later 
work by Naatanen in 1995 suggests that the MMN occurs as the result of automatic 
central auditory processing and is not attention dependent and therefore it reflects the 
operation of automatic sensory (echoic) memory. However, Woldorff et al. (1991) 
argue that the MMN is not entirely reflective of automatic processing as its 
amplitude is in fact altered by attention. 
Evidence from electrophysiological and magneto-encephalographic studies shows 
that at least two cortical generators contribute to the main sub-components of the 
MMN. Using dipole modeling, Alho (1995) identified a generator located bilaterally 
in the supra-temporal plane of the auditory cortex. Giard et al. (1990), using source- 
current density mapping, identified a generator located in the frontal cortex in the 
right hemisphere. This particular generator has been implicated in the orientation of 
attention to facilitate a subsequent behavioural response. 
Kathmann et al. (1999) investigated the stability of the MMN under different 
stimulus and attention conditions. The MMN was recorded in two groups of healthy 
subjects in two different conditions, one in which the subjects had no instructed 
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focus for attention, and the other in which subjects were required to perform a visual 
vigilance task. The MMN was elicited using two different deviant stimulus types 
within the same paradigm: those which differed from the standard stimuli in terms of 
duration and those which differed in terms of frequency. The same subjects 
underwent the same recording procedure at a later date to test the reproducibility of 
the MMN. The results of this study showed that the duration deviants elicited larger 
amplitude MMNs compared to the frequency deviants. There was better replicability 
of amplitudes for the MMN elicited using the duration deviants. Moreover, the retest 
reliability of the MMN was maximal using the duration deviants in conjunction with 
the visual vigilance task. The issue of MMN replicability is discussed further in 
Chapter 3. 
2.3.3. The "basic" N2, N2b and N2c 
The "basic" N2 is thought to be an attention-independent component elicited in 
response to repetitive homogenous stimuli (Picton et al., 1974). The N2b is a sharp 
negative component, recorded at fronto-central scalp areas, in response to attended 
stimuli therefore, in contrast to the basic N2, it is dependent on controlled processing 
(Naatanen et al., 1982). It often precedes the P3b component (described in the 
following section) as it occurs in response to unexpected and infrequent stimuli. The 
N2c (also know as the classification N2) was first reported by Ritter et al. (1982) and 
distinguished from the other N2 components by its comparatively posterior scalp 
distribution. It was elicited in tasks which required classification of visual stimuli 
into one of two possible categories. Ritter et al. (1983) found that the latency and 
duration of the N2c was dependent on experimental conditions hence making it 
representative of stimulus classification processing. 
2.3.4. P3 (P3a and P3b) 
The P3 (also known as the P300) is a large positive waveform, with peak latency 
between 300 to 800 ms, first identified by Sutton et al. in 1965. The P3 complex is 
thought to be composed of overlapping subcomponents. The most commonly 
explored subcomponents are known as the P3a and P3b. These are derived using 
different experimental paradigms and vary in their scalp distribution. 
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The P3b normally has a maximal scalp distribution over midline . nd parietal regions 
and is usually elicited by tests resembling the classic "oddball" paradigm. This 
involves the presentation of two different stimuli with one type having greater 
probability of occurrence than the other. The subject is required to attend to the rare 
"target" stimulus and make some meaningful response, for example mental counting 
or pressing a button whenever a target occurs. The P3b response is elicited in 
response to the rare attended stimulus and is seen maximally over central and parietal 
scalp areas. The latency of this response depends on the ease with which the rare 
deviant stimulus can be distinguished from the frequent standard stimuli (Coles & 
Rugg, 1995). The more difficult the distinction between standard and deviant stimuli, 
the longer is the delay to peak latency. This has led to the assumption that the P3b 
may be a used to gauge "stimulus evaluation time" (Donchin & Coles, 1988). The 
amplitude depends on the probability of the target stimulus. In general, the rarer the 
occurrence of the target stimulus, the greater the amplitude (Coles & Rugg, 1995). 
The P3a component was first reported by Squires et al. (1975). The authors identified 
2 distinct late positive components of the auditory ERP which differed in their 
latency and scalp distribution. The earlier P3a component, observed with a latency of 
around 240 msec, was elicited in response to infrequent and unpredictable deviations 
in a sequence of auditory tones. Moreover, it was observed regardless of whether the 
subject was attending to or ignoring the deviant tones. In the ignore condition, the 
P3a had maximal distribution over frontal scalp areas. The later P3b component, 
observed with a latency of around 350 msec, was observed only in the attending 
conditions, with the same tones, and had maximal distribution over parietal scalp 
areas. 
The P3a is also observed when a third "novel" type of stimulus is added to the 
oddball paradigm described earlier (Knight et al., 1989). For example, novel sounds 
such as a whistle or a dog bark interspersed between target high pitch and non-target 
low pitch tones would yield a P3a in response to the novel sounds. Thus the P3a is 
thought to represent processes that are involved in the subconscious capture of 
attention by salient events (Knight, 1998). 
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There is no clear consensus in the existing literature about the exact location of the 
P3 generator source. There are thought to be at least two different sources in the 
hippocampal formation and the amygdala (Yingling & Hosobuchi, 1984; McCarthy 
et al., 1989). The prevalent view is that the scalp recorded P3 may in fact represent 
the summation of activities originating in a number of different generator sources 
(McCarthy & Wood, 1987; McCarthy et al., 1997; Picton, 1992; Nishitani et al., 
1999). 
Studies incorporating a dual-task test that requires subjects to respond to 2 different 
types of target stimuli, have reported that the P300 is reciprocally distributed across 
the 2 tasks. In other words, a larger P300 in response to one task results in a smaller 
P300 in the other task within the same test (Wickens et al., 1983; Sirevaag et al., 
1989; Strayer & Kramer, 1990). This points towards the P300 providing an index of 
the allocation of information processing resources in multi-component tasks (Nash & 
Fernandez, 1996). 
2.4. Cognitive ERPs and epilepsy studies 
The following sections provide an overview of literature relating to ERPs in patients 
with epilepsy. As with most clinical research investigating ERPs, studies 
investigating the effects of epilepsy have focussed largely on the P3 component. 
A number of studies have explored changes in auditory ERPs in patients with 
epilepsy. These studies include ERP test batteries which have been, in some cases, 
complemented with neuropsychological and neuroimaging investigations. The 
following studies describe changes in cortical function in patients with epilepsy with 
emphasis on auditory ERP findings. Table 2.1 provides a summary of findings from 
studies which have examined the effects of epilepsy on the P3. 
2.4.1. Effects of epilepsy on the MMN 
Currently there is very little published literature on the effects of epilepsy on the 
MMN. Preliminary results from a study carried out by Gene-Cos et al. (2000) show 
significantly reduced MMN amplitude, at Cz, in patients with epilepsy compared 
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with healthy controls and a group with non-epileptic seizure disorder. This finding 
may have important implications with respect to the role of epilepsy-related EEG 
disturbances on MMN formation. However, the extent to which differences in 
seizure type contribute to MMN disruption, and whether factors such as duration of 
epilepsy and the severity of seizures contribute aberrations of this component, is yet 
to be ascertained. 
2.4.2. Effects of partial epilepsy on the P3 
Drake et at. (1986) carried out a study that supports the view that ERPs are altered by 
partial epilepsy. This study examined a group of patients with complex partial 
epilepsy, with or without secondary generalisation, who had no structural 
abnormalities detected by neurological and computed tomography (CT) examination. 
The results showed that both N2 and P3b latencies, obtained using an auditory 
oddball procedure, were significantly delayed at Cz and Pz in the patient group 
compared to a healthy control group. In addition, P3b amplitude was found to be 
significantly larger in the patient group. No behavioural measures were obtained in 
this study so it is difficult to draw any conclusions about how patients with partial 
epilepsy may have been affected in terms of cognition in association with this P3b 
latency delay and amplitude enhancement. 
Further evidence for ERP changes in relation to cryptogenic partial epilepsy (CPE) is 
provided by the results of a study by Soysal et al. (1999). This study compared ERPs 
obtained from a group of patients with CPE and a group with idiopathic generalised 
epilepsy (IGE) to those recorded from age-matched healthy controls. Significantly 
prolonged latencies to N2 and P3b peak at Cz, were seen in the CPE group, 
compared to the healthy control group. The IGE group were also reported to have N2 
and P3b delayed latency but this finding failed to reach statistical significance. In 
contrast to Drake et al. 's findings described earlier, N2 and P3b amplitudes at Fz and 
Cz were smaller in comparison to those of their respective controls groups. However, 
this finding also failed to reach statistical significance so it is difficult to make any 
firm inference with regard to the effect of epilepsy on ERP amplitude. Squires et al. 
(1983) suggest that disruption of P3 latency and amplitude are reflective of different 
underlying pathophysiology. Abnormality of latency is thought to be indicative of 
medial temporal lobe pathology, whereas amplitude reduction with normal latency, is 
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thought to point towards abnormalities in brain regions that subserve attentional or 
motivational functions. The results of Soysal et al. 's investigations failed to show 
any significant effects of type and serum level of AED in the patient group, 
suggesting that ERP latency increase may occur as a consequence of the seizures 
rather than drug treatment. However, the majority of the CPE patient group were 
taking sedative drugs such as carbamazepine (CBZ), phenytoin (PHT) and 
phenobarbital (PHB), whereas the majority of the IGE group were on sodium 
valproate (VPA) monotherapy. Hence the non-homogeneous distribution of AED 
therapy between the two patient groups makes it difficult to disentangle the exact 
effects of AEDs from the effects of seizure type on the ERP results reported. 
Triantafyllou et al. (1992) compared ERP components obtained from patients with 
IGE, temporal lobe epilepsy (TLE) and frontal lobe epilepsy (FLE). N2 and P3b 
latencies were reported to be significantly delayed in the TLE group when compared 
to the IGE group. P3b latency was also delayed in patients who had abnormalities in 
their EEG compared to those who had normal EEGs regardless of epilepsy type. 
Fukai et al. (1990) compared the P3b in patients with IGE and TLE. P3b latencies at 
Cz and Pz were found to be significantly prolonged in patients with TLE compared 
to those in patients with IGE and healthy controls. Moreover, in the TLE group, 
latencies were more markedly delayed in patients with bilateral EEG abnormalities 
compared to those with just unilateral EEG foci. The effects of epilepsy duration or 
seizure manifestation (i. e. simple partial seizures (SPS) vs. SPS with secondary 
generalisation, and generalised tonic-clonic seizures (GTCS) vs. GTCS plus absence 
seizures) and of anti-epileptic drugs were not found to be significant for P3b 
amplitude or latency within the seizures groups. Furthermore, comparison of the 
effects of AED monotherapy and polytherapy, within therapeutic range, on P3b 
latency did not yield any significant correlation in either of the seizure groups. The 
results of this study also substantiate the hypothesis that epileptogenic foci arising 
from hippocampal disruption contribute to alteration of the P3b component. 
Mervaala et al. (1992) investigated auditory ERPs, using sphenoidal electrode 
recordings, in patients undergoing surgery for intractable TLE. A test battery 
comprising both ERP and neuropsychological testing was carried out pre- and post- 
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operatively on the same group of patients. The ERP protocol allowed for eliciting 
both Pia and P3b components. Neuropsychological assessment consisted of WAIS, 
Wechsler Memory Scale and unspecified tests to assess language and frontal lobe 
functions. Both pre- and post-operative results showed significant lateralising 
asymmetries in both P3a and P3b amplitudes with attenuation corresponding to the 
hemisphere that contained, or had previously contained, the epileptogenic focus. The 
pre- and post-operative results also showed significant P3a and P3b latency delays 
occurring bilaterally, as compared to a healthy control group, with no significant 
asymmetry. Taking into account the theory of amplitude and latency disruption 
reflecting different pathophysiology (Squires et al., 1983) the authors suggest that 
their finding of simultaneous lateralised amplitude attenuation and non-lateralising 
latency delay, in the same patients, points to focal functional pathology concurrent 
with more widespread disruption of signal processing. The results of Mervaala et 
al. 's study failed to reveal any significant correlation between ERP disturbance and 
performance on any of the neuropsychological tests. The authors suggest that this 
may be explained by the fact the behavioural results, although differentiating well 
between inter-lobe profiles, cannot extricate any functional overlap between the two 
hemispheres. A factor which may have been worthy of consideration is the impact of 
AED on the results. Pre-operatively, the patients were all on therapeutic doses of 
CBZ and/or gabapentin (GBT) combined with VPA but it is unclear what AED 
treatment status was post-operatively. The patients included in this study were 
reported to be suffering from highly variable pre-operative seizure frequency, 
ranging from 5 to 50 seizures per month. However, the impact of seizure frequency 
on the extent of ERP disturbance was not examined. Post-operatively, the majority of 
patients were reported to be seizure free so it is feasible, as Nishitani et al. (1999) 
suggest in their study detailed below, that the post-operative ERP attenuation 
reported occurred as a consequence of the surgical resections rather than the 
epilepsy. 
Some studies suggest that ERP alteration may not necessarily be a consequence of 
epilepsy alone. Nishitani et at. (1999) carried out a study investigating pre- and post- 
operative ERPs in the same group of patients with intractable temporal lobe epilepsy. 
This study reported attenuation of scalp-recorded P3b amplitude over temporal 
regions corresponding to the resected side, whereas this amplitude had been 
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symmetric pre-surgery, and comparable to that obtained from a healthy control 
group, regardless of the site of the epileptogenic focus. Interestingly, the peak latency 
and amplitude of the P3b, recorded at Pz, did not differ significantly from that 
obtained from the healthy control group. These results combined with event-related 
magnetic fields (ERF) recorded in response to the oddball task led the authors to 
conclude that the hippocampus contributes to the scalp-recorded P3b at the 
corresponding anterior temporal region and does not alter its appearance and 
distribution normally recorded over the surface of the scalp at Pz. So in contrast to 
the results obtained in the studies outlined above (Drake et al., 1986; Triantafyllou et 
al., 1992; Mervaala et al., 1992; Fukai et al., 1990; Soysal et al., 1999), Nishitani et 
al. 's results show that the P3b remained preserved in a group of patients with 
intractable complex partial seizures and amplitude attenuation was only noted in 
association with surgical excision of structures implicated in the generation of this 
component. One possible explanation for the lack of significant ERP changes in 
association with TLE in Nishitani et al. 's study is the relatively small sample size, 
the aforementioned studies that have found significant ERP alteration in relation to 
epilepsy, reported results from comparatively larger sample sizes. 
There is further evidence to suggest that ERPs may be preserved in the presence of 
partial epilepsy. Verleger et al. (1997) recorded ERPs in patients with partial seizures 
and IGE using two auditory tasks and one visual task as well as verbal memory and 
short-term learning assessed with Rey Auditory Verbal Learning Test (RAVLT). 
IGE patients had significantly delayed latencies with the auditory oddball task, 
mainly for NI and increasing for N2b and P3b, with the delay being correlated to the 
duration of epilepsy in both groups. However, there were no significant ERP changes 
in the partial seizure group compared to a healthy age-matched control group. It is 
reasonable to assume, on the basis of the finding that duration of epilepsy contributes 
to degree of ERP latency delay, that there may be some discrepancy in epilepsy 
duration between the sample included in Verleger et al. 's study and the samples 
included in other studies which report significant ERP delay in association with 
partial epilepsy. Moreover, seizure frequency and severity may also vary between 
these studies with contradictory findings. Interestingly, the partial seizure group 
showed significant verbal memory impairment, whereas this was not the case in the 
IGE group who had shown significant ERP delays. The authors suggest that 
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electrophysiological delays, observed in association with IGE, reflect a slowing of 
brain processes which may be caused by seizure activity, or may be due to some sort 
of compensatory process which tries to counteract epileptic activity and may be 
occurring as an automatic process or as a result of medication. With the visual task, 
the posterior N2 was significantly delayed in partial seizure patients especially in 
those with a temporal lobe focus. The authors suggest that this particular finding may 
relate to specific impairment of the occipito-temporal visual pathway in the partial 
seizure patients. 
However, there is a reasonable amount of further evidence to suggest the presence of 
P3 alteration, in relation to partial epilepsy, prior to any surgical intervention. For 
example, Trinka et al. (2001) report delayed P3a and P3b latency, at the Cz 
electrode, in a group of patients with localisation- related TLE. This finding also 
lends support to the proposed role of the hippocampus, as part of the limbo-cortical 
network, in the detection of novel auditory events (Knight, 1998). Significant P3b 
amplitude reduction was also seen at electrodes T4 and T6, only in those patients 
with right sided TLE, which had been classified according to ictal EEG localisation, 
in comparison to healthy controls. Furthermore, the results of Trinka et al's study 
showed that visually elicited P3a and P3b, in the same group of patients, showed no 
significant difference to visual P3a and P3b components obtained from a healthy 
control group. The effects of AEDs are also considered by the authors as the patients 
studied were all on stable AED therapy (CBZ, PHT and VPA) and the authors 
suggest that it is unlikely that auditory ERPs would be selectively altered due to 
AED effect without any disruption of the visual ERPs. The authors suggest in their 
conclusion that modality specific P3 components are highly reflective of the integrity 
of different information processing pathways. 
2.4.3. Effects of generalised epilepsy on cognitive ERPs 
Comparatively few studies have found any association between generalised epilepsy 
and ERP alteration. As some of the studies in the previous section highlight, P3 
latency and amplitude either remain preserved in IGE patients (Fukai et al. 1990), or 
any observed latency delay fails to reach statistical significance (Soysal et al. 1999). 
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There are, however, a few studies which have noted significant alterations of 
endogenous potentials. 
Koseoglu and Karaman (2001) reported significant delay of Ni, N2, P2 and P3b 
components, at electrodes Fz and Cz, in patients with IGE compared to healthy 
controls. Moreover, sub-grouping of the patient sample revealed that patients who 
had suffered from over 100 seizures in the past, and those with a previous history of 
status epilepticus, showed significantly greater P3b delay, at Cz, compared to those 
who had suffered from less than 10 seizures overall. Also, patients on more than one 
type of AED were found to have significantly longer P3b latency compared to those 
on monotherapy. However, there is no clarification as to AED type in the study 
sample. Factors such as age of epilepsy onset, duration of epilepsy and seizure 
frequency (in the 3 months preceding assessment) had no significant impact on 
ERPs. P3b amplitude was found to be significantly larger at Fz in patients who had 
EEG abnormalities compared to those with no inter-ictal EEG abnormalities. 
However, the authors admit that this finding is likely to be attributed to technical 
error due to ERP baselines being shifted away from baseline at stimulus onset when 
epochs coincided with the occurrence of EEG abnormalities. A proportion of the 
patient sample was re-tested after 3 months and patients who had complied with their 
AED regimen showed significantly shorter P3b latencies at Fz and Cz compared to 
those obtained at the initial assessment. The authors postulate that this observation 
must have been the consequence of interictal epileptiform activity suppression 
because no link was found between ERP characteristics and reduction in clinical 
seizure frequency. However, again it is unclear what AEDs the patients were taking 
and whether there were any changes in AED type between the test and re-test 
session. The conclusions of this study are limited by its exclusion of any recordings 
from parietal electrodes as the P3b is often maximal at the Pz electrode. 
Sunaga et al. (1994) examined the P3b in a group of children (age range from 6 to 15 
years). They reported longer P3b latency at Cz and Pz in a group of children with 
IGE compared to healthy controls. However, a group of children with TLE showed 
no significant difference in P3b in comparison to healthy controls. The effects of age 
were ruled out from the results of this study by application of an age-correction 
technique. Also, there was no significant correlation between epilepsy duration and 
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AED effects on P3b latency. The authors speculate that their findings support the 
role of the mesencephalic reticular formation and the thalamus in IGE 
epileptogenesis (Nowack & Theodoridis, 1991; Fromm, 1991) on the premise that 
these structures are implicated in the generation of the P3b (Yingling & Hosobuchi, 
1984). However, Sunaga et al. 's results conflict with other studies that have shown 
P3b latency delay in partial epilepsy (Drake et al., 1986; Soysal et al., 1999; 
Triantafyllou et al., 1992; Fukai et al., 1990; Mervaala et al., 1992; Trinka et al., 
2001) with the underlying theory that hippocampal dysfunction disrupts P3b 
generation. 
Verleger et al. (1997) reported significant Ni, N2b and P3b delays in patients with 
IGE. Similarly Soysal et al. (1999) found longer P3b latency in patients with IGE but 
these findings failed to reach statistical significance. 
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Chapter II 
2.4.4. Effects of AED therapy on cognitive ERPs 
A few studies have attempted to explore the direct effects of AEDs on cognitive 
ERPs. The increasing variety of AED treatment and combination therapies makes it 
difficult to draw any direct inferences from the studies that have attempted to assess 
the influence of drugs on ERPs. As most of the studies described earlier have 
examined AED effects as a confounding variable, the following section focuses 
mainly on studies that have been carried out with the aim of assessing direct AED 
effects on ERPs. 
Meador et al. (1990) carried out a randomized, double-blind, triple crossover trial to 
examine the effects of CBZ, PHB and PHT in patients with complex partial seizures 
(CPS). This study failed to find any significant difference in the P3b component 
obtained with the different drug treatments. Hence the authors conclude that the 
differential cognitive effects of AEDs may be subtle. However, their results may be 
limited due to the fact that patients were only assigned each drug for a period of 3 
months, therefore this may have been insufficient time for any detrimental effects on 
cognition to manifest. 
Panagopoulos et al. (1997) found significant P3b latency prolongation at Cz in 
relation to VPA monotherapy in patients with IGE compared to IGE patients on CBZ 
monotherapy and healthy non-medicated controls. All patients included in the study 
were found to have no significant overt cognitive impairment as assessed by the Mini 
Mental State (MMS) assessment. The authors also report that epilepsy duration, time 
period from last seizure, prior to assessment date, and plasma levels of AED showed 
no significant correlation to P3 prolongation in either of the seizure groups. The 
results of this study may be limited by the fact that it is unclear as to what, if any, 
differences in dose level existed within and between the patient groups. Moreover, 
the possibility of drug toxicity which may have contributed to the findings is not 
apparent from the report. 
Misra et al. (1997) investigated the effects of PHT on ERPs. This study found no 
significant difference in P3b latency between healthy controls and patients 
undergoing PHT monotherapy, for at least 6 months, for the management of simple 
partial or generalised seizures. All participants in the study underwent 
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neuropsychological assessment, using the Weschler Memory Scale, Benton visual 
retention test, and Standard Progressive Matrices, which tested reasoning and spatial 
ability. There were no significant group differences in behavioural cognitive 
function. One patient was noted to have clinical signs of PHT toxicity but this 
patient's neuropsychology and ERPs remained preserved. 
Chen et al. (1996) investigated the effects of AED therapy on cognitive function, 
using ERP and psychometric assessment, in children (age range 7 to 15 years) with 
newly diagnosed epilepsy. The children were randomly allocated to CBZ, PHB or 
sodium valproate (VPA) treatment after diagnosis. The patients were tested on three 
occasions - before commencing AED treatment then at 6 and 12 months after the 
start of drug therapy. There were no significant changes to P3b latency in relation to 
CBZ or VPA treatment. However, at the 6 and 12 month follow-up assessments, P3b 
latency in the group of children receiving PHB was significantly delayed at Cz and 
Pz in comparison to the baseline values. P3b amplitudes at Cz and Pz were 
significantly reduced in all treatment groups at the 6 and 12 month follow-up 
assessments. However, the authors deduce that P3b amplitude is not a sensitive 
measure for cognitive function because it did not correlate with the psychometric 
results. Factors such as seizure type and frequency were not considered in this study 
so it is difficult to draw any firm conclusions about the independent effects of AED 
treatment on the reported ERP latency delay and amplitude attenuation. 
A more recent study by Chen et al. (2001) examined the effects of AEDs in seizure- 
free children with epilepsy, aged 6 to 12 years, before and after complete drug 
withdrawal. The children had undergone fixed CBZ, VPA or PHB monotherapy, for 
at least 1 year, and were examined before AED reduction, then 1 and 7 months after 
complete treatment withdrawal. P3b latency was significantly delayed in the PHB 
group, compared to the other AED groups, at baseline and became significantly 
shorter at the 1 and 7 month re-tests. Furthermore, after 1 and 7 months following 
drug withdrawal, P3b amplitudes were significantly larger at Cz and Pz, compared to 
respective baseline values in all three test groups. Patients with PHB treatment had 
greater increase of P3b amplitudes after drug withdrawal compared to the other 
treatment groups. However, this group difference failed to reach statistical 
significance so, reinforcing conclusions from their earlier study, the authors state that 
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P3b amplitude is not a sensitive measure of AED effects on cognitive function. The 
study concludes that only long-term PHB treatment impairs cognitive function in 
children and this impairment is reversible following drug withdrawal. 
2.4.5. Summary of the effects of epilepsy on cognitive ERPs 
In summary, the majority of studies to date report latency delays of N2 and P3 
components in patients with epilepsy, particularly with partial epilepsy, with good 
correspondence to the site of the epileptogenic focus. A comparatively small number 
of studies have also demonstrated ERP delays in relation to generalised epilepsy. 
Endogenous potential impairments are thought to reflect the effects of 
epileptogenesis on the generator sources of these components. The contributions of 
AED effects on ERP amplitude reduction and latency delay remains a confusing 
issue as it is difficult to because of owing to such large variability between AED 
types and levels both within and between studies. 
3.0. Introduction to the investigations in this thesis 
This thesis aims explore the effects of different seizure types on a range of cognitive 
functions assessed with neuropsychology and ERPs. The integrity of frontal lobe 
functions will be assessed using tests of card sorting ability (WCST), spatial working 
memory (SWM) and planning ability (Tower of London/Stockings of Cambridge 
test). An MMN task and a novel sounds task, to obtain P3a components, will be used 
to assess the electrophysiological integrity of frontal lobe functions as this is the 
proposed location for the neural generators for these ERPs. Word list learning and 
story recall tests will be employed to assess the efficiency of temporal lobe functions. 
Temporal lobe structures are implicated in the generation of the P3b and also the 
MMN therefore a standard auditory oddball task will be employed. A dual target 
oddball task, requiring subjects to respond to auditory and additional visual targets 
will also be employed as increasing task demand may increase the sensitivity of 
detecting ERP changes that may be absent from responses to the standard oddball 
task. The following chapter (3) examines the stability of the MMN to establish 
optimal stimulus criteria for use with the subsequent longitudinal study. Chapters 4, 
5 and 6 report neuropsychological and ERP investigations in patients with epilepsy 
and document results over a 12 month time period to examine time-related changes 
that may occur as a consequence of different seizure types. 
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Chapter III 
REPEATABILITY OF THE MISMATCH NEGATIVITY RECORDED WITH 
DIFFERENT STIMULUS AND ATTENTION CONDITIONS. 
3.1. Introduction 
Many every day auditory events are ignored while others, depending on their 
importance for ongoing information processing, are assigned for further cognitive 
analysis. The brain's automatic detection of a low-probability change in a 
homogenous sequence of auditory stimuli elicits a mismatch negativity (MMN) 
potential. This mechanism is critical in enabling the execution of an appropriate 
behavioural response to the detected auditory change and may be part of an inherent 
pre-conscious survival system. The MMN is thought to represent pre-attentive or 
echoic memory processing mechanisms (Naatanen, 1990; Tiitinen et al., 1994). 
Consequently, the MMN may be a useful tool for assessing automatic stimulus 
discrimination (Naatanen, 1992) and decay of a memory trace in the human auditory 
cortex (Pekkonen et al., 1994). This component is elicited in response to infrequent 
"deviant" tones presented in a sequence of repetitive "standard tones". It is obtained 
by subtracting the averaged response to the standard stimuli from that for the deviant 
stimuli and this subtraction helps eliminate contamination from overlapping event- 
related potential (ERP) components such as the Ni and N2 (Naatanen, 1990). 
The clinical utility of the MMN has been investigated in many studies including 
investigations of Alzheimer's disease (Pekkonen et al., 1994), Parkinson's disease 
(Pekkonen et al., 1995a), developmental dysphasia (Korpilahti & Lang, 1994), 
chronic pain (Dick et al., 2003) and recovery from coma (Kane et al., 1993). The 
MMN may also have important implications for revealing novel insights into the 
pathophysiology underlying various neuropsychiatric disorders (Gene-Cos et al., 
1999). 
The role of attention on the generation of the MMN remains the subject of some 
ongoing debate. Naatenen (1990) argues that the MMN is purely pre-attentive and 
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elicited when subjects perform an attention engaging task which helps divert their 
attention from the auditory stimuli. However, Woldorff et al. (1991) suggest that the 
MMN is not entirely reflective of automatic processing as its amplitude is in fact 
altered by attention. A study by Kane et al. (1993) found that the MMN could be 
elicited in comatose patients up to 48 hours before they actually regained 
consciousness which supports its automatic pre-attentive generation. In Kathmann et 
al. 's study (1999), the repeatability of the MMN elicited using duration increment 
deviants was enhanced when subjects performed a visual vigilance task to engage 
attention as opposed to when they had no instructed focus for attention which lends 
further support to this theory. 
Attempts to identify the neural generator sources of the MMN have also led to 
greater insight into its functional significance. Evidence from electrophysiological 
and magnetoencephalographic (MEG) studies shows that at least two cortical source 
generators contribute to the main sub-components of the MMN. The MMN is 
thought to be generated by an automatic comparison mechanism which detects the 
physical characteristics of a deviant stimulus and compares them with a sensory 
memory trace of the repetitive standard tones (Naatanen, 1990). A generator which 
underlies this particular process has been identified in the supra-temporal plane of 
the auditory cortex in both hemispheres (Alho, 1995). This detection of mismatch is 
thought to trigger the orienting of attention towards the detected change so that the 
appropriate behavioural response can be executed. A source generator located in the 
frontal cortex in the right hemisphere is thought to provide the mechanism which 
establishes effective orienting of attention towards the pre-attentively detected 
change (Giard et al., 1990). Recent functional imaging studies have provided some 
evidence to support this hypothesis. Sevostianov et al. (2002) found a right 
hemispheric predominance in the bitemporal lobe activation resulting from pre- 
attentive detection of deviant auditory tones associated with the MMN. Spatio- 
temporal source imaging has also revealed the generation of MMN subcomponents 
in the cingulum and the right inferior temporal gyrus (Waberski et al., 2001). 
At present there is no standardised protocol for recording the MMN which makes 
cross-study result comparisons difficult. Although any distinguishable change in 
terms of frequency, duration, intensity and inter-stimulus interval may elicit an 
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MMN, it is worth exploring which stimulus parameter and experimental condition 
elicits the most replicable response to help establish a protocol. This issue of 
individual and group-level MMN repeatability has important implications for both 
clinical and research investigations that involve assessing changes in echoic auditory 
memory over a period of time. 
Several studies have explored the effects of deviant tone changes in terms of 
frequency, duration (Pekkonen et al., 1995b; Escera & Grau, 1996; Kathmann et al., 
1999 and Tervaniemi et al., 1999) and intensity (Tervaniemi et al., 1999) from the 
standard tone and the inter-stimulus interval (Escera et al., 2000 and Kujala et al., 
2001) on repeatability of the MMN. 
Pekkonen et al. (1995b) reported significant inter-session repeatability of MMN 
amplitude using a duration deviant with 0.5 s inter-stimulus interval at electrode F4. 
Frequency deviants and 1.5 s inter-stimulus interval failed to yield significantly 
repeatable MMNs. Kathmann et al. (1999) investigated the stability of the MMN 
recorded using different stimulus (frequency/duration deviants) and attention 
(reading/visual vigilance task) conditions. The results demonstrated better 
repeatability with duration increase deviants compared to frequency increase 
deviants. MMN stability in children, aged from 7 to 11 years, was investigated by 
Uwer & von Suchodoletz (1999). Significant individual-level stability was achieved 
with the duration deviant, but not with the frequency deviant, and one of two syllable 
deviants tested. 
The aim of the present study was to investigate how different stimulus parameters 
and attention engaging tasks affect MMN repeatability to help establish a protocol 
that could be used confidently for longitudinal studies. 
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3.2. Method 
3.2.1. Subjects 
Twenty-eight healthy volunteers, 17 females and 11 males, aged between 21 and 42 
years (mean age 30 + 6.7 years) underwent components of the test battery shown in 
Table 3.1. Details of participants in the different recording conditions are shown in 
Table 3.2. Sixteen participants underwent a further re-test sessions at a later date - 
details of these recording conditions and participant details are listed in Table 3.3. 
All participants provided informed consent. They were all reported to be free from 
any neurological and psychiatric disorders and had no history of alcohol or drug 
abuse. In all recording conditions, subjects were instructed to carry out a task which 
provided them with a focus for attention (reading or visual vigilance) and to ignore 
the auditory tones presented as detailed below. 
3.2.2. Recording conditions and stimulus parameters 
The MMN was recorded in the conditions summarised in Table 3.1. As the table 
shows, the MMN was recorded using two different distracter tasks with three 
different stimulus parameters. Duration and frequency increase deviants and duration 
decrease deviant stimuli were included in the experimental protocol. Frequency 
decrease deviants were not included in the current study as most previous studies 
have concluded that duration decrease deviants yield better repeatability compared to 
frequency decrease deviants (Pekkonen et al., 1995; Kathmann et al. 1999; 
Tervaniemi et al., 1999). Therefore, in order to prevent the experimental sessions in 
the current study from being too long in duration, and so minimise fatigue effects 
contaminating the results, only frequency increase deviants were examined. 
VISUAL VIGILANCE 
READING TASK TASK 
Duration Duration Frequency Duration Duration Frequency 
Increase Decrease Increase Increase Decrease Increase 
(DIR) (DDR) (FIR) (DIV) (DDV) (FIV) 
Standard 800 Hz 800 Hz 800 Hz 800 Hz 800 Hz 800 Hz 
tone 50 ms 100 ms 50 ms 50 ms 100 ms 50 ms 
Deviant 800 Hz 800 Hz 1000 Hz 800 Hz 800 Hz 1000 Hz 
tone 100 ms 50 ms 50 ms 100 ms 50 ms 50 ms 
Table 3.1. Recording conditions and stimulus parameters used for 
investigating MMN repeatability. 
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3.2.2.1. Reading task 
The auditory tones described in Table 3.1 were presented at 70 dB binaurally via 
earphones. The probability of occurrence of the standard tones in each condition was 
85% (P=0.85) with a total of 850 presentations. The probability of occurrence of the 
deviant stimuli was 15% (P=0.15) leading to a total of 150 presentations. An inter- 
stimulus interval (ISI) of 0.5 sec was used in all conditions. The deviant tones in all 
conditions were interspersed with a random distribution among the standard tones 
except that two or more deviant tones never occurred in succession. 
3.2.2.2. Visual vigilance task 
For this task, a secondary visual vigilance test was incorporated into the MMN 
recording procedure using the stimulus parameters described in Table 3.1. The visual 
task required subjects to count the number of changes to a visual pattern presented on 
a monitor screen placed centrally, 1m in front of them. The visual pattern consisted 
of a series of regular parallel black and white lines starting with a horizontal 
orientation. Throughout the test, the orientation of the lines alternated between 
horizontal and vertical with varying intervals not exceeding 20 seconds. The deviant 
tones and visual changes were interspersed with a random distribution among the 
frequent tones. A total of 44 visual changes were presented. Two or more deviant 
tones were never presented in immediate succession and the deviant tones and visual 
changes were never presented simultaneously or in succession. 
Condition N Age (mean + SD years) 
DDR 14 28.7 +7.4 
DDV 14 28.8+7.4 
DIR 17 29.8+6.5 
DIV 14 30.1+7.6 
FIR 18 29.8+6.5 
FIV 15 29.9 +7.6 
Table 3.2. Details of participants in the within-session MMN repeatability study. 
Condition N Age (mean + SD years) 
DDR 8 30.8+7.8 
DIR 8 30.3+6.8 
FIR 8 29.9+7.8 
Table 3.3. Details of participants in the test-retest MMN repeatability study. 
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3.2.3. Procedure 
Subjects detailed in Table 3.2 all participated in an initial test session with all or part 
of the test conditions presented to them in random order. For all conditions involving 
the reading task, subjects were instructed to begin reading one minute before the test 
commenced and to ignore the ensuing auditory events. They were instructed to 
continue reading throughout the duration of the test until asked to stop by the 
investigator. For all conditions involving the visual vigilance task, subjects were 
instructed to ignore any subsequent auditory stimuli and concentrate on the visual 
task. Immediately after the end of the test, subjects were asked to report the number 
of visual changes that they had managed to count. Subjects detailed in Table 3.3 
were re-tested after an interval of 1 to 8 months (mean 4.4 ± 2.3), and underwent 
repeats of conditions FIR, DIR and DDR. These re-test conditions were selected on 
the basis of having the highest, lowest and intermediate mean peak amplitude (mpa) 
repeatability, at electrode Fz, and peak latency repeatability from the initial within- 
session results (see section 3.3.1). 
3.2.4. ERP recording 
The electroencephalogram (EEG) was recorded from the scalp by attaching eight 
silver/silver-chloride electrodes, using Ten-20 conductive paste, in accordance with 
the Standard International 10-20 Electrode Placement System (Jasper, 1958). The 
locations of these electrodes were: Fz, Cz, Pz, F3 and F4. Linked mastoid electrodes 
were used as a reference for the active scalp electrodes. A ground electrode was 
attached to the centre of the forehead. The electro-oculogram (EOG) was recorded, 
to monitor both horizontal and vertical eye movements, by attaching a pair of bipolar 
electrodes above the right eye and just below the outer canthus of the right eye. 
Electrode impedances were maintained below 5K Ohms. For all recordings, subjects 
were seated in a comfortable chair and instructed to keep their eyes open and stay as 
still as they could possibly manage in an attempt to minimise myogenic and ocular 
artefacts. 
Recordings were performed using Neuroscan version 4.1 software (Neuroscan, Inc., 
Sterling, Virginia) in continuous acquisition mode. All signals were amplified with a 
band pass of 0.15 Hz to 100 Hz and digitised at a rate of 500 Hz. The continuous 
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data was processed off-line to correct for ocular contributions to the EEG data. The 
data was then epoched starting at 100 ms before stimulus onset and ending at 500 ms 
after. Artifact rejection, on trial-based epochs, was performed to exclude any epochs 
with data outside the amplitude range of ±70 µV. Baseline correction was performed 
using the 100 ms pre-stimulus data against which amplitude measures were taken. 
3.2.5. Data analysis 
To examine within-session repeatability, the continuous EEG data for each subject 
was epoched into two comparable files. This was achieved by splitting the recorded 
data into two sets according to the first and second half of the recording period. The 
two sets were subsequently averaged to obtain two difference waveforms per subject 
ensuring that the number of accepted sweeps after artifact rejection was the same 
within 10 sweeps between the two sets. The difference waveforms were measured to 
obtain values for peak amplitude, mean peak amplitude (mpa) (peak ±10 ms) and 
peak latency at electrodes Fz, Cz, F3 and F4. The waveforms were superimposed 
graphically to obtain a visual check of repeatability. To carry out statistical 
evaluation of repeatability at the intra-individual level, the technique described by 
Bland & Altman (1986) was applied to the waveform measures obtained. This 
technique involves calculation of the within subject co-efficient of variation (CV). 
This was derived by firstly carrying out a one-way ANOVA on the paired measures 
for each subject in each condition. The square root of the residual mean square value 
was then calculated to obtain the standard deviation (SD) of the paired measure 
differences. Finally, the SD was divided by the total sample mean, in each condition 
and multiplied by 100 to obtain a percentage value expression for CV. Therefore, the 
lower CV values closest indicate the better within subject repeatability. 
For inter-session repeatability analysis, MMN set 1 and set 2 data were subjected to a 
similar calculation of CV with the addition of set 3 data obtained from the re-test 
conditions. 
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3.3. Results 
3.3.1. Within-session MMN repeatability 
Figure 3.1 illustrates the spread of MMN difference waveform variation between set 
1 and set 2 in each recording condition at electrode Fz. Visual inspection of the 
responses showed that the MMN variation between set 1 and 2 was minimal in the 
DIR condition. This was supported by the CV values calculated for within-session 
mean peak amplitude (Table 3.4) and peak latency (Table 3.5). The lowest CV 
values, indicating least variation and best repeatability, between sets was observed in 
the responses obtained in the DIR condition at electrodes Fz and Cz (25% and 18% 
respectively). CV values at electrodes F3 and F4 were also indicative of good 
repeatability in the DIR condition (29% and 28% respectively). However, at these 
two sites, the lowest values were obtained in the DIV condition for electrode F3 
(27%) and in the FIR condition for electrode F4 (28%). The poorest CV values for 
mean peak amplitude across all electrode sites were observed in the DDR and FIV 
conditions. In general, better mean peak amplitude repeatability, assessed by CV 
values, was observed with conditions employing reading self-selected text compared 
to the conditions with the visual vigilance task i. e. DIR versus DIV, FIR versus FIV. 
However, the DDR condition showed poorer mean peak amplitude repeatability with 
generally higher CV values compared to the DDV task. 
As Table 3.5 shows, peak latency showed best repeatability in the DIR condition 
(CV = 5%) and poorest repeatability in the FIR and FIV conditions (CV =18% in 
both cases). Better peak latency repeatability, as shown by the CV values, was 
observed in more of the reading task conditions compared to the visual vigilance task 
conditions i. e. DDR versus DDV and DIR versus DN. However, FIR and FIV 
showed similar CV values indicating similar latency repeatability with the conditions 
employing frequency deviants regardless of task type. 
Visual inspection of the MMN difference waveforms shown in Figure 3.1 also shows 
that the responses obtained in the frequency deviant conditions were generally 
smaller amplitude and with less well defined peaks than those obtained in the 
duration deviant conditions. 
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Fz Cz F4 F3 
DDR 53.61 41.68 55.89 53.25 
DDV 44.97 43.29 43.46 39.97 
DIR 25.04 18.30 28.49 28.63 
DIV 34.28 30.71 38.77 26.70 
FIR 42.09 31.34 27.96 33.94 
FIV 49.54 47.85 47.55 46.00 
Table 3.4. CV values (%) for within-session MMN mean peak amplitude 
repeatability (between set 1 and set 2) obtained in each initial test condition. 
Bold values = lowest inter-condition CV value indicating best repeatability 
Peak latency 
DDR 6.008 
DDV 8.567 
DIR 5.329 
DIV 9.579 
FIR 18.494 
FIV 17.864 
Table 3.5. CV values (%) for within-session MMN peak latency repeatability 
(between set 1 and set 2) obtained in each initial test condition. 
Bold values = lowest inter-condition CV value indicating best repeatability 
3.3.2. Inter-session MMN repeatability 
Figures 3.2 to 3.5 illustrate the MMN difference waveforms at electrode Fz obtained 
for each participant in the initial (set 1 and set 2) and retest (set 3) conditions. Again 
visual inspection shows that the waveforms obtained in the DIR condition are similar 
in the test-retest superimposition. This is supported by the low CV values (from 27% 
to 33%), as shown in Table 3.6, obtained for mean peak amplitude at electrodes Fz, 
Cz, F3 and F4 that indicate the best repeatability. Furthermore, the best inter-session 
peak latency repeatability, out of the conditions tested, was obtained in the DIR 
condition (5%). Table 3.7 lists the CV values obtained for inter-session peak latency 
repeatability. The FIR condition yielded the poorest peak latency repeatability 
between sessions (23%). 
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Fz Cz F4 F3 
DDR 42.09 38.44 43.63 36.27 
DIR 26.84 28.61 32.69 30.54 
FIR 37.78 35.42 42.46 36.34 
Table 3.6. CV values (%) for within-session MMN mean neck amnlil : ude 
repeatability (between set 1, set 2 and set 3) obtained in each retest condition. 
Bold values = lowest inter-condition CV value indicating best repeatability 
Peak latency 
DDR 6.31 
DIR 5.30 
FIR 22.59 
Table 3.7. CV values (%) for inter-session MMN peak latency repeatability 
(between set 1, set 2 and set 3) obtained in each retest condition. 
Bold values = lowest inter-condition CV value indicating best repeatability 
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Figure 3.1. Individual MMN waveforms at Fz superimposed for each set 
obtained within-session in each recording condition. 
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Figure 3.2. Individual MMN 1,2 (within-session sets) and 3 (retest set) 
difference waveforms at electrode Fz in condition DDR. 
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Figure 3.3. Individual MMN 1,2 (within-session sets) and 3 (retest set) 
difference waveforms at electrode Fz in condition DIR. 
s02 s06 
Sll 
S1S 
S25 
s16 
s27 
-10 µV 
600 
msec 
10 
SET 1 SET 2 SET 3 
-79- 
Figure 3.4. Individual MMN 1,2 (within-session sets) and 3 (retest set) 
difference waveforms at electrode Fz in condition FIR. 
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3.4. Discussion 
The results of the present study show that the best short term and long term 
repeatability of the MMN was elicited using the duration increment deviant tone 
condition combined with a reading task. In this study, the physical difference 
between the duration deviants to the standard tones (50 ms vs. 100 ms) was greater 
than the difference between the frequency deviants to the standard tones (800 Hz vs. 
1000 Hz). There is a possibility that this factor may have contributed to the finding 
of better repeatability with use of the duration deviant when compared to the 
frequency deviants. However, it is not possible to make direct comparisons of the 
magnitude of frequency and duration deviant difference from the standard tones 
because different there are specific rules governing the relationship between a 
physical stimulus parameter and its perceptual scale (Stevens, 1957). Kujala et al. 
(2001) suggest that a greater physical difference between the standard and the 
deviant tone pairs, in the temporal domain, yields higher MMN re-test reliability and 
is supported by evidence from studies by Pekkonen et al. (1995b), Joutsiniemi et al. 
(1997) and Tervaniemi (1999). 
Pekkonen et al. (1995b) reported good long-term (1 month) test-rest stability of 
MMN amplitude using both frequency and duration deviants. However, only the 
duration condition yielded significant individual test-retest reliability assessed using 
Pearson product-moment correlation co-efficients. 
Joutsiniemi et al. (1997) found that a greater difference duration decrease 
deviant (25 msec vs. 75 msec) elicited a higher prevalence of clear MMN responses 
in a group of 40 healthy volunteers, assessed by visual inspection, compared to a 
smaller difference deviant (50 msec vs. 75 msec). However, although test-retest 
MMN waveforms in the 25 msec deviant condition appeared to be visually 
replicable, the repeatability failed to reach statistical significance using Pearson's 
product-moment of correlation and the authors suggest that better methods for MMN 
quantification should be employed for investigations involving clinical follow-up. 
The effect of duration, frequency and intensity deviant conditions on the test-retest 
reliability of the MMN was assessed by Tervaniemi et al. (1999). This study 
employed two different duration decrease deviant tones (33 and 66% decrease from 
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the standard), two different frequency deviants - one 10% increase and one 10% 
decrease from the standard, and one intensity decrease (-15 dB from 60 dB above 
subjective threshold) deviant. The duration deviant with the largest difference from 
the standard (66% decrease) yielded the highest test-retest correlation suggesting that 
a large physical difference from the standard elicits the most stable MMN. 
Both within-session and test-retest MMN repeatability was found to be better, as 
indicated by the CV values, for duration deviant conditions compared to frequency 
deviant conditions. This finding is in keeping with results from studies by Kathmann 
et al. (1999), Pekkonnen et al. (1995b) and Uwer & von Suchodoletz (1999). A 
possible explanation for the finding of better repeatability with the duration deviant 
conditions compared to frequency deviant conditions may be that the detection 
mechanism of the duration deviant may be more stable and less prone to interference 
than the frequency MMN. 
Giard et al. (1995) suggest that there may be two distinct locations for the 
supratemporal generators of frequency and duration MMN. In support of this theory, 
Frodl-Bauch et al. (1997) found from dipole source mapping that the location of the 
duration MMN generator is posterior and superior to the frequency generator on the 
supratemporal plane. Further evidence for different duration and frequency MMN 
generators is provided from the investigation of the duration and frequency MMN in 
schizophrenia (Michie et al., 2000). The stimulus parameters included duration 
increase deviants (100 ms vs. 50 ms standards), small frequency increment deviants 
(700 Hz vs. 633 Hz standards) and large frequency increment deviants (1000 Hz vs. 
633 Hz). The authors observed that the large frequency deviants yielded slightly 
smaller and considerably shorter latency MMNs, in controls, similar to the 
observations of the visually inspected frequency and duration MMNs obtained in this 
current study (Figure 3.1). Patients with schizophrenia showed significant duration 
MMN attenuation, compared to healthy controls, whereas no significant difference 
existed between the two groups in the small or large frequency deviant conditions 
although there was a reported trend towards significance in the latter condition. 
Liasis et al. (2000) also provide evidence from an intra-cranial single case study that 
different neuronal populations are activated in response to duration and frequency 
MMN. This finding also points towards a high degree of specialisation of echoic 
memory. 
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The finding of better MMN repeatability with the reading task conditions compared 
to the visual vigilance task conditions may be a demonstration of the effects of 
attention on MMN generation and stability. Kathmann et al. (1999) reported better 
MMN test-retest stability with use of a visual vigilance task, similar to the task 
employed in this study, however, this finding was in comparison to conditions where 
participants had no instructed focus for attention. In the current study, it is possible 
that reading self-selected text helped divert the participants' attention away from the 
auditory tones better than performing a monotonous vigilance task. Therefore there 
may have been different modulation of deviant tone N2 components in the repeat 
visual vigilance task sessions which contributed to greater MMN variation. 
Recently, Muller et al. (2002) reported that modality of attention results in 
MMN amplitude modulation for smaller magnitude deviant conditions compared to 
conditions with a larger difference between the standard and deviant stimuli. This 
study reports that performance of a concurrent auditory discrimination task, in a 
group of healthy volunteers, alters MMN amplitude elicited with small standard- 
deviant difference but this effect diminishes on retest with increasing automaticity of 
the task which leads to fewer demands on attention. Hence the authors suggest that 
although MMN amplitude, elicited by small deviant contrasts, is vulnerable to 
modulation from attention effect this is diminished with the course of task execution. 
Again the observation that visual task combined with frequency deviant condition 
yielded the poorest CV values substantiates the theory that conditions with small 
standard-deviant difference generate a more fragile MMN. Alternatively, it may be 
another piece of evidence to suggest that the frequency MMN is less stable than the 
duration MMN. One possible method of verifying the latter suggestion would be to 
repeat the current study using similar magnitude standard-deviant frequency and 
duration deviants. 
In conclusion, this study has demonstrated good short-term and long-term MMN 
repeatability with use of a duration increment deviant in combination with a reading 
task condition. This provides valuable information relating to optimal stimulus 
parameters for studies requiring repeated MMN measures as an index of echoic 
memory processing over a period of time. 
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Chapter IV 
BASELINE STUDY: ELECTROPHYSIOLOGICAL AND 
NEUROPSYCHOLOGICAL COMPARISON OF DIFFERENT SEIZURE 
TYPE GROUPS WITH HEALTHY CONTROLS. 
4.1. Introduction 
There is some evidence linking epilepsy and seizure type to the nature of cognitive 
function impairment assessed with neuropsychological testing. Hirtz & Nelson 
(1983) state that greater, and more diffuse, cognitive problems are seen in patients 
with generalised seizures compared to those seen in patients with focal seizures. As 
highlighted in the following studies, most research in this domain focuses on linking 
the site of the epileptic focus to focal cognitive disruption. 
Several studies have explored the effects of different types of epilepsy on memory 
function. Aikia et al (1995) found that although verbal learning memory function in 
patients with newly diagnosed cryptogenic partial epilepsy did not significantly vary 
from healthy controls, 52% of the patient group had at least mild impairment of 
delayed recall on the modified Rey's Auditory Verbal Learning Test (RAVLT) 
compared with only 15 % of controls. The authors postulate that newly diagnosed 
patients who have early memory deficits are likely to go on to develop intractable 
chronic epilepsy and are more vulnerable to the cognitive side-effects of anti- 
epileptic drug (AED) therapy. This idea is substantiated by later work (Aikia, 1999) 
which demonstrated that verbal memory impairment at the time of diagnosis of 
partial epilepsy, in association with EEG measures, could correctly predict the 2-year 
prognosis of these patients. 
Verbal semantic and episodic memory functions were investigated by Giovagnoli 
(1999) in patients with lateralised temporal lobe epilepsy (TLE) and also patients 
with extra-temporal lobe epilepsy (ExTLE). There was significant impairment of 
semantic memory in patients with left TLE compared to healthy controls. Episodic 
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memory was significantly impaired in patients with TLE and ExTLE compared to 
controls. 
Blake et al. (2000) prospectively examined long-term retention of memory in 
patients with TLE using a story recall test with a short (30 minute) and long (8-week) 
recall. The results showed that despite normal learning and retention over a shorter 
30-minute delayed recall, patients with left temporal foci performed poorly on the 8 
week recall test compared with those who had right sided foci and compared to 
healthy controls. The authors concluded that there is evidence for an extended 
period of memory consolidation which is disrupted when there is functional 
impairment of hippocampal-cortical interactions and that the critical region for this 
process, at least for verbal memory, is situated in the left temporal lobe. 
Bergin et al. (2000) found that remote memory function was significantly impaired in 
patients with TLE in comparison to healthy controls, whereas those with primary 
generalised epilepsy or ExTLE showed no significant difference to controls. 
Moreover, performance was unrelated to factors such as verbal IQ, educational 
achievement, social class or drug treatment. 
Some studies have demonstrated a link between epilepsy type and impairments in 
aspects of executive function. Giovagnoli (2001) investigated the modified 
Wisconsin Card Sorting Test (mWCST), short term memory and word learning 
performance in patients with frontal lobe epilepsy (FLE) and patients with TLE who 
had unilateral left or right sided lesions. This study found impaired mWCST 
performance in patients with left TLE compared to healthy controls. Furthermore, 
patients with left hippocampal sclerosis who had sorting impairment also had poorer 
learning scores than patients without sorting impairment. The authors suggest that 
only TLE patients with left hippocampal lesions are likely to be impaired on card 
sorting performance and that this may be due to involvement of the learning and 
associative functions that are subserved by the hippocampus. Left FLE patients had 
significantly impaired performance on the mWCST compared to controls and left 
TLE patients. Moreover, the left FLE group showed significant correlation between 
mWCST scores and attentive matrices test scores. Therefore, the authors suggest that 
sorting impairment in the left FLE group is probably due to attention deficits. The 
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authors conclude that different cognitive dysfunctions may contribute to sorting 
impairment in different focal epilepsy groups. 
There is also some evidence linking electrophysiological changes to epilepsy and 
seizure type. In contrast to the neuropsychology studies, some ERP studies reveal 
altered information processing even in the absence of apparent structural 
abnormalities. Drake et al. (1986) found N2 and P3b delay, and significantly larger 
P3b amplitude, with an auditory oddball task, in patients with cryptogenic complex 
partial seizures (CPS) with or without secondary generalisation compared to healthy 
controls. Soysal et al. (1999) also found significantly prolonged N2 and P3b latencies 
in patients with cryptogenic partial epilepsy (CPE) compared to healthy controls. 
ERP studies provide some evidence to suggest that epileptogenic foci arising from 
hippocampal disruption contribute to P3b aberration. The following studies have 
investigated how ERP components differ between seizure groups. Triantafyllou et al. 
(1992) compared ERP components between different seizure type groups and found 
that N2 and P3b latencies were significantly delayed in a TLE group compared to an 
idiopathic generalised epilepsy (IGE) group. Fukai et al. (1990) found significantly 
delayed P3b latencies in patients with TLE compared to an IGE group and a healthy 
control group. 
Trinka et al. (2001) found latency delays in auditory P3a, obtained with a passive 
oddball task, and P3b, obtained with a standard oddball task, from patients with 
localisation-related TLE. There was significant attenuation of P3a amplitude 
corresponding to right sided TLE in comparison to healthy controls. Interestingly 
there was no significant disruption of visually elicited P3a or P3b in the same group 
of patients. The authors suggest that modality specific P3 components may be useful 
for assessing the integrity of different information processing pathways. Abubakr and 
Wambacq (2003) found significantly smaller P3b amplitudes ipsilateral to the side of 
the epileptogenic focus recorded post-ictally (up to 6 hours post-seizure) compared to 
pre-ictal amplitudes in a group of patients with partial seizures with secondary 
generalisation. There was no difference in P3b amplitude recorded pre- and inter- 
ictally. The authors state that studies that restrict their analysis to electrodes at 
temporal scalp locations, hence neglecting electrophysiological changes occurring in 
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extra-temporal sources of the P3, may fail to yield P3b asymmetries linked to 
epileptogenic site. 
Pre- and post-surgery investigations also provide useful insight into the effects of 
epileptic foci on cognitive ERPs. Mervaala et al. (1992) found lateralising 
asymmetries in P3a and P3b amplitude, with attenuation corresponding to the 
hemisphere that contained or had previously contained the epileptogenic focus. This 
was noted both pre- and post-operatively in patients undergoing surgery for 
intractable TLE. There was also a pre- and post-operative delay of P3a and P3b 
components, compared to healthy controls, with no lateralisation. There was no 
significant correlation between ERP latency delay or amplitude reduction and 
performance on WAIS, Wechsler Memory Scale and tests of language and frontal 
lobe function. However, the authors suggest that the behavioural tests were designed 
for differentiating between inter-lobe profiles rather than inter-hemispheric effects. 
The effect of seizures on ERPs is difficult to assess from the results of this study as 
the patients were reported to be largely seizure free post-operatively therefore the 
reported P3 latency and amplitude changes may have resulted from surgical 
excisions rather than epilepsy alone. This possibility is supported by a similar study 
conducted by Nishitani et al. (1999) which reports post-operative attenuation of 
scalp-recorded P3b amplitude over temporal regions corresponding to the resected 
side, whereas pre-operatively the amplitude had been symmetrical and comparable to 
a healthy control group. Several other studies also show preservation of scalp- 
recorded P3 amplitude regardless of lateralised epileptic focus site (Wood et al., 
1982; Johnson et al., 1988; Nelson et al., 1991; Puce & Bladin, 1991 and Verma et 
al., 1993). 
There is some further evidence to suggest that ERPs may be preserved in the 
presence of partial epilepsy. Verleger et al. (1997) found significantly delayed NI, 
N2 and P3b latencies in patients with IGE compared to healthy controls, whereas no 
significant ERP changes were observed in a partial epilepsy group. However, the 
partial seizure group, but not the IGE group, had significantly impaired performance 
on RAVLT. The authors suggest that ERP delay in the IGE group may result as a 
consequence of seizure activity causing general slowing of brain processes. 
-87- 
Chapter IV 
The aim of the current study was to investigate the effect of seizure type on cognitive 
function using a wide range of event-related potential (ERP) and neuropsychological 
tests. The contributions of AED treatment effects were assessed by including a group 
of non-epileptic patients who were on AED therapy for the management of chronic 
pain conditions. 
Hypotheses 
It was hypothesised that the seizure groups in this study would show differences in 
cognitive performance depending on the nature of their seizures, and that the pain 
group would show similarities in performance to the healthy control group. The 
following hypotheses underlie the basis of this investigation: 
The PGS and FSG groups will show non- specific cognitive impairments i. e. deficits 
in frontal lobe function tests (WCST, planning and SWM) and temporal lobe 
function tests (RAVLT and story recall). 
The PGS group will show delay/attenuation of components affected by generalised 
electrophysiological disruption i. e. MMN, P3a and P3b components. 
The FSG groups will show delay/attenuation of components with neural generator 
locations within structures of the temporal lobe, and also components affected by 
generalised electrophysiological disruption i. e. MMN and P3b and also P3a. 
The FS group will show focal cognitive impairments i. e. deficits in tests of temporal 
lobe function (RAVLT and story recall). 
The FS group will show ERP delay/attenuation of components with neural generator 
locations within structures of the temporal lobe i. e. for MMN and P3b components. 
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4.2. Method 
4.2.1. Subjects 
Thirty-six individuals with clinically diagnosed epilepsy were recruited through an 
out-patient epilepsy clinic. Six individuals taking anti-epileptic drug (AED) 
treatment for the management of a chronic pain condition were recruited through 
out-patient pain and facial pain clinics. Fourteen healthy control volunteers were 
recruited by advertisement to college and hospital staff and local members of the 
public. All participants declared themselves to be free from alcohol and drug abuse. 
Criteria for exclusion of participants from this study were any progressive 
neurological disorder, severe hearing, speech or vision impairment, and non-English 
speaking individuals. Neuropsychological and electrophysiological testing was only 
carried out if the epilepsy patients had been seizure free for at least 48 hours prior to 
the session. Table 4.1 shows details of sex, age and handedness for these three 
groups. The full demographic details for each individual participant are listed in 
Appendix I and Appendix II lists AED medication details. 
The epilepsy group was sub-classified depending on seizure type based on the 
International League Against Epilepsy (ILAE) Classification (see Table 1.1 in 
Chapter 1). Three seizure-type groups comprised 12 individuals with primary 
generalised seizures (PGS), 12 with focal seizures with secondary generalisation 
(FSG) and 12 with focal seizures (FS). Informed verbal and written consent, in 
accordance with the local research ethics committee, was obtained from all 
participants. Table 4.2 shows the demographic details for these seizure groups. 
Epilepsy Pain Controls 
Female 16 4 8 
Male 20 2 6 
Age (years) 36 47 34 
SD 10 12 11 
L handed 3 0 2 
R handed 33 6 12 
NART score 110 115 118 
SD 9 9 6 
Table 4.1. Summary of demographic data for the epilepsy, pain and healthy 
control groups. 
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PGS group FSG group FS group 
Female 4 5 7 
Male 8 7 5 
Age years 35 37 37 
SD 10 9 13 
L handed 1 2 0 
R handed 11 10 12 
Duration of epilepsy 15 13 13 
SD (years) 11 12 9 
NART score 110 109 112 
SD 9 8 9 
Table 4.2. Summary of demographic data for epilepsy seizure-type groups. 
4.2.2. Neuropsychological tests 
All participants completed a Hospital Anxiety and Depression (HAD) questionnaire 
and National Adult Reading Test (NART) at the start of each test session. Visual 
reaction time (simple and choice), spatial working memory (SWM) and planning 
tests were performed using the CANTAB neuropsychological test battery with the 
investigator providing all participants with a standard set of instructions. Appendix 
III lists further details of the tests used from the CANTAB test battery. A 
computerised version of the WCST was administered after a standard set of 
instructions provided by the investigator. Verbal memory was assessed using the 
RAVLT. This test involves presentation and recall of a 15-word list over 5 learning 
trials followed by a distracter trial and a final recall trial. Long-term verbal memory 
was assessed by presentation and recall of a 28 or 30 unit story from the Adult 
Memory and Information Processing test Battery (AMIPB) (Coughlan and Hollows, 
1985) or a comparable format story supplied by D. Upton, Institute of Neurology 
(personal communication), with immediate recall and delayed recall following a 30 
minute interval. Appendix Ell lists the stories and word lists used in this 
investigation. 
4.2.3. ERP tests and stimulus parameters 
For all ERP recordings participants were instructed to sit in a chair facing a centrally 
placed monitor, positioned 1 metre away, which displayed instructions for each test. 
For all ERP tests that did not involve reading or performing a visual vigilance task, 
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participants were instructed to fixate on a cross in the centre of the monitor in an 
attempt to minimise eye movements. All auditory tones, pure sinusoidal with 5 ms 
rise and fall time, were created using STIM software (Neuroscan 4.1) and delivered 
at 60 dB SPL through earphones. 
4.2.3.1. Mismatch negativity (MMN) recording 
Standard tones with 800 Hz frequency and 50 ms duration were presented with a 
frequency of 85% leading to a total of 850 presentations during each session. Rare 
deviant tones with 800 Hz frequency and 100 ms duration were used for 150 
presentations. Stimuli were presented at a rate of 2 tones per second. The deviant 
tones were interspersed among the frequent tones with a random distribution except 
that two deviant tones were never presented in immediate succession. 
Participants were instructed to begin reading text of their choice one minute before 
the test was commenced and to ignore the ensuing auditory events. They were 
instructed to continue reading throughout the test until asked to stop by the 
investigator. 
4.2.3.2. P3b standard oddball recording 
Frequent auditory stimuli (non-targets) with 1000 Hz frequency and 200 ms duration 
(P= 0.85) were presented 255 times. Rare deviant tones (targets) with 1500 Hz 
frequency and 200 ms duration (P= 0.15) were presented 45 times. Stimulus 
presentation rate was 1 per second. The target tones were interspersed with a random 
distribution among the non-target tones except that two or more target tones were 
never presented in immediate succession. 
Participants were instructed to press a button on a response keypad, using their 
dominant hand, as quickly as possible each time they heard a target tone. 
All subjects were administered with an initial practice run, comprising a short series 
of target and non-target tones, to ensure that they could distinguish between the 
different tones. When subjects were able to correctly identify 3 successive target 
tones they were administered with the complete test. 
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4.2.3.3. Pia novel sounds task recording 
Standard non-target auditory stimuli with 1000 Hz frequency and 200 ms duration 
(P= 0.7) were presented 210 times. Rare target deviant tones with 1500 Hz frequency 
and 200 ms duration (P= 0.15) were presented 45 times. Individual, rare non-target 
"novel" sounds, for example emulations of a dog bark, train, bell chime etc., all with 
200 ms duration were also presented 45 times. Stimulus presentation rate was 1 per 
second. The target tones and non-target novel sounds were interspersed with a 
random distribution among the frequent tones. Two or more deviant or novel stimuli 
were never presented in succession. Also, deviant tones and novel sounds were never 
presented in succession of each other. 
Participants were instructed to press a button on a response keypad, using their 
dominant hand, as quickly as possible, each time they heard a target tone. They were 
instructed to ignore all other tones including any novel sounds. All subjects were 
administered with an initial practice run, comprising a short series of target and non- 
target tones, to ensure that they could distinguish between the different tones. When 
subjects were able to correctly identify 3 successive target tones they were 
administered with the complete test. 
4.2.3.4. Dual target oddball (DTO) task recording 
This test required participants to perform a visual vigilance task in addition to 
concurrently performing the standard P3b oddball task. The visual pattern consisted 
of a series of regular parallel black and white lines starting with a horizontal 
orientation. Throughout the test, the orientation of the lines alternated between 
horizontal and vertical with varying intervals not in excess of 20 seconds. The 
standard, frequent auditory tones with 1000 Hz frequency and 200 ms duration (P= 
0.85) were presented 255 times. The rare, target deviant tones with 1500 ms 
frequency and 200 ms duration (0.15) were presented 45 times. A total of 24 visual 
changes were presented concomitantly with the frequent auditory stimuli. Auditory 
stimulus presentation rate was l per second. The target auditory tones and target 
visual changes were interspersed randomly among the frequent non-target auditory 
tones. Two or more deviant tones never occurred in succession, also, deviant tones 
and visual changes never occurred simultaneously or in succession. 
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Participants were instructed to press a button on a response keypad, using their 
dominant hand, as quickly as possible, each time they heard a deviant tone. In 
addition to this, they were instructed to silently count the number of changes to the 
pattern on the screen. Before the test was carried out, a practice test was administered 
in order to minimise learning error. The practice test was carried out until 
participants correctly counted 3 successive visual targets and correctly responded to 
3 consecutive auditory targets. Immediately after the end of the test, participants 
were asked to verbally report the total number of visual changes that had they 
managed to count. 
4.2.4. ERP recording procedures 
The electroencephalogram was recorded from the scalp by attaching silver/silver- 
chloride electrodes, using Ten-20 conductive paste, in accordance with the Standard 
International 10-20 Electrode Placement System (Jasper, 1958). The electrode 
locations were Fz, Cz, Pz, F3, F4, P3 and P4. These were all referred to linked 
mastoid electrodes. Linked mastoids appear to be the prevalent choice of reference in 
scalp- recorded ERP investigations as they contribute smaller amounts of myogenic 
and movement- related artefact contamination to the signal of interest compared to 
most non-cephalic references (e. g. nose). Limitations of this reference in its use with 
epilepsy patients are discussed in Chapter 8 (section 8.1.8). A ground electrode was 
attached at Fpz. The electro-oculogram (EOG) was recorded by attaching a set of 
bipolar electrodes at the outer canthus of each eye to monitor horizontal movements 
and another set of bipolar electrodes above and below the right eye to monitor 
vertical movements. 
Neuroscan version 4.1 software (Neuroscan Inc., Sterling, Virginia) was used to 
record the EEG in continuous acquisition mode. All signals were amplified with a 
band pass of 0.15 Hz to 100 Hz. The continuous EEG data was processed off-line to 
correct for ocular contributions. The data was then epoched starting at 100 ms before 
stimulus onset and ending at 500 ms after for the MMN and 1000 ms after for the 
oddball and novel sounds ERPs. Artefact rejection, using trial-based epochs, was 
performed to exclude any epochs containing data outside the amplitude range of +70 
µV. Baseline correction was performed using the 100 ms pre-stimulus interval. The 
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artefact and baseline corrected epochs were sorted into averages according to 
stimulus type as detailed below. The averages were filtered offline, using a zero- 
phase shift digital filter, with a low-pass filter value of 30 Hz cut-off. 
4.2.5. ERP data analysis 
All ERP amplitude measures were taken with respect to the pre-stimulus corrected 
baseline. All ERPs elicited using the oddball and novel sounds tasks were measured 
for sub-components Ni, N2 and P3. 
4.2.5.1. MMN analysis 
A MMN difference waveform was obtained by subtracting the averaged responses to 
the frequent standard tones from the averaged responses to the rare deviant tones. 
The difference waveform was measured to obtain values for peak latency, onset, 
offset and duration at the electrode where the response was maximal and/or easiest 
to identify (Fz, Cz or F4). Values for mean peak amplitude (mpa) (peak ±10 ms) 
were taken at electrodes Fz, Cz, Pz, F3 and F4 using the peak latency identified at the 
electrode where the response was maximal. 
4.2.5.2. P3b standard oddball task analysis 
P3b peak amplitude and latency measures were taken from the averaged responses to 
the rare target auditory tones at electrodes Cz, Pz, P3 and P4. 
4.2.5.3. P3a novel sounds task analysis 
P3a peak amplitude and latency measures were taken from the averaged responses to 
the novel auditory sounds at electrodes Fz, Cz, F3 and F4. 
4.2.5.4. DTO task analysis 
P3b peak amplitude and latency measures were taken from the averaged responses to 
the rare auditory target sounds at electrodes Cz, Pz, P3 and P4. Responses to the 
visual targets were averaged and measured for peak amplitude and latency at 
electrodes Cz, Pz, P3 and P4. 
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4.2.6. Statistical analyses 
All clinical, neuropsychological and ERP results were analysed using one-way 
ANOVA with post-hoc Dunnett's test, using a Bonferroni corrected significance cut- 
off level of 0.017, to account for multiple comparisons (3 seizure groups individually 
compared to one normal control group =3 paired comparisons). A separate 2-tailed 
independent t-test was performed to compare the pain group results with the healthy 
control group using a 0.05 significance level. 
4.3. Results 
4.3.1. Demographic measures 
Tables 4.1 and 4.2 show a summary of demographic measures of the different 
participant groups. There was no difference in distribution of sex and handedness 
between the epilepsy patient group and healthy controls. The epilepsy group and 
healthy control group did not significantly differ in terms of age, however, the pain 
group was significantly older than the healthy control group (p<0.05). The different 
seizure-type groups showed no significant age difference when compared separately 
to the normal control group with a one-way ANOVA. 
The healthy control group showed significantly higher IQ scores, assessed using the 
NART test, when compared to the epilepsy group (p= 0.003 with independent t-test). 
However, there was no significant seizure group effect when the sub-groups were 
compared to the healthy controls using a one-way ANOVA. The pain group IQ 
scores did not differ significantly from the healthy control group. There was no 
significant difference for duration of epilepsy between the three seizure groups. 
4.3.2. Clinical and neuropsychological measures 
4.3.2.1. HAD results 
Figures 4. la and 4.1b show the HAD scores for the different seizure type groups, the 
healthy control group and the pain group. There were no significant differences in 
anxiety and depression scores between the seizure groups compared to the healthy 
control group. The pain group had significantly higher depression scores compared 
to the healthy control group (p =0.045 using an independent t-test). 
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Figures 4.1a and 4.1b. HAD anxiety (a) and depression scores (b) for healthy 
control group, different seizure type groups and pain group at baseline. 
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4.3.2.2. WCST results 
Figures 4.2a and 4.2b show WCST total error and perseverative error scores across 
the different experimental and control groups. Tables 4.3a and 4.3b show a summary 
of the main statistical findings. There was a significant group effect on total error 
score with comparison of the seizure groups to controls (p= 0.017). Group effect 
showed a trend towards significance for perseverative error score (p= 0.080). 
Post-hoc Dunnett's test, with Bonferroni correction at the p<_ 0.017 level, revealed 
that the PGS group had a significantly higher total error score compared to healthy 
controls (p= 0.017). Perseverative error score was also higher for the PGS group 
compared to controls (p= 0.033), however, this finding failed to reach the corrected 
significance level. 
There was no significant difference in task performance between the pain and 
healthy control groups. 
d. f. F 
Total errors 3,42 3.82 0.017* 
Perseverative errors 3,42 2.409 0.080 
Table 4.3a. Seizure groups vs. control group: WCST baseline summary of group 
effects with p<_ 0.1 from one-way ANOVA analysis. 
Mean SD Uncorrected Bonferroni 
Error Significance corrected 
score (p<0.05) Significance 
(<0.017) 
Seizure g roups vs. control group 
TE -controls 19.07 10.99 
TE - PGS 33.92 20.80 --- 
ý- 0.017* 
PE -controls 7.43 3.52 
PE -PGS 12.25 
7 6.63 ý0.033* 
Table 4.3b. Seizure groups vs. control group: WCST baseline summary of post- 
hoc Dunnett's test results with p<_ 0.1. 
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Figure 4.2a and 4.2b. WCST total error (a) perseverative error (b) scores for 
the different seizure type groups, the healthy control group and the pain group 
at baseline. 
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4.3.2.3. Visual reaction time results 
This test provided measures of simple and choice movement and reaction time. 
Reaction time (RT) represents the speed with which a subject releases a press pad in 
response to a visual stimulus and movement time (MT) is the time taken to touch the 
stimulus after the press-pad has been released. Tables 4.4a and 4.4b show a summary 
of the main statistical findings. Comparison of the seizure groups to controls showed 
that group effect was significant for simple RT (p= 0.033) and showed a trend 
towards significance for choice RT (p= 0.081). Group effect was also significant for 
simple MT (p= 0.043) and for choice MT (p= 0.008). 
Dunnett's post-hoc tests showed that the FSG group had significantly slower simple 
RTs compared to healthy controls (p= 0.011). Simple MT was slower for the PGS 
group (p= 0.090), FSG group (p= 0.029) and the FS group (p= 0.095) compared to 
controls but these findings failed to reach the corrected significance level. Choice RT 
was slower for the FSG group compared to controls (p= 0.034) but this also failed to 
reach the significance at the corrected level. Choice MT was significantly slower for 
the FSG group compared to controls (p= 0.004). Choice MT was also slower for the 
other seizure groups compared to controls -PGS group (p= 0.037) and FS group (p= 
0.050), however, these failed to reach the corrected significance level. 
The pain group had significantly delayed choice RT, simple MT and choice MT 
compared to the healthy control group (independent samples t-test p= 0.003,0.017 
and 0.004 respectively). 
d. f. F 
Simple RT 3,46 3.16 0.033* 
Choice RT 3,46 2.39 0.081 
Simple MT 3,46 2.93 0.043* 
Choice MT 3,46 4.41 0.008* 
Table 4.4a. Seizure groups vs. control group: visual RT test baseline summary 
of group effects with p<_ 0.1 from one-way ANOVA analysis. 
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Mean SD Uncorrected Bonferroni 
Time Significance corrected 
(msec) (p<-0.05) Significance 
(p: 50.017) 
Seizure groups vs. control group 
Simple RT - 
controls 
- 
! 339.64 
-- - 
65.74 
--- --- - 
! 
--- -- -- 
! 
Simple RT - 
i 
FSG 481.08 130.94 i 0.011* 
Choice RT - 
controls 324.64 43.01 
Choice RT - 
FSG 438.08 161.87 0.034* 
Simple MT - 
controls 311.64 87.96 
Simple MT - 
PGS 
-. . - --'-. -504`67_.. _. 
225.01 0.090 
__-. _- 
»- 
--- - Simple MT - 
FSG 548.67 249.20 0.029* 
Simple MT - 
FS 502.20 302.18 0.095 
Choice MT 
controls 315.36 77.34 
Choice MT -! 
PGS 431.58 121.10 0.037* 
Choice MT - 
FSG 469.08 114.67 0.004** 
Choice MT - ! 
FS 425.50 143.26 0.050* 
Table 4.4b. Seizure groups vs. control group: visual RT test baseline summary 
of post-hoc Dunnett's test results with p<_ 0.1. 
4.3.2.4. SWM results 
This test provides measures for SWM between errors, total errors, within errors, 
double errors and a strategy score. Between errors, calculated for trials with 4 or 
more tokens only, represent the number of times a subject revisits a box in which a 
target token has previously been found. Within errors, calculated for trials with 4 or 
more tokens only, represent the number of errors made within a search i. e. the 
number of times a subject revisits a box already found to be empty during that same 
search. Double errors, calculated for trials with 4 or more tokens only, represent the 
number of times a subject commits an error that can be categorised as both a within 
and a between error. Strategy score represents the use of a predetermined sequence 
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to complete the task. Owen et al. (1990) suggest that an efficient strategy is to begin 
each search sequence with a specific box and then return to that same box, after a 
token has been found, to start the new search sequence. A high score represents poor 
use of this strategy and a low score corresponds to efficient strategy use. 
The results of this study failed to find any significant group effect on SWM 
performance with comparison of the individual seizure groups the control group. 
The pain group showed significantly lower double error scores compared to controls 
(independent t-test p= 0.039) but a significantly higher strategy score i. e. poorer 
strategy score than controls (p= 0.016). There was a trend towards significance for 
lower within error scores for the pain group compared to controls (p= 0.063). 
4.3.2.5. Planning (Stockings of Cambridge/Tower of London test) results 
This test provides measures of mean initial thinking time (MIT), mean subsequent 
thinking time (MST) and the number of problems solved in minimum moves 
(PSMM). These measures are taken at different levels of task complexity ranging 
from 2 to 5 move tasks. Initial thinking time represents the difference in time taken 
for the subject to select the first ball for the same problem in the copy and follow 
conditions. The PSMM score is an indication of the number of occasions that a 
subject manages to successfully complete a test problem in the minimum possible 
number of moves. 
Tables 4.5a and 4.5b show a summary of the main statistical findings. With 
comparison of the different seizure groups to the healthy control group, a significant 
group effect was found for MST at the 3-move level (p= 0.024). Post-hoc Dunnett's 
test showed slower MST, at the 3- move level, for the PGS group compared to 
controls (p= 0.020) but this failed to reach the corrected significance level. 
There was no significant difference in task performance between the pain group 
compared to the control group. 
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d. f. F 
MST 3-move level 3,43 3.49 0.024* 
Table 4.5a. Seizure groups vs. control group: Tower of London (planning) test 
baseline summary of group effects with p<_ 0.1 from one-way ANOVA analysis. 
Mean SD Uncorrected Bonferroni 
Time Significance corrected 
(msec) (p: 50.05) Significance (P: 50.017) 
Seizure groups vs. control group 
MST 3-move 
level -controls 322.57 448.96 
MST 3-move 
level - PGS 1266.75 1482.24 0.020* 
Table 4.5b. Seizure groups vs. control group: Tower of London (planning) test 
baseline summary of post-hoc Dunnett's test results with p<_ 0.1. 
4.3.2.6. RA VLT results 
This test involves presentation and recall of a 15-word list, over 5 consecutive 
learning trials (trials 1 to 5) followed by a distracter trial, comprising 15 different 
words (trial 6), and a final recall trial (trial 7) for which the subject is required to 
recall the initial word list learnt during trials 1 to 5. Figures 4.3a, 4.3b, 4c and 4d 
show the RAVLT scores obtained for trials 1,5,6 and 7 for the seizure, pain and 
control groups. Tables 4.6a and 4.6b show a summary of the main statistical findings. 
Comparison of the different seizure groups to the healthy control group showed that 
there was a significant group effect on recall of trial 1 (p= 0.003), trial 5 (p= 0.035), 
trial 6 (p= 0.009) and trial 7 (p= 0.007). 
Post-hoc Dunnett's test revealed that recall scores for trial 1 for the FSG group were 
significantly lower than the control group (p= 0.001). Trial 5 recall scores were 
lower for the PGS group compared to the control group (p= 0.061) but this failed to 
reach the Bonferroni corrected significance level. Recall scores for the distracter list 
(trial 6) were significantly lower for the PGS group (p= 0.015) and for the FSG 
group (p= 0.018) compared to controls. The latter failed to reach significance at the 
corrected level. Recall scores after presentation of the initial word list, in trial 7, 
following presentation and recall of the distracter list, was significantly lower for the 
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FSG group (p= 0.005) and the FS group (p= 0.014). Trial 7 recall scores for the PGS 
group were also lower than controls (p= 0.065) but this finding failed to reach 
statistical significance. 
The pain group showed a trend towards significantly lower trial 7 recall scores 
compared to healthy controls (p= 0.054 with an independent samples t-test). 
d. f. F p 
Trial 1 recall 3,45 5.29 0.003** 
Trial 5 recall 3,45 3.12 0.035* 
Trial 6 recall 3,45 4.31 0.009** 
Trial 7 recall 3,45 4.60 0.007** 
Table 4.6a. Seizure groups vs. control group: RAVLT baseline summary of 
group effects with p<_ 0. lfrom one-way ANOVA analysis. 
Mean SD Uncorrected Bonferroni 
Recall Significance corrected 
score (p50.05) Significance 
(%) (p: 50.017) 
seizure groups vs. control group 
Trial 1- 
controls 48.07 12.87 
Trial 1- 
FSG 29.47 12.53 0.001*** 
Trial 5- 
controls 91.40 9.60 
Trial 5- 
PGS 73.93 17.27 0.061 
Trial 6- 
controls 47.60 1 13.07 
Trial 6- 
PGS 31.53 11.20 1 0.015* 
Trial 6- 
4 
FSG 32.20 14.13 0.018* 
Trial 7- 
controls 83.80 16.27 
Trial 7- 
PGS 63.67 14.73 0.065 
_ Trial 7- i V 
FSG 55.33 25.80 0.005** 
Trial 7- 
FS 58.87 26.93 0.014* 
Table 4.6b. Seizure groups vs. control group: RAVLT baseline summary of 
post-hoc Dunnett's test results with p<_ 0.1. 
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Figures 4.3a, 4.3b, 4.3c and 4.3d. RAVLT trial 1 (a), 5 (b), 6 (c) and trial 7 (d) 
scores for the different seizure type groups, pain group and healthy control 
group at baseline. 
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4.3.2.7. Story recall results 
Figures 4.4a and 4.4b show immediate and delayed story recall scores for seizure, 
pain and control groups. Tables 4.7a and 4.7b show a summary of the main statistical 
findings. Control vs. seizure groups comparison revealed a significant group effect 
on immediate story recall (p= 0.002) and delayed recall (p= 0.003). Retention scores, 
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which represent the proportion of story retained in the delayed recall compared to the 
immediate recall, were not significantly different for controls vs. seizure groups. 
Post hoc Dunnett's test revealed lower immediate recall scores for the PGS group 
(p= 0.002) and for the FSG group p= 0.006) and the FS group (p= 0.052) but the 
latter groups' results showed only a trend towards significance. Delayed recall, after 
a 30 minute interval, scores were significantly lower for the PGS group (p= 0.001) 
and the FSG group (p= 0.011) in comparison to controls. The FS group showed a 
trend towards significantly lower delayed recall scores compared to controls (p= 
0.062). The pain group also showed a trend toward significantly lower delayed recall 
scores compared to the control group (p= 0.068). There was no significant group 
difference for immediate recall and retention scores. 
d. f. F p 
Immediate recall 3,45 5.66 0.002** 
Delayed recall 3,45 5.53 0.003** 
Table 4.7a. Seizure groups vs. control group: story recall baseline summary of 
group effects with p<_ 0.1 from one-way ANOVA analysis. 
Mean SD Uncorrected Bonferroni 
recall Significance corrected 
sore (p: 50.05) Significance (%) (p: 50.017) 
Seizure groups vs. control group 
Immediate recall 
- controls 78.56 11.64 _ Immediate recall _ ý------- ----- -------- ---- - ---- 
- PGS 51.98 20.25 0.002** 
Immediate recall 
- FSG 
Immediate recall 
60.42 
--- 
24.13 0.006** 
- FS 69.45 14.76 0.052 
Delayed recall 
controls 70.92 12.36 
Delayed recall - 
PGS 40.67 22.81 0.001*** 
Delayed recall - 
FSG 50.89 
- 
24.50 
-- 
0.011* 
Delayed recall - 
t --- ' 
FS 61.90 20.54 0.062 
Table 4.7b. Seizure groups vs. control group: story recall test baseline summary 
of post-hoc Dunnett's test results with p5 0.1. 
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Figures 4.4a and 4.4b. Immediate (a) and delayed (b) story recall scores for the 
seizure, pain and healthy control groups at baseline. 
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Significant at p5 0.01 for groups 1 and 2 vs. 0 using one-way ANOVA and post-hoc 
Dunnett's test. 
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'ý**Significant at p<_ 0.001 for group 1 vs. 0 using one-way ANOVA and post-hoc Dunnett's test. 
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4.3.3. ERP behavioural results 
Button press latency values to the correctly detected target auditory tones in the P3b 
standard oddball task, P3a novel task and DTO task are summarised in Table 4.8. 
The accuracy scores of target auditory tone detection, for all tasks, and visual change 
detection, for the DTO task, are summarised in Table 4.9. 
Comparison of the different seizure groups to controls failed to show any difference 
in RT or accuracy of responses to target auditory tones for all three tasks. 
The pain group showed a trend towards significantly slower RTs to target tones in 
the standard oddball task compared to controls (p= 0.055). For the P3a novel sounds 
task, the pain group had significantly delayed RTs to target tones (p= 0.019) and 
significantly lower accuracy scores (p= 0.021) compared to controls. The pain group 
also showed significantly slower RTs to auditory targets in the DTO task (p= 0.015) 
and lower accuracy scores (p= 0.041) compared to controls. There was no significant 
difference in visual change detection accuracy in the DTO task for the seizure groups 
and pain group compared to controls. 
Control PGS FSG FS Pain 
P3b oddball task RT 312.52 321.42 352.96 337.68 345.63 (ms) 36.50 42.70 51.36 68 15 02 22 SD . . 
P3a novel task RT 360.24 368.48 383.28 371 33 408 38* (ms) 42.17 41.62 44.29 . 62 73 . 24 72 SD . . 
DTO task auditory 
target RT (ms) 
370.13 386.03 376.22 375.60 376.34* 
SD 
35.31 25.90 25.53 47.10 34.64 
Table 4.8. Button press latency values in response to correctly detected auditory 
targets in the standard P3b oddball test, the P3a novel sounds test and the DTO 
task, obtained at baseline. * p<_ 0.05 for pain group vs. control group using 
independent t-test. 
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Control PGS FSG FS Pain 
P3b oddball task 91.76 87.04 77.58 79.27 90.37 
accuracy (%) 9.76 23.82 21.73 21 69 10 86 SD . . 
P3a novel task 71.11 68.89 69.49 56.84 50.38* 
accuracy (%) 19.16 26.64 19.78 32.69 15.24 SD 
DTO task auditory 55.87 51.33 46.22 52.78 38.89* 
target accuracy (%) 14.45 17.31 23.71 23.47 18 93 SD . 
DTO task visual 95.83 92.71 88.89 96 30 97 22 target accuracy (%) 5.02 7.63 9.74 . 4.86 . 2.15 
SD 
Table 4.9. Target detection accuracy scores in t he standard P3b oddball test. the 
P3a novel sounds test and the DTO task, obtained at baseline. * p<_ 0.05 for pain 
group vs. control group using independent t-test. 
4.3.4. ERP results 
4.3.4.1. MMN results 
Tables 4.10 and 4.11 show a summary of the peak latency, onset, offset and duration 
measures from the main waveform and mean peak amplitude measures taken at 
electrodes Fz, Cz, Pz, F3 and F4. Figures 4.5a and 4.5b show the group averaged 
MMN difference waveforms obtained for the seizure groups compared to the healthy 
control group and for the pain group compared to the healthy control group. Tables 
4.12a and 4.12b show a summary of the main statistical findings. 
There was a trend towards significant group effect for MMN MPA at F3 (p= 0.067) 
and for MMN offset (p= 0.068) when the seizure groups were compared to the 
healthy control group. Dunnett's post-hoc test revealed that the PGS seizure group 
had longer MMN offset in comparison to healthy controls (p= 0.040) but this failed 
to reach the Bonferroni corrected significance level. 
There was no significant difference between MMN measures from the pain and 
healthy control groups. 
-109- 
Chapter IV 
Control PGS FSG FS Pain 
Peak lat. (ms) 169.90 185.43 189.17 184.91 170.17 
SD 30.08 16.97 26.42 19.04 15.08 
Onset (ms) 87.71 96.83 91.87 95.84 90.76 
SD 13.39 22.62 14.60 18.18 12.86 
Offset (ms) 226.98 244.26 240.72 239.78 235.52 
SD 13.31 24.04 12.83 17.44 12.31 
Duration (ms) 139.27 147.43 148.84 143.95 144.76 
SD 20.90 30.05 19.36 30.39 14.43 
Table 4.10. MMN peak latency, onset, offset and duration values obtained at 
baseline. 
Control PGS FSG FS Pain 
MPA at Fz (ms) -4.96 -5.37 -3.31 -5.54 -4.55 
SD 1.95 3.41 0.94 2.05 1.79 
MPA at Cz (ms) -4.90 -6.01 -3.78 -5.24 -4.40 
SD 1.76 3.12 1.40 2.20 1.49 
MPA at Pz (ms) -2.78 -3.99 -2.62 -2.94 -2.42 
SD 1.37 2.60 1.45 1.50 1.14 
MPA at F3 (ms) -4.48 -5.26 -2.87 -4.76 -4.03 
SD 3.75 3.75 1.15 1.66 1.48 
MPA at F4 (ms) -4.91 -4.65 -3.41 -5.46 -4.30 
SD 2.33 2.82 1.12 1.96 1.74 
Table 4.11. MMN mpa values, at electrodes Fz, Cz, Pz, F3 and F4, obtained at 
baseline. 
d. f. F 
MMN offset 3,46 2.53 0.068 
MMN MPA at F3 3,46 2.56 0.067 
Table 4.12a. Seizure groups vs. control group: MMN baseline summary of 
group effects with p<_ 0.1 from one-way ANOVA analysis. 
Mean SD 
Latency 
(msec) 
Uncorrected 
Significance 
(p<_0.05) 
Bonferroni 
corrected 
Significance 
(n: _0.017) 
Seizure groups vs. control group 
MMN offset - 
controls 226.98 [ 13.31 
MMN offset - 
PGS 244.26 24.04 0.040* 
Table 4.12b. Seizure groups vs. control group: MMN baseline summary of post- 
hoc Dunnett's test results with p<_ 0.1. 
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4.3.4.2. P3b standard oddball task results 
Tables 4.13 and 4.14 show a summary of the measures obtained at electrode Pz from 
the different experimental and control groups. Tables 4.15a and 4.15b show a 
summary of the main statistical findings. Figures 4.6a and 4.6b show the group 
averaged P3 waveforms, obtained in response to the auditory targets in the standard 
oddball task, for the seizure groups compared to the healthy control group and for the 
pain group compared to the healthy control group. 
Group effect was significant for Ni amplitude at Cz when the seizure groups were 
compared to the healthy control group (p= 0.012) and showed a trend towards 
significance for N2 amplitude (p= 0.061) and P3b amplitude (p= 0.072) also at Cz. 
Dunnett's post-hoc tests revealed larger Ni amplitude for the PGS group compared 
to healthy controls at Cz (p= 0.020) and also larger N2 amplitude at Cz (p= 0.090) 
for the PGS group. However, these post-hoc findings failed to reach the Bonferroni 
corrected significance level. 
There was no significant difference in Ni, N2 or P3b measures between the pain and 
healthy control groups. 
Control PGS FSG FS Pain 
N1 lat. (ms) 103.18 96.76 91.21 96.11 96.24 
SD 18.67 10.79 13.59 13.89 7.18 
N2 lat. (ms) 201.78 216.83 222.77 214.77 212.44 
SD 20.46 31.84 20.85 33.19 14.66 
P3b lat. (ms) 340.95 344.91 359.72 350.72 350.07 
SD 29.08 26.50 26.44 29.33 35.52 
Table 4.13. Peak latency values for N1, N2 and P3b components, measured at 
Pz, obtained with the standard oddball task at baseline. 
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Control PGS FSG FS Pain 
Ni amp. (µV) -4.18 -5.74 -3.45 -3.71 -3.89 
SD 2.81 2.43 1.49 3.43 1.85 
N2 amp. (pV) -2.71 -4.03 -2.32 -1.45 -0.33 
SD 3.33 3.31 4.92 3.69 2.84 
P3b amp. (pV) 11.20 9.09 10.53 11.79 9.12 
SD 5.89 4.99 5.96 6.16 3.34 
Table 4.14. Peak amplitude values for Ni, N2 and P3b components, measured 
at Pz, obtained with the standard oddball task at baseline. 
d. f. F p 
amp. at Cz Ni 3,46 4.10 0.012* 
N2 amp. at Cz 3,46 2.63 0.061 
P3 amp. at Cz 3,46 2.49 0.072 
Table 4.15a. Seizure groups vs. control group: standard oddball task baseline 
summary of group effects with p<_ 0.1 from one-way ANOVA analysis. 
Mean SD Uncorrected Bonferroni 
Amp. Significance corrected 
(µV) (p: 50.05) Significance 
(1)50.017) 
seizure groups vs. control group 
N1 amp. at Cz 
-controls -6.96 2.85 
Ni amp. at Cz 
-PGS -10.99 4.60 0.020* 
N2 amp. at Cz 
-controls -5.75 4 ý - ý- +- N2 amp. at Cz -- .. __. -F-- I -- 
= --- -! ------- -- ----- -- -ý--- --- ýý-- ,i-- 
-PGS -10.70 6.38 0.090 
Table 4.15b. Seizure groups vs. control group: standard oddball task baseline 
summary of post-hoc Dunnett's test results with p<_ 0.1. 
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Figure 4.6a. Group averaged waveforms obtained at baseline, in response to 
target tones in the standard oddball task, from the seizure groups and the 
healthy control group. 
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Figure 4.6b. Group averaged waveforms, obtained at baseline in response to 
target tones, in the standard oddball task, from the pain group and the healthy 
control group. 
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4.3.4.3. P3a novel sounds task results 
Tables 4.16 and 4.17 show a summary of the measures obtained at electrode Cz from 
the different experimental and control groups. Tables 4.18a and 4.18b show a 
summary of the main statistical findings. Figures 4.7a and 4.7b show the group 
averaged P3 waveforms, obtained in response to the novel non-target sounds, in the 
P3a novel sounds task, for the seizure groups compared to the healthy control group 
and for the pain group compared to the healthy control group. 
Group effect was significant for N1 amplitude at Cz when the seizure groups were 
compared to the healthy control group (p= 0.013). Dunnett's post-hoc test revealed 
that Ni amplitude for the PGS group was larger than the healthy control group (p= 
0.035) at Cz, however, this failed to reach the corrected significance level. 
Also with comparison of the seizure groups to controls, group effect showed trends 
towards significance for N2 latency at F3 electrodes Fz (p= 0.095), Cz (p= 0.08) and 
F3 (p= 0.054). However, post-hoc analyses failed to yield any significant group 
differences. There were no significant differences revealed with Dunnett's pot-hoc 
tests in P3a latency and amplitude measures from the different seizure groups 
compared to controls. 
The pain vs. control group comparison revealed that NI latency was significantly 
longer at Cz in the pain group compared to controls (p = 0.044 using independent t- 
test) and showed a trend towards significant delay at F3 (p= 0.057) and F4 (p= 
0.063). 
Control PGS FSG FS Pain 
N1 lat. (ms) 99.20 109.28 107.60 104.12 111.48* 
SD 9.77 10.70 15.57 16.18 15.49 
N2 lat. (ms) 189.61 208.57 202.11 182.75 201.60 
SD 14.60 42.21 17.73 23.64 25.51 
P3a lat. (ms) 267.74 274.93 290.29 266.15 262.79 
SD 18.78 30.97 39.44 23.73 17.01 
Table 4.16. Peak latency values for N1, N2 and P3a components, measured at 
Cz, obtained with the novel sounds task at baseline. *p5 0.05 pain group vs. 
control group. 
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Control PGS FSG FS Pain 
N1 amp. (µV) -6.61 -10.14* -5.81 -6.21 -6.28 
SD 2.60 2.86 3.99 4.26 3.05 
N2 amp. (µV) -6.45 -4.59 -6.00 -4.94 -4.13 
SD 4.04 5.09 6.21 4.72 3.81 
P3a amp. (ttV) 10.38 5.34 8.74 9.63 7.30 
SD 6.41 3.08 7.55 5.82 7.10 
Table 4.17. Peak amplitude values for Ni, NZ and P3a components, measured 
at Cz, obtained with the novel sounds task at baseline. *p<_ 0.05 PGS group vs. 
control group. 
d. f. F p 
amp. at Cz Ni 3,46 3.99 0.013* 
N2 lat. at Fz 3,46 2.25 0.095 
N2 lat. at Cz 3,46 2.40 0.080 
N2 lat. at F3 3,46 2.73 0.054 
Table 4.18a. Seizure groups vs. control group: novel sounds task baseline 
summary of group effects with p<_ 0.1 from one-way ANOVA analysis. 
Mean SD 
Amp. 
(AV) 
Uncorrected 
Significance 
(p: 50.05) 
Bonferroni 
corrected 
Significance 
(n: _0.017) 
PGS group vs. control group 
Ni amp. at Cz 
-controls -6.61 2.60 
Ni amp. at Cz 
-PGS -10.14 2.86 
Table 4.18b. Seizure groups vs. control group: novel 
summary of post-hoc Dunnett's test results with p<_ 0.1. 
_0.035* 
1 
sounds task baseline 
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Figure 4.7a. Group averaged waveforms obtained at baseline, in response to 
non-target sounds in the P3a novel sounds task, from the seizure groups and the 
healthy control group. 
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Figure 4.7b. Group averaged waveforms obtained at baseline, in response to 
non-target sounds in the P3a novel sounds task, from the pain group and the 
healthy control group. 
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4.3.4.4. DTO task results - auditory targets - Tables 4.19 and 4.20 show a summary 
of the measures obtained at electrode Pz from the different experimental and control 
groups. Tables 4.21a and 4.21b show a summary of the main statistical findings. 
Figures 4.8a and 4.8b show the group averaged P3b waveforms, obtained in response 
to the auditory targets in the DTO task, for the seizure groups compared to the 
healthy control group and for the pain group compared to the healthy control group. 
Comparison of seizure groups to the healthy control group revealed that there was 
significant group effect on NI amplitude at Cz (p= 0.01) and Pz (p= 0.01) and 
showed a trend towards significance at P3 (p= 0.082). Post-hoc Dunnett's testing 
revealed that N1 amplitude at Cz was significantly larger for the PGS group 
compared to the healthy control group (p = 0.017). 
Group effect showed trends towards significance for N2 latency at electrodes Cz (p= 
0.082), Pz (p= 0.082), P3 (p= 0.072) and P4 (p= 0.089). Post-hoc Dunnett's test 
revealed that N2 latency was delayed for the PGS group compared to controls at 
electrodes Cz (p= 0.035), Pz (p= 0.033), P3 (p= 0.028) and P4 (p= 0.036). However, 
these findings failed to reach the corrected significance level. 
There were no significant differences in Ni, N2 or P3b measures between the pain 
and healthy control groups although N2 latency showed a trend towards significantly 
delay at P3 (p= 0.057) and P4 (p = 0.072) using independent sample t-tests. 
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Control PGS FSG FS Pain 
N1 lat. (ms) 99.53 93.51 95.99 101.92 101.41 
SD 16.46 12.68 16.22 22.09 11.63 
N2 lat. (ms) 213.18 248.59* 234.18 231.16 234.91 
SD 20.71 42.01 30.58 36.51 29.91 
P3b lat. (ms) 338.01 365.72 366.65 352.39 355.50 
SD 37.50 30.67 36.07 22.78 61.55 
Table 4.19. Peak latency values for N1, N2 and P3b components, measured at 
Pz, obtained with auditory targets in the DTO task at baseline. *p<_ 0.05 PGS 
group vs. control group. 
Control PGS FSG FS Pain 
Ni amp. (µV) -4.36 -6.13 -3.70 -3.12 -4.81 
SD 1.91 2.75 2.05 1.46 2.53 
N2 amp. (µV) -2.28 -2.27 -3.07 -2.78 -1.35 
SD 3.82 2.86 2.92 3.88 3.27 
P3b amp. (pV) -8.17 -7.57 -6.03 -9.54 -7.02 
SD 5.55 3.54 3.20 6.28 3.18 
Table 4.20. Peak amplitude values for N1, N2 and P3b components, measured 
at Pz, obtained with auditory targets in the DTO task at baseline. 
d. f. F p 
amp. at Cz Ni 3,42 4.29 0.01** 
Ni amp. at Pz 3,42 4.27 0.01** 
Ni amp. at P3 3,42 2.39 0.082 
N2 lat. at Cz 3,42 2.39 0.082 
N2 lat. at Pz 3,42 2.39 0.082 
N2 lat. at P3 3,42 2.50 0.072 
N2 lat. at P4 3,42 2.32 0.089 
Table 4.21a. Seizure groups vs. control group: DTO task (responses to auditory 
targets) baseline summary of group effects with p_< 0.1 from one-way ANOVA 
analysis. 
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Mean SD Uncorrected Bonferroni 
AmpJlat. Significance corrected 
(µV/msec) (p50.05) Significance 
(p: 50.017) 
Seizure g roups vs. control group 
N1 amp. atCz 
-controls =6.98 ý 2.26 ! ý --- -- --- -... - -- ý- amp. at Cz Ni _ . _-_ - -- _ __- -- ----- - ----- -- ----- 
-PGS -10.41 4.49 0.017* 
N2 lat. at Cz - 
controls 213.17 20.22 
N2 lat. at Cz - 
PGS 247.50 39.93 0.035* 
N2 lat. at Pz 
controls 213.18 20.71 
N2 lat. at Pz - 
PGS 248.59 42.01 0.033* 
N2 lat. at P3 - 
controls 212 85 19.18 
N2 lat. at P3 - 
PGS 249.06 1! 41.02 0.028* 
N2 lat. at P4 - 
controls 213.84 21.17 
N2lat. atP4- 
PGS 11 248.75 42.35 i 0.036* 
Table 4.21b. Seizure groups vs. control group: DTO task (responses to auditory 
targets) baseline summary of post-hoc Dunnett's test with p<_ 0.1. 
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Figure 4.8a. Group averaged waveforms obtained at baseline, in response to 
auditory targets in the DTO task, from the seizure groups and the healthy 
control group. 
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Figure 4.8b. Group averaged waveforms obtained at baseline, in response to 
auditory targets in the DTO task, from the pain group and the healthy control 
group. 
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4.3.4.5. DTO task results - visual targets 
A large positive ERP component, with a latency of around 600 msec for healthy 
controls, was identified in the averaged responses to the visual targets. This 
component had maximal distribution at central and parietal electrodes and was 
labelled the P6 component for ease of reference. Tables 4.22 and 4.23 show a 
summary of the measures obtained at electrode Cz from the different experimental 
and control groups. Tables 4.24a and 4.24b show a summary of the main statistical 
findings. Figures 4.9a and 4.9b show the group averaged P3 waveforms, obtained in 
response to the visual targets in the DTO task, for the seizure groups compared to the 
healthy control group and for the pain group compared to the healthy control group. 
With comparison of the seizure groups to the healthy control group, there was a 
significant group effect on NI amplitude at Cz (p= 0.015) and trends towards 
significance at electrodes Pz (p= 0.067) and P3 (p= 0.084). Post-hoc Dunnett's test 
revealed that Ni amplitude at electrode Cz was significantly larger for the PGS 
group compared to the healthy control group (p= 0.005). N1 amplitude was also 
larger for the PGS group compared to healthy controls at Pz (p= 0.033) and P3 (p= 
0.035) but these findings failed to reach the corrected significance level. With 
comparison of the seizure groups to the healthy control group, there was a trend 
towards significant group effect on NI latency at Pz (p= 0.086) and P4 (p= 0.094). 
Post-hoc Dunnett's tests revealed Ni latency delay for the FSG group, compared to 
controls, at Pz (p= 0.023) and P4 (p= 0.033) however these findings failed to reach 
the corrected significance level. 
There was also a trend towards significant group effect on N2 latency at electrode P3 
(p= 0.069). N2 latency was significantly delayed for the FS group, compared to 
healthy controls at electrode P3 (p= 0.017). 
There was a trend towards significantly larger Ni amplitude for the pain group 
compared to the healthy control group at Cz (p= 0.081). There was also a trend 
towards significant Ni delay for the pain group at P3 (p= 0.059). 
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Control PGS FSG FS Pain 
Ni lat. (ms) 86.36 96.60 101.56* 95.60 94.43 
SD 9.20 15.87 19.52 16.06 13.02 
N2 lat. (ms) 349.63 360.14 354.41 382.22 364.79 
SD 19.82 31.77 42.01 48.15 16.63 
P6 lat. (ms) 579.48 574.72 595.48 593.56 606.22 
SD 27.82 38.00 33.11 55.57 50.63 
Table 4.22. Peak latency values for Ni, N2 and P6 components, measured at Cz, 
obtained with visual targets in the DTO task at baseline. *p<_ 0.05 using one-way 
ANOVA and post-hoc Dunnett's test. 
Control PGS FSG FS Pain 
Ni amp. (µV) 4.34 9.34** 6.62 7.41 6.95 
SD 2.61 4.81 2.87 3.99 3.51 
N2 amp. (µV) 3.48 5.61 4.17 4.65 4.48 
SD 2.91 2.99 4.29 4.02 3.78 
P6 amp. (µV) 13.07 13.51 7.69 9.70 8.96 
SD 7.88 6.41 4.80 6.49 6.37 
Table 4.23. Peak amplitude values for N1, N2 and P6 components, measured at 
Cz, obtained with visual targets in the DTO task at baseline. **p<_ 0.01 using 
one-way ANOVA and post-hoc Dunnett's test. 
d. f. F 
Ni amp. at Cz 3,42 3.93 0.015* 
Ni amp. at Pz 3,42 2.57 0.067 
Ni amp. at P3 3,42 2.37 0.084 
Ni lat. at Pz 3,42 2.35 0.086 
Ni lat. at P4 3,42 2.27 0.094 
N2 lat. at P3 3,42 2.55 0.069 
Table 4.24a. Seizure groups vs. control group: DTO task (responses to visual 
targets) baseline summary of group effects with p_< 0.1 from one-way ANOVA 
analysis. 
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Mean SD Uncorrected Bonferroni 
Amp. /lat. Significance corrected 
(µv/msec) (p50.05) Significance 
(<_0.017) 
Seizure groups vs. control group 
Ni Namp. at Cz 
______________- 
- controls -4.34 2.61 
N1 amp. at Cz 
- PGS -9.34 4.81 0.005** 
N1 amp. at Pz 
- controls -3.43 1.54 
N1 amp. at Pz 
- PGS -6.42 4.22 0.033* 
N1 amp. at P3 
- controls -2.59 1.28 
N1 amp. at P3 
- PGS -5.36 4.10 0.035* 
N1 lat. at Pz - 
controls 85.25 10.40 
N1 lat. at Pz - 
FSG 101.69 20.39 0.023* 
N1 lat. at P3 - 
controls 85.58 12.40 
Ni lat. at P3 - 
FSG 100.32 21.13 0.093 
N1 lat. at P4 - 
controls 84.37 12.47 
N1 lat. at P4 - 
PGS 97.69 17.77 0.077 
N1 lat. at P4 - 
FSG 100.48 20.09 0.033* 
N2 lat. at P3 - 
controls 352.17 19.40 
N2 lat. at P3 - 
FS 389.05 46.36 0.017* 
Table 4.24b. Se izure Erouus vs. contro l groun! DTO tack (recnnncPC to vice 
targets) baseline summary of post-hoc Dunnett's test results with p<_ 0.1. 
Lal 
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Figure 4.9a. Group averaged waveforms obtained at baseline, in response to 
visual targets in the DTO task, from the seizure groups and the healthy control 
group. 
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Figure 4.9b. Group averaged waveforms obtained at baseline, in response to 
visual targets in the DTO task, from the pain group and the healthy control 
group. 
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4.4. Discussion 
The main significant neuropsychology findings were obtained from the results of the 
word list learning (assessed with the RAVLT) and story recall tests. The FSG group 
showed significantly lower number of words recalled after the first presentation of a 
15 item word list. However, in the final learning trial (trial 5), where subjects are 
required to recall the same word list after its fifth presentation, there were no 
differences between the seizure groups in comparison to controls. When the 
distracter 15-item word list was presented (trial 6), the PGS and FSG groups showed 
poor recall in comparison to healthy controls. 
These results suggest that the PGS and FSG groups may be impaired in the 
early stages of learning of new information due to the lower recall in trial 6 for the 
former group and in trial 1 for the latter group. With delayed recall of the initial word 
list (trial 7), following presentation of the distracter list, all three seizure groups 
showed lower recall scores compared to controls but this difference failed to reach 
statistical significance for the PGS group. Interestingly, there was no significant 
difference in the retention score (% trial 7 score/trial 5 score) between the seizure 
groups compared to controls suggesting that despite slower learning, newly acquired 
information is preserved after a short distraction filled interval. 
Aikia et al. (1995) reported significantly reduced retention scores after a 
longer 90-minute delay in patients with newly diagnosed cryptogenic partial 
epilepsy. Due to the required 30-minute delayed recall of the story test, it was 
difficult to implement a longer delay for the list learning test in the current study in 
case the two tests confounded each other. 
The story recall results lend further support to the theory that the PGS and FSG 
groups may have impairments of learning new information. Immediate recall scores 
were significantly lower for both these groups in comparison to controls (PGS group 
p= 0.002 and FSG group p= 0.006). Moreover, recall after a 30 minute delay showed 
that these differences persisted (PGS group p= 0.001 and FSG group p= 0.001). Both 
immediate and delayed recall scores were also lower for the FS group compared to 
controls but these differences failed to reach the corrected significance level (p= 
0.052 and p= 0.062 respectively). 
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Similar to the word list learning test findings, the story retention scores (% 
delayed recall score/immediate recall score) showed no significant difference 
between the seizure groups and controls in this case after a longer 30 minute interval. 
Previous research by Blake et al. (2000) found no significant differences in 
immediate and 30-minute delayed recall when TLE patients, with unilateral 
epileptiform foci, were compared to healthy controls. Their left TLE group, however, 
showed significant impairments on very long term (8 week interval) recall and 
recognition, which they were able to assess as the patients were re-attending for 
follow-up out-patient appointments. The difference in the 30-minute delayed recall 
findings between the current study and those of Blake et al. 's study could be 
accounted for by methodological differences. The current study provided subjects 
with one presentation of the story, whereas Blake et al. required their participants to 
learn the story up to 90-100% correct over two to ten consecutive trials before they 
underwent delayed recall. However, although their patient groups showed lower 
recall scores in the learning trials compared to controls these differences were not 
statistically significant. 
The visual RT task showed that the FSG group had significantly slower simple and 
choice RTs compared to controls (p= 0.011 and p= 0.034 respectively) but the choice 
RT difference failed to reach the corrected significance level. Choice MT was also 
significantly slower for the FSG group compared to controls (p= 0.004) and for the 
PGS and FS group but the latter groups' results failed to reach the Bonferroni 
corrected significance level (p= 0.037 and p= 0.05 respectively). 
The ERP behavioural results in the form of RT and accuracy of target detection 
failed to reveal any significant differences between the seizure groups and controls. 
One notable finding was the lower accuracy scores to the auditory targets in the DTO 
task compared to accuracy of visual target scores. This was apparent for all groups 
including healthy controls. This may be explained by the fact that subjects were 
required to state the number of visual targets detected at the end of each test so they 
may have prioritised visual target detection at the cost of auditory target detection. 
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The results of the current study failed to reveal any significant MMN differences 
between seizure groups and healthy controls. Visual inspection of the waveforms and 
the group averages show that all 3 seizure groups had later peak latency, onset, offset 
and longer MMN duration compared to the healthy control group. However, 
statistical analysis failed to reveal any significant group effect possibly due to the 
fact that the 3 individual seizure groups showed similarities for these MMN 
parameters. The PGS group and FS group appeared to have larger MMN amplitudes 
compared to controls, whereas the FSG group showed smaller amplitudes. Again 
these differences failed to reach any statistical significance. 
There are relatively few studies that have explored MMN in relation to 
epilepsy. A preliminary study by Gene-Cos et al. (2000) demonstrated significantly 
smaller MMN amplitude in patients with epilepsy compared to patients with non- 
epileptic seizures and controls. As the MMN is the earliest recordable ERP response 
that differentiates between usual and unusual auditory stimuli its alteration probably 
relates to changes in underlying mechanisms which help capture attention to novel 
stimuli. The preservation of MMN in the different seizure groups demonstrated by 
the results of the current study suggests that pre-attentive processes are not impaired 
in patients with seizures in the inter-ictal phase. This theory is substantiated further 
by the P3a results. 
No significant group differences were found in P3a responses elicited in response to 
novel non-target sounds in the P3a novel sounds task. The PGS group had larger Ni 
amplitudes compared to the healthy control group (p<0.05) but this finding failed to 
reach statistical significance when accounting for multiple group comparisons. N2 
and P3a components appeared to be later for the PGS group compared to controls but 
these differences were not statistically significant. 
Trinka et al. (2001) reported significantly delayed P3 latencies to novel tones 
in patients with right sided TLE. The authors suggest that epileptogenic processes in 
their right sided TLE group may have been interfering with the normal hippocampal 
processes of novelty detection postulated by Knight (1996). 
The P3b obtained in response to targets in the standard oddball task also failed to 
show any significant differences when the individual seizure type groups were 
compared to the healthy control group. Again the NI component was noted to be 
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larger at Cz in the PGS group compared to controls (p= 0.020) but this finding failed 
to reach statistical significance when applying the Bonferroni correction for multiple 
comparisons. N2 and P3 latencies were longer for the individual seizure groups in 
comparison to controls but these differences were not statistically significant. 
Previous studies have reported significant delays of the P3b components, the 
majority of which are accompanied by N2 delays (Drake et al., 1986; Mervaala et al., 
1992; Triantafyllou et al., 1992; Verleger et al., 1997 and Soysal et al. 1999). 
However, previous research has focussed on comparing an individual seizure or 
epilepsy type group to healthy controls or direct comparison of 2 different seizure or 
epilepsy type groups. Hence the results of this current study may have failed to yield 
statistically significant findings due to the comparatively large number of epilepsy 
sub-groups and consequent multiple statistical comparisons. 
The P3b elicited in response to auditory targets in the DTO task failed to show any 
significant differences between the three seizure groups in comparison to controls. 
As with the ERPs obtained in the standard oddball task, the N2 and P3 latencies were 
longer for all three seizure groups compared to controls, however, these differences 
failed to reach statistical significance. NI amplitude was significantly larger for the 
PGS group compared to controls at Cz (p= 0.017). The ERPs elicited with the visual 
targets in the DTO task did show some significant group differences. As with the 
response to the auditory targets, N1 amplitude was significantly larger for the PGS 
group compared to controls at Cz (p= 0.005). N2 latency was delayed for the FS 
group, compared to healthy controls, at Cz (p= 0.037), P3 (p= 0.017) and P4 (p= 
0.036). However, the corrected significance level was only reached for N2 latency at 
electrode P3. N2 latency also appeared to be delayed for the FSG group but no 
statistical significance was found. The P6 component appeared to have smaller 
amplitude for the FSG and FS groups compared to healthy controls but this 
difference was not statistically significant. 
The P3 may be an index of the allocation of cognitive processing resources in 
complex or multi-component tasks (Strayer and Kramer, 1990). Therefore the higher 
cognitive demand of the oddball task with the DTO task may have been more 
sensitive for detecting cognitive differences between the patient and control groups 
included in the current study. Furthermore, the responses to the visual targets showed 
significant latency delay, as opposed to the auditory targets, in the FS group so there 
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is a possibility that modality specific P3 components may be reflecting the integrity 
of different information processing pathways as Trinka et al. (2001) suggest from 
their findings. This factor is difficult to assess from the patient groups included in the 
current study due to the lack of neuroimaging data. 
The pain group, which was included in this study in an attempt to assess the 
contributions of AEDs on cognitive function, also showed some significant 
differences to controls in cognitive ERP and neuropsychology results. There was 
significantly later MMN offset for the pain group compared to healthy controls (p= 
0.012) and also an Ni latency delay in the P3a novel task response. However, these 
early ERP changes were not noted with comparison of the seizure groups to controls 
suggesting that non-AED effects may be contributing to these pre-attentive 
processing delays. With the DTO task, the pain group showed trends towards 
significant N2 delay to the auditory target so there is a possibility that AED effects 
may be contributing to the N2 delays in the visual target observed in the FS group. 
However, there was a greater incidence of poly-therapy and higher AED dosage 
among the FSG group (see Appendix H) but the N2 delay to the visual targets for this 
group failed to reach statistical significance. 
The pain group showed no significant differences to healthy controls in their 
performance on the word list learning and story recall tests suggesting that the 
impairments observed in the seizure groups may be independent of AED effects. 
However, the pain group had significantly lower recall scores of the initial word list 
after presentation and recall of a distracter list compared to controls (p= 0.054). 
Hence there may be some AED effect on the ability to preserve information during a 
distraction-filled interval. Another possibility is that non-AED effects such as 
depression may be contributing to this impairment in the pain group. The pain group 
did show significantly lower double error scores but poorer strategy scores on the 
spatial working memory task compared to controls (p= 0.039 and p= 0.016 
respectively) suggesting that while they were able to perform this task well they were 
unable to formulate an effective method to facilitate their performance in this task. 
The pain group showed reaction time delays in both visual RT and behavioural ERP 
RT results. This group had significantly slower simple (p<0.05) and choice MT and 
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slower choice RT (p<0.005) compared to healthy controls in the visual RT task. The 
pain group also had slower responses to auditory targets in the P3a novel sounds task 
(p<0.05), the standard oddball task (p= 0.055) and the DTO task (p<0.05). They also 
had lower accuracy scores for target tone detection in the P3a novel task and the 
DTO task (p<0.05) which may also provide evidence that this group is more 
vulnerable to interference from distracters. 
The pain group results may be confounded by the significantly higher depression 
scores in this group compared to controls (p= 0.045). Another limitation of the 
inference of AED effects from the pain group results is that serum drug levels were 
not available at the time of cognitive testing for any of the patients included in this 
study. Patients all reported drug compliance and levels were assumed to be within 
the therapeutic range due to absence of reported side effect indicating toxicity. 
In summary, there were no significant differences in pre-attentive ERPs i. e. the 
MMN and P3a, between different seizure type groups compared to a healthy control 
group. The PGS group show significantly larger amplitude Ni components compared 
to controls in a DTO task. Despite not always reaching the corrected significance 
level, Ni amplitude was observed to be consistently larger for the PGS group, across 
all ERP tests. 
N2 components elicited in response to visual targets in the dual modality ERP 
task show significant delay for the FS group and the late positive component (P6) 
was attenuated for the FS and FSG groups although this difference was not 
statistically significant. 
Primary generalised and focal with secondary generalisation seizures may be 
associated with impairments in learning and recalling newly acquired information as 
shown by their significantly lower scores on the word list learning and story recall 
tests but the newly acquired information, seems to be preserved after a short 
distraction filled interval for the former and 30 minute delay for the latter test as 
indicated by the retention scores. 
The following chapter explores the differences in cognitive function between seizure 
groups and healthy controls approximately 1 year after baseline assessment. It 
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examines the cross-sectional findings comparing all the individuals re-tested at the 
12 month follow-up session. 
Chapter 6 goes on to explore the effects of time on cognitive performance by 
assessing the longitudinal results over three time points -baseline, 6-month follow-up 
and 12-month follow-up for the individuals who participated in all stages of the 
study. 
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Chapter V 
12-MONTH FOLLOW-UP CROSS-SECTIONAL STUDY: 
ELECTROPHYSIOLOGICAL AND NEUROPSYCHOLOGICAL 
COMPARISONS OF DIFFERENT SEIZURE TYPE GROUPS WITH HEALTHY 
CONTROLS. 
5.1. Introduction 
The aim of this study was to examine the effect of seizure type on cognitive function 
using event-related potential (ERP) and neuropsychology tests at a 12-month follow-up 
session. As for the baseline study (Chapter 4), it was hypothesised that seizure groups 
would show differences in cognitive performance depending on seizure type. The 
contributions of anti-epileptic drug (AED) treatment effects were assessed again by 
including a group on non-epileptic patients on AED therapy for the management of 
chronic pain. This study focuses on the cross-sectional results by investigating group 
differences for all participants at 12-month follow-up. Although comparisons are made 
between the results of this investigation and the baseline data, these made are on a 
qualitative basis. The results in Chapter 6 details a statistical investigation of the 
relationship between the results obtained at each time point of the investigation. 
5.2. Method 
5.2.1. Subjects 
Subjects participating in the baseline study (Chapter 4) were re-tested after a 12-month 
interval. Each individual was re-tested at the same time of day as their baseline session. 
28 of the 36 epilepsy patients who had participated in the baseline study were willing or 
able or to attend the follow-up session and all 14 healthy controls and 6 pain patients re- 
attended. Table 5.1 shows details of sex, age and handedness for these groups. For the 
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epilepsy patient group, 3 seizure sub-groups comprised 11 individuals with primary 
generalised seizures (PGS), 7 with focal seizures with secondary generalisation (FSG) 
and 10 with focal seizures (FS). Table 5.2 shows the demographic variables for these 
seizure groups. The full demographic details for each individual participant are listed in 
Appendix I. 
Epilepsy Pain Controls 
Female 12 4 8 
Male 16 2 6 
Age (years) 35 47 34 
SD 10 12 11 
L handed 3 0 2 
R handed 25 6 12 
NART score 111 115 118 
SD 9 9 6 
Table 5.1. Summary of demographic data for the epilepsy, pain and healthy control 
groups participating in the 12 month follow-up session. 
PGS group FSG group FS group 
Female 3 3 6 
Male 8 4 4 
Age years 35 33 35 
SD 10 9 12 
L handed 1 2 0 
R handed 10 5 10 
Duration of epilepsy 15 13 11 
SD (years) 12 10 7 
NART score 112 109 113 
SD 6 8 11 
Table 5.2. Summary of demographic data for epilepsy seizure-type groups 
participating in the 12 month follow-up session. 
5.2.2. Neuropsychological tests 
All subjects completed a Hospital Anxiety and Depression (HAD) questionnaire at the 
start of each session. They then completed a battery of tests identical to those 
administered at baseline (See Chapter 4 section 4.2.2. ), with randomly assigned parallel 
versions of the test administered where available i. e. visual reaction time (RT), Rey's 
Auditory Verbal Learning Test (RAVLT) and story recall tests. Appendix III lists further 
details of neuropsychology tests employed and a glossary of measures obtained from 
CANTAB tests. 
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5.2.3. ERP tests and stimulus parameters 
Participants were instructed to sit in a chair facing a centrally placed monitor, positioned 
1 metre away, which displayed the instructions for each test. For all ERP tests that did 
not involve reading or performing a visual vigilance task, they were instructed to fixate 
on a cross in the centre of the monitor in an attempt to minimise eye movements. As for 
baseline, all auditory tones were sinusoidal with 5 ms rise and fall time delivered 
through ear-phones at 70 dB SPL. 
5.2.3.1. MMN recording 
As for Chapter 4 section 4.2.3.1. 
5.2.3.2. P3b standard oddball recording 
As for Chapter 4 section 4.2.3.2. 
5.2.3.3. P3a "novel sounds" recording 
As for Chapter 4 section 4.2.3.3. The "novel" sounds that were used in the baseline task 
were re-administered in the re-test session. 
5.2.3.4. Dual target oddball (DTO) task recording 
As for Chapter 4 section 4.2.3.2. The number of visual targets was different to the test 
administered at baseline in case subjects were able to recall the number of targets they 
had counted in at baseline. The parallel versions of this test were randomly assigned. 
5.2.4. ERP recording procedures 
As for Chapter 4 section 4.2.4. 
5.2.5. ERP data analysis 
As for Chapter 4 section 5.2.5. 
5.2.6. Statistical analyses 
As for Chapter 4 section 4.2.5.5. 
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5.3 Results - 12-month follow-up cross-sectional results 
5.3.1. Demographic measures 
Tables 5.1 and 5.2 show a summary of the demographic measures of the different 
participant groups. There was no significant difference in age between the epilepsy and 
healthy control groups. However, as for the baseline demographic data, the pain group 
was significantly older than the healthy control group (p<_0.05). The epilepsy sub-groups 
showed no significant age difference according to seizure type. 
The healthy control group showed significantly higher IQ scores that had been assessed 
at baseline using the NART test (Nelson & Willison, 1991) (p= 0.03). However, there 
was no significant group effect when the individual seizure groups were compared to 
healthy controls. The pain group IQ scores did not differ significantly form the healthy 
control group. As at baseline, there was no significant difference for epilepsy duration 
between the three seizure groups. 
5.3.2. Clinical and neuropsychological measures 
5.3.2.1. HAD results 
Figures 5.1a and 5.1b show the HAD scores for the different seizure type groups, the 
healthy control group and the pain group. There were no significant differences in 
anxiety and depression scores between the seizure groups compared to the healthy 
control group. 
There were no significant differences in anxiety and depression scores between the pain 
group and healthy controls. 
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Figures 5.1a and 5.1b. HAD anxiety (a) and depression scores (b) for healthy 
control, pain and seizure groups at 12-month follow-up. 
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5.3.2.2. WCST results 
Figures 5.2a, 5.2b and 5.2c show WCST total error, non-perseverative error and trials 
administered scores. Tables 5.3a and 5.3b show a summary of the main statistical 
findings. There was a significant group effect on non-perseverative error score with 
comparison of the seizure groups to controls (p= 0.026). Group effect showed a trend 
towards significance for number of trials administered (p= 0.055) and for total error 
score (p= 0.089). There was no significant group effect on perseverative error scores. 
Post-hoc Dunnett's test revealed that the FSG group had higher total error scores 
compared to the healthy control group (p= 0.098) but this difference failed to reach 
statistical significance. 
The number of trial administered indicates the ease with which a subject completes the 
WCST. A large number of trials administered score corresponds to greater difficulty of 
task performance. The FS group had a higher number of trials administered score 
compared to controls (p= 0.058) but this failed to reach the Bonferroni corrected 
significance level. 
Non-perseverative error scores were higher for the PGS group compared to controls (p= 
0.031), however, this finding failed to reach the corrected significance level. The FSG 
and FS groups showed trends towards significantly lower non-perseverative error scores 
compared to controls (p= 0.062 and p= 0.065 respectively), however, these findings also 
failed to reach the corrected significance level. 
There was no significant difference in task performance between the pain and healthy 
control groups. 
d. f. F 
Non-perseverative errors 3,37 3.47 0.026* 
Trials administered 3,37 2.77 0.055 
Total errors 3,37 2.34 0.089 
Table 5.3a. Seizure groups vs. control group: WCST 12-month follow-up summary 
of group effects with p<_ 0.1 from one-way ANOVA analysis. 
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Mean SD Uncorrected Bonferroni 
Error Significance corrected 
score (p5O. 05) Significance 
(<_0.017) 
Seizure g roups vs. control group 
NPE -controls 5.71 1.94 
NPE -PGS 11_55 7.41 0.031 * 
NPE -FSG 12.00 6.78 0.062 } 
NPE -FS 
........ 11.00 ........... . 5.40 . _... .. .......... 0.065 
TA -controls _ ..... _-.. _ 
77.36 6.78 
_... _... __............... ......... ........ ......... _... _.. --. _. _... _ ..................... ........ . TA -FS 96.20 20.48 0.058 
TE -controls 12.71 2.30 
TE -FSG 26.83 18.27 0.098 
Table 5.3b. Seizure groups vs. control group: WCST 12-month follow-up summary 
of post-hoc Dunnett's test results with p<_ 0.1. 
Figure 5.2a, 5.2b and 5.2c. WCST total error (a) non-perseverative error (b) and 
trial administered (c) scores for healthy control, pain and seizure groups at 12- 
month follow-up. 
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5.3.2.3. Visual reaction time results 
This test provided measures of simple and choice movement and reaction time. 
Reaction time (RT) represents the speed with which a subject releases a press pad in 
response to a visual stimulus and movement time (MT) is the time taken to touch the 
stimulus after the press-pad has been released. Tables 5.4a and 5.4b show a summary of 
the main statistical findings. 
Comparison of the seizure groups to controls found no significant group effect on simple 
or choice RT. Group effect was significant for simple MT (p= 0.022) and showed a trend 
towards significance for choice MT (p= 0.055). 
Post-hoc Dunnett's tests showed that simple MT was significantly slower for the PGS 
group (p= 0.011) compared to controls. The PGS group also had slower choice MT 
compared to controls (p= 0.085) but this finding failed to reach statistical significance. 
Choice MT was significantly slower for the FSG group compared to controls (p= 0.032) 
at p<_0.05, however, this group difference failed to reach the corrected significance level. 
The pain group had significantly delayed choice RT, simple MT and choice MT 
compared to the healthy control group (independent t-test p= 0.039,0.052 and 0.030 
respectively). Simple reaction time showed a trend towards significant delay for the pain 
group compared to healthy controls (p= 0.069). 
d. f. F 
Simple MT 3,38 3.60 0.022 
Choice MT 3,38 2.76 0.055 
Table 5.4a. Seizure groups vs. control group: visual RT test 12-month follow-up 
summary of group effects with p<_ 0.1 from one-way ANOVA analysis. 
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Mean SD Uncorrected Bonferroni 
Time Significance corrected 
(msec) (p50.05) Significance 
(p: 50.017) 
Seizure groups vs. control group 
Simple MT 
controls 332.07 64.98 
Simple MT - 
PGS 429.18 146.67 0.011* 
Choice MT - 
' 
controls 344.57 73.25 
Choice MT - 
PGS 450.55 196.24 0.085 
Choice MT - i 
FSG 502.86 147.44 0.032* 
Table 5.4b. Seizure groups vs. control group: visual RT test 12-month follow-up 
summary of post-hoc Dunnett's test results with p<_ 0.1. 
5.3.2.4. Spatial working memory (SWM) results 
Figure 5.3 shows strategy scores across the experimental and control groups. There was 
a significant group effect on strategy scores when the seizure groups were compared to 
the healthy control group (F (3,37) =5.95, p= 0.002). Strategy score represents the use 
of a predetermined sequence to complete the task. Owen et al. (1990) suggest that an 
efficient strategy is to begin each search sequence with a specific box and then return to 
that same box, after a token has been found, to start the new search sequence. A high 
score represents poor use of this strategy and a low score corresponds to efficient 
strategy use. 
Dunnett's post-hoc test showed that the FSG group had higher strategy scores, i. e. 
poorer strategy use, (37.86 ± 3.29) compared to controls (28.00 ± 5.81) (p= 0.000) 
which reached significance at the corrected level. 
There was a trend towards significantly poorer strategy score for the pain group 
compared to the healthy control group (p= 0.073). 
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Figure 5.3. SWM strategy scores for healthy control, pain and seizure groups at 12- 
month follow-up. 
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***Significant at p50.001 for group 2 vs. 0 using one-way ANOVA and post-hoc Dunnett's test 
5.3.2.5. Planning test (Stockings of Cambridge/Tower of London test) results 
There was no significant group effect on task performance between the different seizure 
groups compared to the healthy control group. There was no significant difference in 
task performance between the pain group and healthy controls. 
5.3.2.6. RA VLT results 
Figures 5.4a, 5.4b, 5.4c and 5.4d show the RAVLT scores obtained for trials 6 and 7 for 
the seizure, pain and control groups. Tables 5.5a and 5.5b show a summary of the main 
statistical findings. Comparison of the different seizure groups to the healthy control 
group showed that there was a significant group effect on recall of the first trial (trial 1) 
(p= 0.004), the final leaning trial (trial 5) (p= 0.032) and the distracter trial (trial 6) (p= 
0.006). Group effect showed a trend towards significance for the final recall trial 
following the distracter trial (trial 7) scores (p= 0.062). 
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Post-hoc Dunnett's test revealed that recall scores for trial 1 for the FSG group were 
significantly lower than for the control group (p= 0.004) which reached the corrected 
significance level. The FS group also had lower recall scores for trial 1 compared to 
controls (p= 0.016) which also reached the corrected significance level. 
Trial 1 recall scores for the PGS group showed a trend towards being significantly lower 
than controls (p= 0.063). 
Trial 5 recall scores were significantly lower, at the corrected level, for the PGS group 
compared to the control group (p= 0.014). 
Recall scores for the distracter list (trial 6) were significantly lower for the PGS group 
(p= 0.005) and for the FSG group (p = 0.018) compared to controls. The PGS group 
finding for trial 6 recall reached the corrected significance level. 
Delayed recall scores of the initial word list (trial 7) following presentation and recall of 
the distracter list, were significantly lower for the PGS group compared to controls (p= 
0.037) but this difference failed to reach significance at the corrected level. 
The pain group had significantly lower trial 1 recall scores compared to healthy controls 
(p= 0.017) and they also had significantly lower trial 5 recall scores (p= 0.028). 
d. f. F p 
Trial 1 recall 3,37 5.23 0.004** 
Trial 5 recall 3,37 3.26 0.032* 
Trial 6 recall 3,37 4.83 0.006* 
Trial 7 recall 3,37 2.67 0.062 
Table 5.5a. Seizure groups vs. control group: RAVLT 12-month follow-up 
summary of group effects with p<_ 0.1 from one-way ANOVA analysis. 
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Mean SD Uncorrected Bonferroni 
Recall Significance corrected 
score (p50.05) Significance 
(%) (50.017) 
seizure groups vs. control group 
Trial 1- 
controls 58.60 8.33 
Trial 1- 
PGS 47.33 13.86 0.063 
Trial 1- 
FSG 40.00 10.13 0.004** 
Trial 1- -- -- -- ---- 
FS 44.67 13.55 0.016* 
Trial 5- 
controls 94.73 7.92 
Trial 5- 
PGS 76.97 20.43 0.014* 
Trial 6- 
controls ! 58.07 16.00 
Trial 6- 
PGS 37.33 15.77 1 0.005** 
Trial 6- 
FSG 38.07 15.26 0.018* 
Trial 7- 
controls 1 83.33 ! 16.69 
Trial 7- i 
PGS ! 60.67 26.57 0.037* 
Table 5.5b. Seizure groups vs. control group: RAVLT 12-month follow-up 
summary of post-hoc Dunnett's test results with p<_ 0.1. 
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Figures 5.4a, 5.4b, 5.4c and 5.4d. RAVLT trial 1 (a), 5 (b), 6 (c) and 7 (d) scores for 
healthy control, pain and seizure groups at 12-month follow-up. 
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5.3.2.7. Story recall results 
Figures 5.5a, 5.5b and 5.5c show the immediate and delayed story recall scores and 
retention scores for seizure, pain and control groups. Tables 5.6a and 5.6b show a 
summary of the main statistical findings. A significant group effect was found with 
comparison of the different seizure type groups to the healthy control group for 
immediate story recall (p= 0.000), delayed recall (p= 0.000) and the % retained score (% 
delayed recall score/immediate recall score) (p= 0.02). 
Post hoc Dunnett's test revealed significantly lower immediate recall scores for the PGS 
group (p= 0.000), for the FSG group (p= 0.000) and for the FS group (p= 0.017) 
compared to controls. Both findings reached the corrected significance level. 
There were significantly lower delayed recall scores, after a 30 minute interval following 
immediate recall, for the PGS group (p= 0.000), the FSG group (p= 0.000) and for the 
FS group (p= 0.001) in comparison to controls. These results were all significant at the 
corrected significance level. 
The FS group showed lower retention scores compared to controls (p= 0.007) which 
reached significance at the corrected level. 
The pain group showed a trend towards significantly lower immediate recall scores 
compared to controls (p= 0.081). 
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d. f. F p 
Immediate recall 3,37 11.75 0.000*** 
Delayed recall 3,37 12.74 0.000*** 
Retained 3,37 3.72 0.020* 
Table 5.6a. Seizure groups vs. control group: story recall test 12-month follow-up 
summary of group effects with p<_ 0.1 from one-way ANOVA analysis. 
Mean SD Uncorrected Bonferroni 
recall Significance corrected 
sore (p50.05) Significance 
(%) (50.017) 
Seizure groups vs. control group 
Immediate recall 
- controls 79.76 8.67 
ý 
_ - _ý-- _ Immediate recall 
- PGS 52.00 14.27 0.000*** 
Immediate recall 
- FSG_ 46.90 21.40 ý--ýY_- ---- - 
0.000*** 
-----_--------u Immediate recall i 
- FS 62.83 13.92 0.017* 
Delayed recall - 
controls 76.67 10.36 3 
Delayed recall - 
_ 
PGS 45.17 ! 13.71 0.000*** 
Delayed recall - 
-- ---- 
FSG 41.43 22 14 I 0.000*** 
Delayed recall 
FS 51.83 16.56 0.001*** 
Retained - 
controls 
I 95.95 5.10 
Retained -i i 
-- 
FS 80.68 17.72 0.007** 
Table 5.6b. Seizure groups vs. control group: story recall test 12-month follow-up 
summary of post-hoc Dunnett's test results with p<_ 0.1. 
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Figures 5.5a, 5.5b and 5.5c. Story recall immediate (a), delayed (b) and retention (c) 
scores for healthy control, pain and seizure groups at 12-month follow-up. 
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5.3.3. ERP behavioural results 
Button press latency values to the correctly detected target auditory tones in the P3b 
standard oddball task, P3a novel task and the dual target oddball (DTO) task are 
summarised in Table 5.8. The accuracy scores of target auditory tone detection, for all 
tasks, and visual change detection, for the DTO task, are summarised in Table 5.9. 
Comparison of the different seizure groups to controls failed to show any difference in 
RT or accuracy of responses to target auditory tones for all three tasks. The pain group 
showed no significant difference to the healthy control group for RT in all three tasks. 
For the novel tones task, the pain group had significantly lower accuracy scores 
compared to controls (p= 0.039). 
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Control PGS FSG FS Pain 
P3b oddball task 330.96 329.40 359.43 329.10 365.68 
RT (ms) 43.77 38.53 52.99 73.24 37.31 SD 
P3a novel task RT 383.59 361.08 389.62 367.80 407.90 (ms) 42.14 35.01 31.93 68.78 33.82 
SD 
DTO task auditory 391.08 402.38 373.41 375.55 389.25 
target RT (ms) 30.26 29.64 22.80 49.34 34.81 
SD 
Table 5.7. Button press latency values in response to correctly detected auditory 
targets in the standard P3b oddball test, the P3a novel sounds test and the DTO 
task at 12-month follow-up. *p: 50.05 
for pain group vs. control group using 
independent t-test. 
Control PGS FSG FS Pain 
P3b oddball task 91.91 80.67 76.51 77.11 71.11 
accuracy (%) 11.02 30.71 25.13 30.47 25.89 
SD 
P3a novel task 66.02 68.67 66.36 59.78 42.22* 
accuracy (%) 22.33 24.58 17.62 38.38 20.56 
SD 
DTO task auditory 53.49 50.38 45.09 51.33 39.62 
target accuracy (%) 23.37 21.49 18.44 26.20 25.51 
SD 
DTO task visual 92.79 87.93 93.10 98.03 93.68 
target accuracy (%) 7.47 12.29 6.90 1.84 5.94 
SD 
Table 5.8. Target detection accuracy scores in the standard P3b oddball test, the 
P3a novel sounds test and the DTO task at 12-month follow-up. *Significant at 
p<_0.05 for pain group vs. control group using independent t-test. 
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5.3.4. ERP results at 12-month follow-up 
5.3.4.1. MMN results 
Tables 5.9 and 5.10 show a summary of the peak latency, onset, offset and duration 
measures from the main waveform and mean peak amplitude measures taken at 
electrodes Fz, Cz, Pz, F3 and F4. Figures 5.6a and 5.6b show the group averaged MMN 
difference waveforms obtained for the seizure groups compared to the healthy control 
group and for the pain group compared to the healthy control group. Tables 5.11 a and 
5.1 lb show a summary of the main statistical findings. 
Comparison of the seizure groups to the healthy control group showed that there was a 
significant group effect for MMN peak latency (p= 0.016), F3 mpa (p= 0.047) and for 
MMN offset (p= 0.008). There was a trend towards significant group effect for Fz mpa 
(p= 0.067), Cz mpa (p= 0.064) and for MMN duration (p =0.082). 
Dunnett's post-hoc tests revealed that the PGS seizure group showed significantly longer 
MMN peak latency compared to healthy controls (p= 0.007) and also significantly 
longer MMN offset compared to controls (p= 0.003). These findings both reached 
significance at the corrected level. The FSG group showed a trend towards significantly 
longer MMN offset in comparison to controls (p= 0.061). The PGS group also showed 
trends towards significantly larger MMN mpa at Cz and longer MMN duration, 
compared to controls (p= 0.082 and p= 0.052 respectively). 
The pain group had significantly delayed MMN offset compared to controls (p= 0.012). 
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Control PGS FSG FS Pain 
Peak lat. (ms) 168.80 198.69** 177.91 188.34 182.82 
SD 27.41 18.54 32.06 182.13 34.57 
Onset (ms) 71.73 74.85 76.50 67.49 80.85 
SD 12.54 13.95 23.98 17.18 11.38 
Offset (ms) 223.48 252.01** 245.75 240.82 253.10* 
SD 18.31 27.29 16.66 15.18 28.51 
Duration (ms) 151.75 177.16 169.25 173.32 172.25 
SD 22.63 26.37 28.94 27.10 31.79 
Table 5.9. MMN peak latency, onset, offset and duration values obtained at 12- 
month follow-up. *p50.0S pain group vs. control group. **p50.01 PGS vs. control 
group. 
Control PGS FSG FS Pain 
MPA at Fz (ms) -4.17 -5.88 -3.28 -4.42 -3.48 
SD 2.05 2.61 1.29 1.79 1.18 
MPA at Cz (ms) -4.37 -6.90 -3.59 -4.47 -3.77 
SD 2.32 4.23 1.09 2.18 1.05 
MPA at Pz (ms) -2.84 -4.78 -2.49 -3.01 -2.67 
SD 1.80 3.61 0.91 1.78 1.10 
MPA at F3 (ms) -3.74 -5.38 -2.87 -3.69 -3.00 
SD 1.72 2.66 1.01 1.63 0.89 
MPA at F4 (ms) -4.48 -5.18 -3.04 -3.94 -3.21 
SD 2.24 2.61 1.21 1.97 1.14 
Tnhle _5.10. 
MMN mna values. at electrodes Fz. Cz. Pz. F3 and F4_ obtained at 12- 
month follow-up. 
d. f. F p 
MMN peak latency 3,38 3.87 0.016* 
MMN offset latency 3,38 4.55 0.008** 
MMN duration 3,38 2.42 0.082 
MMN m pa at Fz 3,38 2.59 0.067 
MMN m pa at Cz 3,38 2.63 0.064 
MMN m pa at F3 3,38 2.90 0.047* 
Table 5.11a. Seizure groups vs. control group: MMN 12-month follow-up summary 
of group effects with p_< 0.1 from one-way ANOVA analysis. 
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Mean SD Uncorrected Bonferroni 
Mpa/lat. Significance corrected 
(µV/msec) (p50.05) Significance 
(p: 50.017) 
Seizure g roups vs. control group 
MMN peak 
lat. -controls 166.80 
1 
27.41 
MMN peak 
lat. -PGS 198.69 18.54 0.007** 
MMN offset - 
controls 223.48 18.31 ! r 
MMN offset - 
_ 
PGS 252.01 1 27.29 0.003** 
MMN offset 
FSG 245.75 16.66 0.061 
MMN dur. - 
controls 151.75 22.63 
MMN dur. - r 
PGS 177.16 26.37 0.052 
MMN mpa at 
Cz - controls 4.37 2.32 
MMN mpa at , 
t F 
Cz -PGS 6.90 4.23 0.082 
Table 5.11b. Seizure groups vs. control group: MMN 12-month follow-up summary 
of post-hoc Dunnett's test results with p<_ 0.1. 
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Charter V 
5.3.4.2. P3b standard oddball task results 
Tables 5.12 and 5.13 show a summary of the measures obtained at electrode Fz from the 
different experimental and control groups. Tables 5.14a and 5.14b show a summary of 
the main statistical findings. Figures 5.7a and 5.7b show the group averaged P3 
waveforms, obtained in response to the auditory targets in the standard oddball task, for 
the seizure groups compared to the healthy control group and for the pain group 
compared to the healthy control group. 
Comparison of the seizure groups to the healthy control group revealed that group effect 
showed a trend towards significance for NI latency at Cz (p= 0.087) and for NI 
amplitude at Cz (p= 0.073). However, post-hoc Dunnett's test failed to reveal any 
statistically significant group differences for NI latency at Cz. There was a significant 
group effect for Ni amplitude at P3 (F (p= 0.041). Post-hoc Dunnett's tests revealed that 
the FSG group had smaller Ni amplitude at P3 compared to controls (p= 0.078) but this 
failed to reach statistical significance. 
There was a significant group effect for N2 amplitude at Cz (p= 0.044) and also for N2 
latency at Cz (p= 0.021), at Pz (p= 0.022), at P3 (p= 0.019) and at P4 (p= 0.022). Post- 
hoc Dunnett's tests revealed longer N2 latency for the PGS group compared to controls 
at Cz (p= 0.029), Pz (p= 0.028), P3 (p= 0.030) and at P4 (p= 0.030) but these results 
failed to reach significance at the corrected level. N2 latency was also longer for the 
FSG group compared to controls at Cz (p= 0.037), Pz (p= 0.038), P3 (p= 0.030) and at 
P4 (p= 0.034) but these findings also failed to reach significance at the corrected level. 
The FS group also showed N2 latency delay compared to controls at Cz (p= 0.068), Pz 
(p= 0.079), P3 (p= 0.069) and P4 (p= 0.081) but these findings failed to reach statistical 
significance. N2 amplitude showed a trend towards being significantly larger for the 
PGS group, in comparison to controls (p=0.055) but this failed to reach the corrected 
significance level. 
There was a significant group effect on P3b latency at Cz (p= 0.037), at Pz (p= 0.053), at 
P3 (p= 0.054) and a trend towards significant group effect at P4 (p= 0.062). Post-hoc 
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Dunnett's tests showed that P3 latency was delayed for the PGS group compared to 
controls at Cz (p= 0.02 1), Pz (p= 0.030), P3 (p= 0.030) and P4 (p= 0.034) but these 
findings failed to reach significance at the corrected level. 
Comparison of the pain group to healthy controls showed significantly smaller N2 
amplitude for the former group at Cz (p= 0.005), Pz (p= 0.022), P3 (p= 0.022) and a 
trend towards significance at P4 (p= 0.067). The pain group also had significantly 
smaller P3b amplitude at Pz (p= 0.047) and a trend towards significantly smaller P3b 
amplitude at P4 (p= 0.080). N2 latency showed a trend towards significant delay at P4 
(p= 0.082). 
Control PGS FSG FS Pain 
N1 lat. (ms) 91.78 101.27 100.96 89.79 99.35 
SD 12.94 15.53 12.54 11.25 12.04 
N2 lat. (ms) 201.78 234.23* 237.30* 229.54 216.83 
SD 19.67 33.80 25.64 38.09 18.97 
P3b lat. (ms) 341.33 375.63* 371.21 360.14 364.78 
SD 32.14 32.30 23.98 34.88 25.25 
Table 5.12. Peak latency values for N1, N2 and P3b components, measured at Pz, 
obtained from the standard oddball task at 12-month follow-up. *p<_0.05 PGS vs. 
control group and FSG vs. control group. 
Control PGS FSG FS Pain 
Ni amp. (µV) -5.62 -6.14 -3.11 -3.22 -4.04 
SD 2.81 5.16 2.06 2.61 3.20 
N2 amp. (µV) -3.11 -3.72 -2.35 -1.90 -0.83* 
SD 3.09 6.08 3.50 4.54 3.56 
P3b amp. (µV) -10.79 -7.31 -10.61 -10.43 -7.09* 
SD 5.71 3.83 3.53 7.76 1.99 
Table 5.13. Peak amplitude values for Ni, N2 and P3b components, measured at 
Pz, obtained from the standard oddball task at 12-month follow-up. *p50.0S pain 
group vs. control group. 
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d. f. F 
Ni lat. at Cz 3,38 2.35 0.087 
N2 lat. at Cz 3,38 3.65 0.021 * 
N2 lat. at Pz 3,38 3.61 0.022* 
N2 lat. at P3 3,38 3.73 0.019* 
N2 lat. at P4 3,38 3.62 0.022* 
P3b lat. at Cz 3,38 3.13 0.037* 
P3b lat. at Pz 3,38 2.80 0.053 
P3b lat. at P3 3,38 2.78 0.054 
P3b lat. at P4 3,38 2.66 0.062 
N1 amp. at Cz 3,38 2.51 0.073 
Ni amp. at P3 3,38 3.03 0.041 * 
N2 amp. at Cz 3,38 2.96 0.044* 
Table 5.14a. Seizure groups vs. control group: standard oddball task 12-month 
follow-up summary of group effects with p<_ 0.1 from one-way ANOVA analysis. 
Mean SD Uncorrected Bonferroni 
AmpfLat. Significance corrected 
(µV/msec) (p50.05) Significance 
(p: 50.017) 
seizure groups vs. control group 
N1 amp. at P3 
-controls 4.77 2.20 
N1 amp. at P3T 
-PGS 5.49 4.57 0.078 
N2 amp. at Cz 
-controls 5.20 3 49 - - -- ------ . -- ----- - -- - ----- -- ---- --- -- N2 amp. at Cz ; 
-PGS 11.32 9.55 0.055 
N2 lat. at Cz - 
controls 201.67 18.39 
N2 lat. at Cz - 
PGS 233.93 34.77 0 029* 
N2 lat. at Cz - 
FSG 237.30 24.90 L 0 037* . - N2 lat. at Cz - 
FS 230.66 38.51 0.068 
N2 lat. at Pz - 
controls 201.78 19.67 
N2 lat. at Pz - 
PGS 234.23 33.80 0.028* 
Table 5.14b. Seizure groups vs. control group standard oddball task, 12- 
month follow-up summary of post-hoc Dunnett's test results with p<_ 0.1. 
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Mean SD Uncorrected Bonferroni 
AmpJLat. Significance corrected 
(µV/msec) (p<-0.05) Significance 
(p: 50.017) 
seizure group s vs. control group contd. 
N2 lat. at Pz - 
FSG 237.30 25.64 0.038-- 
N2 lat. at Pz - ! ! 
FS 229.54 38.09 0.079 
N2 lat. at P3 - 
controls 201.23 19.63 
N2 lat. at P3 - 
PGS 233.24 33.35 0.030* 
N2 lat. at P3- i 1 -- 
FSG ! 237.97 26.29 0.030* 
N2 lat. at P3 - ! 
FS 229.70 37.97 0.069 
N2 lat. at P4 - , ! ! 
controls 201.23 18.26 
N2 lat. at P4 - 
PGS 233.10 34.55 0.030* 
N2 lat. at P4 - 
FSG 237.30 26.02 0.034* 
_ N2lat. atP4- 
FS 228.77 ! 37.88 0.081 
P3b lat. at Cz 
-controls 339.89 31.96 
P3b lat. at 
-PGS 376.05 33.21 0.021 
P3b lat. at Pz 
-controls 341.33 32.14 
P3b lat. at Pz - -- 
-PGS 375.63 32.30 1 0.030* 
P3b tat. at P3 
-controls 341.88 31 88 
P3b lat t P3 
. 
.a 
-PGS 376.05_ 1 31.96 0.030* 
P3b lat. at P4 
-controls 342.54 1 32.16 
P3b lat. at P4 j - f 
-PGS 376.00 32.50 0.034* 
Table 5.14b contd. Seizure groups vs. control group: standard oddball task 12- 
month follow-up summary of post-hoc Dunnett's test results with p5 0.1. 
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Figure 5.7a. Group averaged waveforms, obtained at 12-month follow-up in 
response to target tones in the standard oddball task, from the seizure groups and 
the healthy control group. 
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Figure 5.7b. Group averaged waveforms, obtained at 12-month follow-up in 
response to the target tones in the standard oddball task, from the pain group and 
the healthy control group. 
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5.3.4.3. Pia novel sounds task results 
Tables 5.15 and 5.16 show a summary of the measures obtained at electrode Fz from the 
different experimental and control groups. Tables 5.17a and 5.17b show a summary of 
the main statistical findings. Figures 5.8a and 5.8b show the group averaged P3 
waveforms, obtained in response to the novel non-target sounds, in the novel sounds 
task, for the seizure groups compared to the healthy control group and for the pain group 
compared to the healthy control group. 
Control vs. seizure groups comparison revealed a significant group effect on Ni 
amplitude at Cz (p= 0.052). Dunnett's post-hoc test revealed that the PGS group had 
larger Ni amplitude compared to controls at Cz (p= 0.086) but this difference failed to 
reach statistical significance. 
There were significant group effects for N2 latency at Fz (p= 0.009), Cz (p= 0.020), F3 
(p= 0.009) and F4 (p= 0.008). Dunnett's tests revealed significantly longer N2 latency 
for the PGS group compared to controls at Fz (p= 0.017) and at F4 (p= 0.017) -both 
significant at the corrected level. N2 latency for the PGS group was also delayed, in 
comparison to controls, at Cz (p= 0.037) and at F3 (p= 0.018) but these failed to reach 
the corrected significance level. The FSG group had significantly delayed N2 latency at 
Fz (p= 0.009), F3 (p= 0.010) and F4 (p= 0.008) -all significant at the corrected level. N2 
latency was also delayed for this group at electrode Cz (p= 0.019), however, this failed 
to reach the corrected significance level. 
Group effect showed a trend towards significance for P3a latency at Cz (p= 0.080) and 
at F4 (p= 0.085) but reached significance for the F3 electrode (p= 0.046). P3a latency 
was longer for the PGS group compared to controls at Cz (p= 0.077), F3 (p= 0.076) and 
F4 (p= 0.097) but failed to reach statistical significance. The FS group showed 
significant P3a latency delay at F3 compared to controls (p= 0.049) but this was outside 
the corrected significance level. 
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The pain group had significantly longer N2 latency compared to controls at Fz (p= 
0.000), at Cz (p= 0.000) at F3 (p= 0.001) and at F4 (p= 0.000). It also had significantly 
smaller P3a amplitude compared to controls at Fz (p= 0.046), at F3 (p= 0.026) and at F4 
(p= 0.026). There was a trend towards significance for smaller P3a amplitude at Cz for 
the pain group compared to controls (p= 0.064). NI latency was longer for the pain 
group compared to controls at Cz (p= 0.090), F3 (p= 0.061) and F4 (p= 0.068) but these 
differences failed to reach statistical significance. 
Control PGS FSG FS Pain 
N1 lat. (ms) 105.39 109.99 108.71 112.10 117.67 
SD 16.46 12.29 13.41 10.91 7.12 
N2 lat. (ms) 185.62 221.69* 230.44** 203.82 231.03*** 
SD 14.22 41.27 21.50 39.20 32.73 
P3a lat. (ms) 270.90 295.04 297.94 289.49 271.83 
SD 26.28 36.55 42.76 43.32 41.39 
Table 5.15. Peak latency values for Ni, N2 and P3a components, measured at Fz, 
obtained from the novel sounds task at 12-month follow-up. *p<_0.05 PGS vs. 
controls. *p50.01 FSG vs. controls. ***p50.001 pain group vs. controls. 
Control PGS FSG FS Pain 
Ni amp. (RV) -7.37 -9.15 -5.51 -6.81 -6.39 
SD 3.43 4.72 3.44 4.63 3.77 
N2 amp. (µV) -4.34 -5.04 -2.42 -4.60 -1.54 
SD 2.68 2.96 3.62 5.00 5.24 
P3a amp. (. tV) -6.45 -4.54 -2.22 -4.20 -1.70* 
SD 3.83 5.81 3.48 7.54 5.99 
Table 5.16. Peak amplitude values for N1, N2 and P3a components, measured at 
Fz, obtained from the novel sounds task at 12-month follow-up. * p<_o. 05 pain group 
vs. controls. 
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d. f. F p 
N2 lat. at Fz 3,38 4.44 0.009* 
N2 lat. at Cz 3,38 3.70 0.020* 
N2 lat. at F3 3,38 4.40 0.009** 
N2 lat. at F4 3,38 4.57 0.008** 
P3a lat. at Cz 3,38 2.43 0.080 
P3a lat. at F3 3,38 2.92 0.046* 
P3a lat. at F4 3,38 2.38 0.085 
Ni amp. at Cz 3,38 2.81 0.052 
Table 5.17a. Seizure groups vs. control group: novel sounds task 12-month follow- 
up summary of group effects with p<_ 0.1 from one-way ANOVA analysis. 
Mean SD Uncorrected Bonferroni 
AmpfLat. Significance corrected 
(µV/msec) (p: 50.05) Significance (<-0.017) 
seizure g roups vs. control group 
Ni amp. at Cz 
-controls 7.13 3.36 
N1 amp. at Cz 
-PGS 11.27 6.20 0.086 
N2 lat. at Fz - 
controls 185.62 14.22 
N2 lat. at Fz - 
PGS 
i 
221.69 41-. 27 
-- ------------- 
0.017* 
N2 lat. at Fz - 
---- - --- ------ 
FSG 230.44 21.50 0.009** 
N2 lat. at Cz - 
controls 184.37 14.06 
N2 lat. at Cz - 
PGS 219.44 40.84 0 037* 4----. _-.. - . N2 lat. at Cz - 
FSG 1 228.89 21.50 0.019* 
Table 5.17b. Seizure groups vs. control group: novel sounds task 12- 
month follow-up summary of post-hoc Dunnett's test results with p_< 0.1. 
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Mean SD Uncorrected Bonferroni 
Amp. /Lat. Significance corrected 
(µV/msec) (p<-0.05) Significance 
(p: 50.017) 
seizure group s vs. control group contd. 
N2 lat. at F3 - 
controls ! 184.63 15.37 
N2 lat. at F3 - 
PGS 220.99 41.01 0.018* 
N2 lat. at F3 - ! ! i 
FSG 
! 
230.01 F 23.48 0.010** 
N2 lat. at F4 
controls 184.50 14.38 
N2 lat. at F4- ; 
PGS 220.92 } 41.50 } 0.0 1.7-* 
N2 lat. at F4 - 
FSG 230.89 24.20 1 0.008** 
P3a lat. at Cz 
-controls 263.75 20.12 
P3a lat. at Cz 
-PGS 295.78 36.69 0.077 
P3a lat. at F3 
-controls 263 20 19.84 
P3a lat. at F3 
_ 
-PGS 295.49 1 37.76 1 0.076 
P3a lat. at F3 ! 
-FS 299.18 42.94 0.049* 
P3a lat. at F4 
-controls 263.75 20.27 
P3a lat. at F4 
-PGS 
1 294.71 38.32 0.097 
Table 5.1,5b contd. Seizure groups vs. control group: novel sounds task 12-month 
follow-up Lummary of post-hoc Dunnett's test results with p<_ 0.1. 
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Figure 5.8a. Group averaged waveforms obtained at 12-month follow-up, in 
response to non-target sounds in the P3a novel sounds task, from the seizure 
groups and the healthy control group. 
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Figure 5.8b. Group averaged waveforms, obtained at 12-month follow-up in 
response to non-target sounds in the P3a novel sounds task, from the pain group 
and the healthy control group. 
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5.3.4.4. DTO task results -auditory targets 
Tables 5.18 and 5.19 show a summary of the measures obtained at electrode Pz from the 
experimental and control groups. Tables 5.20a and 5.20b show a summary of the main 
statistical findings. Figures 5.9a and 5.9b show the group averaged P3 waveforms, 
obtained in response to the auditory targets in the DTO task, for the seizure groups 
compared to the healthy control group and for the pain group compared to the healthy 
control group. 
Control vs. seizure groups comparison revealed that there was significant group effect 
on NI amplitude at Cz (0.023) and at P4 (p= 0.051). Post-hoc Dunnett's tests showed 
that the PGS group had significantly larger N1 amplitude compared to controls at Cz (p= 
0.0 10) there was a trend towards significance at P4 (p= 0.068). 
There was a significant group effect on N2 latency at Cz (p= 0.004), Pz (p= 0.005) and 
P4 (p= 0.005). Post-hoc Dunnett's tests revealed that the PGS group had significantly 
longer N2 latency compared to controls at Cz (p= 0.005), Pz (p= 0.006), P3 (p= 0.003) 
P4 (p= 0.003) -all reaching significance at the corrected level. The FS group also 
showed significantly longer N2 latency compared to controls at Cz (p= 0.007), Pz (p= 
0.01), P3 (p= 0.04) -reaching the corrected significance level, and at P4 (p= 0.025). 
Group effect was significant on P3b latency at Cz (p= 0.000), Pz (p= 0.000), P3 (p= 
0.000) and at P4 (p= 0.000). Post-hoc Dunnett's tests showed that the PGS group had 
significantly longer P3b latency compared to controls at Cz (p= 0.003), Pz (p= 0.003) P3 
(p= 0.003) and P4 (p= 0.003). The FSG group also had significantly longer P3b latency 
compared to controls at Cz (p= 0.001), Pz (p= 0.001), P3 (p= 0.000) and P4 (p= 0.001). 
The FS group also had significant P3b latency delay compared to controls at Cz (p= 
0.003), Pz (p= 0.003), P3 (p= 0.004) and P4 (p= 0.004). All these findings reached the 
corrected significance level. 
Comparison of the pain group and the healthy control group showed significant N2 
latency delay for the former group at Cz (p= 0.014), Pz (p= 0.02), P3 (p= 0.018) and P4 
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(p= 0.016). Ni latency was also longer for the pain group in comparison to the control 
group at Cz (p= 0.091) and P4 (p= 0.094) but these findings failed to reach statistical 
significance. 
Control PGS FSG FS Pain 
N1 lat. (ms) 94.21 100.37 98.31 96.45 104.25 
SD 13.69 14.16 20.24 13.14 8.22 
N2 lat. (ms) 207.75 256.73** 237.97 252.62** 235.55* 
SD 18.33 39.00 38.52 44.19 30.34 
P3b lat. (ms) 332.14 377.35** 388.47*** 375.63** 354.20 
SD 33.35 27.09 27.75 28.27 63.27 
Table 5.18. Peak latency values for N1, N2 and P3b components, measured at Pz, 
obtained from auditory targets in the DTO task at 12-month follow-up. *p5 0.05 
PGS group vs. control group. **p5 0.01 PGS group vs. control group and FS group 
vs. control group. ***p< 0.001 FSG group vs. control group. 
Control PGS FSG FS Pain 
N1 amp. (µV) -3.87 -6.80 -4.27 -3.83 -3.83 
SD 2.21 4.62 1.90 2.33 3.01 
N2 amp. (µV) -1.38 -0.88 -3.07 -1.11 -0.37 
SD 2.91 6.09 2.89 3.63 2.40 
P3b amp. (µV) -8.27 -8.21 -7.51 -10.35 -7.94 
SD 5.84 4.11 4.30 5.77 5.14 
Table 5.19. Peak amplitude values for N1, N2 and P3b components, measured at 
Pz, obtained with auditory targets in the DTO task at 12 month follow-up. 
d. f. F p 
N2 lat. at Cz 3,36 5.29 0.004** 
N2 lat. at Pz 3,36 4.97 0.005** 
N2 lat. at P3 3,36 4.91 0.006** 
N2 lat. at P4 3,36 4.99 0.005** 
P3b lat. at Cz 3,36 8.19 0.000*** 
P3b lat. at Pz 3,36 7.96 0.000*** 
P3b lat. at P3 3,36 8.39 0.000*** 
P3b lat. at P4 3,36 8.07 0.000*** 
Ni amp. at Cz 3,36 3.60 0.023* 
Ni amp. at P4 3,36 2.84 0.051 
Table 5.20a. Seizure groups vs. control group: DTO task (auditory targets) 12- 
month follow-up summary of group effects with p<_ 0.1 from one-way ANOVA 
analysis. 
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Mean SD Uncorrected Bonferroni 
AmpJLat. Significance corrected 
(µV/msec) (p50.05) Significance 
(<_0.017) 
seizure groups vs. control group 
Ni amp. at Cz 
-controls -6.41 2.41 
N1 amp. at Cz 
-PGS -10.69 4.93 0.010** 
N1 amp. at P4 . 
-controls -3.20 1.77 
Ni amp. at P4 11 
-PGS -5.87 4.35 0.068 
N2 lat. at Cz - 
controls 207.42 1 17.13 
---- -- +-- N2 lat. at Cz - 
-- --- -- -- - - +- ------ -- , --------------- - - -ý--- -----. ý__-- 
I PGS 256.57 
_ } ___37.62- _ 
0.005* 
N2 lat. at C-z - 
FS 253.24 43.95 0.007** 
N2 lat. at Pz - 
controls 207.75 18.33 
N2 lat. at Pz - 
i-- -- 
PGS 256.73 39.00 
_ 
0.006** 
N2 lat. at Pz - 
FS 252.62 44.19 0.010** 
N2 lat. at P3 - 
controls 
- 
208.31 
- 
18.10 
-18.10 N2 lat. at P3 - 
PGS 256.68 38.66 0.003** 
N2 lat. at P3 - 
FS 243.08 34.65 1 0.040* 
N2 lat. at P4 - 
controls 207.98 17.50 
N2 lat. at P4 - 
PGS 268.31 1 55.70 0.003** 
N2 lat. at P4-i j 
FS 252.93 44.97 1 0.025* 1 
Table 5.20b. Seizure groups vs. control group: DTO task (auditory 
targets) 12-month follow-up summary of post-hoc Dunnett's test results 
with p5 0.1. 
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Mean SD Uncorrected Bonferroni 
AmpiLat. Significance corrected 
(µV/msec) (p: 50.05) Significance 
( : _0.017) 
seizure grou ps vs. control group contd. 
P3b lat. at Cz 
-controls 331.25 33.07 
P3b lat. at Cz 
-PGS _ 
376.67 
_j_. _ 
27.50 ý---- --- -- ----ý -- 
0.003 
P3b tat. at Cz , - -- ----- 
-FSG 388.03 27.82 0.001*** 
P3blat. atCz 
-FS 375.44 27.58 
j 
0.003** 
P3b lat. at Pz 
-controls 332.14 33.35 
P3b lat. at Pz j 
-PGS 377.35 1 27.09 0.003** 
P3b lat. at Pz , ! ! 
-FSG 388.47 27.75 - 
0.001*** 
P3b lat. at Pz T 
-FS 375.63 28.27 0.003** 
P3b lat. at P3 
-controls 332.59 32.82 
P3b lat. at P3 ! 
-PGS 377.87 
! 
27.26 
! 
0.003** 
P3b lat. at P3 
-FSG 390.24 j 27.39 0.000*** 
P3b lat. at P3 
-FS 376.23 26.79 0.004** 
P3b lat. at P4 
-controls 332.92 32.20 
P3b lat. at P4 
-PGS 
P3b lat. at P4 
378.56 r 26 28 -- -- ---------- - --- -- -ý-- - 
0.003** 
--- ------ --- -- 
-FSG 
P3b lat. at P4 . 
388.91 
-- ---------- 
28.44 
----------r--- - ----- -- -; - 
0.001*** 
---- -- - 
-FS 375.32 28.81 0.004** 
Table 5.20b contd. Seizure groups vs. control group: DTO task (auditory targets) 
12-month follow-up summary of post-hoc Dunnett's test results with p<_ 0.1. 
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Figure 5.9a. Group averaged waveforms obtained at 12-month follow-up, in 
response to auditory targets in the DTO task, from the seizure groups and the 
healthy control group. 
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Figure 5.9b. Group averaged waveforms obtained at 12-month follow-up, in 
response to auditory targets in the DTO task, from the pain group and the healthy 
control group. 
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5.3.4.5. DTO task results - visual targets 
-Tables 5.21 and 5.22 show a summary of the measures obtained at electrode 
Cz from 
the different experimental and control groups. Tables 5.23a and 5.23b show a summary 
of the main statistical findings. Figures 4.10a and 4.10b show the group averaged P3 
waveforms, obtained in response to the visual targets in the oddball with the DTO task, 
for the seizure groups compared to the healthy control group and for the pain group 
compared to the healthy control group. 
Comparison of the seizure groups to the healthy control group showed that there was a 
significant group effect on Ni amplitude at Cz (p= 0.009) and at P3 (p= 0.054). Post-hoc 
Dunnett's tests revealed significantly larger NI amplitude for the PGS group compared 
to controls at Cz (p= 0.009) which reached the corrected level. The PGS group also 
showed larger NI amplitude compared to controls at P3 (p= 0.082) but this failed to 
reach statistical significance. 
There was a significant group effect on N2 latency at Cz (p= 0.008), Pz (p= 0.009), P3 
(p= 0.006) and at P4 (p= 0.014). Post-hoc Dunnett's tests revealed significantly longer 
N2 latency for the FS group compared to controls at Cz (p= 0.004), Pz (p= 0.005), P3 
(p= 0.003) and P4 (p= 0.007). 
There was a significant group effect on P6 latency at Cz (p= 0.011), P3 (p= 0.055) and at 
P4 (p= 0.016). Post-hoc Dunnett's tests revealed significantly delayed P6 latency for the 
FS group compared to controls at Cz (p= 0.005), P3 (p= 0.033) and P4 (p= 0.007). 
Comparison of the pain group to healthy controls showed that N2 amplitude was 
significantly smaller for the former group at Pz (p= 0.040) and showed a trend towards 
significance at P4 (p= 0.81). Also P6 latency was longer for the pain group compared to 
controls at Cz (p= 0.096), Pz (p= 0.093) and at P4 (p= 0.081) but these differences were 
not statistically significant. P6 amplitude was also smaller for the pain group at P3 (p= 
0.076) but this failed to reach statistical significance. 
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Control PGS FSG FS Pain 
N1 lat. (ms) 92.11 97.79 91.67 96.45 88.24 
SD 12.18 12.82 17.80 8.94 15.43 
N2 lat. (ms) 347.75 367.94 349.30 392.21** 355.23 
SD 16.80 38.45 15.95 44.48 23.46 
P6 lat. (ms) 575.60 586.85 605.72 628.94** 608.03 
SD 28.66 30.21 38.97 51.61 54.91 
Table 5.21. Peak latency values for N1, N2 and P6 components measured at Cz, 
obtained with visual targets in the DTO at 12-month follow-up. **p<_ 0.01 FS group 
vs. control group. 
Control PGS FSG FS Pain 
N1 amp. (RV) -5.33 -9.22** -4.60 -6.63 -6.03 
SD 3.36 2.41 1.35 3.24 3.53 
N2 amp. (µV) -2.80 -4.95 -1.59 -2.23 -1.47 
SD 2.96 5.88 2.47 4.52 3.38 
P6 amp. (µV) -13.51 -10.73 -9.56 -9.88 -7.62 
SD 9.25 6.62 7.93 4.41 5.91 
Table 5.22. Peak amplitude values for Ni, N2 and P6 components, measured at Cz, 
obtained with visual targets in the DTO at 12-month follow-up. **p<_ 0.01 PGS 
group vs. control group. 
d. f. F p 
N2 lat. at Cz 3,36 4.49 0.008** 
N2 lat. at Pz 3,36 4.46 0.009** 
N2 lat. at P3 3,36 4.98 0.006** 
N2 lat. at P4 3,36 4.04 0.014* 
P6 lat. at Cz 3,36 4.25 0.011* 
P6 lat. at P3 3,36 2.78 0.055 
P6 lat. at P4 3,36 3.90 0.0 16* 
Ni amp. at Cz 3,36 4.46 0.009** 
Ni amp. at P3 3,36 2.80 0.054 
Table 5.23a. Seizure groups vs. control group: DTO task (visual targets) 12-month 
follow-up summary of group effects with p<_ 0.1 from one-way ANOVA analysis. 
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Mean SD Uncorrected Bonferroni 
Amp. /Lat. Significance corrected 
(µV/msec) (p50.05) Significance 
(<-0.017) 
seizure groups vs. control group 
Ni amp. at Cz 
-controls -5.33 3.36 
N1 amp. at Cz 
-PGS -9.22 2.41 0.009** 
N1 amp. at P3 ! 
-controls 3.36 2.99 -__- Ni amp. at P3} 
-PGS 5.67 2.36 
11 0.082 
N2 lat. at Cz - 
controls 347.75 16.80 
N2 lat. at Cz - 
FS 392.21 44.48 0.004** 
N2 lat. at Pz 
controls 348.52 17 04 
N2 lat. at Pz - 
FS 392.21 44.72 0.005** 
N2 lat. at P3 - , 
controls 349.19 17.75 
N2 lat. at P3 -! 
- r ! 
FS 396.29 44.55 1 0.003** 
N2 lat. at P4 - 
controls . 350.18 f 17.57 
N2 lat. at P4-! 
FS 392.37 44.36 0.007** 
P6 lat. at Cz 
controls 575.60 28.66 
P6 lat. at Cz - 
FS 628.94 51.61 0.005** 
P6 lat. at P3 - 
controls 576.48 28.38 t__ 
P6 lat. at P3 - 
FS 1 616.99 45.14 0.033* 
P6 lat. at P4-j I ! 
controls 350.18 17.57 
P6 lat. at P4 - 
FS 392.37 44.36 ! ! 0.007** 
Table 5.23b. Seizure groups vs. control group: DTO task (visual targets), 12-month 
follow-up summary of post-hoc Dunnett's test results with p<_ 0.1. 
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Figure 5.10a. Group averaged waveforms obtained at 12-month follow-up, in 
response to visual targets in the DTO task, from the seizure groups and the healthy 
control group. 
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Figure 5.10b. Group averaged waveforms obtained at 12-month follow-up, in 
response to visual targets in the DTO task, from the pain group and the healthy 
control group. 
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5.4. Discussion 
As with the baseline results, the FSG group had significantly lower number of words 
recalled after the first presentation of a 15 item word list (RAVLT -trial 1) in 
comparison to controls (p<_0.05). In addition, the FS group also had significantly lower 
trial 1 recall scores compared to controls (p<_0.05). The baseline results failed to reveal 
any significant difference in trial 5 recall with seizure group comparison to controls. In 
contrast to the previous findings, the current results showed lower trial 5 recall scores for 
the PGS group, in comparison to controls (p: 50.05) suggesting that there may be 
deterioration in this group's ability to learn a list of words over 5 consecutive trials. 
Recall scores of the distracter list (trial 6) were lower for the PGS group compared to 
controls (p: 50.017). This difference was also significant in the baseline results. Lower 
trial 6 recall scores for the FSG group at baseline, in comparison to controls, had almost 
reached the corrected significance level (p= 0.018). However, this difference was not 
observed in the current results -possibly due to the reduction in number of FSG group 
patients at the 12-month retest compared to baseline. As seen at baseline, trial 7 results 
(recall of the initial word list after presentation and recall of the distracter list) for the 
seizure groups in comparison to controls failed to reach the corrected significance level. 
The PGS group had lower trial 7 recall scores in comparison to controls (p: 50.05) but 
this difference was outside the corrected significance level. 
Story recall scores in the current study were similar to the baseline results with 
additional significant difference in the FS group compared to controls. The present 
results showed that all 3 seizure groups had significantly lower immediate story recall 
score compared to controls. PGS vs. controls (p<_0.001); FSG vs. controls (p<_0.001) and 
FS vs. controls (p<_0.05). Delayed recall scores were significantly lower for all 3 seizure 
groups in comparison to controls (p<_0.001 for all groups). Retention score was 
significantly lower for the FS group in comparison to controls (p50.05), whereas it had 
been comparable to controls for all 3 seizure groups at baseline. 
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With the SWM task, the FSG group had a significantly poorer strategy score in 
comparison to controls (p<_0.001) but there were no significant differences in other 
aspects of task performance i. e. within-errors, double-errors, between-errors and total 
errors. Therefore there may be some impairment in this group's ability to formulate a 
strategy to facilitate their performance. However, this group was reduced in number to 
only 7 patients so this factor may have contributed to the difference between baseline 
and follow-up results which failed to show any significant differences in SWM scores 
for patients compared to controls. 
In contrast to word list learning performance at baseline, the pain group had significantly 
lower RAVLT trial 1 and trial 5 scores compared to controls (p50.05) but no impairment 
in trial 6 and trial 7 recall which had been significant at baseline. Therefore there is a 
possibility that AED effects may have contributed to the impaired word list learning 
performance of the PGS group. Another possible explanation for this result is that at 
baseline the pain group had focussed all their efforts on learning in the early stages of 
the test at the cost of acquiring new information. In the current study, the pain group 
may have failed to focus their efforts on the initial learning part of this test and therefore 
managed to compensate for their previous impairment of learning new information. As 
seen in the baseline results, the pain group's immediate and delayed story recall scores 
were not significantly different from those of healthy controls. 
The pain group had showed significantly poorer SWM strategy scores at baseline. The 
current results show only a trend towards significantly poorer strategy score. 
The PGS group had significantly slower simple MT compared to controls (p= 0.017). 
Choice MT was slower for the FSG group (p= 0.032) but, although this difference was 
significant at baseline, the current results failed to reach the corrected significance level. 
The behaviour ERP RT latency and accuracy results were not significantly different for 
the patients in comparison to controls. However, the control group did show longer RTs 
in all 3 ERP tests compared to their baseline performance. 
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As seen in the baseline results, the current study revealed that the pain group had 
significantly slower simple and choice MT and slower choice RT compared to controls 
(p<_0.05). Although the pain group had slower RTs to auditory targets in the P3a novel 
sounds task and the P3b standard oddball task, in contrast to the baseline results, the 
current findings failed to reach statistical significance. This may be due to the fact that 
the control group showed slower RTs to targets in all 3 ERP tests compared to baseline 
performance. They did however, in keeping with the baseline results, have significantly 
lower accuracy of target detection in the Pia novel sounds task (p<_0.05). 
In contrast to the results obtained at baseline, there were significant differences in 
MMNs obtained from patients compared to healthy controls at the 12-month follow-up 
re-test. MMN peak latency and MMN offset were significantly delayed for the PGS 
group compared to healthy controls (p<_0.05). The PGS group also had larger MMN mpa 
and longer MMN duration compared to controls but these findings failed to reach 
significance after correction for multiple comparisons (p= 0.082 and p= 0.052 
respectively). The FSG group had longer MMN duration compared to controls but this 
finding also failed to reach the corrected significance level. This finding suggests that 
despite preservation at baseline, the PGS group may have some delay of pre-attentive 
processes. The P3a findings lend further support to this result. 
The PGS group also had significant differences in their ERP responses elicited to novel 
non-target sounds in the P3a novel sounds task. N2 latency for this group was 
significantly delayed in comparison to healthy controls at all electrode sites included in 
the analysis but only reaching the corrected level at Cz and F4 (p= 0.017 for both). In 
keeping with the baseline results, the PGS group showed larger Ni amplitude compared 
to controls but this finding failed to reach statistical significance (p= 0.086). 
The FSG group also had significantly delayed N2 latency at all electrodes but the 
corrected significance level was only reached at Fz (p= 0.009), F3 (p= 0.01) and F4 (p= 
0.008) with Cz (p= 0.019) falling just outside the corrected level. P3a latency was 
delayed at F3 for the FS group compared to controls (p= 0.049) but failed to reach the 
corrected level. These results point towards a possible deterioration in pre-attentive 
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processes in patients with seizures in particular those who suffer from generalised 
seizures. 
There is very little published literature relating the effects of epilepsy on the MMN and 
P3a. Quantitative MRI studies have shown widespread cortical structural abnormalities 
in patients with Juvenile Myoclonic Epilepsy (JME) which incorporates PGS (Sisodiya 
et at., 1995 and Woermann et al., 1998). Interestingly Woermann et al. (1999) 
demonstrated that the mesiofrontal cortex is most severely affected. These observations 
may tie in with the observed MMN and P3a disruption for this group as the frontal 
cortex has been implicated in the generation of these components (Giard et al., 1990; 
Alho et al., 1994 and Knight & Scabini, 1998). 
ERP responses to targets in the standard oddball task showed N2 delays, at all electrodes 
included in the analysis, for the PGS group and FSG seizure group (p<_0.05) in 
comparison to healthy controls but these differences failed to reach the corrected 
significance level. The FS group also had later N2 components compared to controls 
(p<_0.1) but failed this finding failed to reach statistical significance. The P3b component 
was delayed for the PGS group at all electrode sites analysed (p: 50.05) but this finding 
failed to reach the corrected significance level. Previous studies have demonstrated 
delay of P3b and N2 components (Drake et al., 1986; Mervaala et al., 1992; 
Triantafyllou et al., 1992; Verleger et al., 1997 and Soysal et al., 1999). However, as for 
the baseline results, the current results may have failed to yield statistical significance 
due to the large number of statistical comparisons in comparison to previous studies. 
In contrast to the baseline results, the responses to the auditory targets in the DTO task 
showed significant differences between the seizure and healthy control groups. The PGS 
group had significant N2 delay at all analysed electrodes (p<_0.05). The FS group also 
showed significant N2 delay compared to controls at all electrodes (p<_0.05), which 
reached corrected significance at Cz and Pz. N2 delay was also observed in the FS 
group at baseline but had failed to reach corrected significance at all sites apart from F3. 
In contrast to the baseline results, the P3 component to auditory targets was significantly 
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delayed for the PGS, FSG and FS groups, in comparison to controls, at all electrodes 
(p o. O. 5. p5(). 001 and p<_0.05 respectively). 
Responses to visual targets in the DTO task showed significant differences for the 
seirurc groups in comparison to healthy controls. In keeping with the baseline results, 
N1 amplitude was significantly larger for the PGS group compared to controls at Cz 
(p<0,05). N2 latency was significantly longer for the FS group compared to controls at 
all the analysed electrode sites (p<_0.05). At baseline N2 delay for the FS group had 
failed to reach the corrected significance level. Furthermore, the current investigation 
revealed significantly longer P6 latency for the FS group compared to controls (p<_0.05) 
at C,. P3 and P4. In addition, P6 amplitude appeared to be smaller for the FSG and FS 
group% in comparison to controls, as with the baseline findings, this difference was not 
statistically significant. 
The pain group had significantly later MMN offset compared to controls (p= 0.012). 
This finding is in keeping with the baseline results. For responses to the P3a novel 
sound., there was a trend towards significant NI delay for the pain group compared to 
control% (p5O. 1). Tuunainen et al. (1995) reported significant NI latency reduction 
during A\FE) discontinuation in a group of epileptic patients so it is possible that AED 
effect% contributed to the observed NI delay in the current study. The pain group had 
significant N2 latency delay compared to controls at Fz, Cz and F4 (pSO. 001 for all 
three). P3a amplitude was attenuated for the pain group at Fz. F3 and F4 (p: 50.05) 
in 
comparison to controls. 
The pain group had %igniticantly smaller N2 components, compared to controls, elicited 
in re. lxon"e to the targets in the P; h oddball task at all analysed electrode sites (p<_0.05). 
Ilowever. they- did not show any significant N2 or Pah latency delay compared to 
controlh in their standard oddball task responses. P3b amplitude was significantly 
smaller at Pi for the pain group in comparison to controls (p: 50.05). The N2 component 
of the rc,, {xºnse to auditory targets in the DTO task was significantly delayed for the pain 
group in comparison to controls at all electrode sites (p: _0.05). The N2 component of the 
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respcrosc to visual targets in the DTO task was significantly smaller at Pz for the pain 
group in comparison to controls (p50. O5). 
Again inferences about AED effects on cognitive function from the pain group results 
are limited by factors such as small group size, higher age of the pain group compared to 
controls, unavailability of serum drug levels and variation in drug type and dosage both 
within and between the pain and seizure groups. Also there were changes in AED 
regimes for both pain and epilepsy patient groups (see Appendix 11) so it is difficult to 
arse,. % the contributions of AED effects on the current results. In contrast to the baseline 
results. the pain group did not show significantly higher depression scores in comparison 
to control.. On examining the current results, it is apparent that the control group had 
slightly higher depression scores, whereas the pain group had slightly lower depression 
score% in comparison to their respective baseline scores thereby eliminating the inter- 
group difference observed at baseline. 
In summary. the current study has demonstrated some pre-attentive ERP changes in 
epilepsy patient% that were absent in the baseline results. The PGS group showed 
significant N MN peak latency and offset delay in comparison to healthy controls. 
Moreover the PGS group had significant N2 latency delay, compared to controls, 
elicited in response to non-target tones in the Pia novel sounds task. The FSG group 
also showed significant N2 latency delay in this task. In keeping with the baseline 
result., the Pih elicited in response to targets in the standard oddball task did not show 
any statistically significant difference for the seizure groups compared to controls. 
Although the baseline study results did not show any significant difference between 
Kvure group% and controls at baseline, the FS group in the current study showed 
significant N2 and Ph latency delay, in comparison to controls, in their responses to 
visual target% in the I)TO task. The baseline results pointed towards learning and recall 
impairment for the PGS and FSG groups which is supported by the current story recall 
and uord Int learning result.. Additionally, the FS group showed significantly poor 
performance on these tests. Furthermore, although the PGS and FSG groups showed 
prescr ation of retention ability, the FS group showed significantly poor story recall 
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retention scores. whereas similar to the other groups, they had been comparable to 
control' at baselinc. 
In conclusion, the results of the current study suggest that there may be some time- 
related deterioration in pre-attentive cognitive ERP processes and neuropsychological 
perfommnce associated with different seizure types. The following chapter explores the 
effects of time on cognitive performance by analysing data from patients and controls 
who participated in all three stages of the investigation -at baseline, 6-month follow-up 
and 12-month follow-up. 
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Chapter VI 
LONGITUDINAL STUDY: CLCCTKOPIIYSIOLOGICAL AND 
NI; UROPSYCIIOLOGICAL COMPARISONS OF DIFFERENT SEIZURE TYPE 
GROUPS WITH IIEALTIIY CONTROLS AT BASELINE, 6-1%IONTII FOLLOWV- 
UP AND 12-NIONTII FOLLOW-UP. 
6.1. Introduction 
The aim of this study was to examine the effect of seizure type on cognitive function 
using event-related potential (ERP) and neuropsychology tests over the course of a 12- 
month prospective follow-up period. As for the baseline study (Chapter 4) it was 
hypothesised that seizure groups would show differences in cognitive performance 
depending on seizure type. The contributions of anti-epileptic drug (AED) treatment 
effects were assessed by including it group of non-epileptic patients on AED therapy for 
the management of chronic pain. This chapter focuses on the longitudinal results 
obtained from investigating results from subjects that participated in all 3 sessions of the 
investigation. Session I was carried out at baseline, session 2 at 6-month follow-up and 
session 3 at 12-month follow-up. 
6.2 Method 
6.2.1. Subjects 
Subjects participating in the baseline study (Chapter 4) were re-tested after 6- and 12- 
month intervals. Individuals were tested at the same time of day for each session. 24 of 
the 36 epilepsy patients who had participated in the baseline study participated in both 
follow-up session.. All 14 healthy controls and 6 pain group patients attended the 
follow-up sessions. Table 6. I shows details of sex, age and handedness for these groups. 
For the epilepsy group. 3 sub-groups comprised 10 individuals with primary generalised 
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seizures (PGS), 5 with focal seizures with secondary generalisation (FSG) and 9 with 
focal seizures (FS). Table 6.2 shows the demographic variables for these seizure groups. 
The full demographic details for each individual participant are listed in Appendix I and 
Appendix 11 lists AED medication details. 
Epilepsy Pain Controls 
Female 11 4 8 
Male 13 2 6 
Age (years) 35 47 34 
Si) 10 12 11 
1. handed 2 0 2 
R handed 22 6 12 
NART score 111 115 118 
SD) 10 9 6 
Table 6.1. Summary of demographic data for the epilepsy, pain and healthy control 
groups participating in the baseline, 6-month and 12 month follow-up sessions. 
I'GS group FSG group FS group 
Female 3 3 5 
Male 7 2 4 
Age years 36 29 36 
SI) 10 6 13 
1, Banded I 1 0 
It handed 9 4 9 
Duration of epilepsy 15 12 12 
SI) (yeare) 12 8 7 
NART score 112 106 1 14 
SI) 10 6 11 
Table 6.2. Summary of demographic data Tor the seizure-type groups participating 
in the baseline, 6-month and 12 month follow-up sessions. 
6.2.2. Neuropxychological tests 
All %uhjects completed a Hospital Anxiety and Depression (HAD) questionnaire at the 
start of each session. They then completed a battery of tests as detailed in Chapter 4 
(%ection 4.2.2. ), with randomly assigned parallel versions of the test where available i. e. 
visual reaction time (RT), Rey's Auditory Verbal Learning Test (RAVLT) and story 
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recall tests. Appendix III contains further information about the neuropsychology tests 
employed and a glossary of measures obtained from the CANTAB test battery. 
6.2.3. ERI'tests and stimulus parameters 
Participants were instructed to sit in a chair facing a centrally placed monitor, positioned 
I metre away. which displayed the instructions for each test. For all ERP tests that did 
not involve reading or performing a visual vigilance task, they were instructed to fixate 
on a cross in the centre of the monitor in an attempt to minimise eye movements. For all 
3 se=ssions, auditory sinusoidal tones, with 5 msec rise and fall time, were delivered 
through car-phones at 70 dB SPL. 
6.2.3.1. M3 IN recording 
As for Chapter 4 section 4.2.3.1. 
6.2.3.2. Alb standard oddball recording 
As for Chapter 4 section 4.2.3.2. 
6.2.3.3. Ala "novel sounds" recording 
As for Chapter 4 section 4.2.3.3. The "novel" sounds that were used in the baseline task 
were re-administered in the follow-up sessions 
6.2.3.4. Dual target oddball (DTO) task recording 
A% for Chapter 4 section 4.2.3.2. The number of visual targets was different to the test 
adminktrred at baseline in case subjects were able to recall the number of targets they 
had counted at baseline. Different versions of this test, with varying a number of visual 
target.. were randomly assigned to each subject at each test session. 
6.2.4. LRP recording procedures 
A% for Chapter 4 . cction 4.2.4. 
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6.2.5. ERP data anal' si s 
As for Chapter 4 section 4.2.5 
6.2.6. Statistical analyses 
All results were analysed using repeated measures ANOVA. Within-subject factor 
session (baseline, 6-month follow-up and 12-month follow-up) was examined for the 
Neuropsychology and ERP behavioural results. Electrode site was included as a within- 
subject factor for the ERP analyses. Between-subject factor group was included in all 
analyses. In all cases, separate analyses were carried out for seizure groups and controls 
and for the pain group and controls. The Greenhouse-Geisser correction was used to 
adjust the degrees of freedom where appropriate and the correction values of epsilon (E) 
are listed to indicate where this was applied. 
6.3. Results 
The ncuropsychology and ERP results are listed with an initial summary of the main 
significant findings. for each set of results, followed by a more detailed description of 
statistical support of the findings. The result focus on main group effects and significant 
interaction effects including group, and those including session, factors. Significance 
value% have been symbolised according to the following criteria: *p <_ 0.05, ** p <_ 0.01 
. *. p<0. tx)l. 
6.3.1. Demographic measures 
Table% h. 1 and 6.2 show a summary of the demographic measures of the different 
participant group,,. There was no significant difference in age between the epilepsy and 
healthy control groups. However, as seen in the baseline demographic data, the pain 
group was significantly older than the healthy control group (p<0.05 independent t-test). 
The individual sei/ure groups did not significantly differ in age from the control group 
with one-way ANOVA analysis. 
The healthy control group showed significantly higher IQ scores, as assessed at baseline 
using the NART te%t (Nelson and Willison (1991), compared to the overall epilepsy 
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group (p= 0.03 independent t-test). One-way ANOVA with post-hoc Dunnett's test 
revealed that the FSG group had significantly lower NART scores compared to controls 
(p= 0.043). 
There was no significant difference for epilepsy duration between the three 
sci/ure group%. Table 6.3 summarises seizure frequency data obtained from the different 
seiiure groups at each test session. Seizure frequency relates to the number of patients' 
self-reported seizures in the month prior to testing. In cases where patients suffered from 
mvcxkmic Jerks (MMJs), a cluster of h1Js was classified as I seizure. Further details of 
sci/urc frequency are listed in Appendix I. Effects of time and group on seizure 
frequency failed to reach statistical significance with repeated measures ANOVA 
analyck. Time effect showed a trend towards significance (F= (2,42) p= 0.086, E= 
0.556) indicative of a general decrease in seizure frequency for all groups across the 
scssion%. Observation of the seizure frequency data points towards a greater decline in 
sciiure frequency across the sessions for the FSG group in comparison to the other 2 
sci/urc group,. However the small sample sizes and large S. D. values probably 
contributed to the lack of statistical significance. 
Session I Session 2 Session 3 
# scizures/month # seizures/month # seizures/month 
S. D. S. D. S. D. 
I'GS group 7 6 6 
12 11 11 
FS(: group 6 2 3 
8 3 2 
FS group 3 2 2 
6 2 3 
Table 6.3. Seizure frequency relating to the month prior to the 3 sessions. 
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6.3.2. Clinical and neuropsyclzological measures 
6.3.2.1. HAD results 
Results summary: In summary, there were no statistically significant differences in 
anxiety and depression scores between the seizure groups and controls across all test 
sessions. 
Results - detailed account: Figures 6.1a and 6.1b show the distribution of HAD 
anxiety and depression scores across the different seizure groups, pain group and control 
group at all 3 sessions. Comparison of the control and seizure groups revealed that there 
was no significant session effect, group effect or session * group interaction on HAD 
anxiety scores. There was a trend towards a significant group effect on HAD depression 
scores (F(3.34) =2.38. p= 0.087). Figure 6.1 a shows that the FSG and FS groups had the 
highest anxiety scores at all 3 sessions. As Figure 6.1b shows, the FSG group appears to 
have higher depression scores in comparison to all other groups however the large 
standard deviation probably contributed to the lack of statistical significance. 
There were no statistically significant differences in anxiety and depression scores 
between the pain and control groups across all test sessions. As Figure 6.1b shows, the 
pain group appear to have decreasing depression scores over the 3 sessions, whereas the 
control group have slightly incremental depression scores. This may have contributed to 
the ah. ence of the group effect observed at baseline (as reported in Chapter 4). 
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Figure 6.1. HAD anxiety (a) and depression (b) scores for all groups at baseline 
(session 1), 6-month follow-up (session 2) & 12-month follow-up (session 3). Group 
0= control, 1= PGS, 2 =FSG, 3= FS and 4= pain. 
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6.3.2.2. WCST results 
Results summary: All 3 seizure groups had higher non-perseverative error (NPE) and 
total error (TE) scores in comparison to controls. There were no statistically significant 
differences in the number of categories completed (CC), perseverative error (PE) score 
and the number of trials administered (TA) between the seizure groups and controls 
across all test sessions. The pain group had higher PE scores, and also higher TE and 
NPE scores in comparison to controls, however, these error scores improved across the 
sessions for pain and control groups which may indicate practice effects that were absent 
from the seizure groups' results. 
Results - detailed account: Figures 6.2a, 6.2b, 6.2c and 6.2d show the distribution of 
WCST NPE, TE, CC and PE scores across the different seizure groups, pain group and 
control group at all 3 sessions. Table 6.4 and 6.5 list the main statistical findings. 
There was a significant group effect on NPE scores (p= 0.022) and on TE score (p= 
0.026). All 3 seizure groups showed higher error scores for both measures in comparison 
to controls and as Figures 6.2a and 6.2b illustrate, this group difference was most 
apparent for the PGS group. 
Interestingly, the pain group, as well as the control group, showed decreasing NPE and 
TE scores across the 3 sessions. This result may be due to practice effects that were not 
apparent for the seizure groups. As Table 6.5 shows, there was a significant session 
effect on NPE score (p= 0.01) and also a significant group effect (p= 0.014). Both 
groups showed a decline in NPE scores across the 3 sessions but the pain group had 
higher non-perseverative errors in comparison to controls at all 3 sessions. There were 
similar significant session (p= 0.011) and group effects (p= 0.028) on TE scores. There 
was also a significant group effect on PE score (p= 0.016) and trend towards significant 
session effect (p= 0.065) and interaction of group and session (p= 0.09). Despite 
decreasing PE scores across the 3 sessions, the pain group had higher PE scores 
compared to controls across all 3 sessions. As Figure 6.2d shows, the pain group showed 
a large improvement in PE scores from session 1 to 3 however this group * session 
interaction effect failed to reach statistical significance. 
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Between subject factors -group effect 
d. f. F c p 
Non-perseverative errors score 3,33 3.68 - 0.022* 
Total errors score 3,33 3.50 - 0.026* 
Table 6.4. Control vs. seizure groups: statistical summary of results with p<_0.1 
from repeated measures ANOVA of WCST scores obtained at all 3 sessions. 
Within subject factors 
d. f. F E P 
Non-perseverative error score 
Session effect 2,36 6.17 0.759 0.010** 
Perseverative error score 
Session effect 2,36 3.45 0.665 0.065 
Session * group 2,36 2.93 0.665 0.090 
Total errors score 
Session effect 2,36 6.74 0.636 0.011* 
Between subject factors -group effect 
Categories completed 1,18 4.18 - 0.056 
Non-perseverative error score 1,18 7.46 - 0.014* 
Perseverative error score 1,18 7.09 - 0.0 16* 
Total error score 1,18 5.72 - 0.028* 
Table 6.5. Control vs. pain group: statistical summary of results with p<_0.1 from 
repeated measures ANOVA of WCST scores obtained at all 3 sessions. 
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Figure 6.2. WCST non-perseverative error (a), categories completed (b), total error 
(c) and perseverative error (d) scores for all groups at baseline (session 1), 6-month 
follow-up (session 2) & 12-month follow-up (session 3). Group 0= control, I= PGS, 
2 =FSG, 3= FS and 4= pain. 
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6.3.2.3. Visual reaction time results 
Results summary: Simple movement time (MT), choice reaction time (RT) and choice 
MT were slower for the seizure groups in comparison to controls. Although the pain 
group showed similar delays in comparison to controls, they showed an improvement in 
measures of simple and choice RT across the session indicating practice effects that 
were absent from the controls vs. seizure group comparisons. 
Results - detailed account: Figures 6.3a, 6.3b, 6.3c and 6.3d show the distribution of 
visual RT scores of simple RT, simple MT, choice RT and choice MT across the 
different seizure groups, pain group and control group at all 3 sessions. Table 6.6 and 6.7 
list the statistically significant findings. 
There were no significant group, session or interaction of session and group effect on 
simple RT. There was a significant group effect on simple MT (p= 0.0 11), choice RT 
(p= 0.042) and on choice MT (p= 0.015). As illustrated in Figures 6.3b, 6.3c and 6.3d, 
all 3 seizure groups had slower simple MT, choice RT and choice MT compared to 
controls at all 3 sessions. 
Similar to the control vs. seizure group comparisons, the pain group simple MT (p= 
0.015), choice RT (p= 0.008) and choice MT (0.007) were all slower for the pain group 
in comparison to controls. However, in contrast to the seizure group results, RT and 
choice RT decreased across the 3 sessions for the pain and control groups (p= 0.038 and 
0.017 respectively) probably indicating improvement with practice effects. 
Between subjec t factors -group effect 
d. f. F p 
Simple movement time 3,34 4.34 - 0.011* 
Choice reaction time 3,34 3.06 - 0.042* 
Choice movement time 3,34 4.02 - 0.015* 
Table 6.6. Controls vs. seizure groups: statistical summary of results with p<_0.1 
from repeated measures ANOVA of visual RT test scores obtained at all 3 sessions. 
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Within subject factors 
d. f. F p 
Simple reaction time 
Session effect 2,36 4.34 0.664 0.038* 
Choice reaction time 
Session effect 2,36 5.02 0.839 0.017* 
Between subject factors -group effect 
Simple reaction time 1,18 3.44 - 0.080 
Simple movement time 1,18 7.17 - 0.015* 
Choice reaction time 1,18 9.06 - 0.008** 
Choice movement time 1,18 9.14 - 0.007** 
Table 6.7. Controls vs. pain group: statistical summary of results with p<_0.1 from 
repeated measures ANOVA of visual RT test scores obtained at all 3 sessions. 
Figure 6.3. Simple RT (a), simple MT (b), choice RT (c) and choice MT (d) scores 
for all groups at baseline (session 1), 6-month follow-up (session 2) & 12-month 
follow-up (session 3). Group 0= control, 1= PGS, 2= FSG, 3= FS and 4 =pain. 
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6.3.2.4. Spatial working memory results 
Results summary: The control group showed better ability to employ a strategy to 
facilitate task performance in comparison to the seizure groups. The control group also 
showed better strategy scores in comparison to the pain group. However, both groups 
had significant improvement in strategy scores at session 3 compared to their respective 
baseline scores. 
Results - detailed account: Tables 6.8 and 6.9 list the main statistical findings. There 
was a significant group effect on strategy scores (p= 0.037) for the control vs. seizure 
groups comparison. Figure 6.4 shows that strategy scores were higher for all 3 seizure 
groups in comparison to controls at all 3 sessions. This result indicates that the control 
group were better at strategy employment in completing this task in comparison to the 
seizure groups. Interestingly, the control vs. pain group analysis also revealed a 
significant group effect (p= 0.003) and also a significant session effect on strategy scores 
(p= 0.040). As Figure 6.4b shows, the pain group had higher (i. e. poorer) strategy scores 
in comparison to controls at all sessions. However, the session effect relates to 
improvement in scores from session 1 to session 3. 
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Within subject factors 
d. f. F £ p 
Within error scores 
Interaction effect of session * group 6,66 1.96 0.869 0.096 
Between subject factors -group effect 
Strategy scores 3,33 3.18 - 0.037* 
Table 6.8. Controls vs. seizure groups: statistical summary of results with p<_0.1 
from repeated measures ANOVA of SWM test scores obtained at all 3 sessions. 
Within subject factors 
d. f. F £ p 
Within error score 
Interaction e ect of session * group 2,36 2.86 0.892 0.077 
Strategy score 
Session of/, ct 2,36 3.74 0.874 0.040* 
Between subject factors -group effect 
Strategy score 1,18 11.88 - 0.003** 
Table 6.9. Controls vs. pain group: statistical summary of results with p<_0.1 from 
repeated measures ANOVA of SWM test scores obtained at all 3 sessions. 
Figure 6.4. SWM test strategy scores for all groups at baseline (session 1), 6-month 
follow-up (session 2) & 12-month follow-up (session 3). Group 0= control, I= PGS, 
2= FSG, 3= FS and 4 =pain. 
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6.3.2.5. Planning (Tower of London/Stockings of Cambridge) test 
Results summary: There was a significant interaction effect of group and session for 
problems solved in the minimum number of moves (PSMM) from the control vs. seizure 
groups comparison. 
Results -detailed account: Tables 6.10 and 6.11 list the main statistical findings. There 
was a significant session effect on MIT (p= 0.000). Control vs. pain group comparison 
revealed a significant session effect (p= 0.014) and on MIT but no significant interaction 
effect of session and group. Also, there was a significant interaction effect of session and 
group on PSMM (p= 0.025). However as Figure 6.5 shows, there was a varying pattern 
in results between the groups across the sessions. The control vs. pain group comparison 
failed to reveal any significant difference in PSMM between these 2 groups. 
Within subject factors 
d. f. F E p 
Mean initial thinking time 
Session effect 2,66 18.89 0.588 0.000*** 
Problems solved in minimum moves 
Interaction effect of session * group 6,66 2.75 0.880 0.025* 
Table 6.10. Controls vs. seizure groups: statistical summary of results with p<_0.1 
from repeated measures ANOVA of planning test scores obtained at all 3 sessions. 
Within subject factors 
d. f. F E p 
Mean initial thinking time 
Session effect 2,34 7.23 0.520 0.014* 
Table 6.11. Controls vs. pain group: statistical summary of results with p<_0.1 from 
repeated measures ANOVA of planning test scores obtained at all 3 sessions. 
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Figure 6.5. Interaction effects of session and group on PSMM for controls vs. 
seizure groups at baseline (session 1), 6-month follow-up (session 2) & 12-month 
follow-up (session 3). 
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6.3.2.6 RAVLT results 
° Control group 
° PGS group 
° FSG group 
11 FS group 
Results summary: The control group had higher trial 1 (initial learning trial), 5 (final 
learning trial), 6 (distracter trial) and 7 (recall of list learnt prior to distracter trial) recall 
scores in comparison to all seizure groups across all 3 sessions. There was an 
improvement in trial I recall scores at session 3 in comparison to session 1 for the 
control group and PGS groups, whereas FSG and FS group scores remained similar to 
their respective baseline values. The pain group had lower trial 1 recall scores in 
comparison to controls at all 3 sessions and a decrease in scores at session 3 in 
comparison to sessions 1 and 2. The pain group also had lower trial 5 recall scores in 
comparison to the pain group at all 3 sessions, however there was an increase in trial 6 
recall at session 3 in comparison to session 1 for both groups. 
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Results -detailed account: Figures 6.6a, 6.6b and 6.6c show the recall scores for trial 1, 
trial 5 and trial 7 from all groups across all 3 sessions. Tables 6.12 and 6.13 list the main 
statistical findings. 
Control vs. seizure groups comparison revealed a significant session effect on trial 1 
recall (p= 0.024) and also a significant group effect (p= 0.005). Figure 6.6a shows that 
the control group had better trial 1 recall scores than all 3 seizure groups across all 3 
sessions. The FSG group had the lowest scores compared to the control, PGS and FS 
groups at all 3 sessions. The pain also had significantly lower trial 1 recall scores 
compared to controls (p= 0.03) at all 3 sessions. There was also a significant session * 
group interaction for trial 1 recall (p= 0.026). Figure 6.6e shows the nature of this 
interaction. The control group had incremental recall scores across the 3 sessions, 
whereas the pain group's scores, despite remaining lower than controls at all time points, 
showed a slight increase at session 2 compared to session 1 and then a decrease at 
session 3. 
Comparison of control and seizure groups also revealed a significant group effect for 
trial 5 recall (p= 0.041), trial 6 recall (p= 0.003) and for trial 7 recall (p= 0.02). Again 
recall scores for the control group remained higher in comparison to all 3 seizure groups 
across all the sessions. The control group also had higher trial 5 recall scores compared 
to the pain group at all 3 sessions (p= 0.007). In contrast to results obtained from the 
seizure groups, there was an overall improvement in trial 6 recall scores between 
sessions 1 and 3 for both pain and control groups (p= 0.008). 
Within subject factors 
d. f. F E p 
Trial 1 recall 
Session e ect 2,66 4.16 0.895 0.024* 
Between subject factors -group effect 
Trial 1 recall 3,33 5.06 - 0.005** 
Trial 5 recall 3,33 3.07 - 0.041 * 
Trial 6 recall 3,33 5.77 - 0.003** 
Trial 7 recall 3,33 3.76 - 0.020* 
Table 6.12. Controls vs. seizure groups: statistical summary of results with p<_0.1 
from repeated measures ANOVA of RAVLT test scores obtained at all 3 sessions. 
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Within subject factors 
d. f. F E p 
Trial 1 recall 
Session * rou interaction 2,36 4.53 0.797 0.026* 
Trial 6 recall 
Session effect 2,36 5.63 0.994 0.008** 
Between subject factors -group effect 
Trial 1 recall 1,18 5.59 - 0.030* 
Trial 5 recall 1,18 9.29 - 0.007** 
Table 6.13. Controls vs. pain group: statistical summary of results with p<_0.1 from 
repeated measures ANOVA of RAVLT test scores obtained at all 3 sessions. 
Figure 6.6a, b, c&d. RAVLT scores for trial 1 (a) trial 5 (b) trial 6 (c) and trial 7 
(d) recall for all groups at baseline (session 1), 6-month follow-up (session 2) & 12- 
month follow-up (session 3). Group 0= control, I= PGS, 2= FSG, 3= FS and 4 =pain. 
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Figure 6.6e. Interaction effects of session and group on RAVLT trial 1 recall for the 
pain group and control group at baseline (session 1), 6-month follow-up (session 2) 
& 12-month follow-up (session 3). 
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6.3.2.7. Story recall results 
Results summary: The control group had higher immediate and delayed recall scores 
and retention scores in comparison to control groups at all 3 sessions. There was a 
significant group * session interaction effect on retention scores. Although there was an 
increase in retention scores from session 1 to session 3 for the control, PGS and FSG 
groups, the FS group showed a decline in their scores. Comparison of the control and 
pain groups revealed that although the former group had comparatively higher retention 
scores at session 1, both groups showed an increase in scores from session 1 to session 3 
where there was no apparent inter-group difference perhaps due to practice effects. 
Results -detailed account: Figures 6.7a, 6.7b, and 6.7c show the immediate recall, 30- 
minute recall and retention scores for all groups across all 3 sessions. Tables 6.14 and 
6.15 list the main statistical findings. 
The control group had higher immediate (p= 0.000) and delayed (p= 0.000) recall scores 
in comparison to the seizure groups at all 3 sessions. The control group had higher 
retention scores in comparison to the seizure groups at all 3 sessions (p= 0.004). There 
was a significant interaction effect of session and group (p= 0.037). As Figure 6.7d 
illustrates, there was an overall increase in retention scores from session 1 to 2 for the 
control, PGS and FSG groups but the FS group shows a decline in scores across all 3 
sessions. Comparison of the control and pain groups revealed a significant session effect 
on retention score (p= 0.001) and also a significant group effect (p= 0.013) but no 
significant interaction of session and group effect. As Figure 6.7c shows, both groups 
had higher retention scores at session 3 compared to session 1. At session 1 the control 
group had higher retention scores in comparison to the pain group but similar scores 
were seen for both groups at sessions 2 and 3, suggesting improvement across the 
sessions. 
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Within subject factors 
d. f. F c p 
Retention score 
Interaction effect of session * group 6,66 2.54 0.851 0.037* 
Between subject factors -group effect 
Immediate recall score 3,33 8.73 - 0.000*** 
30 minute delayed recall score 3,33 11.00 - 0.000*** 
Retention score 3,33 5.27 - 0.004** 
Table 6.14. Controls vs. seizure groups: statistical summary of results with p<_0.1 
from repeated measures ANOVA of story recall test scores obtained at all 3 
sessions. 
Within subject factors 
d. f. F c p 
30 minute delayed recall score 
Session effect 2,36 3.48 0.742 0.058 
Retention score 
Session effect 2,36 11.15 0.770 0.001*** 
Between subject factors -group effect 
Immediate recall score 1,18 4.02 - 0.060 
30 minute delayed recall score 1,18 6.35 - 0.021 * 
Retention score 1,18 7.56 - 0.013* 
Table 6.15. Controls vs. pain group: statistical summary of results with p50.1 from 
repeated measures ANOVA of story recall test scores obtained groups at all 3 
sessions. 
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Figure 6.7a, b, c&d. Story recall test scores of immediate recall (a) 30-minute 
delayed recall (b) and retention (c) for all groups at baseline (session 1), 6-month 
follow-up (session 2) & 12-month follow-up (session 3). Group 0= control, 1= PGS, 
2= FSG, 3= FS and 4 =pain. 
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Figure 6.7d. Interaction effects of session and group on story recall retention score 
for the seizure groups and control group at baseline (session 1), 6-month follow-up 
(session 2) & 12-month follow-up (session 3). 
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6.3.3. ERP behavioural results 
Tables 6.16 and 6.17 list the main statistical findings for all ERP behavioural results for 
the control group and pain group respectively. 
Within subject factors 
d. f. F E p 
DTO task auditory target RT 
Session effect 2,64 3.58 0.991 
T0.034* 
Between subject effects -group 
DTO task -visual target accuracy 3,32 2.78 - 0.057 
Table 6.16. Controls vs. seizure groups: statistical summary of results with p5O. 1 
from repeated measures ANOVA of ERP RT results obtained at all 3 sessions. 
Within subject factors 
d. f. F E p 
P3b auditory target detection accuracy 
Interaction effect of session * group 2,36 3.96 0.651 0.049* 
DTO task auditory target RT 
Interaction effect of session * group 2,36 3.83 0.819 0.041 * 
Between subject factors -group effect 
P3b reaction time 1,18 9.20 - 0.007** 
P3b accuracy 1,18 6.57 - 0.020* 
Na reaction time 1,18 6.81 - 0.018* 
Na accuracy 1,18 9.52 - 0.006** 
DTO task auditory target accuracy 1,18 6.61 - 0.019* 
Table 6.17. Controls vs. pain group: statistical summary of results with p<_0.1 from 
repeated measures ANOVA of ERP RT results obtained at all 3 sessions. 
6.3.3.1. P3b oddball task behavioural results 
Comparison of the control and seizure groups failed to reveal any significant session, 
group or session * group interaction effects on RT or accuracy of responses to auditory 
targets. However, comparison of the control and pain groups revealed a significant 
group effect on accuracy of auditory target detection (p= 0.020) and also a significant 
interaction effect of session * group (p= 0.049). As Figures 6.8b and 6.8h show, 
although the control group's accuracy scores remained similar across the 3 sessions, the 
pain group had lower accuracy scores at sessions 2 and 3 in comparison to session 1. 
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6.3.3.2. Pia novel sounds task behavioural results 
Comparison of the control and seizure groups failed to find any significant session, 
group or session and group interaction effects on RT or accuracy of responses to 
auditory targets. 
6.3.3.3. DTO task behavioural results 
Comparison of the control and seizure groups revealed a significant session effect on RT 
to the auditory targets (p= 0.034). The control and seizure groups showed slower RTs at 
session 3 in comparison to their respective values at session 1 (Figure 6.8e). Comparison 
of the control and pain groups revealed a significant interaction effect of group and 
session on RT to the auditory targets (p= 0.041) (see Figure 6.8i). The control group had 
increasingly slower RTs across the 3 sessions, whereas the pain group, although slower 
than controls at sessions 1 and 2, had RTs comparable to controls at session 3. 
Figure 6.8a & b. RT for correctly detected targets (a) and accuracy of detection (b) 
in the oddball task for all groups at baseline (session 1), 6-month follow-up (session 
2) & 12-month follow-up (session 3). Group 0= control, 1= PGS, 2= FSG, 3= FS and 
4 =pain. 
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Figure 6.8c & d. RT for correctly detected targets (c), accuracy of detection (d) in 
the Pia novel sounds task for all groups at baseline (session 1), 6-month follow-up 
(session 2) & 12-month follow-up (session 3). Group 0= control, 1= PGS, 2= FSG, 3= 
FS and 4 =pain. 
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Figure 6.8e, f&g. RT for correctly detected auditory targets (e) and accuracy of 
detection (f); visual target detection accuracy (g) in the DTO task for all groups at 
baseline (session 1), 6-month follow-up (session 2) & 12-month follow-up (session 
3). Group 0= control, 1= PGS, 2= FSG, 3= FS and 4 =pain. 
6.8e 
500- 
400- 
300- 
U 
t0 
G) 
200 
>, 100- 
0_ 
t9 C 1 
Error Bars show Mean +/- 1.0 SD 
Bars show Means 
  session 1 
  session 2 
  session 3 
4 
- 222 - 
Chapter VI 
6.8f 
6.8g 
Ö 
O 
100- 
v 
V 
75- 
C 
0 
. .y 
tß 
:: 
'] 
ß 
1111110 
4 
00 
L v 100- 
(0 
c 
O 75- 
V 
d 
d 
50- 
"" 25- 
0-11 
0 
group 
1234 
group 
- 223 - 
Error Bars show Mean +/- 1.0 SD 
Bars show Means 
  session 1 
  session 2 
  session 3 
Error Bars show Mean +/- 1.0 SD 
Bars show Means 
 session 1 
  session 2 
 session 3 
Chapter VI 
Figure 6.8h. Interaction effects of session and group on accuracy of auditory target 
detection in the oddball task for pain and control groups at baseline (session 1), 6- 
month follow-up (session 2) & 12-month follow-up (session 3). 
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Figure 6.8i. Interaction effects of session and group on RT for correctly detected 
auditory targets in the DTO task for pain and control groups at baseline (session 1), 
6-month follow-up (session 2) & 12-month follow-up (session 3). 
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6.3.4. ERP results 
Full details of group averaged ERP data measures are provided in Appendix IV. 
6.4.3.1. MMN results 
Results summary: All seizure groups had earlier MMN onset at session 3 in 
comparison to corresponding onset latencies at sessions 1 and 2. Also, the seizure groups 
had later MMN offset latency compared to controls at all 3 sessions. There was a greater 
increase in MMN duration across the 3 sessions for the seizure groups than that 
observed for controls. Interaction effects of group and session failed to reach statistical 
significance for the control vs. seizure groups' comparisons of peak latency and offset 
but reached significance or showed a trend towards significance for the control vs. pain 
group comparison. The pain group showed an increase in peak latency from session 1 to 
3, whereas the control group showed corresponding decrease. The PGS group had larger 
mean peak amplitude (mpa), at most analysed sites, in comparison to control and other 
seizure groups. 
Results -detailed account: Figures 6.9a, 6.9b, 6.9c, 6.9d and 6.9e show the group 
averaged MMN difference waveforms obtained for each group at each session. Tables 
6.18 and 6.19 list the main statistical findings. Control vs. seizure groups comparison 
revealed a significant main effect of session on MMN onset (p= 0.000). The control 
group had similar onset latency across all the sessions but for all 3 seizure groups, onset 
at session 3 was earlier in comparison to respective onset at sessions 1 and 2. Although 
the seizure groups had longer MMN peak latency compared to controls, at all 3 
sessions, this difference only showed a trend towards significance (p= 0.089). There was 
also a significant main effect of group on MMN offset (p= 0.004). All seizure groups 
had later offset compared to controls at all sessions. There were no significant 
interaction effects of group * session on MMN peak latency and offset. However, this 
interaction effect showed trends towards significance with control vs. pain group 
comparison of peak latency (p= 0.051) and offset (p= 0.068). The control vs. seizure 
groups comparison also revealed a significant main effect of session on MMN duration 
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(p= 0.013). The control and seizure groups had increasing MMN duration from session 1 
to session 3. This increase was more marked in the seizure groups than the control group 
but group effect was not statistically significant. 
There was a significant interaction effect of electrode and group on MMN mpa (p= 
0.040). Figure 6.9f illustrates the nature of this interaction. The PGS group had larger 
mpa at Fz, C, Pz and F3, at all sessions, in comparison to control and other seizure 
groups. 
Within subject factors 
d. f. F £ p 
MMN onset 
Session effect 2,68 10.16 0.953 0.000*** 
MMN duration 
Session effect 2,68 4.95 0.891 0.013* 
MMN m pa 
Electrode effect 4,136 24.17 0.540 0.000*** 
Interaction effect of electrode * up 12,136 2.29 0.540 0.040* 
Between subject factors -group effect 
MMN peak latency 3,34 2.36 - 0.089 
MMN offset 3,34 5.32 - 0.004** 
Table 6.18. Controls vs. seizure groups: summary of results with p<_0.1 from 
repeated measures ANOVA of MMN results obtained all 3 sessions. 
Within subject factors 
d. f. F E P 
MMN peak Iatency 
Interaction effect of session * group 2,36 3.50 0.827 0.051 
MMN onset 
Session effect 2,36 4.09 0.834 0.033* 
MMN offset 
Interaction effect session * group 2,36 3.17 0.785 0.068 
MMN duration 
Session effect 2,36 4.21 0.771 0.036* 
MMNma 
Electrode effect 4,72 19.85 0.466 0.000*** 
Interaction effect of electrode * session 8,144 2.14 0.452 0.092 
Between subject factors -group effect 
MMN offset 1,18 4.99 - 0.038* 
MIN duration 1,18 3.64 - 0.072 
Table 6.19. Controls vs. pain group: summary of significant statistical results with 
p<_O. 1 repeated measures ANOVA of MMN results obtained at all 3 sessions. 
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Chapter VI 
Figure 6.9f. Interaction effect of electrode and group on MMN mpa for seizure and 
control groups. 
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6.3.4.2. P3b standard oddball task results 
Results summary: The control group had shorter N2 latencies in comparison to all 
seizure groups at all sessions. Control and seizure groups showed an increase in N2 
latency from session 1 to 3 -this was more notable for the seizure groups but failed to 
yield a significant group * session interaction effect. Larger N1 and N2 amplitudes were 
observed at Cz for the PGS group, in comparison to control, FSG and FS groups, at all 
sessions. P3b latency remained similar for the control group but increased for all 3 
seizure groups across the sessions. There was a marked increase in P3b latency across 
the sessions for the PGS group. P3b amplitude was largest at Pz for all groups. Control 
vs. pain group comparisons failed to yield any significant group * session interaction 
effects. 
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Result -detailed account: Figures 6.1Oa to 6.1Oe show the group averaged responses to 
auditory targets obtained for each group at each session. Tables 6.20 and 6.21 list the 
main statistical findings. 
There was a significant electrode effect (p= 0.001), group effect (p= 0.042) and also a 
significant interaction effect of electrode and group on NI amplitude (p= 0.012). As 
Figure 6.10f shows, larger Ni amplitudes were observed for the PGS group in 
comparison to all other groups, at all sites but most notably at Cz. 
There were significant effects of group (p= 0.034) and session (p= 0.041) on N2 latency. 
The control group had shorter N2 latencies in comparison to all seizure groups at all 3 
sessions. All groups showed an increase in N2 latency from session 1 to 3 which was 
more notable for the seizure groups in comparison to controls but group * session 
interaction effect failed to reach statistical significance. Control vs. seizure groups 
comparison also revealed a significant electrode effect on N2 amplitude (p= 0.000) and a 
significant interaction effect of electrode and group (p= 0.009). As Figure 6.10g shows, 
similar to NI amplitude findings, the PGS group had larger N2 amplitudes at Cz, in 
comparison to the other groups. 
There was a significant session effect on P3b latency (p= 0.001) and also a significant 
interaction effect of session and group (p= 0.007). As Figure 6.10h shows, the control 
group's latency remained similar, whereas the seizure groups had latency increases 
across the 3 sessions. In particular, the PGS group had a marked increase in P3b latency 
across the sessions in comparison to the other seizure and control groups. 
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Within subject factors 
d. f. F E P 
Ni latency 
Interaction effect of session * group 6,68 1.99 0.940 0.085 
Ni amplitude 
Electrode effect 3,102 108.67 0.518 0.000*** 
Interaction effect of electrode * group 9,102 2.55 0.518 0.042* 
N2 latency 
Session effect 2,68 3.47 0.919 0.041 * 
N2 amplitude 
Electrode effect 3,102 48.22 0.487 0.000*** 
Interaction effect of electrode * rou 9,102 3.67 0.487 0.009** 
P3 latency 
Session effect 2,68 9.49 0.739 0.001*** 
Interaction effect of session * group 6,68 3.84 0.739 0.007** 
P3 amplitude 
Electrode effect 3,102 29.15 0.595 0.000*** 
Between subject factors -group effect 
Ni amplitude 3,34 4.22 - 0.012* N2 latency 3,34 3.24 - 0.034* 
Table 6.20. Controls vs. seizure groups: summary of results with p<_0.1 from 
repeated measures ANOVA of responses to auditory targets in the P3b oddball task 
obtained at all 3 sessions. 
Within subject factors 
d. f. F e p 
Ni latency 
Electrode effect 3,54 2.73 0.762 0.070 
Ni amplitude 
Electrode effect 3,54 51.60 0.520 0.000*** 
N2 latency 
Interaction e ect of session * group 2,36-- T2.60 0.884 0.096 
N2 amplitude 
Electrode effect 3,54 6.65 0.536 0.007** 
Session effect 2,36 3.72 0.856 0.042* 
P3 latency 
Session effect 2,36 3.46 0.766 0.057 
P3 amplitude 
Electrode effect 3,54 10.48 0.778 0.000*** 
Between subject factors -group effect N2latency 1,18 3.60 - 0.0 44 
i awe o. cji. t. ontruis vs. pain group: summary of results with p50.1 from repeated 
measures ANOVA of responses to auditory targets in the P3b oddball task obtained 
at all 3 sessions. 
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Figure 6.10a. Group averaged P3b waveforms obtained in response to auditory 
target tones in the standard oddball task at the 3 test sessions for the control group. 
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Figure 6.10b. Group averaged P3b waveforms obtained in response to auditory 
target tones in the standard oddball task at the 3 test sessions for the PGS group. 
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Figure 6.10c. Group averaged P3b waveforms obtained in response to auditory 
target tones in the standard oddball task at the 3 test sessions for the FSG group. 
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Figure 6.10d. Group averaged P3b waveforms obtained in response to auditory 
target tones in the standard oddball task at the 3 test sessions for the FS group. 
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Figure 6.10e. Group averaged P3b waveforms obtained in response to auditory 
target tones in the standard oddball task at the 3 test sessions for the pain group. 
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Figure 6.10f. Interaction effect of electrode and group on N1 amplitude for seizure 
and control groups. 
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Figure 6.10g. Interaction effect of electrode and group on N2 amplitude for seizure 
and control groups. 
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Figure 6.10h. Interaction effect of session and group on P3b latency for seizure and 
control groups at baseline (session 1), 6-month follow-up (session 2) and 12-month 
follow-up (session 3). 
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Summary: The PGS group had larger Ni amplitudes at all electrodes in comparison to 
controls. N2 latency decreased for the control group across the 3 sessions, whereas all 3 
seizure groups showed an overall increase. In particular, the FSG and FS groups 
showed a marked increase from session 2 to 3 and although the FS group had shorter N2 
latency in comparison to controls at baseline, at session 3 it was comparatively longer. 
Comparison of the control and pain group revealed increasing N2 latency for the latter 
group across the sessions. Both PGS and FS groups had later P3a latencies in 
comparison to controls at all 3 sessions. The control group had a slight decrease in N2 
latency across the sessions, whereas all 3 seizure groups showed an increase. The control 
group had a slight decrease in latency across the sessions, whereas all 3 seizure groups 
showed an increase. 
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Results -detailed account: Figures 6.11a to 6.11e show the group averaged responses 
to auditory targets obtained for each group at each session. Tables 6.22 and 6.23 list the 
main statistical findings. 
There was a significant interaction effect of electrode and group on Ni amplitude (p= 
0.005) (Figure 6.110. The PGS group had larger Ni amplitudes at all electrodes in 
comparison to controls. 
There were significant effects of session (p= 0.004) and group (p= 0.026) on N2 latency 
and also interaction effect of session and group (p= 0.045) (Figure 6.11g). The control 
group had a slight decrease in N2 latency across the 3 sessions, whereas all 3 seizure 
groups showed an overall increase. In particular, the FSG and FS groups showed a 
marked increase from session 2 to 3. At sessions 1 and 2, the FS group had shorter N2 
latency in comparison to controls but at session 3 this was comparatively delayed. Both 
PGS and FS groups had longer N2 latencies in comparison to controls at all 3 sessions. 
Comparison of control and pain groups also revealed a significant interaction effect of 
group * session on N2 latency (p= 0.003). As Figure 6.11h shows, the control group 
showed an overall decrease in N2 latency across the sessions, whereas the pain group 
showed an increase. 
There was a significant electrode effect on N2 amplitude (p= 0.01) and a trend towards a 
significant group effect (p= 0.068). Largest N2 amplitudes were observed at Fz and Cz 
for all groups. The FS group had smaller N2 amplitudes in comparison to the control and 
other seizure groups. 
There was a significant effect of session (p= 0.001) on P3a latency and a trend towards 
significant effect of group (p= 0.093) and interaction of session and group (p= 0.053). 
As Figure 6.11 i shows, the control group had a slight decrease in latency across the 
sessions whereas, all 3 seizure groups showed an increase compared to their respective 
baseline latencies. This interaction effect was not significant for the control vs. pain 
group comparison. 
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Within subject factors 
d. f. F £ p 
N1 latency 
Electrode effect 3,102 4.74 0.803 0.007** 
Ni amplitude 
Electrode effect 3,102 3.72 0.757 0.024* 
Interaction effect of electrode * rou 9,102 3.27 0.757 0.005** 
N2 latency 
Session effect 2,68 6.96 0.782 0.004** 
Interaction effect of session * group 6,68 2.50 0.782 0.045* 
N2 amplitude 
Electrode effect 3,102 5.40 0.566 0.010** 
P3a latency 
Session effect 2,68 8.45 0.892 0.001*** 
Interaction effect of session * group 6,68 2.29 0.892 0.053* 
Na amplitude 
Electrode effect 3,102 31.60 0.482 0.000*** 
Session effect 2,68 2.78 0.952 0.072 
Between subject factors -group effect 
N2 latency 3,34 3.51 - 0.026* 
N2 amplitude 3,34 2.60 - 0.068 
P3a latency 3,34 2.32 - 0.093 
Table 6.22. Controls vs. seizure groups: summary of results with p5". 1 t-rom 
repeated measures ANOVA of responses to auditory targets in the P3a novel 
sounds task obtained at all 3 sessions. 
Within subject factors 
d. f. F £ p 
Nl latency 
Electrode effect 3,54 4.54 0.806 0.012* 
N2 latenc 
Session effect 2,36 3.47 0.823 0.053* 
Interaction effect of session* group 2,36 7.93 0.823 0.003** 
N2 amplitude 
Electrode effect 3,54 3.84 0.603 0.036* 
Session effect 2,36 3.075 0.910 0.064 
P3 amplitude 
Electrode effect 3,54 14.67 0.527 0.000*** 
Between subject factors -group effect 
Ni latency 1,18 4.94 - 0.039* 
N2latency 1,18 12.12 - 0.003** 
N2 am litude 1,18 4.70 - 0.044* 
Table 6.23. Controls vs. pain group: summary of results with p<_0.1 from repeated 
measures ANOVA of responses to auditory targets in the P3a novel sounds task 
obtained at all 3 sessions. 
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Figure 6.1Ia. Group averaged P3a waveforms obtained in response to novel non- 
target sounds in the P3a novel sounds task at the 3 test sessions for the control 
group. 
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Figure 6.11b. Group averaged P3a waveforms obtained in response to novel non- 
target sounds in the P3a novel sounds task at the 3 test sessions for the PGS group. 
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Figure 6.11c. Group averaged Pia waveforms obtained in response to novel non- 
target sounds in the P3a novel sounds task at the 3 test sessions for the FSG group. 
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Figure 6.11d. Group averaged P3a waveforms obtained in response to novel non- 
target sounds in the P3a novel sounds task at the 3 test sessions for the FS group. 
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Figure 6.11e. Group averaged P3a waveforms obtained in response to novel non- 
target sounds in the P3a novel sounds task at the 3 test sessions for the pain group. 
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Figure 6.111% Interaction effect electrode and group on Ni amplitude for seizure 
and control groups. 
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Figure 6.11g. Interaction effect of session and group on N2 latency for seizure and 
control groups at baseline (session 1), 6-month follow-up (session 2) and 12-month 
follow-up (session 3). 
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Figure 6.11h. Interaction effect of session and group on N2 latency for pain and 
control groups at baseline (session 1), 6-month follow-up (session 2) and 12-month 
follow-up (session 3). 
240 
230 
u 
d 
220 
v 210 
d 
200 
N 
Z 
190 
180 
i 
i 
1 2 
session 
° Controls 
° Pain 
3 
Figure 6.11i. Interaction effect of session and group on P3a latency for seizure and 
control groups at baseline (session 1), 6-month follow-up (session 2) and 12-month 
follow-up (session 3). 
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6.3.4.4. DTO task -auditory targets 
Results summary: Control vs. seizure groups comparison revealed a varying pattern in 
Ni latency across the sessions for the seizure groups. The PGS group had the largest Ni 
amplitudes in comparison to all other groups at all sessions. All 3 seizure groups showed 
longer N2 latencies at session 3 in comparison to their respective latencies at sessions 1 
and 2. The pain group also had longer N2 latency compared to controls at all 3 sessions. 
The control group showed a decrease in P3b latency across the 3 sessions, whereas all 3 
seizure group showed increasing latency. The control group had larger P3b amplitudes 
in comparison to the PGS and FS groups. Furthermore, the PGS group had the smallest 
P3b amplitude at Cz in comparison to all other groups. 
Results -detailed account: Figures 6.12a to 6.12e show the group averaged responses 
to auditory targets obtained for each group at each session. Tables 6.24 and 6.25 list the 
main statistical findings. Comparison of the control group and seizure groups revealed 
significant interaction effects of electrode * group (p= 0.034) and electrode * session * 
group (p= 0.017) on NI latency (Figures 6.12f, 6.12g and 6.12h). At baseline, the PGS 
group had shorter Ni latencies, at all electrodes, in comparison to controls, whereas the 
FSG group had comparatively longer latencies. At session 2, all seizure groups had 
longer N1 latencies in comparison to controls, moreover, the PGS group had the longest 
latencies in comparison to all groups. At session 3, the FSG group had the longest NI 
latencies in comparison to all other groups. Across all 3 sessions, the FS groups had NI 
latencies most comparable with the control group. The PGS group had larger NI 
amplitudes than control and other seizure groups, at all sites and across all 3 sessions p= 
0.041). 
There were significant effects of group (p= 0.02) and session (p= 0.03) on N2 latency 
with the control vs. seizure groups comparison. All 3 seizure groups had longer N2 
latencies in comparison to the control group all sessions. The PGS group had the longest 
N2 latencies, out of all the seizure groups, in comparison to controls however there was 
no significant group * session interaction effect. The control group had a decrease in N2 
latency across the sessions. All 3 seizure groups showed similar N2 latencies at session 2 
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to their respective latencies at baseline, however, they all had comparatively longer 
latencies at session 3. The pain group also had significantly longer N2 latency in 
comparison to controls at all sessions (p= 0.006) and a there was a trend towards 
significant interaction effect of group * session on N2 latency (p= 0.055). 
There were significant effects of group (p= 0.025) and session (p= 0.000) on P3b latency 
and also a significant interaction effect of session and group (p= 0.006). As Figure 6.12i 
shows, the control group had decreasing P3b latency across the sessions, whereas all 3 
seizure group showed increasing latency. A significant interaction effect of electrode 
and group (p= 0.049) The control group had larger P3b amplitudes in comparison to the 
PGS and FS groups. Furthermore, the PGS group had the smallest P3b amplitude at Cz 
in comparison to all other groups. 
Within subject factors 
d. f. F £ p 
NI latency 
Interaction effect of electrode * group 9,93 2.32 0.784 0.034* 
Interaction effect of session * group 6,62 1.93 0.943 0.094 
Interaction effect of electd*sess* rou 18,186 2.16 0.685 0.017* 
N1 amplitude 
Electrode effect 3,93 129.18 0.587 0.000*** 
N2 latency 
Session effect 2,62 3.73 0.984 0.030* 
N2 amplitude 
Electrode effect 3,93 25.20 0.717 0.000*** 
P3 latenc 
Session effect 2,62 12.24 0.767 0.000*** 
Interaction effect of session * group 6,62 3.86 0.767 0.006** 
P3 amplitude 
Electrode effect 3,93 21.28 0.644 0.000*** 
Interaction effect of electrode * rou 9,93 2.29 0.644 0.049* 
Between subject factors -group effect 
N1 amplitude 3,31 3.10 - 0.041* 
N2 latenc 3,3 1 3.78 - 0.020* 
P3latenc 3,31 3.57 - 0.025* 
Table 6.24. Controls vs. seizure groups; summary results with p<_0.1from repeated 
measures ANOVA of responses to auditory targets in the DTO task obtained at all 
3 test sessions. 
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Within subject factors 
d. f. F E p 
Ni latency 
Session effect 2,36 3.68 0.981 0.036* 
Interaction effect of electrode * session 6,108 3.06 0.710 0.019* 
Ni amplitude 
Electrode effect 3,54 75.98 0.624 0.000*** 
N2 latency 
Electrode effect 3,54 3.62 0.887 0.024* 
Interaction effect of electrode * group 3,54 2.61 0.887 0.069 
Interaction effect of session * group 2,36 3.21 0.958 0.055 
N2 amplitude 
Electrode effect 3,54 9.08 0.513 0.002** 
Session effect 2,36 4.36 0.879 0.025* 
Interaction effect of electrode * session 6,108 2.89 0.686 0.027* 
P3 amplitude 
Electrode effect 3,54 5.21 0.593 0.013* 
Between subject factors -group effect 
N2 latenc 1,18 9.53 - 0.006** 
Table 6.25. Controls vs. pain group: summary of results with p<_0.1 from repeated 
measures ANOVA of responses to auditory DTO task obtained from the pain and 
control groups at all 3 test sessions. 
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Figure 6.12a. Group averaged P3b waveforms obtained in response to the auditory 
target tones in the DTO task at the 3 test sessions for the control group. 
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Figure 6.12b. Group averaged P3b waveforms obtained in response to the auditory 
target tones in the DTO task at the 3 test sessions for the PGS group. 
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Figure 6.12c. Group averaged P3b waveforms obtained in response to the auditory 
target tones in the DTO task at the 3 test sessions for the FSG group. 
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Figure 6.12d. Group averaged P3b waveforms obtained in response to the auditory 
target tones in the DTO task at the 3 test sessions for the FS group. 
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Figure 6.12e. Group averaged P3b waveforms obtained in response to the auditory 
target tones in the DTO task at the 3 test sessions for the pain group. 
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Figures 6.12f, g&h. Interaction effect of session and group on N1 latency for 
seizure and control groups at baseline (session 1) (f), 6-month follow-up (session 
2) (g) and 12-month follow-up (session 3) (h). 
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Figure 6.12i. Interaction effect of session and group on P3 latency for seizure 
and control groups at baseline (session 1), 6-month follow-up (session 2) and 12- 
month follow-up (session 3). 
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6.3.4.5. DTO task - visual targets 
Results summary: Control vs. seizure group comparisons revealed that Ni 
amplitudes were larger at Cz, at all 3 sessions, for control and seizure groups. The 
FSG and FS groups had N2 longer latencies in comparison to controls whereas the 
PGS group latencies were similar to controls. All 3 seizure groups had longer P6 
latency at session 3 in comparison to their respective latencies at session 1. The 
largest increase was seen for the FS group which had shorter latencies in comparison 
to all groups at session 1 but the longest at session 3. The FS group showed the 
greatest increase in latency across the sessions. In addition, the control vs. pain group 
comparison revealed longer comparatively longer P6 latency for the latter group at 
all 3 sessions with the largest inter-group difference observed at session 2. 
Results -detailed account: Figures 6.13a to 6.13e show the group averaged 
responses to visual targets obtained for each group at each session. Tables 6.26 and 
6.27 list the main statistical findings. The PGS group had the largest Ni amplitudes, 
compared to controls and other seizure groups, at all sites and across all sessions (p= 
0.028). 
There were significant effects of group (p= 0.03) and electrode (p= 0.001) on N2 
latency. The FSG and FS groups had longer latencies in comparison to controls, 
whereas the PGS group latencies were most similar to controls. All groups showed 
the shortest N2 latencies at Cz and longest latencies at P4. 
There was a significant session effect on P6 latency and also a significant interaction 
effect of session (p= 0.009) and group (p= 0.02). As Figure 6.13f shows, all 3 seizure 
groups had longer P6 latency at session 3 in comparison to their respective session 1 
latencies. The greatest increase was seen for the FS group which had shorter 
latencies in comparison to all groups at session 1 but the longest at session 3. The 
pain group showed a trend towards significantly longer P6 latency in comparison to 
controls (p= 0.068) at all sessions and, as Figure 6.13g shows, this inter-group 
difference was greatest at session 2 (p= 0.049). 
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Within subject factors 
d. f. F £ p 
Nl latency 
Interaction effect of electrode * session 6,186 1.93 0.733 0.095 
Ni amplitude 
Electrode effect 3,93 77.78 0.516 0.000*** 
N2 latenc 
Electrode effect 3,93 7.01 0.813 0.001 
P6 latenc 
Session e ect 2,62 5.26 0.945 0.009** 
Interaction effect of session * group 6,62 2.81 0.945 0.020* 
Between subject factors -group effect 
Ni amplitude 3,31 3.45 - 0.028* 
N2latenc 3,31 3.41 - 0.030* 
Table 6.26. Controls vs. seizure groups: summary of results with p<_0.1 from 
repeated measures ANOVA of responses to visual targets in the DTO task 
obtained at all 3 test sessions. 
Within subject factors 
d. f. F £ p 
Ni latency 
Electrode effect 3,54 2.85 0.829 0.057 
Interaction effect of electrode * session 6,108.. 2.51 0.715 0.045* 
Nl amplitude 
Electrode effect 3,54 32.66 0.416 0.000*** 
N2 latency 
Electrode effect 3,54 5.42 0.768 0.005** 
N2 amplitude 
Session effect 2,36 3.01 0.912 0.068 
P6 latenc 
Interaction effect of session * group 2,367777 3.47 0.881 0.049* 
Between subject factors -group effect 
P6 latenc 1,18 3.77 - 0.068 
Table 6.27. Controls vs. pain group: summary of significant statistical results 
from repeated measures ANOVA of responses to visual targets in the DTO task 
obtained at all 3 test sessions. 
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Figure 6.13a. Group averaged P6 waveforms obtained in response to the visual 
targets in the DTO task at the 3 test sessions for the control group. 
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Figure 6.13b. Group averaged P6 waveforms obtained in response to the visual 
targets in the DTO task at the 3 test sessions for the PGS group. 
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Figure 6.13c. Group averaged P6 waveforms obtained in response to the visual 
targets in the DTO task at the 3 test sessions for the FSG group. 
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Figure 6.13d. Group averaged P6 waveforms obtained in response to the visual 
targets in the DTO task at the 3 test sessions for the FS group. 
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Figure 6.13e. Group averaged P6 waveforms obtained in response to the visual 
targets in the DTO task at the 3 test sessions for the pain group. 
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Figure 6.13f. Interaction effect of session and group on P6 latency for seizure 
and control groups at baseline (session 1), 6-month follow-up (session 2) and 12- 
month follow-up (session 3). 
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Figure 6.13g. Interaction effect of session and group on P6 latency for pain and 
control groups at baseline (session 1), 6-month follow-up (session 2) and 12- 
month follow-up (session 3). 
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6.4. Discussion 
Results of perseverative error score obtained from seizure groups with the WCST 
test were not significantly different to controls. The results of this current study 
contrast with previous studies that have shown a link between frontal damage and 
impaired WCST performance (Milner, 1963 and Bornstein, 1986). In particular, 
Milner (1963) found that the presence of dorsolateral pre-frontal damage in epileptic 
patients was linked to poor WCST performance. However, other studies have 
demonstrated that there is no link between frontal lobe damage and sorting 
impairment assessed with the WCST (Anderson et at. 1991, Mountain & Snow, 1993 
and Anderson et al. 1995). Furthermore, Upton & Thompson (1996) found no 
evidence to support the link between mWCST performance, with measures of CC 
and PE, and location of epileptogenic foci. 
In contrast to the seizure group findings, the pain group did show PE deficits in 
comparison to controls. The pain group had significantly higher perseverative error 
scores (p= 0.016) and, similar to the seizure groups, higher NPE (p= 0.014) and total 
error scores (p= 0.028) in comparison to controls at all 3 sessions. However, in 
contrast to the groups' results, NPE and TE scores decreased significantly across the 
sessions for pain and control groups and PE showed a trend towards significant 
decrease. This decline in error scores across the sessions may indicate practice 
effects that were absent in the epilepsy patients. 
The current study did demonstrate some SWM impairment for the seizure groups. 
The control group was significantly better at strategy formation to facilitate task 
performance in comparison to the seizure groups (p= 0.037). Owen et al. (1990) 
found significant SWM impairment, from the CANTAB test battery, indicated by the 
number of between and within search errors, in patients who had undergone 
unilateral or bilteral frontal lobe excisions. The authors found that these patients were 
significantly impaired, in comparison to controls, in their use of strategy for 
improving their performance on the test. The same patients underwent a planning 
task, again using the CANTAB test battery and were found to have a significantly 
longer movement time and required a larger number of moves to complete problems 
in comparison to controls. Later work by Owen et al. (1995) demonstrated that 
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patients who had undergone temporal lobe or amygdalo-hippocampectomy excision 
were unimpaired on the planning task, whereas the frontal lobe group showed 
deficits in planning time and accuracy. Moreover, the temporal and amgydalo- 
hippocampectomy groups showed unimpaired SWM strategy scores and overall task 
performance and the authors suggest that the deficits observed with the different 
lesion localisation have a high degree of psychological specificity. Miotto et al. 
(1996) found deficits in strategy formation, in an "Owl Spatial Working Memory 
Task, " requiring search of owls hidden in trees, in patients who had undergone either 
left or right frontal cortex excisions, lending further support to the role of the pre- 
frontal cortex in spatial working memory. The effect of focal structural impairment 
in relation to SWM and planning performance results in the current study is difficult 
to assess due to the lack of seizure localisation data. Hence the lack of significant 
findings with respect to different seizure types may be due to the limitations of 
grouping criteria. 
In addition, the pain vs. controls comparison revealed a significant group effect on 
strategy scores with the pain group showing poorer strategy employment in 
comparison to controls (p= 0.003) suggesting that impaired strategy use may not be 
specific to a diagnosis of epilepsy or the presence of seizures. This finding raises the 
possibility of AED effects contributing to impairment of frontal lobe functions. 
However, in contrast to the seizure groups' results, there was significant 
improvement of strategy scores across the sessions for both AED and healthy control 
groups (p=0.040). 
Aikia et al (1995) demonstrated that verbal learning memory impairment in patients 
with newly diagnosed cryptogenic partial epilepsy, assessed using the RAVLT, could 
help predict the long-term seizure prognosis. Word list learning results from the 
current study showed that all 3 seizure groups were impaired in recall of a 15 word 
list in comparison to controls at all 3 test sessions. Moreover, although there was an 
improvement in trial 1 recall scores at session 3 in comparison to session 1 for the 
control and PGS groups, the FSG and FS groups' scores remained similar to their 
respective baseline scores. The FSG group had the lowest recall scores across all 
analysed trials at all 3 sessions indicating that this seizure type may be associated 
with greater impairment of verbal learning memory in comparison to having focal or 
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generalised seizures alone. However, these results highlight that although the 
epilepsy patients have worse RAVLT performance than controls, there is no 
progressive deterioration over time. 
Control vs. pain group comparisons of RAVLT results yielded some similar findings 
to the control vs. seizure groups comparison. The pain group had significantly lower 
trial 1 recall scores in comparison to controls at all 3 sessions (p= 0.03) and a 
decrease in recall at session 3 compared to their scores at sessions 1 and 2 (p= 
0.026). The control group had higher trial 5 recall scores in comparison to the pain 
group at all 3 sessions (p= 0.007). The results of the baseline study (Chapter 4) 
revealed significant group differences in trial 6 and 7 recall at baseline which were 
not significant at 12-month follow-up (Chapter 5) suggesting that the focus of the 
pain groups efforts may have shifted from the early to the later stages of learning 
trials, across the sessions. From the current analysis, although the control group 
showed higher trial 6 recall scores in comparison to the pain group, in contrast to 
results obtained from the epilepsy patients, both groups had an increase in recall at 
session 3 compared to their respective scores at session 1 (p= 0.008). This may again 
point towards practice effects and an improvement in ability to learn newly presented 
distracter information. 
The story recall test results in this study showed that the control group had 
significantly higher immediate, 30 minute delayed recall and retention scores in 
comparison to all seizure groups at all 3 sessions. There was an increase in retention 
scores from session 1 to session 3 for the control, PGS and FSG groups but the FS 
group showed significant decline in their scores (p= 0.037). At baseline, the FS 
group had the retention scores most comparable to the control group hence there may 
have been greater scope for deterioration for this group over time. This group did not 
have any apparent increase in seizure frequency over the course of the sessions so 
this finding may be representing cumulative effects of seizures. Blake et al. 2000 
reported that extended long-term (8 week) memory retention, assessed with the 
AMIPB story recall test, in patients with TLE was significantly impaired in left TLE 
patients. Several other studies have linked memory deficits in patients with epilepsy 
to temporal lobe foci -particularly left sided (Delaney et al. 1980; Mungas et al. 1985 
and Hermann et al. 1987). However, the lack of neuroimaging and seizure focus 
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localisation information for the present study makes it difficult to assess the impact 
of epileptogenic focus laterality on the extent of story recall deficit. Investigation of 
FS patients with clearly defined structurally localised impairment would be required 
to shed light on this matter. 
Comparison of the control and pain groups showed that the pain group had lower 
delayed recall scores in comparison to controls at all 3 sessions (p= 0.021). However, 
the control group had comparatively higher retention scores at session 1 (p= 0.013) 
but both groups had an increase in scores from session 1 to session 3 (p= 0.001) 
where there was no apparent inter-group difference. This result also points towards 
practice effects contributing to improved performance for the pain group similar to 
the control, PGS and FSG groups' results but contrasting with the FS group's 
performance. 
The visual RT results showed that all 3 seizure groups had significantly slower 
simple MT, choice RT and choice MT compared to controls at all 3 sessions (p= 
0.011,0.042 and 0.015 respectively). Similar to the control vs. seizure groups results, 
simple MT, choice RT and choice MT were all longer for the pain group in 
comparison to controls (p= 0.015,0.008 and 0.007 respectively). In contrast to the 
seizure groups' results, simple RT and choice RT decreased across the 3 sessions for 
the pain and control groups (p= 0.038 and 0.017 respectively) indicating the 
possibility of improvement with practice. However choice RT remained longer for 
the pain group in comparison to controls at all 3 sessions raising the possibility of 
higher demand visual RT performance being vulnerable to the effects of AEDs. This 
conclusion is limited by the fact that age-related slowing of RT may have contributed 
to slower choice RT observed for the pain group (Salthouse & Somberg, 1982 and 
Wilkinson & Allison, 1989). 
Interestingly, the pain group showed significant impairment in behavioural ERP 
results, whereas differences between the control and seizure groups did not reach 
statistical significance. The pain group had slower RTs and lower accuracy of target 
detection in comparison to controls at all 3 sessions for P3b standard task (p= 0.007 
and 0.02 respectively). The pain group also had comparatively slower RTs and lower 
accuracy of target detection in the Pia task (p= 0.018 and 0.006 respectively). In the 
dual target oddball (DTO) task, the control group had increasingly slower RTs across 
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the 3 sessions whereas the pain group, although slower than controls at sessions 1 
and 2, had an increase in their session 3 RTs where they showed similar performance 
to controls (p= 0.041). The pain group had lower accuracy of auditory target 
detection in the DTO task compared to controls at all 3 sessions (p= 0.019). This 
result may again be confounded by the aforementioned age- related slowing of RT. 
This study has demonstrated that there were significant differences in MMNs 
obtained from patients with epilepsy in comparison to healthy controls. MMN offset 
was significantly longer for the PGS group in comparison to controls and other 
seizure groups at all 3 sessions (p=0.004). The cross-sectional analyses in Chapter 4 
(baseline data) and Chapter 5 (12-month follow-up data) demonstrated that MMN 
offset delay reached statistical significance at 12-month follow-up for the PGS 
group. All 3 seizure groups and the control group showed significant shortening of 
MMN onset latency from session 1 to session 3. The effect of earlier onset across the 
sessions led to a corresponding increase in MMN duration across the sessions for 
control and seizure groups (p= 0.013). The PGS group had larger MMN mpa in 
comparison to the other groups at Cz (p= 0.04), whereas the FSG group had 
comparatively smaller amplitudes at most sites. 
These MMN findings may be related to the nature of pathophysiology 
underlying different seizure types. In particular, structural imaging evidence that has 
demonstrated mesio-frontal cortical abnormalities linked to PGS (Woermann et al. 
1999) and quantitative pathological studies have demonstrated frontal 
microdysgenesis in patients with idiopathic generalised epilepsy (Meencke, 1985). 
Savic et al. (1998) reported from investigation of CT and MRI images that brain 
contours were most markedly abnormal in the frontal lobe of patients with GTCS. 
These observations of changes in frontal lobe structure in association with 
generalised seizures lend support to the hypothesis that the MMN component may be 
vulnerable to disruption in patients with generalised seizures due to the location of 
generator sources (Giard et al. 1990 and Alho et al. 1994). 
A possible explanation for the observed amplitude differences may be that 
this parameter is not affected by the integrity of the frontal cortex generator. It is 
possible that disruption of the supra-temporal cortex in the FSG group, which had the 
smaller MMN amplitudes in comparison to controls and other seizure groups, may 
have contributed to attenuation of MMN amplitude. However, the lack of 
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neuroimaging data in the current study makes it difficult to draw firm conclusions. 
Further research into the relationship between focal imaging changes and MMN in 
seizure patients may help shed further light on this matter. 
The MMN results from the pain group showed similarities to the seizure group 
findings. Both groups had similar MMN peak latency at session 1. Moreover, whilst 
peak latency for the control group decreased across the sessions, the pain group had a 
trend towards longer peak latency at sessions 2 and 3 in comparison to session 1 (p= 
0.051). The pain group also had longer offset latency in comparison to controls at all 
3 sessions (p= 0.038). Therefore it is possible that AED effects may contribute to 
slowing of pre-attentive auditory mechanisms. However, with the epilepsy patients, it 
was the PGS group that showed the most marked MMN and P3a changes despite the 
other seizure groups also being on AED therapy. 
The effects of chronic pain directly on MMN were investigated by Dick et al. 
(2003). The authors found significantly attenuated MMN amplitude in the presence 
of chronic pain and an attentionally demanding task. They conclude that MMN is 
most disrupted in chronic pain when attentional resources are strongly taxed. Lack of 
significant differences in amplitude between pain and control groups in the current 
study may be due to the fact that patients were in remission or their pain was well 
controlled with medication at the time of testing. However, Dick et al. state that most 
of their test group was on medication "for a variety of medical conditions. " Hence 
their conclusions exclude the effects of possible medication effects. The paucity of 
literature on the effects of chronic pain on the MMN makes it difficult to draw 
inferences about the contributions of AED effects on pre-attentive processes. 
Results of the current study demonstrate significant differences in P3a novel task 
responses obtained from patients with epilepsy in comparison to healthy controls. 
The PGS group had larger Ni amplitudes at all electrodes in comparison to controls, 
whereas the FSG and FS groups had comparatively smaller amplitudes (p= 0.005). 
Modulation of N1 amplitude is thought to represent a filtering mechanism for 
auditory inputs (Woldorff & Hillyard 1991). As for the MMN, neural generators for 
the magnetic counterpart of the Ni are thought to be located in the superior temporal 
plane of the auditory cortex (Woldorff et al. 1993). This may lend further support to 
the theory that focal impairment of these particular neural systems, and consequently 
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alteration of pre-attentive and early attentive auditory processing, may be contribute 
to the observed Ni amplitude differences associated with the seizure groups. 
Both PGS and FS groups had longer N2 latencies in comparison to controls at 
all 3 sessions. The control group had a slight decrease in N2 and P3a latencies across 
the sessions whereas all 3 seizure groups showed an increase (p= 0.045 and 0.053 
respectively). Control vs. pain group comparison revealed that N2 latency was longer 
for the pain group in comparison to controls at all 3 sessions (p= 0.003). Moreover, 
the pain group showed an increase in N2 latency across the sessions (p= 0.003). 
Again this may represent AED effects on the slowing of early attentional processes 
which support the MMN changes described above. 
However, P3a latency increased across the sessions for all seizure groups, 
whereas the control group showed a corresponding decline (p= 0.053). Although the 
group effect failed to reach statistical significance, Pia latency was longer for the 
PGS group at all 3 sessions in comparison to controls and other seizure groups. The 
absence of significant difference between the control and pain group P3a latency 
results suggests that P3a aberration may result as a consequence of seizures and not 
AED effects. Generators for the P3a have been identified in the frontal cortex 
(Knight & Scabini 1998) so P3a delay, coupled with the observation of delayed 
MMN offset and duration for this group, points towards the theory that increased 
latency of ERPs with frontal cortex neural sources may be a consequence of 
structural frontal cortex impairment associated with generalised seizures (Meencke 
1985; Savic et al. 1998 and Woermann et al. 1999). 
The results of the responses to auditory targets in the P3b standard oddball task also 
showed significant differences between seizure and control groups. In keeping with 
the novel sounds task results, larger Ni (p= 0.042) and N2 (p= 0.009) amplitudes 
were observed for the PGS group in comparison to controls, FSG and FS groups at 
all sites. All seizure groups had longer N2 latencies in comparison to controls (p= 
0.034) and all 3 seizure groups showed an increase in N2 latency from session 1 to 3 
(p= 0.041). The N2 component is thought to represent stimulus evaluation and 
classification so this finding may point towards deterioration of these processes in 
association with all 3 seizure types. There was an increase in P3b latency across the 
sessions for all 3 seizure groups in comparison to controls with the largest increase 
for the PGS and FSG groups (p= 0.007). These findings are in keeping with previous 
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studies that have reported N2 and P3b latency delays in patients with epilepsy (Drake 
et al. 1986, Mervaala et al. 1992, Triantafyllou et al. 1992 and Soysal et al. 1999). 
Control vs. pain group comparisons of Ni, N2 and P3b failed to reveal any 
significant group or session effects suggesting that the results obtained from the 
epilepsy patients may be unrelated to AED effects. 
The standard oddball task results were supported by the results from responses to 
auditory targets in the DTO task. The PGS group had the longest N2 latency, out of 
all the seizure groups, in comparison to controls at all sessions. All 3 seizure groups 
showed longer N2 latencies at session 3 in comparison to their respective latencies at 
sessions 1 and 2 (p= 0.02). The control and pain group comparison revealed a trend 
towards significant group * session interaction effect on N2 latency (p= 0.055). N2 
latency decreased across the sessions for controls but the pain group had an increase 
in latency from session 1 to 2 followed by a decrease at session 3. The pain group 
had longer N2 latency at all 3 sessions in comparison to controls (p= 0.006) at all 3 
sessions. Hence, as for pre-attentive processing, the early stages of stimulus 
evaluation may be prone to disruption by AED effects. 
The control group had similar P3b latency across the 3 sessions whereas all 3 
seizure groups showed increasing latency (p= 0.035). The FSG group had the largest 
increase in P3b latency from session 1 to 3. The control group had larger P3b 
amplitudes in comparison to the PGS and FS groups (p= 0.035), furthermore, the 
PGS group had the smallest P3b amplitude at Cz in comparison to all other groups 
(p= 0.025). Interestingly, the behavioural data showed that the auditory target 
detection was lower than visual target detection for all groups -including the pain 
and control groups. This may have been due to the fact that the subjects were 
required to provide a count of the visual targets immediately after the test and so may 
have focussed more effort into the visual targets at the cost of auditory target 
detection. 
ERP responses to the visual targets in the DTO task also showed some significant 
differences between control and seizure groups. The PGS group had the larger NI 
amplitude in comparison to controls (p= 0.028). The FSG and FS groups had longer 
N2 latencies in comparison to controls (p= 0.03) but PGS group N2 latency was 
similar to that for controls. All 3 seizure groups had longer P6 latency at session 3 in 
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comparison to their respective latencies at session 1 (p= 0.009). The largest increase 
was seen for the FS group which had shorter latencies in comparison to all groups at 
session 1 but the longest at session 3 (p= 0.030). The FS group showed the greatest 
increase in P6 latency across the sessions. The control vs. pain group comparison 
revealed a significant interaction effect of group and session on P6 latency, whilst P6 
latency remained higher for the pain group at all sessions, the largest inter-group 
difference observed at session 2 (p= 0.049). These results suggest that the seizure 
groups showed a progressive increase in latency across the sessions, the pain group 
showed a variable latency pattern across time which may be attributed to factors 
related to their clinical condition aside from AED effects. 
Inferences about the effects of AEDs on cognitive function from the current study 
results remain speculative for a number of reasons. Small sample size, lack of AED 
serum level data and differences in drug types and dosage between the pain and 
seizure groups may be limiting factors in the current study results. Moreover, the 
effect of chronic pain itself may impact directly on cognitive function. Individuals 
with chronic pain report problems with attention, concentration and memory 
(Jamison et al. 1988). These problems have been confirmed with formal tests of 
cognitive function revealing attention and memory deficits in this group (Grace et al. 
1999 and Dick et al. 2002). Also age effects may have contributed to the differences 
in results obtained from the control and pain group comparisons as the latter group 
was significantly older. 
In conclusion, the current study has revealed significant MMN offset latency delay 
and larger MMN amplitude for the PGS group, compared to controls and other 
seizure groups, across all 3 test sessions. The NI component was significantly larger 
for the PGS group across all sessions and with all ERP tasks. All seizure groups 
showed progressive delays of N2 and P3a/P3b/P6 components in the standard 
oddball, novel sounds and the DTO task. All seizure groups were impaired in 
strategy formation in a spatial working memory task. Verbal learning and memory 
was most impaired in the FS and FSG groups as demonstrated by the story recall and 
word list learning test results. The pain group, included in the study to assess the 
contributions of AED effects on cognitive performance, showed increasing MMN 
peak latency and N2 latency of non-target responses of the novel sounds task, from 
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sessions 1 to 3. The pain group also showed impairments in perseverative function 
and some aspects of verbal learning and memory across all test sessions. However, 
these findings may be a consequence of cognitive impairment linked directly to the 
chronic pain condition itself. Also, the control and pain groups showed 
improvements in some aspects of neuropsychological performance over time, which 
were not evident in the epilepsy patients, suggesting that seizures may hamper 
practice effects and hence limit the scope for improvement in performance. 
The following chapter explores the relationship between certain 
neuropsychological outcomes and ERP measures. 
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Chapter VII 
RELATIONHIP BETWEEN BASELINE ELECTROPHYSIOLOGY AND 12- 
MONTH FOLLOW-UP NEUROPSYCHOLOGY RESULTS FROM 
PATIENTS WITH EPILEPSY. 
7.1. Introduction 
There are no previous studies examining the predictive value of ERP data on 
neuropsychological outcomes in patients with epilepsy. The aim of this study was to 
investigate the relationship between ERP latency/amplitude modulation at baseline 
and neuropsychological outcomes at 12-month follow-up in patients with epilepsy. It 
was hypothesised that ERP dysfunction, identified at baseline, would correlate with 
neuropsychological impairment at 12-month follow-up that had not manifested at 
baseline. 
7.2. Method 
7.2.1. Subjects 
Results from subjects who participated in the baseline study (detailed in Section 
4.2.1. ) and also participated in the 12-month follow-up study (detailed in Section 
5.2.1) were used for this investigation, 
7.2.2. Procedure 
In order to limit the number of correlations performed, only those ERP results from 
the baseline study (Chapter 4) which showed significant latency or amplitude 
difference to controls, were identified and correlated with neuropsychological results 
that had been normal at baseline, but showed significant change at 12-month follow- 
up (Chapter 5). The correlations carried out on the basis of neuropsychological tests 
thought to share the closest functional localisation with ERP neural generators. 
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7.2.3. Statistical analysis 
Result were analysed with SPSS for Windows using Spearman's correlation. 
7.3. Results 
Tables 7.1,7.2 and 7.3 show the results obtained from correlation of baseline ERP 
results with neuropsychological measures obtained at 12-month follow-up in the 
PGS, FSG and FS groups. 
Most of the correlations failed to show any statistical significance. However, there 
was a significant correlation between baseline Ni amplitude, obtained in response to 
visual targets with the dual target oddball (DTO) task, and story recall test immediate 
recall scores from the primary generalised seizure group (PGS) group (r= -0.778, p= 
0.023) . Figure 
7.1 illustrates this relationship. Smaller Ni amplitude was related to 
lower immediate recall scores. Although a similar relationship was observed between 
NI amplitude at Pz and immediate recall scores, this correlation failed to reach 
statistical significance (p= 0.091). 
There was also a trend towards significance in the correlation between baseline 
MMN offset and 12-month follow-up Wisconsin Card Sorting Test (WCST) non- 
perseverative error (NPE) scores obtained from the PGS group (r= 0.624, p= 0.054). 
Figure 7.2 illustrates this relationship. Longer MMN offset latency was related to 
higher NPE scores which indicate a poor level of performance un-related to 
perseveration in the WCST. 
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Figure 7.1. Relationship between NI amplitude (at P3) at baseline and story 
recall test immediate recall score at 12-month follow-up for the PGS group. 
Spearman's r= -0.778, p= 0.023. 
100 
0 v 
. fl 80 d 
E 
E 
' 60 
v 
a) 
40 
0 
N 
20 
. 
U 
-15 -10 -5 0 
NI amplitude (microV) 
Figure 7.2. Relationship between MMN offset at baseline and SWM strategy 
score at 12-month follow-up for the PGS group. Spearman's r= 0.624, p= 0.054. 
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12-month RAVLT RAVLT Story Story Story 
follow-up --ý Trial 5 Trial 7 Recall recall recall 
Immediate Delayed delayed 
Baseline 
Ni lat. at Pz - -0.224 0.100 -0.300 -0.300 0.300 
DTO task -VT 
N1 lat. at P4 - 0.224 0.100 -0.300 -0.300 0.300 
DTO task - VT 
Table 7.2. Relationship between baseline ERF measures and neuropsychology 
measures at 12-month follow up obtained from the FSG group. Spearman's 
correlation co-efficient r values and significance values p<_ 0.1 indicated where 
applicable. DTO= dual target oddball, VT= visual targets. 
12-month RAVLT RAVLT Story Story Story 
follow-up -º Trial 5 Trial 7 Recall recall recall 
Immediate Delayed delayed 
Baseline 
N2 lat. at P3 - -0.048 -0.371 0.548 0.333 -0.216 
DTO task -VT 
Table 7.3. Relationship between baseline ERP measures and neuropsychology 
measures at 12-month follow up obtained from the FS group. Spearman's 
correlation co-efficient r values and significance values p<_ 0.1 indicated where 
applicable. DTO= dual target oddball, VT= visual targets. 
7.4. Discussion 
The results of the current study provide little evidence to support the predictive value 
of ERPs on neuropsychological outcomes. However, there was a significant 
correlation between baseline Ni amplitude, obtained in response to visual targets 
with the dual target oddball task, and story recall test immediate recall scores from 
the focal PGS group (p= 0.023). Smaller Ni amplitude was related to lower 
immediate recall scores. The NI amplitude is implicated as an index of a filtering 
mechanism for auditory inputs (Woldorff & Hillyard 1991). Neural generators for 
the magnetic counterpart of the Ni are thought to be been located in the superior 
temporal plane in the auditory cortex (Woldorff et al. 1993). This may be an 
interesting finding with respect to possible links between the pathophysiology 
underlying primary generalised seizures and enhanced amplitude of the Ni 
component along with impairment of aspects of memory recall given that Ni 
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amplitude was consistently larger for the PGS group, in comparison to controls and 
other seizure groups, in the previous analyses detailed in earlier chapters. It is 
difficult to conclude whether this larger amplitude represents an electrophysiological 
impairment or whether it is an enhancement of early attentive mechanisms to 
compensate for deficits in later-stage information processing. 
There was also a trend towards significance in the correlation between baseline 
MMN offset and 12-month follow-up Wisconsin Card Sorting Test (WCST) non- 
perseverative error (NPE) scores obtained from the primary generalised seizure 
(PGS) group (p= 0.054). Longer MMN offset latency was related to higher NPE 
scores which indicate a poorer level of performance. The MMN is thought to have a 
neural generator located in the right frontal cortex which has been implicated in the 
orientation of attention (Giard et al., 1990). However, the relationship between MMN 
offset and WCST performance is limited by the fact that NPE scores do not relate to 
frontal lobe impairment. It is perseveration i. e. difficulty in switching to a new 
sorting rule, reflected by perseverative error (PE) scores, that is thought to provide an 
index of frontal impairment (Janowsky et al., 1989). The lack of significant PE 
changes in the cross-sectional 12-month assessment meant that this parameter was 
excluded from further analysis in the current study. 
The results of this study are confounded by a number of different factors. Results 
from the cross-sectional studies were used to select the ERP and neuropsychology 
results for the correlations tested in the current study. However, the correlation 
analyses performed in the current study included results from patients who had 
participated at both baseline and 12-month follow-up therefore the patients' results 
that had contributed to the cross-sectional analyses were not all included in the 
current analyses which may have led to loss of significant findings. This was a 
difficult factor to control for as at baseline, it was impossible to predict the patients 
who would attend at follow-up. The cross-sectional analyses could have been 
performed on the patients who had attended both baseline and final follow-up 
sessions but this would have led to reduction of sample sizes in the cross-sectional 
analyses detailed in Chapters 4 and 5. Also, the localisation specificity of the 
neuropsychology tests was difficult to relate to the ERPs recorded in the current 
study. Although ERPs provide electrophysiological correlates of early stimulus 
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evaluation, the neuropsychological tests probably relate to more complex 
mechanisms of cognitive processing. The lack of significant clinical deterioration in 
terms of the seizure frequency, detailed in Chapter 6, may have also contributed to 
lack of significant findings in the clinical group included in this current study. 
A few studies have attempted to explore the relationship between ERP and 
neuropsychological data albeit in a non-predictive manner. Mervaala et al. (1992) 
found no significant correlation between neuropsychological data and P3b or P3a 
results obtained from patients with temporal lobe epilepsy. Their neuropsychological 
measures included a memory quotient test, C- score and D- score tests and Rey's 
Delayed Picture Naming test. The authors comment that this may be due to the 
difference in functional processes underlying performance in the ERP and 
neuropsychology tests. Roxborough et al. (1993) and Souza et al. (1995) found a 
significant relationship between verbal fluency scores and P3b latency in patients 
with schizophrenia. The latter study failed to identify any correlation between verbal 
recall and P3b latency. Verbal fluency is thought to reflect mainly frontal function 
(Benton, 1968), but Souza et al. conclude that their findings reflect that impairments 
giving rise to changes in P3b latency appear to be closely linked to processes that 
disrupt verbal fluency in patients with schizophrenia. 
In conclusion, lack of previous studies examining the predictive value of ERPs 
makes it difficult to assess the value of the results of the current study. There is some 
suggestion from the current results that certain neuropsychological impairments 
correlate with previously detected electrophysiological amplitude/latency 
modulations in patients with PGS. However, methodological limitations, for example 
small sample sizes, lend caution to any conclusions about the predictive value of 
ERPs from the results of this study. Nevertheless, there is clearly scope for further 
investigation. Larger sample sizes and ERP correlates specific to certain 
neuropsychology measures would provide greater validity to the results of any future 
studies. 
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OVERALL DISCUSSION AND CONCLUSIONS 
8.1. Limitations of the methodology 
8.1.1. Sample size 
The findings of this thesis are limited by the small seizure-group sample sizes in the 
studies reported in Chapters 4,5 and 6. This was largely due to time-restrictions. The 
recruitment process was carried out over a period of 12 months but had to be limited 
thereafter to provide sufficient time for the follow-up sessions. Another reason for 
the limitations of sample size was that a larger number of patients initially agreed to 
participate in the study but failed to attend for their first session. Also, fewer patients 
attended for their follow-up sessions for a variety of reasons, which hampered the 
sample sizes further. 
The smallest group was the chronic pain condition group, which proved to be a 
particularly difficult group to recruit. Many of these patients were unable to take part 
in the study as their day-to-day activities were restricted by their pain condition. 
The results in the MMN repeatability study (Chapter 3) may have provided further 
useful information if the same subjects had undergone all the different experimental 
conditions at the re-test sessions. However, due to the time constraints, and in order 
to minimise subject fatigue effects, it was considered best to limit the number of 
experimental conditions according to the amount of time each subject had to offer to 
the study. 
8.1.2. Lack of neurohnaging data 
Neuroimaging data would have provided the scope for analysis of any cognitive 
changes in relation to any cortical structural anomalies. However, not all patients had 
undergone structural imaging so no firm conclusion can be drawn from the current 
study about the relationship between lateralised or focal lesions on cognitive 
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impairment. Another problem with lack of neuroimaging data is that unknown focal 
lesions may have contributed to impairment of behavioural or functional processes. 
8.1.3. Correlative anti-epileptic drug (AED) levels 
AED effects were analysed on the assumption of patient compliance with treatment. 
Although all epilepsy patients were being monitored clinically in the Neurology 
Clinic, information relating to their serum drug levels was not available at times 
coinciding with their attendance for the experimental sessions. Serum levels would 
have helped to validate the conclusions relating to AED effects. 
8.1.4. Seizure frequency data 
Seizure frequency data was based on patients' self-reported seizures. Whilst some 
patients were meticulous in recording seizure frequency, other patients were less 
certain about how often they were having seizures. 
8.1.5. Duration of epilepsy data 
Patients with seizures were studied at different stages of their epilepsy. There was 
large variation in the duration of epilepsy both within and between the different 
seizure type groups. Therefore, the small seizure group sample sizes investigated in 
this thesis were insufficient to detect any ERP or behavioural changes that may occur 
at different rates according to different epilepsy duration. 
8.1.6. Statistical correction for multiple comparisons 
The application of the Bonferroni adjustment for multiple test comparisons, in 
Chapters 3 and 4, may have led to an increase in type II error rate i. e. significant 
differences may have been incorrectly deemed non-significant. Epidemiologists 
argue that "Bonferroni adjustments are, at best, unnecessary and, and worst 
deleterious to sound statistical inference" (Perenger, 1998). However the Bonferroni 
correction was used in the cross-sectional analyses of results in Chapters 4 and 5 to 
provide an indication of the significant findings that survived this conservative 
correction and hence help minimise Type I error. Findings that reached the 
conventional significance level (p<0.05) but failed to reach the Bonferroni corrected 
significance level are also listed to provide the reader with an indication results that 
may have incorrectly been categorised as lacking statistical significance. 
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8.1.7. Sensitivity of the neuropsychology tests 
The range of neuropsychology tests used for assessment of cognitive function may 
have been insufficient to detect the functional changes reflected by the ERP tests as 
reported in Chapters 5 and 6. In particular, the notable MMN and P3a changes 
reported in Chapters 5 and 6 suggest changes in pre-attentive processes which are 
difficult to assess with neuropsychological testing. 
8.1.8. Technical aspects 
Linked-mastoid reference electrodes were used for the cognitive ERP studies 
included in this thesis. This is the reference of choice for most cognitive ERP studies. 
However this may have been a limiting factor in the results of this study as patients 
with lateralised EEG abnormalities in the temporal region may have contaminated 
the reference. However the raw EEG data, from which the ERP epochs were derived, 
was visually inspected and sections contaminated with deviations from background 
EEG activity were excluded from the ERP epochs. Appendix V details the number 
of EEG epochs included in the final averaged waveforms for all the ERPs included in 
this thesis. 
8.2. Synthesis of main findings 
8.2.1. Mismatch Negativity (MMN) repeatability study 
The methodology development study, detailed in Chapter 3, helped establish the 
optimal stimulus and recording parameters for the subsequent prospective epilepsy 
study (Chapters 4- 7). The use of a duration increment deviant in conjunction with a 
reading task yielded the most robust MMN. 
8.2.2. Prospective epilepsy study: baseline cross-sectional study 
The cross-sectional study at baseline, detailed in Chapter 4, revealed memory 
impairment in patients with primary generalised seizures (PGS) and focal with 
secondary generalised seizures (FSG). The FSG group showed significantly lower 
word list recall, in the first presentation and recall trial, in comparison to healthy 
controls. Interestingly though, the retention ability in the final learn and recall trial 
was comparable for the FSG and healthy controls suggesting that despite initially 
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slower learning, newly acquired information remains preserved after a short 
distraction-filled delay. Both PGS and FSG groups showed significantly lower 
immediate and delayed story recall in comparison to controls. However the story 
information remained preserved as reflected by the retention scores which failed to 
show any significant control vs. seizure group differences. 
The pain group, which was included in the study to assess the contributions of anti- 
epileptic drugs (AEDs) on cognitive function, showed significantly longer movement 
and reaction times (RTs) in a visual reaction time (RT) task in comparison to 
controls. The FSG and PGS groups also showed some similar delays in RT and 
movement time. Therefore there is a possibility that AED effects may be contributing 
to impaired reaction and movement time. However, conclusions drawn about AED 
effects from results of the pain group included in this investigation may be 
confounded by significantly higher age and higher depression scores in comparison 
to controls, small group size, lack of serum drug level availability and variation in 
drug types and levels both within and between the groups. 
There was little evidence of significant ERP alteration in association with different 
seizure types at baseline. However, an interesting finding was that the primary 
generalised (PGS) group showed larger NI amplitudes in comparison to controls. 
Although this difference only reached the corrected significance level with ERPs 
obtained from the dual target oddball (DTO) task, it was a consistent finding across 
the standard oddball and novel sounds task results. In conclusion, the baseline study 
findings demonstrated little difference in ERP findings between the 3 seizure-type 
groups in comparison to healthy controls. The pain group showed some significant 
ERP differences in comparison to controls. MMN offset latency was significantly 
longer than respective control latencies. As these findings failed to reach corrected 
statistical significance in the controls vs. seizure groups comparisons, it is possible 
that non-AED effects may have contributed to these ERP observations in the pain 
group (Dick et al., 2003). 
8.2.3. Prospective epilepsy study: 12-, nonth follow-up cross-sectional study 
The cross-sectional study, detailed in Chapter 5, examined results obtained from all 
patients who attended the 12-month follow-up session. The impaired memory 
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performance for the PGS and FSG groups observed at baseline was also apparent in 
the results of this study. Additionally, the FS group showed also showed impairments 
in aspects of verbal learning memory that had failed to reach statistical significance 
at baseline. The FSG group also showed significantly impaired strategy use to 
facilitate performance on the spatial working memory (SWM) task. 
The results of this study demonstrated significant pre-attentive ERP changes, in 
relation to different seizure types, that had not been apparent at baseline. The PGS 
group had significantly longer MMN peak latency and offset in comparison to 
controls suggesting that there may be some deterioration over time in pre-attentive 
processes related to primary generalised seizures. This finding was substantiated by 
the significantly delayed N2 component, obtained in response to non-targets in the 
P3a novel sounds task, for the PGS and FSG groups. In contrast to the baseline 
results, ERPs elicited in response to auditory targets in the dual target oddball (DTO) 
task showed significantly longer N2 latency for PGS and FS groups, and longer P3b 
latency for the PGS, FSG and FS groups, in comparison to healthy controls. 
Furthermore, visual target evoked ERPs in the DTO showed significant N2 and P6 
component delays for the FS group in comparison to controls. 
In conclusion, the results of this study suggested that there may have been some 
time-related deterioration in behavioural and ERP processes in association with 
different seizure types. The effects of time on cognitive function were investigated 
by analysing results obtained in all 3 sessions and detailed in Chapter 6. 
8.2.4. Prospective epilepsy study: 12-month follow-up longitudinal study 
The longitudinal study, detailed in Chapter 6, examined results obtained at each of 
the three time points at which subjects were assessed. In contrast to the cross- 
sectional study at 12-month follow-up, this study focussed on the effects of time on 
changes occurring over the course of the different time points of assessment. An 
interesting finding from analysis of the neuropsychology results was an improvement 
in some aspects of performance for the control and pain groups that was absent from 
the seizure groups performances. In contrast to the seizure groups' results, non- 
perseverative error (NPE) and total error (TE) scores, in the Wisconsin card-sorting 
test (WCST) decreased significantly across the sessions for pain and control groups 
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and perseverative errors (PE) showed a trend towards significant decrease. This 
decline in error scores across the sessions may indicate practice effects that were 
absent in the epilepsy patients. 
The control group was significantly better at strategy formation to facilitate task 
performance in comparison to the seizure groups, and also the pain group, at all 3 
sessions but there was no significant deterioration in performance of the seizure 
groups over time. This finding suggests that impaired strategy use may not be 
specific to a diagnosis of epilepsy or the presence of seizures and raises the 
possibility of AED effects contributing to impairment of frontal lobe functions. 
Word list learning results from this study showed that all 3 seizure groups were 
impaired in recall of a 15 word list (RAVLT) in comparison to controls at all 3 test 
sessions. Moreover, although there was an improvement in trial 1 recall scores at 
session 3 in comparison to session 1 for the control and PGS groups, the FSG and FS 
groups' scores remained similar to their respective baseline scores. The FSG group 
had the lowest recall scores across all analysed trials at all 3 sessions indicating that 
this seizure type may be associated with greater impairment of verbal learning 
memory in comparison to having focal or generalised seizures alone. However, these 
results highlight that although the epilepsy patients have worse RAVLT performance 
than controls, there was no progressive deterioration over time. The pain vs. control 
group analysis revealed that the former group had comparatively lower trial 1 and 
trial 5 recall scores at all 3 sessions. However, although the control group had higher 
trial 6 (presentation of a new 15 word list) recall scores in comparison to the pain 
group, in contrast to results obtained from the epilepsy patients, both groups had 
significantly higher scores at session 3 in comparison to their respective scores at 
session 1. This may again point towards practice effects with an improvement in 
ability, in individuals without epilepsy, to learn newly presented distracter 
information. 
Story recall results of immediate, 30 minute delayed recall and retention scores were 
significantly higher for the control group in comparison to all seizure groups at all 3 
sessions. Although there was an increase in retention scores from session 1 to session 
3 for the control, PGS and FSG groups, the FS group showed a significant decline in 
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their scores. At baseline, the FS group had the retention scores most comparable to 
the control group hence there may have been greater scope for deterioration for this 
group over time. There was no apparent increase in seizure frequency over the course 
of the sessions so this finding is not explained by worsening of epilepsy -although it 
could be related to the cumulative effects of continuing seizures. The pain group had 
significantly lower delayed story recall scores in comparison to controls at all 3 
sessions. However, although the control group had comparatively higher retention 
scores at session 1, both groups had an increase in scores from session 1 to session 3 
where there was no apparent inter-group difference. This result also points towards 
practice effects contributing to improved performance for the pain group similar to 
the control, PGS and FSG groups' results but contrasting with the FS group's 
performance. 
All 3 seizure groups had significantly slower simple movement time (MT), choice 
RT and choice MT compared to controls at all 3 sessions. Similar to the control vs. 
seizure groups' comparisons, simple MT, choice RT and choice MT were all longer 
for the pain group in comparison to controls. However, in contrast to the seizure 
groups' results, simple RT and choice RT decreased across the 3 sessions for the pain 
and control groups indicating improvement with practice. However choice RT 
remained longer for the pain group in comparison to controls at all 3 sessions raising 
the possibility that higher demand visual RT performance may be vulnerable to the 
effects of AEDs. This conclusion is limited by the fact that age-related slowing of RT 
may have contributed to the consistently slower choice RT observed for the pain 
group (Salthouse & Somberg, 1982 and Wilkinson & Allison, 1989). 
There were significant differences in MMNs obtained from patients with epilepsy in 
comparison to healthy controls. MMN offset was significantly delayed for the PGS 
group in comparison to control, FSG and FS groups, at all 3 sessions. Also, MMN 
peak amplitude was significantly larger for the PGS groups, compared to the other 
seizure and control groups, across all test sessions. The MMN results from the pain 
group showed some similarities to the seizure group findings. The control and pain 
groups had similar MMN peak latency at session 1 but although peak latency for the 
control group decreased across the sessions, the pain group had significantly longer 
latency at sessions 2 and 3 in comparison to session 1. The pain group also had 
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longer offset latency in comparison to controls at all 3 sessions. Therefore it is 
possible that AED effects may contribute to slowing of pre-attentive auditory 
mechanisms. This result may substantiate impairment of frontal function as indicated 
by SWM test strategy results described earlier. However, with the epilepsy patients, 
it was the PGS group that showed the most marked MMN and P3a changes despite 
the other seizure groups also being on AED therapy. 
There were also significant differences in P3a novel task responses obtained from 
patients with epilepsy in comparison to healthy controls. The PGS group had 
significantly larger N1 amplitudes in comparison to controls, whereas the FSG and 
FS groups had smaller amplitudes in comparison to controls. Both PGS and FS 
groups had longer N2 latencies in comparison to controls at all 3 sessions. The 
control group had a decrease in N2 and P3a latencies across the sessions, whereas all 
3 seizure groups showed a significant increase. In addition, the pain group also had 
significantly longer N2 latency in comparison to controls at all 3 sessions. Moreover, 
the pain group showed a significant increase in N2 latency across the sessions. Again 
this may represent AED effects on slowing of early attentional processes which 
support the MMN changes described above. N2 latency has also been reported to 
increase with decreased discriminabilty of auditory targets (Fitzgerald & Picton, 
1983 and Perrault & Picton, 1984). Therefore the results of this study may be a 
reflection of AED processes interfering with the ability to distinguish between 
relevant and non-relevant stimuli. P3a latency increased across the sessions for all 
seizure groups, whereas the control group showed a corresponding decline. The PGS 
group showed longer Pia latency, compared to controls and other seizure groups, at 
all 3 sessions, however, this observation was not statistically significant. Generators 
for the P3a have been identified in the frontal cortex (Knight & Scabini, 1998) so 
Pia delay, coupled with the observation of delayed MMN offset and duration for this 
group, points towards the theory that increased latency of ERPs with frontal cortex 
neural sources may be a consequence of frontal cortex impairment associated with 
generalised seizures (Meencke 1985; Savic et at., 1998 and Woermann et al., 1999). 
In keeping with the results to non-targets in the novel sounds task, responses to 
targets in the P3b oddball task revealed significantly larger Ni and the observation of 
larger N2 amplitudes for the PGS group in comparison to controls, FSG and FS 
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groups. All seizure groups had longer N2 latencies in comparison to controls and all 
3 seizure groups showed a significant increase in N2 latency from session 1 to 3. The 
N2 component is thought to represent stimulus evaluation and classification so this 
finding may point towards deterioration of these processes in association with all 3 
seizure types. There was an increase in P3b latency across the sessions for all 3 
seizure groups in comparison to controls with the largest increase for the PGS and 
FSG groups. These findings are in keeping with previous studies that have reported 
N2 and P3b latency delays in patients with epilepsy (Drake et al. 1986, Mervaala et 
al. 1992, Triantafyllou et al. 1992 and Soysal et al. 1999). Control vs. pain group 
comparisons of Ni, N2 and P3b failed to reveal any significant group or session 
effects suggesting that the results obtained from the epilepsy patients may be 
unrelated to AED effects. 
The standard oddball task results were supported by the results from responses to 
auditory targets in the dual target (DTO) task. The PGS group had the longest N2 
latency, of all the seizure groups, in comparison to controls at all sessions. All 3 
seizure groups showed longer N2 latencies at session 3 in comparison to their 
respective latencies at sessions 1 and 2. The pain group also had significantly longer 
N2 latency at all 3 sessions in comparison to controls at all 3 sessions. Hence, as for 
pre-attentive processing, the early stages of stimulus evaluation and/or discrimination 
may be prone to disruption by AED effects. All 3 seizure groups showed a 
significant increase in P3b latency across the sessions supporting the findings from 
the standard oddball task. 
ERP responses to the visual targets in the DTO task also showed some significant 
differences between control and seizure groups. Again, the PGS group had 
significantly larger N1 amplitude in comparison to controls and other seizure groups. 
The FSG and FS groups had significantly longer N2 latencies in comparison to 
control and PGS groups. All 3 seizure groups had significantly longer P6 latency at 
session 3 in comparison to their respective latencies at session 1. Thus the seizure 
groups showed a progressive increase in P6 latency across the sessions, whereas the 
pain group showed a variable latency pattern across time which may be attributed to 
factors related to their clinical condition aside from AED effects. 
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In conclusion, this study revealed that the Ni component was significantly larger for 
the PGS group across all sessions and with all ERP tasks. All seizure groups showed 
progressive delays of N2 and P3a/P3b/P6 components in the standard oddball, novel 
sounds and the oddball with the visual vigilance task. All seizure groups were 
impaired in strategy formation in the SWM task across all sessions. Verbal learning 
and memory was most impaired in the FS and FSG groups as demonstrated by the 
story recall and word list learning test results but there was no significant 
deterioration over time. The pain group, included in the study to assess the 
contributions of AED effects on cognitive performance, showed increasing delays of 
MMN peak latency and N2 latency in responses non-targets sounds in the novel 
sounds task, across the 3 sessions, and also impairments in perseverative function 
and some aspects of verbal learning and memory, which were evident at all 3 test 
sessions. However these findings may be a consequence of cognitive impairment 
linked directly to the chronic pain condition itself (Jamison et al., 1988; Grace et al., 
1999, Dick et al., 2002 and Dick et al., 2003). Also, the control and pain groups 
showed improvements in some aspects of neuropsychological performance over 
time, which were not evident in the epilepsy patients, suggesting that seizures may 
hamper practice effects and hence limit the scope for improvements in performance. 
8.2.5. Prospective epilepsy study: predictive value of ERPs on behavioural 
outcomes 
This study attempted to assess the predictive value of baseline ERP results with 
respect to neuropsychological outcomes in patients with epilepsy at 12-month 
follow-up. In general, there was little evidence to support the predictive value of 
ERPs. However, there was a significant correlation between baseline Ni amplitude, 
obtained in response to visual targets with the dual target oddball task (DTO), and 
12-month follow-up immediate story recall scores for the PGS group. This may be an 
interesting finding with respect to possible links between the pathophysiology 
underlying primary generalised seizures given the NI amplitude enhancement and 
impaired aspects of memory recall for the PGS group, across all sessions, revealed in 
the earlier analyses. There was also a trend towards significance for the correlation 
between baseline MMN offset latency and 12-month follow-up WCST non- 
perseverative error (NPE) scores for the PGS group. 
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In conclusion, there was some suggestion that in PGS, neuropsychological 
impairments correlate with previously detected ERP latency delays or amplitude 
enhancements and this may be linked to pathophysiological processes underlying this 
seizure type. However, larger sample sizes, ERP correlates specific to behavioural 
measures and structural neuroimaging investigation would provide greater validity to 
the results of any future studies. 
8.3. Overall conclusions 
The investigations included in this thesis have helped establish a valuable MMN 
protocol for use in studies with subsequent clinical follow-up. The prospective 
epilepsy study demonstrated significant changes in some ERP measures, in relation 
to seizure type, over a 12-month follow-up period. Although the seizure groups 
showed significant impairments in aspects of behavioural performance, there was no 
significant progressive deterioration over time. The lack of significant change in 
seizure frequency over the course of the study may have prevented any significant 
deterioration in behavioural performance over time. However, the results lend 
support to the theory that ERP alterations over time may be reflecting 
pathophysiological processes underlying different seizure types. Furthermore, there 
may be some predictive value for NI amplitude enhancement and MMN offset 
latency delay on neuropsychological outcomes in relation to PGS. AED effects may 
contribute to early pre-attentive and early attentional processes but this conclusion is 
limited by the clinical condition of the pain group included in the investigations. 
Ideally, administration of AEDs to healthy volunteers or the assessment of drug-free 
seizure patients would be required for obtaining more reliable insight into AED 
effects on cognitive function. As there was little difference in the ERP results 
between control and seizure groups at baseline, it is possible that the 12-month 
follow-up time was inadequate to detect any possible developing neuropsychological 
deficits. Hence a longer time-course for any follow-up investigations may help shed 
further light on any predictive role of ERPs on subsequent cognitive impairments. 
Monitoring of structural cortical changes may also help tie in the links between any 
electrophysiological changes and neuropsychological impairment. 
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APPENDIX I: PARTICIPANT DETAILS 
Control group (Group 0) 
Subject 
ID 
Age 
(years) 
Sex Hand Study 
sessions 
attended 
S14 53 M R 1,2and3 
S15 26 M R 1,2 and 3 
S21 25 F R 1,2and3 
S35 22 M R 1,2 and 3 
S39 27 F R 1,2 and 3 
S41 57 M R 1,2 and 3 
S42 28 F L 1,2 and 3 
S43 34 F R 1,2 and 3 
S44 36 F R 1,2 and 3 
S47 42 F R 1,2 and 3 
S50 24 F R 1,2and3 
S52 24 F R 1,2 and 3 
S55 38 M R 1,2 and 3 
S56 37 M L 1,2 and 3 
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APPENDIX II: MEDICATION DETAILS 
Glossary of medication abbreviations 
CBZ carbamazepine/tegretol 
CBZr carbamazepine/tegretol retard 
oCBZ oxycarbazepine/trileptal 
GBT gabapentin/neurontin 
LMT lamotrigine/lamictal 
LVT levateracetam/keppra 
MYS mysoline/primidone 
PHB phenobarbital 
PHT phenyotoin/epanutin 
VPA sodium valproate/epilim 
TOP topiramate/topomax 
Baseline medication summary for epilepsy and pain patients (total daily dosage mg) 
Patient Med 1 Med 2 Med 3 Med 4 
GROUP 1 -Primary Generalised Seizures 
S04 CBZ 800 LMT 400 
S05 CBZ 800 LMT 400 CLOB rn 
S06 CBZ 800 LMT 200 
S18 oCBZ 300 
S19 LVT 3000 LMT 500 CLOB 60 
S22 No meds 
S23 LMT 175 
S25 LMT 500 
S27 No meds 
S31 LMT 800 TOP 400 
S51 CBZ 2200 GBT 2400 
S53 CBZ 400 
GROUP 2 -Focal with secondary generalised seizures 
SO1 oCBZ 1200 
S02 No meds 
S07 CBZ 400 LMT 500 
S08 LMT 550 VPA 200 PHB 30 
S09 No meds 
S10 CBZ 100 PHT 300 
S16 CBZ 500 
S20 CBZr 1600 GBT 600 CLOB 10 
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GROUP 2 -Focal with secondary generalised seizures contd. 
S28 CBZr 1200 LMT 300 LVT 3000 
S33 LMT 200 MYS 250 PHT 25 
S40 VPA 1400 
S45 PHT 600 
GROUP 3 -Focal seizures 
S03 CBZ 800 
Si! CBZ 200 
S12 LMT 300 
S17 CBZr 2000 PHT 300 
S24 LMT 300 
S29 PHT 375 CLOB prn 
S32 CLOB 20 
S34 LMT 350 
S36 CBZr 1200 GBT 600 LMT 300 
S38 CBZr 800 LMT 200 
S46 CBZ 400 LMT 400 
S54 No meds 
GROUP 4 -AED treatment (pain) control group 
S13 GBT 900 
S26 oCBZ 1500 GBT 900 
S30 CBZ 200 
S37 GBT 2400 VPA 600 
S48 oCBZ 1800 
S49 CBZ 200 
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12-month follow-up medication summary (total daily dosage mg) 
*AED addition #AED withdrawal (±) change from baseline dose 
Patient Med 1 Med 2 Med 3 Med 4 
GROUP 1-Primary Generalised Seizures 
S04 CBZ 800 LMT 400 
S05 CBZ 800 LMT 600 (+200) CLOB m 
S06 CBZ 800 LMT 200 
S19 LVT 3000 LMT 600 (+100) CLOB 60 (-40) 
S22 No meds 
S23 LMT 175 
S25 LMT 450 (-50) 
S27 No meds 
S31 LMT 800 TOP 400 
S51 CBZ 2200 GBT 3200 (+800) 
S53 CBZ 800 
GROUP 2 -Focal with secondary generalised seizures 
SO1 oCBZ 1200 
S07 CBZ 0 (-400) LMT 525 LVT 2000* 
S08 LMT 550 VPA 200 PHB 30 
S09 CBZ 600 (+600) 
S20 CBZr 1600 GBT 0 (-600) CLOB 10 TOP 50* 
S28 CBZr 0 (-1200) LMT 350 (+50) LVT 3000 
S40 VPA 1400 
GROUP 3 -Focal seizures 
S03 CBZr 800 
S11 CBZ 200 
S12 LMT 375 (+75) 
S24 LMT 300 
S29 PHT 375 CLOB pm LVT 1500* 
S34 LMT 350 
S36 CBZr 1200 GBT 600 LMT 300 
S38 CBZr 800 LMT 0 (-200) 
S46 CBZ 400 LMT 400 
S54 LMT 150* 
GROUP 4 -AED treatment (pain) group 
S13 GBT 900 
S26 oCBZ 1500 GBT 0 (-900) 
S30 CBZ 1000 (+800) 
S37 GBT 2400 VPA 400 (-200) PHT 300* 
S48 oCBZ 1800 
S49 CBZ 200 
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APPENDIX III: NEUROPSYCHOLOGY TESTS 
STORY RECALL TESTS 
AMIPB - STORY RECALL FORM 1 
Mrs Angela Harper was sitting in her bedroom mending the curtains when she heard 
a noise coming from the kitchen. She rushed to investigate and found a boy climbing 
out of the window with her handbag. She threw a vase at him but it missed and he 
ran off laughing. She chased after him, past the shops and into the park but he got 
away by squeezing through some railings. On her way back home Mrs Harper 
phoned the police. She described the thief as quite tall and neatly dressed. He had a 
scar on his face but she could not remember the colour of his hair. 
AMIPB - STORY RECALL FORM 2 
Mr Peter Williams who died last month has left two hundred thousand pounds to a 
charity that provides seaside outings for the children of refugees. His younger 
brother, who lives in Canada, will inherit his house, his yacht and his Rolls-Royce 
car. 
Mr Williams came from a poor family but he was determined to do well. He worked 
extremely hard and everyone liked him. His first job was as a butcher's boy but the 
earned extra money by doing night-work in a laundry. When he was thirty he bought 
a van and started a removals business. However, he eventually made his fortune 
selling paintings and antique clocks. 
STORY RECALL FORM 3 (D. Upton, Intitute of Neurology, London) 
Mr Brian Kelly, a Security Express employee, was shot dead on Monday during a 
bank raid in Brighton. The four raiders all wore masks and one carried a sawn off 
shotgun. Police detectives were sifting through the evidence last night. A police 
spokesman said "He was a very brave man, he went for the armed raider and put up 
one hell of a fight". 
The raiders escaped in a white car that had a dent in it on the right hand door. The car 
carrying the raiders was last seen heading in Northerly direction on the main road 
towards London. 
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RAVLT WORD LISTS 
List A' B' AC2 BC2 A/JG3 B/JG3 C 
Drum Desk Doll Dish Violin Orange Book 
Curtain Ranger Mirror Jester Tree Armchair Flower 
Bell Bird Nail Hill Scarf Toad Train 
Coffee Shoe Sailor Coat Ham Cork Rug 
School Stove Heart Tool Suitcase Bus Meadow 
Parent Mountain Desert Forest Cousin Chin Harp 
Moon Glasses Face Water Earth Beach Salt 
Garden Trowel Letter Ladder Knife Soap Finger 
Hat Cloud Bed Girl Stair Hotel Apple 
Farmer Boat Machine Foot Dog Donkey Chimney 
Nose Lamb Milk Shield Banana Spider Button 
Turkey Gun Helmet Pie Radio Bathroom Log 
Colour Pencil Music Insect Hunter Casserole Key 
House Church Horse Ball Bucket Soldier Rattle 
River Fish Road Car Field Lock Gold 
APPENDIX III 
CANTAB test descriptions and glossary of measures 
(Abridged version adapted from CANTAB for Windows Test Administration 
Guide, CeNeS Limited, 1999. ) 
REACTION TIME (RT) -PARALLEL VERSION TEST 
Display: In the simple RT task, the subject has to hold the press-pad down, then release 
it and touch the screen when a yellow dot appears in the centre, neither touching too 
soon nor too late. In the choice RT task, the yellow dot may appear in any one on 5 
locations. 
Task: The task is divided into practice and test components. Subjects are required to 
reach a criterion level of at least 9 out of 10 correct responses in the practice block 
before being presented with the test block. If the subjects fail to reach the criterion in the 
first practice block then a second practice block is given. After a second block of 
practice, the task proceeds to the test block irrespective of how will the subject has 
performed. 
Simple movement time: This is the time taken to touch the stimulus after the press pad 
has been released and in trials where stimuli appear in one location only. 
RT Simple reaction time: This is the speed with which the subject releases the press pad 
in response to the onset of a stimulus in a single location. NB: Subjects engaged in 
reaction time tasks have the opportunity to make a variety of errors. Most are errors of 
commission ('too soon', 'inaccurate' and 'wrong circle'), but it is possible to make an 
error of an omission by not responding ('too late'). 
RT Five-choice movement time: This is the time taken to touch the stimulus after the 
press pad has been released and in trials where one of five possible different stimuli have 
been presented. 
RT Five-choice reaction time: This is the speed with which the subject releases the 
press pad in response to a stimulus in any one of five locations. 
STOCKINGS OF CAMRIDGE (SOC) / TOWER OF LONDON TEST 
Display: The subject is shown two displays containing 3 coloured balls. The displays are 
presented in such a way that they can easily be perceived as stacks of coloured balls held 
in stockings or socks suspended from a beam. 
Task: The subject must use the balls in the lower display to copy the pattern shown in 
the upper display. The balls can only be moved one at by touching the required ball, then 
the position to which the ball should be moved. The time taken to complete the pattern 
and the number of moves required are taken as measures of the subject's planning 
ability. At first, it is only necessary to move one ball, the number being increased in 
steps to four moves. At this point, a procedure controlling for motor performance is 
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inserted. The upper display moves one ball at a time, repeating the moves made by the 
subject in the corresponding previous planning phase. The subject must follow the upper 
display by moving the balls in the lower display. The difference in time complete 
(particularly to initiate) each problem is taken as an index of the additional time taken to 
plan the solution of the copying, as distinct from the motor "following" task. A second 
block of planning problems of 2,4 and 5 moves follows, and the test is completed by a 
second block of motor control sets. Should the subject make more than double the 
number of moves for the simplest solution, the problem is terminated and if this occurs 
on 3 consecutive occasions, the entire test terminates. There is no time limit. 
Mean initial thinking time (2/3/4/5 moves): Subjects are encouraged to plan their 
moves before actually enacting the solution to the problems Initial thinking time is the 
difference in time taken to select the first ball for the same problem under the copy and 
follow conditions. Therefore, this gives an indication of the time taken to plan the 
problem solution. The metric reports average initial thinking time for 2/3/4/5 move 
problems. Please note that initial thinking time and subsequent thinking time may well 
interact both with one another and with other SOC metrics, such as Minimum Move 
Solutions. For example, some impulsive subjects may record very brief initial thinking 
time latencies, but fail to solve any of the presented problems. This score may be 0 if the 
subject is slower in the 'follow' condition. 
Mean subsequent thinking time (2/3/4/5 moves): This measure reflects the subject's 
speed of movement after the initial move has been made for 2/3/4/5/ move problems. 
This metric is obtained by calculating the difference in time between selecting the first 
ball and completing the problem for the same problem under the two conditions (copy 
and follow) and dividing this result by the number of moves made. Please note that 
initial thinking time and subsequent thinking time may well interact both with one 
another and with other SOC metrics, such as Minimum Move Solutions. For example, 
some impulsive subjects may record very brief initial thinking time latencies, but fail to 
solve any of the presented problems. This score may be 0 if the subject is slower in the 
'follow' condition. 
Problems solved in minimum moves (PSMM): This is a fundamental metric test, 
recording the number of occasions upon which the subject has successfully completed a 
test problem in the minimum possible number of moves. For the clinical setup, this is 
scored out of a possible 12 problems since eight practice problems are excluded from the 
calculation (the first six problems in the first block and the first two problems in the 
second block). 
SPATIAL WORKING MEMORY (SWM) 
This test is one of SWM and strategy performance. The aim of this test is that the subject 
should find a blue "token" in each of the display boxes and use them to fill up an empty 
column on the right hand side of the screen, whilst not returning to boxes where a blue 
token has previously been found. 
Display: The test begins with a number of coloured squares (boxes) being shown on the 
screen. The number of boxes is gradually increased until it is necessary to search a total 
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of eight boxes. The colour and position of the boxes are changed from trial to trial to 
discourage the use of stereotyped search strategies. 
Task: The subject must touch each box in turn until one opens with a blue token inside 
(a search). Returning to an empty box already sampled on this search is an error. When 
the blue token has been found, the subject has to place it in the right column ("black 
hole") by touching the right hand side of the screen. The box that contained the blue 
token will not contain another blue token on this trial. Returning to this box is also an 
error. The subject must then begin a new search for the next blue token. It may be in any 
of the boxes that have so far been empty. The order in which the subject searches the 
boxes is determined by the subjects themselves, but the number of empty boxes the must 
visit (discounting errors) is determined by the computer. At the end of each trial, when 
the column is full, a COMPLETE massage is displayed followed shortly afterwards by a 
NEW SET message. 
Between errors: Between errors are defined as times the subject revisits a box in which 
a token has previously been found. This is calculated for trials of four or more tokens 
only. 
Double errors: These are occasions where the subject has committed an error that can 
be categorised as both a within and a between error, This is calculated for trials of four 
or more tokens only. 
Total errors: This is the number of times a box is selected that is certain not to contain a 
blue token and therefore should not have been visited by the subject, i. e. between errors 
+ within errors - double errors. 
Within errors: Within errors are defined as the number of errors made within a search, 
i. e. the number of times a subject revisits a box already found to be empty during the 
same search. . This 
is calculated for trials of four or more tokens only. 
Strategy: Owen et al. (1990) have suggested that an efficient strategy for completing this 
task is to follow a predetermined sequence by beginning with specific box and then, 
once a blue token has been found, to return to that box to start the new search sequence. 
An estimate of the use of this strategy is obtained by counting the number of times the 
subject begins a new search with the same box. A high score represents poor use of this 
strategy and a low score equates to effective use. 
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APPENDIX IV: ERP DATA 
page 
MMN peak latency details 312 
MMN onset details 312 
MMN offset details 313 
MMN duration details 313 
MMN mpa details 314 
Standard oddball task N1 details 317 
Standard oddball task N2 details 320 
Standard oddball task P3b details 324 
Novel sounds task N1 details 328 
Novel sounds task N2 details 332 
Novel sounds task P3a details 336 
DTO task -auditory target Ni details 340 
DTO task -auditory target N2 details 344 
DTO task -auditory target P3b details 348 
DTO task -visual target Ni details 352 
DTO task -visual target N2 details 356 
DTO task -visual target P3b details 360 
Group 0= Control 
Group 1= PGS 
Group 2= FSG 
Group 3= FS 
Group 4= Pain 
Variable suffix number (i. e. 1,2 or 3) indicates session number 
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MMN PEAK LATENCY (msec) 
GRP N Minimum Maximum Mean Std. Deviation 
0 PKLAT1 14 121.410 209.300 169.89643 30.083593 
PKLAT2 14 111.270 211.830 167.58571 31.520161 
PKLAT3 14 118.870 206.760 166.80071 27.413303 
Valid N (listwise) 14 
1 PKLATI 10 157.610 219.570 184.05300 18.168936 
PKLAT2 10 114.650 260.000 183.35100 41.415843 
PKLAT3 10 157.750 221.130 198.64800 19.546668 
Valid N (listwise) 10 
2 PKLAT1 5 144.230 230.430 193.84400 31.262666 
PKLAT2 5 138.310 210.140 186.78400 28.289646 
PKLAT3 5 129.860 190.700 168.73200 28.425631 
Valid N (listwise) 5 
3 PKLATI 9 161.970 219.440 188.71667 19.281990 
PKLAT2 9 165.350 208.450 191.07889 13.561114 
PKLAT3 9 152.680 212.680 187.23111 18.799505 
Valid N (Iistwise) 9 
4 PKLAT1 6 151.830 188.040 170.16500 15.081775 
PKLAT2 6 144.230 247.320 185.63333 37.242085 
PKLAT3 6 149.300 243.940 182.81667 34.572620 
Valid N (listwise) 6 
MMN ONSET (msec) 
GRP N Minimum Maximum Mean Std. Deviation 
0 ONSET1 14 54.650 103.660 87.71000 13.385015 
ONSET2 14 67.320 104.510 87.00357 13.510858 
ONSET3 14 48.730 90.140 71.72929 12.543854 
Valid N (listwise) 14 
1 ONSET1 10 73.910 141.300 98.80100 22.874211 
ONSET2 10 64.790 154.370 98.59100 29.961326 
ONSET3 10 44.510 96.900 74.76100 14.700868 
Valid N (listwise) 10 
2 ONSET1 5 75.000 105.430 90.24600 11.318318 
ONSET2 5 48.730 112.960 84.90200 25.532254 
ONSET3 5 42.820 119.720 78.14200 28.118898 
Valid N (listwise) 5 
3 ONSET1 9 64.130 112.110 93.42222 15.103336 
ONSET2 9 58.030 124.790 82.81778 19.497193 
ONSET3 9 46.200 96.900 67.41778 18.216050 
Valid N (listwise) 9 
4 ONSET1 6 71.740 108.700 90.75667 12.860950 
ONSET2 6 77.460 90.990 83.94500 4.620644 
ONSET3 6 62.250 90.140 80.84667 11.377860 
Valid N (listwise) 6 
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MMN OFFSET (msec) 
GRP N Minimum Maximum Mean Std. Deviation 
0 OFFSET1 14 207.610 251.550 226.98429 13.306977 
OFFSET2 14 183.940 261.690 228.61071 21.473282 
OFFSET3 14 179.720 243.940 223.48143 18.313711 
Valid N (listwise) 14 
1 OFFSET1 10 215.220 288.040 248.00000 24.528426 
OFFSET2 10 208.450 326.760 260.33800 31.647796 
OFFSET3 10 219.440 320.000 253.40900 28.345850 
Valid N (listwise) 10 
2 OFFSET1 5 219.570 254.350 239.87800 13.112668 
OFFSET2 5 216.900 396.060 261.52200 75.613830 
OFFSET3 5 228.730 278.590 245.97000 20.217121 
Valid N (Iistwise) 5 
3 OFFSETI 9 201.690 257.460 237.94000 16.941544 
OFFSET2 9 218.590 271.830 245.06889 19.183472 
OFFSET3 9 210.990 260.850 241.12556 16.071779 
Valid N (listwise) 9 
4 OFFSET1 6 224.510 259.150 235.51833 12.310960 
OFFSET2 6 228.730 271.830 240.84333 16.600038 
OFFSET3 6 231.270 303.100 253.10000 28.510651 
Valid N (listwise) 6 
MMN DURATION (ursec) 
GRP N Minimum Maximum Mean Std. Deviation 
0 DUR1 14 111.550 181.690 139.27429 20.897254 
DUR2 14 101.400 173.240 141.60714 21.955838 
DUR3 14 102.260 193.520 151.75214 22.634404 
Valid N (listwise) 14 
1 DUR1 10 109.790 211.980 149.19900 32.464667 
DUR2 10 78.590 207.890 161.74700 41.412642 
DUR3 10 141.970 232.390 178.64800 27.302078 
Valid N (listwise) 10 
2 DUR1 5 133.720 171.740 149.63200 15.743904 
DUR2 5 111.550 347.330 176.62000 98.029451 
DUR3 5 119.150 208.730 167.82800 34.949751 
Valid N (listwise) 5 
3 DUR1 9 89.580 186.960 144.51778 26.385194 
DU R2 9 127.600 191.830 162.25111 24.908552 
DUR3 9 135.210 212.950 173.70778 28.713478 
Valid N (listwise) 9 
4 DUR1 6 122.820 161.960 144.76167 14.434184 
DUR2 6 139.430 194.370 156.89833 20.596804 
DUR3 6 144.500 231.550 172.25333 31.786004 
Valid N (listwise) 6 
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MMN MPA AT Fz (µV) 
GRP N Minimum Maximum Mean Std. Deviation 
0 FZAMP1 14 2.161 8.025 4.96279 1.952692 
FZAMP2 14 2.479 8.685 4.52586 1.782684 
FZAMP3 14 1.446 7.551 4.17179 2.051038 
Valid N (listwise) 14 
1 FZAMP1 10 . 868 14.047 5.44960 3.680576 
FZAMP2 10 1.493 12.200 4.51680 2.956036 
FZAMP3 10 2.882 11.190 5.55000 2.487709 
Valid N (listwise) 10 
2 FZAMP1 5 1.993 4.069 3.15480 . 851762 
FZAMP2 5 2.526 4.618 3.23020 . 825785 
FZAMP3 5 2.423 4.973 3.73720 
. 938807 
Valid N (listwise) 5 
3 FZAMP1 9 2.818 9.435 5.95811 2.084266 
FZAMP2 9 1.646 10.079 4.72144 2.857089 
FZAMP3 9 2.256 7.397 4.34289 1.877734 
Valid N (listwise) 9 
4 FZAMP1 6 2.413 7.194 4.54583 1.788894 
FZAMP2 6 2.181 6.225 3.72150 1.656159 
FZAMP3 6 2.431 5.801 3.47900 1.176046 
Valid N (listwise) 6 
1IMN MPA AT Cz (µV) 
GRP N Minimum Maximum Mean Std. Deviation 
0 CZAMP1 14 2.589 8.598 4.90929 1.757267 
CZAMP2 14 2.154 8.862 4.31736 1.749506 
CZAMP3 14 1.346 8.903 4.36979 2.317054 
Valid N (listwise) 14 
1 CZAMP1 10 1.865 12.514 5.97700 3.191640 
CZAMP2 10 . 973 15.910 4.53190 4.230599 
CZAMP3 10 2.317 17.790 6.60740 4.336085 
Valid N (Iistwise) 10 
2 CZAMP1 5 1.828 5.462 4.13420 1.398551 
CZAMP2 5 2.908 5.459 3.92560 1.003649 
CZAMP3 5 3.295 4.618 4.08500 . 497019 
Valid N (Iistwise) 5 
3 CZAMP1 9 2.327 9.171 5.71633 2.292344 
CZAMP2 9 1.954 9.922 5.17133 2.802566 
CZAMP3 9 2.408 8.983 4.42644 2.302845 
Valid N (listwise) 9 
4 CZAMP1 6 2.092 6.236 4.40400 1.494523 
CZAMP2 6 1.831 5.385 3.64767 1.419760 
CZAMP3 6 2.205 5.161 3.76600 1.046100 
Valid N (listwise) 6 
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MMN MPA AT Pz (µV) 
GRP N Minimum Maximum Mean Std. Deviation 
0 PZAMPI 14 . 657 5.114 2.77993 1.372242 
PZAMP2 14 . 397 5.761 2.26600 1.396802 
PZAMP3 14 . 133 5.613 2.84421 1.797115 
Valid N (listwise) 14 
1 PZAMP1 10 . 
927 8.918 4.19540 2.817700 
PZAMP2 10 
. 
420 13.415 3.75370 3.644361 
PZAMP3 10 . 352 13.048 4.36600 3.521903 
Valid N (listwise) 10 
2 PZAMP1 5 1.205 4.668 2.88440 1.391704 
PZAMP2 5 . 805 4.750 2.98880 1.443413 
PZAMP3 5 1.931 3.515 2.89080 . 722330 
Valid N (listwise) 5 
3 PZAMP1 9 . 958 5.935 3.17356 1.662837 
PZAMP2 9 . 
800 5.821 3.47000 1.761297 
PZAMP3 9 1.070 6.218 2.98311 1.882686 
Valid N (listwise) 9 
4 PZAMPI 6 . 
207 3.339 2.41983 1.139240 
PZAMP2 6 . 
295 3.989 2.36383 1.280421 
PZAMP3 6 1.529 4.227 2.66833 1.104977 
Valid N (listwise) 6 
MAIN MPA AT F3 (µV) 
GRP N Minimum Maximum Mean Std. Deviation 
0 F3AMP1 14 2.109 7.011 4.48829 1.533457 
F3AMP2 14 2.059 7.319 4.09871 1.436721 
F3AMP3 14 1.779 6.442 3.73707 1.715368 
Valid N (Iistwise) 14 
1 F3AMP1 10 . 
331 14.559 5.29380 3.957261 
F3AMP2 10 1.389 12.627 4.21790 3.121180 
F3AMP3 10 2.347 10.444 5.04890 2.548788 
Valid N (listwise) 10 
2 F3AMP1 5 . 
823 3.956 2.51180 1.404605 
F3AMP2 5 1.646 4.124 2.91140 
. 923252 
F3AMP3 5 2.275 3.526 3.06900 . 506439 
Valid N (Iistwise) 5 
3 F3AMP1 9 2.582 7.991 5.04122 1.583103 
F3AMP2 9 1.713 9.089 4.63056 2.478444 
F3AMP3 9 1.125 6.095 3.66467 1.731861 
Valid N (listwise) 9 
4 F3AMP1 6 1.812 6.341 4.02783 1.477622 
F3AMP2 6 1.708 5.800 3.37433 1.448587 
F3AMP3 6 2.231 4.743 2.99767 
. 893350 
Valid N (listwise) 6 
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MMN MPA AT Fz (µV) 
GRP N Minimum Maximum Mean Std. Deviation 
0 F4AMP1 14 1.321 9.519 4.91071 2.325028 
F4AMP2 14 2.570 7.925 4.56193 1.504526 
F4AMP3 14 1.544 9.382 4.48186 2.237511 
Valid N (listwise) 14 
1 F4AMP1 10 . 646 11.286 4.61940 2.990459 
F4AMP2 10 1.362 8.711 4.08770 2.211139 
F4AMP3 10 . 740 9.609 4.82780 2.457200 
Valid N (listwise) 10 
2 F4AMP1 5 2.067 3.799 3.20260 . 808381 
F4AMP2 5 1.165 4.219 2.68260 1.205106 
F4AMP3 5 2.275 4.644 3.30340 
. 
875988 
Valid N (listwise) 5 
3 F4AMP1 9 2.623 9.601 5.60522 2.258084 
F4AMP2 9 1.739 9.819 4.62056 2.537120 
F4AMP3 9 1.125 7.587 3.93300 2.095613 
Valid N (listwise) 9 
4 F4AMP1 6 2.658 6.503 4.30300 1.740059 
F4AMP2 6 1.996 5.482 3.11517 1.277448 
F4AMP3 6 2.231 5.362 3.21283 1.141043 
Valid N (listwise) 6 
STANDARD ODDBALL TASK Ni LATENCY AT Cz (msec) 
GRP N Minimum Maximum Mean Std. Deviation 
0 CZN1 LATZ 14 79.720 138.590 102.07214 17.826817 
CZN1LAT2 14 73.520 112.250 93.77214 11.504474 
CZN 1 LAT3 14 70.420 112.250 92.33429 12.628973 
Valid N (Iistwise) 14 
1 CZN1LAT1 10 85.920 110.700 96.14100 8.005975 
CZN1LAT2 10 64.230 129.300 95.98600 19.422311 
CZN1LAT3 10 87.460 124.650 100.83700 13.751634 
Valid N (listwise) 10 
2 CZN1LAT1 5 81.270 102.960 90.56400 8.414053 
CZN1LAT2 5 78.170 109.150 93.97000 11.818230 
CZN 1 LAT3 5 87.460 120.000 103.88800 12.328734 
Valid N (listwise) 5 
3 CZN 1 LAT1 9 81.270 120.000 97.10444 12.143211 
CZN 1 LAT2 9 51.830 120.000 95.38222 19.404568 
CZN 1 LAT3 9 71.970 110.700 89.87444 11.280662 
Valid N (listwise) 9 
4 CZN1LAT1 6 87.460 104.510 96.76000 6.502615 
CZN1LAT2 6 71.970 112.250 94.17667 13.279402 
CZNILAT3 6 81.270 115.350 99.08500 12.110177 
Valid N (listwise) 6 
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STANDARD ODDBALL TASK Ni LATENCY AT Pz (msec) 
GRP N Minimum Maximum Mean Std. Deviation 
0 PZN1LAT1 14 76.620 138.590 103.17929 18.669442 
PZNILAT2 14 75.070 112.250 93.21857 11.244002 
PZN1LAT3 14 68.870 110.700 91.78000 12.936043 
Valid N (listwise) 14 
1 PZN 1 LAT1 10 81.270 121.550 96.14200 11.803108 
PZN 1 LAT2 10 67.320 126.200 96.91500 19.861375 
PZN1LAT3 10 82.820 129.300 100.32400 16.035856 
Valid N (listwise) 10 
2 PZN1LAT1 5 79.720 92.110 84.67600 5.296993 
PZN1LAT2 5 78.170 112.250 94.59000 12.849963 
PZN1LAT3 5 84.370 116.900 103.88600 13.706828 
Valid N (listwise) 5 
3 PZN 1 LAT1 9 82.820 120.000 97.44889 11.825969 
PZN 1 LAT2 9 50.280 120.000 94.86444 19.972910 
PZN1 LAT3 9 70.420 109.150 89.53111 11.899050 
Valid N (listwise) 9 
4 PZN1LAT1 6 87.460 102.960 96.24333 7.181481 
PZN1LAT2 6 71.970 112.250 94.69333 13.706732 
PZN1LAT3 6 82.820 112.250 99.35167 12.037469 
Valid N (listwise) 6 
STANDARD ODDBALL TASK Ni LATENCY AT P3 (msec) 
GRP N Minimum Maximum Mean Std. Deviation 
0 P3N 1 LAT1 14 76.620 138.590 102.84643 18.950084 
P3N 1 LAT2 14 73.520 113.800 93.77214 11.711342 
P3N1LAT3 14 65.770 112.250 92.62643 14.111288 
Valid N (listwise) 14 
1 P3N 1 LAT1 10 85.920 120.000 95.67600 10.432765 
P3N 1 LAT2 10 68.870 123.100 95.90500 19.749773 
P3N 1 LAT3 10 81.270 129.300 101.25400 16.025929 
Valid N (listwise) 10 
2 P3N1LAT1 5 81.270 92.110 86.22600 4.822150 
P3N1LAT2 5 76.620 112.250 94.90000 13.209222 
P3N 1 LAT3 5 84.370 118.450 103.88800 13.486928 
Valid N (listwise) 5 
3 P3N1LAT1 9 76.620 118.450 96.24333 14.408979 
P3N 1 LAT2 9 51.830 118.450 95.89778 19.796778 
P3N1LAT3 9 70.420 110.700 90.04778 12.049636 
Valid N (listwise) 9 
4 P3N1LAT1 6 89.010 104.510 98.31000 5.458113 
P3N1LAT2 6 70.420 115.350 95.72667 15.075043 
P3N1LAT3 6 82.820 115.350 100.63333 12.988953 
Valid N (listwise) 6 
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STANDARD ODDBALL TASK Ni LATENCY AT P4 (msec) 
GRP N Minimum Maximum Mean Std. Deviation 
0 P4N1LAT1 14 76.620 141.690 104.50786 19.756184 
P4N 1 LAT2 14 68.870 113.800 93.72643 12.398284 
P4N1LAT3 14 61.130 109.150 90.89500 14.534864 
Valid N (listwise) 14 
1 P4N1LAT1 10 82.820 112.250 97.07100 9.901443 
P4N1LAT2 10 67.320 127.750 97.99900 19.567858 
P4N 1 LAT3 10 79.720 129.300 100.63400 16.270438 
Valid N (listwise) 10 
2 P4N1LAT1 5 81.270 90.560 85.29600 4.323723 
P4N1LAT2 5 82.820 110.700 95.21000 10.953792 
P4N1LAT3 5 81.270 121.550 103.26800 15.194797 
Valid N (listwise) 5 
3 P41\11 LAT1 9 75.070 121.550 97.44889 15.202041 
P4N1LAT2 9 50.280 123.100 95.03778 21.319786 
P4N1LAT3 9 71.970 109.150 89.87556 11.825932 
Valid N (listwise) 9 
4 P4N1LAT1 6 90.560 110.700 99.08333 7.048778 
P4N1LAT2 6 73.520 112.250 94.95167 13.197972 
P4N 1 LAT3 6 82.820 118.450 101.65000 13.482887 
Valid N (Iistwise) 6 
STANDARD ODDBALL TASK Ni AMPLITUDE AT Cz (µV) 
GRP N Minimum Maximum Mean Std. Deviation 
0 CZN1AMP1 14 -11.821 -2.373 -6.95950 2.849711 
CZN1AMP2 14 -10.054 -5.181 -7.66371 1.530822 
CZN1AMP3 14 -14.241 -4.314 -8.13393 3.191730 
Valid N (listwise) 14 
1 CZN1AMP1 10 -20.996 -5.263 -11.74120 4.701476 
CZN1AMP2 10 -18.329 -5.157 -10.08000 4.719754 
CZN1AMP3 10 -19.074 -4.329 -10.77660 5.358178 
Valid N (listwise) 10 
2 CZN1AMP1 5 -9.849 -2.990 -6.32540 2.787659 
CZN1AMP2 5 -5.566 -. 022 -2.62060 2.204274 
CZN1AMP3 5 -8.849 -4.040 -6.20780 2.187882 
Valid N (listwise) 5 
3 CZN1AMP1 9 -12.544 . 410 -7.02844 4.484762 
CZN1AMP2 9 -10.581 -1.025 -7.02433 3.251626 
CZN1AMP3 9 -14.013 -1.445 -6.72511 4.159236 
Valid N (listwise) 9 
4 CZN1AMP1 6 -10.487 -1.896 -7.02750 2.989749 
CZN1AMP2 6 -11.546 -4.033 -6.74000 3.057580 
CZN1AMP3 6 -9.778 -. 606 -6.81467 3.302258 
Valid N (listwise) 6 
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STANDARD ODDBALL TASK Ni AMPLITUDE AT Pz (µV) 
GRP N Minimum Maximum Mean Std. Deviation 
0 PZN1AMP1 14 -10.408 -1.108 -4.18071 2.812265 
PZN1AMP2 14 -8.638 -2.352 -5.75500 2.145026 
PZN1AMP3 14 -9.752 -2.329 -5.61907 2.806995 
Valid N (Iistwise) 14 
1 PZN1AMP1 10 -10.976 -3.126 -6.14740 2.448709 
PZN1AMP2 10 -10.958 1.500 -6.76320 4.104518 
PZN1AMP3 10 -15.651 -. 576 -6.42710 5.342878 
Valid N (listwise) 10 
2 PZN1AMP1 5 -6.570 -2.689 -3.79760 1.573874 
PZN1AMP2 5 -3.048 . 584 -1.29100 1.336412 
PZNIAMP3 5 -7.213 -1.711 -3.49320 2.285342 
Valid N (listwise) 5 
3 PZN1AMP1 9 -7.566 . 869 -3.26111 2.828995 
PZN1AMP2 9 -7.518 . 281 -4.06056 2.489648 
PZNIAMP3 9 -8.694 . 187 -3.31733 2.751158 
Valid N (listwise) 9 
4 PZN1AMP1 6 -6.131 -1.332 -3.88650 1.849673 
PZN1AMP2 6 -8.045 -1.254 -4.23567 2.354903 
PZN 1 AM P3 6 -7.137 1.313 -4.03617 3.202205 
Valid N (listwise) 6 
STANDARD ODDBALL TASK Nl AMPLITUDE AT P3 (DV) 
GRP N Minimum Maximum Mean Std. Deviation 
0 P3N1AMP1 14 -10.189 . 
220 -3.35071 2.980135 
P3N1AMP2 14 -7.623 -1.758 -4.75707 1.606682 
P3N1AMP3 14 -7.994 -1.256 -4.77400 2.199630 
Valid N (Iistwise) 14 
1 P3N1AMP1 10 -10.059 -1.984 -4.98840 2.684052 
P3N1AMP2 10 -11.120 1.165 -5.56530 3.689222 
P3N1AMP3 10 -13.576 . 302 -5.73650 4.738926 
Valid N (Iistwise) 10 
2 P3N1AMP1 5 -3.976 -1.298 -2.41860 1.217005 
P3N1AMP2 5 -2.612 . 
441 -1.41120 1.277651 
P3N 1 AMP3 5 -4.384 . 314 -2.03120 1.798672 
Valid N (listwise) 5 
3 P3N1AMP1 9 -6.079 -. 009 -2.26633 2.116779 
P3N1AMP2 9 -5.529 . 
169 -2.99411 1.959760 
P3N1AMP3 9 -6.335 . 
878 -3.22956 2.300091 
Valid N (listwise) 9 
4 P3N1AMP1 6 -5.817 -. 557 -2.94650 2.022342 
P3N1AMP2 6 -6.314 -2.057 -3.80750 1.677036 
P3N1AMP3 6 -6.304 1.835 -3.22033 3.305264 
Valid N (listwise) 6 
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STANDARD ODDBALL TASK Ni AMPLITUDE AT P4 (RV) 
GRP N Minimum Maximum Mean Std. Deviation 
0 P4N1AMP1 14 -9.106 3.114 -2.41493 3.530214 
P4N1AMP2 14 -7.726 -1.532 -4.72221 2.307928 
P4N1AMP3 14 -9.410 -. 665 -4.52607 2.865840 
Valid N (listwise) 14 
1 P4N1AMP1 10 -7.297 -1.280 -3.58320 2.088243 
P4N1AMP2 10 -11.124 3.007 -5.52380 4.349382 
P4N1AMP3 10 -11.538 1.830 -5.16010 4.725184 
Valid N (listwise) 10 
2 P4N 1 AM P1 5 -4.624 -1.182 -2.20760 1.433319 
P4N1AMP2 5 -2.451 . 230 -. 95880 . 979882 
P4N1AMP3 5 -6.398 -. 798 -2.50540 2.295462 
Valid N (listwise) 5 
3 P4N1AMP1 9 -5.918 . 136 -2.28689 2.027795 
P4N1AMP2 9 -6.781 1.553 -2.85622 2.657686 
P4N 1 AM P3 9 -7.175 . 
327 -2.39400 2.310410 
Valid N (listwise) 9 
4 P4N1AMP1 6 -5.493 -1.114 -2.88067 1.680139 
P4N1AMP2 6 -5.219 -. 725 -2.44750 1.532974 
P4N1AMP3 6 -6.377 . 208 -3.09367 2.400968 
Valid N (listwise) 6 
STANDARD ODDBALL TASK N2 LATENCY AT Cz (ursec) 
GRP N Minimum Maximum Mean Std. Deviation 
0 CZN2LAT1 14 185.070 236.200 203.10857 18.396983 
CZN2LAT2 14 168.030 231.550 197.90786 17.073477 
CZN2LAT3 14 171.130 230.000 201.67000 18.394935 
Valid N (listwise) 14 
1 CZN2LAT1 10 180.420 271.830 216.98600 31.894887 
CZN2LAT2 10 192.820 291.970 228.91700 28.389363 
CZN2LAT3 10 183.520 301.270 233.70800 36.638548 
Valid N (listwise) 10 
2 CZN2LAT1 5 203.660 264.080 225.04000 24.529781 
CZN2LAT2 5 202.110 237.750 223.18400 15.748460 
CZN2LAT3 5 200.560 281.130 239.91600 29.755106 
Valid N (listwise) 5 
3 CZN2LAT1 9 171.130 290.420 217.08889 35.227042 
CZN2LAT2 9 177.320 270.280 211.07444 29.568757 
CZN2LAT3 9 175.770 307.460 227.65222 39.818271 
Valid N (Iistwise) 9 
4 CZN2LAT1 6 200.560 230.000 212.70000 9.868749 
CZN2LAT2 6 203.660 230.000 220.96167 10.929638 
CZN2LAT3 6 194.370 240.850 215.54000 19.858379 
Valid N (listwise) 6 
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STANDARD ODDBALL TASK N2 LATENCY AT Pz (msec) 
GRP N Minimum Maximum Mean Std. Deviation 
0 PZN2LAT1 14 177.320 236.200 201.78071 20.456840 
PZN2LAT2 14 164.930 231.550 197.35429 18.695364 
PZN2LAT3 14 169.580 231.550 201.78071 19.673422 
Valid N (listwise) 14 
1 PZN2LAT1 10 175.770 274.930 217.76100 34.103748 
PZN2LAT2 10 186.620 290.420 229.22600 28.457292 
PZN2LAT3 10 180.420 296.620 233.87300 35.609703 
Valid N (listwise) 10 
2 PZN2LAT1 5 202.110 274.930 226.90000 29.600539 
PZN2LAT2 5 200.560 239.300 223.18400 16.959945 
PZN2LAT3 5 200.560 282.680 239.91600 30.688790 
Valid N (listwise) 5 
3 PZN2LAT1 9 172.680 293.520 219.50000 35.377301 
PZN2LAT2 9 178.870 268.730 210.54667 29.600023 
PZN2LAT3 9 171.130 305.920 227.07333 39.548956 
Valid N (listwise) 9 
4 PZN2LAT1 6 197.460 239.300 212.44167 14.657292 
PZN2LAT2 6 208.310 230.000 221.47833 9.736507 
PZN2LAT3 6 192.820 240.850 216.83167 18.969539 
Valid N (listwise) 6 
STANDARD ODDBALL TASK N2 LATENCY AT P3 (msec) 
GRP N Minimum Maximum Mean Std. Deviation 
0 P3N2LAT1 14 177.320 234.650 201.55214 19.865319 
P3N2LAT2 14 166.480 230.000 198.01786 18.657283 
P3N2LAT3 14 169.580 230.000 201.22714 19.631527 
Valid N (listwise) 14 
1 P3N2LAT1 10 178.870 278.480 218.89300 33.491426 
P3N2LAT2 10 183.520 290.420 227.67600 29.078701 
P3N2LAT3 10 183.520 298.170 232.94300 35.135962 
Valid N (listwise) 10 
2 P3N2LAT1 5 200.560 270.280 224.73000 27.771373 
P3N2LAT2 5 200.560 234.650 221.01400 14.427281 
P3N2LAT3 5 200.560 284.230 241.15600 31.189473 
Valid N (listwise) 5 
3 P3N2LAT1 9 175.770 288.870 217.85556 33.737644 
P3N2LAT2 9 177.320 268.730 209.68556 29.379568 
P3N2LAT3 9 175.770 307.460 227.25556 39.426530 
Valid N (listwise) 9 
4 P3N2LAT1 6 200.560 231.550 211.40833 11.719318 
P3N2LAT2 6 208.310 230.000 221.73667 9.380652 
P3N2LAT3 6 195.920 239.300 216.05667 18.950859 
Valid N (listwise) 6 
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STANDARD ODDBALL TASK N2 LATENCY AT P4 (msec) 
GRP N Minimum Maximum Mean Std. Deviation 
0 P4N2LAT1 14 178.870 236.200 202.66643 19.939505 
P4N2LAT2 14 166.480 233.100 197.13286 18.898894 
P4N2LAT3 14 172.680 230.000 201.22714 18.256706 
Valid N (Iistwise) 14 
1 P4N2LAT1 10 169.580 270.280 216.67600 32.358600 
P4N2LAT2 10 186.620 288.870 228.60500 28.261961 
P4N2LAT3 10 185.070 298.170 232.32400 36.321446 
Valid N (listwise) 10 
2 P4N2LAT1 5 202.110 268.730 225.66000 26.999642 
P4N2LAT2 5 203.660 237.750 223.18400 15.126194 
P4N2LAT3 5 199.010 281.130 240.22600 30.961503 
Valid N (listwise) 5 
3 P4N2LAT1 9 175.770 290.420 220.87556 33.902189 
P4N2LAT2 9 177.320 276.420 210.71222 31.888269 
P4N2LAT3 9 172.680 305.920 226.39667 39.385063 
Valid N (listwise) 9 
4 P4N2LAT1 6 21.060 237.750 183.81500 80.687583 
P4N2LAT2 6 206.760 230.000 222.51167 9.818624 
P4N2LAT3 6 194.370 243.940 217.86333 19.110024 
Valid N (Iistwise) 6 
STANDARD ODDBALL TASK N2 AMPLITUDE AT Cz (µV) 
GRP N Minimum Maximum Mean Std. Deviation 
0 CZN2AMP1 14 -14.641 . 
347 -5.74693 4.667567 
CZN2AMP2 14 -18.081 1.656 -6.43229 5.688762 
CZN2AMP3 14 -11.808 . 
377 -5.20257 3.485880 
Valid N (Iistwise) 14 
1 CZN2AMP1 10 -20.094 -. 325 -11.23930 6.490165 
CZN2AMP2 10 -16.371 -. 599 -7.73490 4.469831 
CZN2AMP3 10 -28.020 6.652 -11.23940 10.067045 
Valid N (listwise) 10 
2 CZN2AMP1 5 -8.390 -. 207 -4.12480 3.951489 
CZN2AMP2 5 -8.220 . 677 -2.81660 3.476555 
CZN2AMP3 5 -7.585 . 936 -2.79080 3.097659 
Valid N (listwise) 5 
3 CZN2AMP1 9 -14.376 . 334 -5.33444 5.056405 
CZN2AMP2 9 -16.219 -. 212 -6.30700 5.108205 
CZN2AMP3 9 -13.355 -. 025 -4.85811 4.482682 
Valid N (listwise) 9 
4 CZN2AMP1 6 -5.434 5.069 -2.35267 3.824063 
CZN2AMP2 6 -12.296 5.480 -3.84850 6.327175 
CZN2AMP3 6 -7.020 9.869 1.23200 5.450671 
Valid N (listwise) 6 
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STANDARD ODDBALL TASK N2 AMPLITUDE AT Pz (µV) 
GRP N Minimum Maximum Mean Std. Deviation 
0 PZN2AMP1 14 -11.236 1.344 -2.70579 3.330932 
PZN2AMP2 14 -12.689 4.536 -4.14507 5.426865 
PZN2AMP3 14 -8.254 3.725 -3.10514 3.090399 
Valid N (listwise) 14 
1 PZN2AMP1 10 -10.439 . 561 -4.28330 3.494057 
PZN2AMP2 10 -7.084 2.748 -2.69440 2.896162 
PZN2AMP3 10 -17.330 6.863 -3.45120 6.338099 
Valid N (listwise) 10 
2 PZN2AMP1 5 -1.823 1.014 -. 26940 1.275728 
PZN2AMP2 5 -5.771 1.934 -. 88320 3.216823 
PZN2AMP3 5 -2.168 1.731 -. 55260 1.810379 
Valid N (Iistwise) 5 
3 PZN2AMP1 9 -10.092 2.698 -1.62633 4.099564 
PZN2AMP2 9 -12.617 3.236 -2.36067 4.911104 
PZN2AMP3 9 -8.811 . 
319 -3.09833 2.634429 
Valid N (listwise) 9 
4 PZN2AMP1 6 -2.976 4.842 -. 32067 2.842798 
PZN2AMP2 6 -6.511 . 
986 -1.98950 3.066178 
PZN2AMP3 6 -3.724 6.294 . 82717 3.556970 
Valid N (listwise) 6 
STANDARD ODDBALL TASK N2 AMPLITUDE AT P3 (µV) 
GRP N Minimum Maximum Mean Std. Deviation 
0 P3N2AMP1 14 -11.236 1.331 -2.21050 3.464806 
P3N2AMP2 14 -12.655 3.948 -3.90857 4.500278 
P3N2AMP3 14 -6.868 2.003 -2.66607 2.413232 
Valid N (listwise) 14 
1 P3N2AMP1 10 -10.499 -1.023 -4.48360 3.274606 
P3N2AMP2 10 -6.586 1.922 -2.52250 2.659169 
P3N2AMP3 10 -17.900 3.702 -4.02100 5.896449 
Valid N (listwise) 10 
2 P3N2AMP1 5 -2.482 . 
541 -. 71760 1.266761 
P3N2AMP2 5 -4.526 1.883 -1.85840 2.602561 
P3N2AMP3 5 -1.777 2.181 . 21180 1.684409 
Valid N (listwise) 5 
3 P3N2AMP1 9 -8.664 1.947 -1.72467 3.646124 
P3N2AMP2 9 -11.195 2.951 -2.49389 4.250909 
P3N2AMP3 9 -6.290 2.140 -2.33833 2.828127 
Valid N (listwise) 9 
4 P3N2AMP1 6 -3.548 . 112 -2.08750 1.520631 
P3N2AMP2 6 -7.683 1.459 -2.07967 3.266563 
P3N2AMP3 6 -2.201 4.911 . 39700 2.718234 
Valid N (listwise) 6 
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STANDARD ODDBALL TASK N2 AMPLITUDE AT P4 (µV) 
GRP N Minimum Maximum Mean Std. Deviation 
0 P4N2AMP1 14 -10.011 1.819 -2.04450 3.514379 
P4N2AMP2 14 -9.742 3.821 -3.57900 4.196260 
P4N2AMP3 14 -7.972 2.891 -2.74936 3.189301 
Valid N (listwise) 14 
1 P4N2AMP1 10 -9.257 2.437 -2.21530 3.660211 
P4N2AMP2 10 -6.485 2.739 -2.71090 2.591965 
P4N2AMP3 10 -11.483 5.818 -2.47240 5.339072 
Valid N (listwise) 10 
2 P4N2AMP1 5 -1.010 1.428 . 
05020 1.056388 
P4N2AMP2 5 -5.083 1.336 -1.51320 2.711117 
P4N2AMP3 5 -1.933 3.267 . 40600 2.226688 
Valid N (Iistwise) 5 
3 P4N2AMP1 9 -7.074 3.534 -1.21056 2.875647 
P4N2AMP2 9 -9.753 3.472 -1.47733 3.920248 
P4N2AMP3 9 -9.086 2.997 -2.28089 3.388290 
Valid N (listwise) 9 
4 P4N2AMP1 6 -3.982 -. 707 -1.84983 1.255280 
P4N2AMP2 6 -6.319 . 781 -2.05350 2.557990 
P4N2AMP3 6 -2.452 4.453 . 21950 2.938785 
Valid N (listwise) 6 
STANDARD ODDBALL TASK P3b LATENCY AT Cz (msec) 
GRP N Minimum Maximum Mean Std. Deviation 
0 CZP3LAT1 14 295.070 383.380 340.10929 29.499177 
CZP3LAT2 14 284.230 401.970 339.11357 33.557548 
CZP3LAT3 14 291.970 392.680 339.88929 31.956291 
Valid N (listwise) 14 
1 CZP3LAT1 10 33.800 383.380 314.49200 102.645404 
CZP3LAT2 10 320.860 423.660 365.81800 29.243499 
CZP3LAT3 10 333.800 440.700 378.42100 34.011566 
Valid N (listwise) 10 
2 CZP3LAT1 5 312.110 403.520 349.91400 33.883658 
CZP3LAT2 5 347.750 400.420 361.38200 22.379058 
CZP3LAT3 5 340.000 415.920 369.44000 29.047782 
Valid N (listwise) 5 
3 CZP3LAT1 9 252.390 398.870 341.11000 44.250287 
CZP3LAT2 9 318.310 428.310 351.87889 33.783688 
CZP3LAT3 9 329.150 437.610 356.52556 34.401886 
Valid N (listwise) 9 
4 CZP3LAT1 6 298.170 397.320 349.55333 37.662964 
CZP3LAT2 6 309.010 388.030 352.91167 33.081926 
CZP3LAT3 6 326.060 398.870 364.53000 26.244252 
Valid N (listwise) 6 
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STANDARD ODDBALL TASK P3b LATENCY AT Pz (msec) 
GRP N Minimum Maximum Mean Std. Deviation 
0 PZP3LAT1 14 295.070 381.130 340.94500 29.078732 
PZP3LAT2 14 287.320 400.520 338.78857 32.683662 
PZP3LAT3 14 293.520 397.320 341.32857 32.136215 
Valid N (listwise) 14 
1 PZP3LAT1 10 282.680 381.830 343.25300 28.709972 
PZP3LAT2 10 322.960 422.110 365.71800 28.021787 
PZP3LAT3 10 333.800 439.150 377.64500 33.316185 
Valid N (listwise) 10 
2 PZP3LAT1 5 316.760 406.620 350.13600 34.336040 
PZP3LAT2 5 346.200 398.870 361.38000 21.588287 
PZP3LAT3 5 340.000 415.920 369.75000 29.076716 
Valid N (listwise) 5 
3 PZP3LAT1 9 309.010 397.320 351.36111 29.355421 
PZP3LAT2 9 321.410 428.310 351.70667 33.454314 
PZP3LAT3 9 330.700 440.700 356.86889 35.332503 
Valid N (Iistwise) 9 
4 PZP3LAT1 6 298.170 394.230 350.07167 35.517038 
PZP3LAT2 6 307.460 386.480 351.62000 32.423303 
PZP3LAT3 6 327.610 397.320 364.78833 25.247835 
Valid N (listwise) 6 
STANDARD ODDBALL TASK P3b LATENCY AT P3 (msec) 
GRP N Minimum Maximum Mean Std. Deviation 
0 P3P3LAT1 14 299.720 380.280 342.31643 28.591544 
P3P3LAT2 14 288.870 375.630 335.13143 27.932012 
P3P3LAT3 14 293.520 395.770 341.88071 31.883720 
Valid N (listwise) 14 
1 P3P3LAT1 10 287.320 381.830 343.40800 27.265972 
P3P3LAT2 10 324.510 422.110 366.64800 27.518344 
P3P3LAT3 10 333.800 436.060 378.11100 32.908448 
Valid N (listwise) 10 
2 P3P3LAT1 5 318.310 408.170 351.77400 34.201081 
P3P3LAT2 5 346.200 395.770 360.45000 20.179789 
P3P3LAT3 5 340.000 415.920 370.05800 28.582542 
Valid N (listwise) 5 
3 P3P3LAT1 9 310.560 397.320 351.53333 30.083740 
P3P3LAT2 9 318.130 426.760 350.65444 33.209065 
P3P3LAT3 9 330.700 442.250 357.73000 35.363570 
Valid N (listwise) 9 
4 P3P3LAT1 6 298.170 392.680 349.29667 35.330616 
P3P3LAT2 6 84.930 369.550 300.86500 109.355331 
P3P3LAT3 6 329.150 398.870 365.82000 25.827548 
Valid N (listwise) 6 
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STANDARD ODDBALL TASK P3b LATENCY AT P4 (ursec) 
GRP N Minimum Maximum Mean Std. Deviation 
0 P4P3LAT1 14 296.620 381.830 341.88071 29.201530 
P4P3LAT2 14 287.320 403.520 339.55571 33.241966 
P4P3LAT3 14 293.520 397.320 342.54429 32.163406 
Valid N (listwise) 14 
1 P4P3LAT1 10 285.770 386.480 342.47900 28.569176 
P4P3LAT2 10 324.510 419.010 366.18300 27.025849 
P4P3LAT3 10 333.800 439.150 378.36500 33.243978 
Valid N (Iistwise) 10 
2 P4P3LAT1 5 316.760 406.620 351.15600 33.809264 
P4P3LAT2 5 347.750 394.230 361.07200 18.899958 
P4P3LAT3 5 340.000 411.270 370.05800 26.804957 
Valid N (Iistwise) 5 
3 P4P3LAT1 9 309.010 395.770 351.01333 28.445762 
P4P3LAT2 9 319.860 428.310 352.22222 33.680051 
P4P3LAT3 9 330.700 439.150 356.69667 34.873658 
Valid N (listwise) 9 
4 P4P3LAT1 6 293.520 400.420 350.07167 38.983043 
P4P3LAT2 6 307.460 384.930 351.10333 31.501652 
P4P3LAT3 6 327.610 400.420 365.82167 27.377443 
Valid N (Iistwise) 6 
STANDARD ODDBALL TASK P3b AMPLITUDE AT Cz (µV) 
GRP N Minimum Maximum Mean Std. Deviation 
0 CZP3AMP1 14 . 004 16.427 7.51743 5.452015 
CZP3AMP2 14 . 511 18.352 9.29271 5.701812 
CZP3AMP3 14 -. 527 19.167 8.07793 5.870840 
Valid N (listwise) 14 
1 CZP3AMP1 10 -14.530 13.948 1.27810 7.842272 
CZP3AMP2 10 -12.150 13.456 . 97500 7.000650 
CZP3AMP3 10 -16.990 6.759 1.53020 7.108907 
Valid N (Iistwise) 10 
2 CZP3AMP1 5 -. 655 13.875 5.05520 5.674729 
CZP3AMP2 5 5.159 14.856 9.89700 4.735111 
CZP3AMP3 5 1.478 11.489 6.92120 3.611255 
Valid N (listwise) 5 
3 CZP3AMP1 9 -3.025 15.415 7.46900 5.472333 
CZP3AMP2 9 -2.634 15.907 7.21222 7.083954 
CZP3AMP3 9 -8.425 18.380 5.72456 8.910352 
Valid N (listwise) 9 
4 CZP3AMP1 6 -3.345 9.973 5.90233 4.899062 
CZP3AMP2 6 -2.863 9.231 4.48883 5.735590 
CZP3AMP3 6 1.950 9.108 5.41833 2.645326 
Valid N (listwise) 6 
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STANDARD ODDBALL TASK P3b AMPLITUDE AT Pz (µV) 
GRP N Minimum Maximum Mean Std. Deviation 
0 PZP3AMP1 14 5.198 22.716 11.19936 5.889046 
PZP3AMP2 14 2.856 21.673 12.98229 6.091266 
PZP3AMP3 14 . 
681 18.338 10.79321 5.714611 
Valid N (listwise) 14 
1 PZP3AMP1 10 -. 137 16.524 8.01400 4.748137 
PZP3AMP2 10 -2.690 13.075 7.20890 5.121244 
PZP3AMP3 10 1.910 13.817 7.74150 3.735655 
Valid N (listwise) 10 
2 PZP3AMP1 5 4.378 16.986 9.82760 4.734292 
PZP3AMP2 5 7.110 19.894 12.71000 4.687168 
PZP3AMP3 5 6.935 16.632 10.88940 4.268555 
Valid N (listwise) 5 
3 PZP3AMP1 9 -. 232 18.608 10.48222 6.565208 
PZP3AMP2 9 -. 375 21.450 11.48889 7.242488 
PZP3AMP3 9 -2.184 17.161 8.92878 6.512060 
Valid N (Iistwise) 9 
4 PZP3AMP1 6 4.906 13.402 9.12367 3.343801 
PZP3AMP2 6 . 
146 12.134 7.43900 4.758243 
PZP3AMP3 6 3.966 9.498 7.09050 1.990817 
Valid N (listwise) 6 
STANDARD ODDBALL TASK P3b AMPLITUDE AT P3 (µV) 
GRP N Minimum Maximum Mean Std. Deviation 
0 P3P3AMP1 14 4.462 18.225 10.43757 4.858113 
P3P3AMP2 14 3.566 18.943 11.05000 4.726097 
P3P3AMP3 14 1.257 17.125 9.85393 4.643998 
Valid N (listwise) 14 
1 P3P3AMP1 10 . 
601 12.410 6.24500 3.534325 
P3P3AMP2 10 -2.029 15.114 7.42090 4.669640 
P3P3AMP3 10 -2.560 13.666 5.85240 4.432721 
Valid N (listwise) 10 
2 P3P3AMP1 5 3.705 15.633 8.83620 4.412622 
P3P3AMP2 5 4.803 17.759 10.05000 4.835047 
P3P3AMP3 5 6.460 13.833 9.87180 3.549330 
Valid N (listwise) 5 
3 P3P3AMP1 9 -. 917 15.252 8.91756 5.523446 
P3P3AMP2 9 . 
329 17.591 9.51956 5.956875 
P3P3AMP3 9 -. 964 14.780 8.45989 5.526727 
Valid N (listwise) 9 
4 P3P3AMP1 6 4.099 10.799 7.30550 2.671728 
P3P3AMP2 6 
. 
645 10.076 6.26383 4.189977 
P3P3AMP3 6 4.492 6.896 5.95200 
. 831602 
Valid N (listwise) 6 
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STANDARD ODDBALL TASK P3b AMPLITUDE AT P4 (µV) 
GRP N Minimum Maximum Mean Std. Deviation 
0 P4P3AMP1 14 . 298 23.553 9.80236 6.119888 
P4P3AMP2 14 -. 304 20.772 10.97386 5.891373 
P4P3AMP3 14 -2.929 18.344 9.56414 5.408818 
Valid N (listwise) 14 
1 P4P3AMP1 10 1.790 16.070 8.04980 4.442183 
P4P3AMP2 10 . 036 12.025 6.47830 3.756804 
P4P3AMP3 10 . 690 13.249 6.81880 3.824869 
Valid N (listwise) 10 
2 P4P3AMP1 5 3.822 14.898 9.83840 5.339986 
P4P3AMP2 5 5.683 15.362 10.03960 3.912346 
P4P3AMP3 5 4.261 15.494 9.25420 4.550375 
Valid N (listwise) 5 
3 P4P3AMP1 9 . 050 15.428 8.85356 6.143888 
P4P3AMP2 9 2.540 18.217 10.39544 5.446831 
P4P3AMP3 9 -. 453 15.621 8.17078 5.425923 
Valid N (listwise) 9 
4 P4P3AMP1 6 5.909 10.259 7.57183 1.684131 
P4P3AMP2 6 . 
030 7.927 5.43117 3.099805 
P4P3AMP3 6 1.991 6.894 5.32400 1.766921 
Valid N (listwise) 6 
NOVEL SOUNDS TASK Nl LATENCY AT Fz (msec) 
GRP N Minimum Maximum Mean Std. Deviation 
0 FZN 1 LAT1 14 78.170 127.750 99.75000 11.441935 
FZN1LAT2 14 90.560 118.450 102.07286 8.348730 
FZN1LAT3 14 56.480 123.100 105.39214 16.460009 
Valid N (Iistwise) 14 
1 FZN1LAT1 10 96.760 141.690 110.39500 12.895384 
FZN 1 LAT2 10 89.010 140.140 108.07000 13.896659 
FZN1LAT3 10 92.110 124.650 108.06900 11.053653 
Valid N (listwise) 10 
2 FZN1LAT1 5 85.920 129.300 109.77600 17.954165 
FZN 1 LAT2 5 84.370 135.490 106.67600 22.087052 
FZN 1 LAT3 5 98.310 124.650 109.46600 12.605916 
Valid N (listwise) 5 
3 FZN 1 LAT1 9 85.920 137.040 106.05556 16.395154 
FZN1LAT2 9 93.660 113.800 102.78556 6.638456 
FZN1LAT3 9 101.410 124.650 110.01778 9.234120 
Valid N (listwise) 9 
4 FZN1 LAT1 6 84.370 127.750 111.74000 16.705089 
FZN1LAT2 6 81.270 118.450 105.79667 13.730855 
FZN 1 LAT3 6 104.510 124.650 117.67000 7.118817 
Valid N (listwise) 6 
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NOVEL SOUNDS TASK Nl LATENCY AT Cz (msec) 
GRP N Minimum Maximum Mean Std. Deviation 
0 CZN1LAT1 14 82.820 124.650 99.19643 9.774455 
CZN1LAT2 14 87.460 120.000 101.96214 8.965368 
CZN1LAT3 14 53.380 123.100 104.39714 16.746906 
Valid N (listwise) 14 
1 CZN1LAT1 10 96.760 135.490 109.93000 11.505705 
CZN1LAT2 10 93.660 138.590 107.91400 13.283033 
CZN 1 LAT3 10 92.110 121.550 107.29400 10.477463 
Valid N (listwise) 10 
2 CZN 1 LAT1 5 85.920 127.750 109.15600 17.216688 
CZN1LAT2 5 84.370 140.140 107.60600 23.646457 
CZN1LAT3 5 98.310 126.200 110.08600 14.141246 
Valid N (listwise) 5 
3 CZN1LAT1 9 82.820 143.240 105.19444 18.738135 
CZN1LAT2 9 90.760 112.250 100.39778 6.536740 
CZN 1 LAT3 9 98.310 124.650 110.70556 9.980714 
Valid N (listwise) 9 
4 CZN1LAT1 6 87.460 126.200 111.48000 15.487346 
CZN1LAT2 6 81.270 118.450 101.41000 13.109929 
CZN1LAT3 6 106.060 123.100 117.16000 6.228644 
Valid N (Iistwise) 6 
NOVEL SOUNDS TASK Ni LATENCY AT F3 (ursec) 
GRP N Minimum Maximum Mean Std. Deviation 
0 F3N1LAT1 14 84.370 124.650 99.30643 9.996021 
F3N 1 LAT2 14 87.460 120.000 101.21929 8.109854 
F3N 1 LAT3 14 54.930 126.200 104.95071 16.834357 
Valid N (listwise) 14 
1 F3N1LAT1 10 99.860 144.490 110.83000 13.628223 
F3N 1 LAT2 10 89.010 138.590 107.64000 13.471572 
F3N1LAT3 10 92.110 124.650 108.22500 10.177831 
Valid N (listwise) 10 
2 F3N1LAT1 5 87.460 127.750 110.39400 17.023708 
F3N1LAT2 5 82.820 140.140 108.22600 23.913989 
F3N1LAT3 5 99.860 127.750 111.63600 12.277900 
Valid N (listwise) 5 
3 F3N1 LAT1 9 89.010 138.590 108.12111 15.913811 
F3N1LAT2 9 93.660 115.350 102.26889 7.514765 
F3N1LAT3 9 98.310 126.200 111.22111 9.455917 
Valid N (listwise) 9 
4 F3N1LAT1 6 82.820 132.390 111.73833 17.461906 
F3N1LAT2 6 84.370 121.550 103.21500 12.864531 
F3N 1 LAT3 6 109.150 126.200 119.22500 5.778819 
Valid N (listwise) 6 
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NOVEL SOUNDS TASK Nl LATENCY AT F4 (ursec) 
GRP N Minimum Maximum Mean Std. Deviation 
0 F4N 1 LAT1 14 79.720 127.750 102.07429 10.968824 
F4N1LAT2 14 87.460 118.450 102.07143 9.660998 
F4N 1 LAT3 14 56.480 123.100 105.61500 15.920871 
Valid N (listwise) 14 
1 F4N1 LAT1 10 98.310 137.040 112.87400 11.959598 
F4N1LAT2 10 90.560 138.590 108.07100 12.921794 
F4N1LAT3 10 90.560 120.000 107.86600 10.559947 
Valid N (listwise) 10 
2 F4N1LAT1 5 84.370 127.750 109.46600 17.813020 
F4N 1 LAT2 5 82.820 138.590 108.84400 23.378050 
F4N1LAT3 5 99.860 127.750 111.01600 13.301133 
Valid N (listwise) 5 
3 F4N1LAT1 9 89.010 143.240 106.91667 16.490180 
F4N 1 LAT2 9 89.010 123.100 103.81889 9.954926 
F4N 1 LAT3 9 101.410 126.200 110.87778 9.532986 
Valid N (listwise) 9 
4 F4N1LAT1 6 89.010 132.390 114.06000 15.475466 
F4N1LAT2 6 90.560 123.100 105.79667 11.402936 
F4N 1 LAT3 6 106.060 127.750 118.96833 7.632104 
Valid N (listwise) 6 
NOVEL SOUNDS TASK Ni AMPLITUDE AT Fz (µV) 
GRP N Minimum Maximum Mean Std. Deviation 
0 FZNIAMP1 14 -11.848 -3.284 -7.07593 2.198975 
FZN1AMP2 14 -11.217 -2.056 -7.20193 3.044286 
FZN1AMP3 14 -12.492 -. 718 -7.36564 3.425798 
Valid N (listwise) 14 
1 FZNIAMP1 10 -17.457 -4.555 -9.42190 3.970027 
FZN1AMP2 10 -15.753 -5.303 -8.95230 3.295237 
FZNIAMP3 10 -19.010 -2.571 -8.64160 4.644834 
Valid N (listwise) 10 
2 FZNIAMP1 5 -9.363 -1.154 -6.47380 3.275100 
FZNIAMP2 5 -12.373 -3.127 -5.45980 3.941275 
FZN1AMP3 5 -12.211 -1.627 -5.95300 4.007028 
Valid N (listwise) 5 
3 FZN1AMP1 9 -10.103 2.969 -5.15367 4.467181 
FZNIAMP2 9 -16.365 -2.636 -7.39211 4.395813 
FZN1AMP3 9 -15.270 -2.214 -6.85922 4.913371 
Valid N (listwise) 9 
4 FZN1AMP1 6 -10.173 -2.214 -5.87667 3.115234 
FZNIAMP2 6 -11.516 -1.519 -6.15867 3.341408 
FZN1AMP3 6 -12.402 -1.448 -6.39317 3.767530 
Valid N (listwise) 6 
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NOVEL SOUNDS TASK Nl AMPLITUDE AT Cz (µV) 
GRP N Minimum Maximum Mean Std. Deviation 
0 CZN1AMP1 14 -11.075 -2.147 -6.61264 2.598030 
CZN1AMP2 14 -11.697 -3.437 -7.22543 2.683289 
CZN1AMP3 14 -13.808 -1.282 -7.12543 3.335621 
Valid N (listwise) 14 
1 CZN1AMP1 10 -16.309 -6.361 -10.30010 3.122848 
CZN1AMP2 10 -19.723 . 532 -9.86800 5.377832 
CZN1AMP3 10 -26.530 -2.534 -11.07440 6.499370 
Valid N (listwise) 10 
2 CZN1AMP1 5 -8.324 -2.589 -6.46600 2.298683 
CZN1AMP2 5 -11.158 -2.687 -5.40180 3.354840 
CZN1AMP3 5 -14.746 -3.437 -7.41320 4.584626 
Valid N (listwise) 5 
3 CZN1AMP1 9 -10.419 . 
203 -5.35889 3.895169 
CZN 1 AMP2 9 -15.526 -2.772 -7.00189 3.951988 
CZN1AMP3 9 -13.204 -1.362 -6.49444 4.487161 
Valid N (listwise) 9 
4 CZN1AMP1 6 -9.609 -2.460 -6.27800 3.053896 
CZN1AMP2 6 -11.556 -. 507 -5.83633 4.010927 
CZN1AMP3 6 -13.045 1.130 -6.09817 4.675257 
Valid N (listwise) 6 
NOVEL SOUNDS TASK Nl AMPLITUDE AT F3 (µV) 
GRP N Minimum Maximum Mean Std. Deviation 
0 F3N1AMP1 14 -11.264 -2.441 -6.72157 2.297247 
F3N1AMP2 14 -11.659 . 
884 -6.64086 3.368863 
F3N1AMP3 14 -11.054 -. 040 -6.19786 3.229279 
Valid N (listwise) 14 
1 F3N1AMP1 10 -16.536 -2.926 -8.75050 3.991167 
F3N1AMP2 10 -13.465 -3.199 -8.10610 3.120732 
F3N1AMP3 10 -17.460 -. 740 -7.53710 4.609480 
Valid N (Iistwise) 10 
2 F3N1AMP1 5 -9.114 . 
229 -5.50720 3.535436 
F3N1AMP2 5 -11.201 -1.666 -4.93580 3.731442 
F3N1AMP3 5 -9.696 -3.200 -5.71940 2.738581 
Valid N (listwise) 5 
3 F3N1AMP1 9 -11.501 -. 956 -5.86822 3.622262 
F3NIAMP2 9 -17.661 -1.773 -7.79622 5.055091 
F3N1AMP3 9 -16.109 -2.086 -6.79800 5.037178 
Valid N (listwise) 9 
4 F3N1AMP1 6 -11.220 -2.051 -6.19283 3.514371 
F3N1AMP2 6 -11.182 -. 367 -5.55850 3.500761 
F3N1AMP3 6 -10.871 -. 740 -5.55083 3.449246 
Valid N (listwise) 6 
- 331 - 
APPENDIX IV 
NOVEL SOUNDS TASK Ni AMPLITUDE AT F4 (µV) 
GRP N Minimum Maximum Mean Std. Deviation 
0 F4N1AMP1 14 -11.302 -3.036 -7.08071 2.360027 
F4N1AMP2 14 -15.450 -2.269 -7.54221 3.455631 
F4N1AMP3 14 -15.255 -1.182 -7.76807 4.081283 
Valid N (listwise) 14 
1 F4N1AMP1 10 -14.937 -3.786 -8.85170 3.518338 
F4N1AMP2 10 -16.469 -1.779 -7.91160 5.081920 
F4N1AMP3 10 -17.930 -2.375 -8.60080 4.516136 
Valid N (Iistwise) 10 
2 F4N1AMP1 5 -9.191 . 
882 -5.72520 3.879856 
F4N1AMP2 5 -11.954 -2.297 -5.34500 3.972139 
F4N1AMP3 5 -13.274 -1.579 -5.59420 4.687331 
Valid N (Iistwise) 5 
3 F4N1AMP1 9 -11.127 -. 738 -5.21800 3.560496 
F4N1AMP2 9 -13.068 -1.700 -7.20556 3.678741 
F4N1AMP3 9 -14.990 -2.464 -7.30178 4.059406 
Valid N (Iistwise) 9 
4 F4N1AMP1 6 -10.506 -2.450 -5.99333 3.264624 
F4N1AMP2 6 -14.369 -1.230 -5.81200 4.839273 
F4N1AMP3 6 -11.777 -2.355 -6.79083 3.306417 
Valid N (Iistwise) 6 
NOVEL SOUNDS TASK N2 LATENCY AT Fz (msec) 
GRP N Minimum Maximum Mean Std. Deviation 
0 FZN2LAT1 14 171.130 219.150 190.82429 14.230916 
FZN2LAT2 14 168.030 205.210 188.94286 11.381097 
FZN2LAT3 14 161.830 212.960 185.62357 14.220424 
Valid N (listwise) 14 
1 FZN2LAT1 10 146.340 279.580 209.94900 46.959367 
FZN2LAT2 10 160.280 273.380 217.91500 40.379754 
FZN2LAT3 10 164.930 288.870 223.18200 43.190483 
Valid N (listwise) 10 
2 FZN2LAT1 5 177.320 234.650 205.21000 26.134118 
FZN2LAT2 5 180.420 226.900 208.61800 23.041938 
FZN2LAT3 5 217.610 264.080 234.33800 18.891018 
Valid N (listwise) 5 
3 FZN2LAT1 9 149.440 222.250 180.25000 25.272388 
FZN2LAT2 9 150.990 236.200 184.38222 28.568431 
FZN2LAT3 9 155.630 287.320 204.69444 41.470849 
Valid N (listwise) 9 
4 FZN2LAT1 6 157.180 231.550 204.17833 28.680961 
FZN2LAT2 6 183.520 276.480 220.70500 33.170891 
FZN2LAT3 6 195.920 293.520 231.03167 32.728041 
Valid N (listwise) 6 
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NOVEL SOUNDS TASK N2 LATENCY AT Cz (msec) 
GRP N Minimum Maximum Mean Std. Deviation 
0 CZN2LAT1 14 171.130 220.700 189.60714 14.602050 
CZN2LAT2 14 163.380 206.760 187.56500 12.099140 
CZN2LAT3 14 160.280 211.410 184.36714 14.058621 
Valid N (listwise) 14 
1 CZN2LAT1 10 149.440 278.030 209.85900 46.541505 
CZN2LAT2 10 166.480 273.380 217.76100 37.897772 
CZN2LAT3 10 161.830 282.680 220.85900 42.758894 
Valid N (listwise) 10 
2 CZN2LAT1 5 177.320 230.000 203.66000 24.838410 
CZN2LAT2 5 181.970 225.350 208.30800 22.018733 
CZN2LAT3 5 214.510 260.990 232.48000 18.677548 
Valid N (listwise) 5 
3 CZN2LAT1 9 150.990 220.700 179.38778 23.988739 
CZN2LAT2 9 149.440 234.650 184.55333 26.553628 
CZN2LAT3 9 155.630 295.070 214.50556 50.678973 
Valid N (listwise) 9 
4 CZN2LAT1 6 160.280 233.100 201.59667 25.509114 
CZN2LAT2 6 181.970 271.830 219.67167 31.669801 
CZN2LAT3 6 191.270 291.970 230.77333 33.035831 
Valid N (listwise) 6 
NOVEL SOUNDS TASK N2 LATENCY AT F3 (msec) 
GRP N Minimum Maximum Mean Std. Deviation 
0 F3N2LAT1 14 168.490 216.060 190.63786 14.140762 
F3N2LAT2 14 165.080 214.510 189.50786 13.470124 
F3N2LAT3 14 161.830 217.610 184.62857 15.367279 
Valid N (listwise) 14 
1 F3N2LAT1 10 146.340 273.380 210.16900 46.171855 
F3N2LAT2 10 161.830 273.380 217.76000 40.542236 
F3N2LAT3 10 164.930 284.230 222.40900 42.940121 
Valid N (listwise) 10 
2 F3N2LAT1 5 177.230 236.200 206.43200 26.305752 
F3N2LAT2 5 180.420 228.450 210.47800 22.359863 
F3N2LAT3 5 211.410 264.080 233.40800 21.194326 
Valid N (listwise) 5 
3 F3N2LAT1 9 149.440 222.250 178.35667 25.609223 
F3N2LAT2 9 152.540 237.750 184.55333 27.834231 
F3N2LAT3 9 152.540 290.420 204.69556 41.844017 
Valid N (listwise) 9 
4 F3N2LAT1 6 155.630 228.450 203.92000 29.371890 
F3N2LAT2 6 181.970 274.930 219.41333 33.393325 
F3N2LAT3 6 189.720 291.970 229.48333 33.724604 
Valid N (listwise) 6 
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NOVEL SOUNDS TASK N2 LATENCY AT F4 (msec) 
GRP N Minimum Maximum Mean Std. Deviation 
0 F4N2LAT1 14 169.590 219.150 191.48857 14.580125 
F4N2LAT2 14 168.030 211.410 189.82929 12.534475 
F4N2LAT3 14 161.830 214.510 184.50357 14.383710 
Valid N (listwise) 14 
1 F4N2LAT1 10 144.790 279.580 209.70400 47.525463 
F4N2LAT2 10 161.830 276.480 219.23000 40.166760 
F4N2LAT3 10 161.830 282.680 222.48900 43.401103 
Valid N (listwise) 10 
2 F4N2LAT1 5 180.420 234.650 207.07000 25.773249 
F4N2LAT2 5 180.420 228.450 211.38600 20.094020 
F4N2LAT3 5 216.060 265.630 234.95800 19.299396 
Valid N (listwise) 5 
3 F4N2LAT1 9 155.630 220.700 181.62444 24.554596 
F4N2LAT2 9 150.990 239.300 183.86667 28.899001 
F4N2LAT3 9 155.630 287.320 205.55444 40.672873 
Valid N (listwise) 9 
4 F4N2LAT1 6 157.180 231.550 203.40333 28.860336 
F4N2LAT2 6 183.520 265.630 219.93000 29.924523 
F4N2LAT3 6 191.270 293.520 230.25667 33.821297 
Valid N (listwise) 6 
NOVEL SOUNDS TASK N2 AMPLITUDE AT Fz (µV) 
GRP N Minimum Maximum Mean Std. Deviation 
0 FZN2AMP1 14 -10.937 . 973 -5.33314 2.728081 
FZN2AMP2 14 -11.638 . 758 -4.91714 3.318986 
FZN2AMP3 14 -8.076 . 
853 -4.33950 2.676292 
Valid N (listwise) 14 
1 FZN2AMP1 10 -11.305 -. 717 -4.68530 3.108719 
FZN2AMP2 10 -7.488 3.011 -2.77770 3.113315 
FZN2AMP3 10 -11.347 -1.385 -5.10150 3.117311 
Valid N (listwise) 10 
2 FZN2AMP1 5 -4.868 1.141 -. 98200 2.402069 
FZN2AMP2 5 -7.852 2.878 -3.06420 4.176074 
FZN2AMP3 5 -5.400 4.708 -1.81040 3.948775 
Valid N (listwise) 5 
3 FZN2AMP1 9 -16.528 . 280 -6.43622 5.195801 
FZN2AMP2 9 -11.153 -3.172 -7.14456 3.188549 
FZN2AMP3 9 -15.160 -. 560 -5.47600 4.429299 
Valid N (listwise) 9 
4 FZN2AMP1 6 -7.852 . 575 -3.28833 3.266379 
FZN2AMP2 6 -5.023 8.786 -. 05517 4.943475 
FZN2AMP3 6 -8.157 4.384 -1.53567 5.240982 
Valid N (listwise) 6 
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NOVEL SOUNDS TASK N2 AMPLITUDE AT Cz (µV) 
GRP N Minimum Maximum Mean Std. Deviation 
0 CZN2AMP1 14 -16.511 . 375 -6.44814 4.038336 
CZN2AMP2 14 -12.788 . 793 -4.52050 4.487415 
CZN2AMP3 14 -9.983 2.278 -3.89029 4.101966 
Valid N (listwise) 14 
1 CZN2AMP1 10 -17.356 1.214 -5.26590 5.221148 
CZN2AMP2 10 -13.548 4.616 -3.43520 4.882504 
CZN2AMP3 10 -16.369 -. 075 -6.15710 5.501216 
Valid N (listwise) 10 
2 CZN2AMP1 5 -3.325 -. 620 -2.43520 1.055033 
CZN2AMP2 5 -10.027 6.426 -1.80360 6.418109 
CZN2AMP3 5 -4.789 3.059 -. 63780 3.229289 
Valid N (listwise) 5 
3 CZN2AMP1 9 -13.141 . 369 -5.88678 4.833052 
CZN2AMP2 9 -15.614 -1.920 -6.74133 4.491093 
CZN2AMP3 9 -13.520 1.366 -4.53444 4.337218 
Valid N (listwise) 9 
4 CZN2AMP1 6 -10.273 1.366 -4.13367 3.805884 
CZN2AMP2 6 -5.202 9.755 -. 62883 5.465533 
CZN2AMP3 6 -5.454 6.847 -. 53167 4.589488 
Valid N (listwise) 6 
NOVEL SOUNDS TASK N2 AMPLITUDE AT F3 (µV) 
GRP N Minimum Maximum Mean Std. Deviation 
0 F3N2AMP1 14 -9.746 3.411 -3.91850 2.998106 
F3N2AMP2 14 -8.730 5.369 -3.03129 3.911366 
F3N2AMP3 14 -7.968 7.162 -2.16793 3.550795 
Valid N (listwise) 14 
1 F3N2AMP1 10 -10.387 1.556 -3.37560 3.394104 
F3N2AMP2 10 -6.822 3.282 -1.92150 3.131544 
F3N2AMP3 10 -9.601 . 171 -3.33240 3.290502 
Valid N (listwise) 10 
2 F3N2AMP1 5 -4.849 1.638 -. 38720 2.583639 
F3N2AMP2 5 -5.719 4.329 -1.45460 4.334434 
F3N2AMP3 5 -3.946 3.617 -1.01600 2.966995 
Valid N (listwise) 5 
3 F3N2AMP1 9 -14.801 1.908 -5.41467 5.004347 
F3N2AMP2 9 -11.550 -1.588 -5.54833 3.620276 
F3N2AMP3 9 -10.750 . 360 -4.23578 4.326993 
Valid N (listwise) 9 
4 F3N2AMP1 6 -5.714 . 
360 -2.43733 2.642231 
F3N2AMP2 6 -2.383 9.909 1.33567 4.423970 
F3N2AMP3 6 -6.436 4.994 -. 33400 4.108058 
Valid N (listwise) 6 
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NOVEL SOUNDS TASK N2 AMPLITUDE AT F4 (µV) 
GRP N Minimum Maximum Mean Std. Deviation 
0 F4N2AMP1 14 -10.608 3.325 -4.26286 3.832061 
F4N2AMP2 14 -9.334 2.012 -4.25786 3.474087 
F4N2AMP3 14 -8.994 3.561 -3.21193 3.625948 
Valid N (listwise) 14 
1 F4N2AMP1 10 -10.904 -. 637 -3.81700 3.095636 
F4N2AMP2 10 -8.558 2.703 -2.03130 3.536066 
F4N2AMP3 10 -10.907 -. 790 -5.34160 3.005443 
Valid N (listwise) 10 
2 F4N2AMP1 5 -4.064 1.261 -. 62140 2.022797 
F4N2AMP2 5 -7.419 1.943 -2.06780 3.427989 
F4N2AMP3 5 -5.622 5.626 -. 57000 4.285191 
Valid N (listwise) 5 
3 F4N2AMP1 9 -18.718 . 364 -5.94756 6.135381 
F4N2AMP2 9 -12.021 -1.553 -7.23189 3.548570 
F4N2AMP3 9 -13.330 . 503 -5.36256 4.299543 
Valid N (listwise) 9 
4 F4N2AMP1 6 -7.419 . 503 -3.51200 3.141152 
F4N2AMP2 6 -3.628 7.772 -. 49533 4.246165 
F4N2AMP3 6 -7.127 4.754 -2.04233 4.480357 
Valid N (listwise) 6 
NOVEL SOUNDS TASK P3a LATENCY AT Fz (msec) 
GRP N Minimum Maximum Mean Std. Deviation 
0 FZP3LAT1 14 236.200 296.620 268.17857 19.028476 
FZP3LAT2 14 240.850 305.920 265.41714 20.564909 
FZP3LAT3 14 240.850 336.200 270.89643 26.275239 
Valid N (listwise) 14 
1 FZP3LAT1 10 234.650 352.390 283.14100 31.437908 
FZP3LAT2 10 256.340 336.900 290.35400 25.795803 
FZP3LAT3 10 257.890 360.140 299.69500 34.919058 
Valid N (listwise) 10 
2 FZP3LAT1 5 245.490 296.620 269.35200 21.595214 
FZP3LAT2 5 243.940 316.760 272.44800 26.894004 
FZP3LAT3 5 260.990 305.920 282.98600 19.394972 
Valid N (listwise) 5 
3 FZP3LAT1 9 236.200 287.320 257.73222 17.969459 
FZP3LAT2 9 231.550 332.250 270.11556 31.371653 
FZP3LAT3 9 242.390 370.990 286.46222 44.811208 
Valid N (Iistwise) 9 
4 FZP3LAT1 6 234.650 287.320 260.47000 17.016546 
FZP3LAT2 6 237.750 332.250 272.60667 32.492263 
FZP3LAT3 6 230.000 350.850 271.83333 41.388159 
Valid N (Iistwise) 6 
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NOVEL SOUNDS TASK P3a LATENCY AT Cz (msec) 
GRP N Minimum Maximum Mean Std. Deviation 
0 CZP3LAT1 14 237.750 293.520 267.73714 18.783985 
CZP3LAT2 14 242.390 305.920 265.19143 19.948559 
CZP3LAT3 14 239.300 305.920 263.75357 20.119855 
Valid N (listwise) 14 
1 CZP3LAT1 10 236.200 346.200 281.74700 29.343301 
CZP3LAT2 10 253.240 332.250 289.64700 24.844598 
CZP3LAT3 10 256.340 363.240 300.50200 34.983482 
Valid N (listwise) 10 
2 CZP3LAT1 5 247.040 296.620 269.35200 21.980793 
CZP3LAT2 5 242.390 316.760 271.83000 27.541730 
CZP3LAT3 5 264.080 305.920 284.53600 18.768488 
Valid N (listwise) 5 
3 CZP3LAT1 9 237.750 285.770 256.51000 18.419661 
CZP3LAT2 9 233.100 330.700 270.62667 30.630813 
CZP3LAT3 9 233.100 369.440 274.75778 44.028969 
Valid N (Iistwise) 9 
4 CZP3LAT1 6 233.100 285.770 262.79333 17.009698 
CZP3LAT2 6 236.200 335.350 273.89667 33.121261 
CZP3LAT3 6 226.900 350.850 271.31667 41.891872 
Valid N (listwise) 6 
NOVEL SOUNDS TASK P3a LATENCY AT F3 (msec) 
GRP N Minimum Maximum Mean Std. Deviation 
0 F3P3LAT1 14 234.650 295.070 267.29357 19.667490 
F3P3LAT2 14 236.200 305.920 264.30571 20.812627 
F3P3LAT3 14 237.750 305.920 263.20071 19.838203 
Valid N (listwise) 14 
1 F3P3LAT1 10 236.200 352.390 281.28100 31.305122 
F3P3LAT2 10 254.790 333.800 289.95800 24.266320 
F3P3LAT3 10 257.890 367.890 299.87500 36.738800 
Valid N (listwise) 10 
2 F3P3LAT1 5 245.490 293.520 269.66200 19.183839 
F3P3LAT2 5 242.390 312.110 272.20800 25.746384 
F3P3LAT3 5 264.080 304.370 282.05600 17.755889 
Valid N (listwise) 5 
3 F3P3LAT1 9 236.200 285.770 257.54333 17.778105 
F3P3LAT2 9 234.650 332.250 269.07778 31.098216 
F3P3LAT3 9 242.390 367.890 297.40111 45.152803 
Valid N (Iistwise) 9 
4 F3P3LAT1 6 237.750 285.770 259.69500 15.960933 
F3P3LAT2 6 231.550 330.700 270.54000 33.620766 
F3P3LAT3 6 228.450 352.390 271.83167 42.540276 
Valid N (Iistwise) 6 
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NOVEL SOUNDS TASK P3a LATENCY AT F4 (rosec) 
GRP N Minimum Maximum Mean Std. Deviation 
0 F4P3LAT1 14 239.300 298.170 269.39714 18.981601 
F4P3LAT2 14 237.750 305.920 265.08000 21.542446 
F4P3LAT3 14 237.750 304.320 263.75071 20.267598 
Valid N (listwise) 14 
1 F4P3LAT1 10 234.650 349.300 281.20200 30.718782 
F4P3LAT2 10 260.990 330.150 290.21400 23.767416 
F4P3LAT3 10 260.990 369.440 299.63500 36.540191 
Valid N (Iistwise) 10 
2 F4P3LAT1 5 243.940 291.970 266.56200 22.359863 
F4P3LAT2 5 243.940 305.920 270.59000 22.438679 
F4P3LAT3 5 260.990 302.820 285.46600 18.377336 
Valid N (listwise) 5 
3 F4P3LAT1 9 234.650 287.320 257.37111 18.525827 
F4P3LAT2 9 231.550 327.610 270.45667 29.976833 
F4P3LAT3 9 243.940 370.990 286.63444 45.071588 
Valid N (Iistwise) 9 
4 F4P3LAT1 6 234.650 290.420 259.18000 18.077397 
F4P3LAT2 6 237.750 333.800 272.09000 32.737741 
F4P3LAT3 6 236.200 352.390 273.64000 40.533209 
Valid N (listwise) 6 
NOVEL SOUNDS TASK P3a AMPLITUDE AT Fz (MV) 
GRP N Minimum Maximum Mean Std. Deviation 
0 FZP3AMP1 14 -1.850 11.700 6.19193 3.742884 
FZP3AMP2 14 -1.470 19.082 6.34907 4.883526 
FZP3AMP3 14 -. 248 13.411 6.45414 3.831660 
Valid N (Iistwise) 14 
1 FZP3AMP1 10 -1.709 9.338 4.25250 3.383083 
FZP3AMP2 10 -1.774 11.651 4.52830 4.306057 
FZP3AMP3 10 -1.126 17.530 5.03630 5.878657 
Valid N (listwise) 10 
2 FZP3AMP1 5 -. 155 17.331 7.09540 8.148440 
FZP3AMP2 5 1.187 17.003 8.16500 5.761956 
FZP3AMP3 5 -3.280 5.605 . 88480 3.212310 
Valid N (listwise) 5 
3 FZP3AMP1 9 -3.192 14.339 5.27878 5.306352 
FZP3AMP2 9 . 055 18.008 6.78811 5.519826 
FZP3AMP3 9 -12.920 14.914 3.36300 7.498669 
Valid N (listwise) 9 
4 FZP3AMP1 6 -. 090 17.101 5.51717 6.787503 
FZP3AMP2 6 -4.000 13.816 3.95567 6.997007 
FZP3AMP3 6 -5.990 8.244 1.70133 5.988529 
Valid N (Iistwise) 6 
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NOVEL SOUNDS TASK P3a AMPLITUDE AT Cz (µV) 
GRP N Minimum Maximum Mean Std. Deviation 
0 CZP3AMP1 14 -2.132 20.120 10.39779 6.409730 
CZP3AMP2 14 -2.508 23.093 10.43286 6.628835 
CZP3AMP3 14 -. 394 20.781 10.59693 6.712724 
Valid N (listwise) 14 
1 CZP3AMP1 10 . 928 9.849 5.21010 3.058591 
CZP3AMP2 10 1.134 10.851 6.94870 3.750377 
CZP3AMP3 10 . 157 17.260 7.23210 6.271479 
Valid N (listwise) 10 
2 CZP3AMP1 5 . 
741 21.696 10.27440 8.300075 
CZP3AMP2 5 2.988 18.813 11.74540 6.019247 
CZP3AMP3 5 . 376 11.618 4.12200 4.365055 
Valid N (listwise) 5 
3 CZP3AMP1 9 1.881 18.163 8.48433 5.251407 
CZP3AMP2 9 -. 156 24.250 8.96544 8.236298 
CZP3AMP3 9 -9.900 21.609 7.08333 8.557786 
Valid N (listwise) 9 
4 CZP3AMP1 6 . 
234 18.863 7.29567 7.097653 
CZP3AMP2 6 -3.115 15.419 5.54017 7.793608 
CZP3AMP3 6 -3.301 12.736 4.48700 5.291934 
Valid N (listwise) 6 
NOVEL SOUNDS TASK P3a AMPLITUDE AT F3 (µV) 
GRP N Minimum Maximum Mean Std. Deviation 
0 F3P3AMP1 14 -2.065 10.564 5.05150 3.376938 
F3P3AMP2 14 . 168 15.272 6.00036 3.833847 
F3P3AMP3 14 . 148 11.210 6.60079 3.177402 
Valid N (listwise) 14 
1 F3P3AMP1 10 -1.317 6.022 2.72810 2.455375 
F3P3AMP2 10 -. 829 12.350 4.92310 3.834025 
F3P3AMP3 10 -1.570 15.080 4.04600 5.011444 
Valid N (listwise) 10 
2 F3P3AMP1 5 -. 659 17.852 6.17740 7.524889 
F3P3AMP2 5 1.670 14.126 6.95580 4.573414 
F3P3AMP3 5 -1.667 6.422 2.59700 3.060728 
Valid N (listwise) 5 
3 F3P3AMP1 9 -5.030 9.961 3.80278 5.355900 
F3P3AMP2 9 -6.814 14.100 4.28544 5.525390 
F3P3AMP3 9 -8.610 11.764 3.35511 5.993493 
Valid N (listwise) 9 
4 F3P3AMP1 6 -. 668 14.232 4.47333 5.885356 
F3P3AMP2 6 -. 596 14.623 5.04333 6.284597 
F3P3AMP3 6 -5.989 7.292 2.01533 5.234973 
Valid N (listwise) 6 
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NOVEL SOUNDS TASK P3a AMPLITUDE AT F4 (µV) 
GRP N Minimum Maximum Mean Std. Deviation 
0 F4P3AMP1 14 . 
237 13.225 6.52207 3.134992 
F4P3AMP2 14 -. 254 18.950 6.52093 4.807047 
F4P3AMP3 14 -1.786 14.594 6.21843 3.913213 
Valid N (listwise) 14 
1 F4P3AMP1 10 -1.444 7.617 2.97820 3.015019 
F4P3AMP2 10 . 325 10.675 4.25860 3.401614 
F4P3AMP3 10 -. 113 18.160 5.26230 5.220272 
Valid N (listwise) 10 
2 F4P3AMP1 5 -1.752 15.763 6.63160 7.802812 
F4P3AMP2 5 -. 467 12.905 5.74180 4.956631 
F4P3AMP3 5 . 272 
8.188 3.43280 3.105678 
Valid N (listwise) 5 
3 F4P3AMP1 9 -3.434 12.271 4.98200 5.036174 
F4P3AMP2 9 -10.407 14.350 3.90711 6.859834 
F4P3AMP3 9 -10.950 14.217 2.45822 6.936291 
Valid N (listwise) 9 
4 F4P3AMP1 6 . 
077 13.235 4.68333 5.760919 
F4P3AMP2 6 -2.431 11.960 3.42967 5.796094 
F4P3AMP3 6 -5.565 9.000 1.00250 5.472424 
Valid N (listwise) 6 
DTO TASK -AUDITORY TARGET Ni LATENCY AT Cz (ursec) 
GRP N Minimum Maximum Mean Std. Deviation 
0 CZN1LAT1 14 79.720 127.750 99.08500 14.857793 
CZNILAT2 14 79.720 120.000 95.76429 11.571326 
CZN1LAT3 14 67.320 112.250 93.99286 13.508217 
Valid N (listwise) 14 
1 CZN1 LAT1 8 82.820 110.700 94.43625 9.220015 
CZN1LAT2 8 78.170 129.300 105.28250 18.182701 
CZN1LAT3 8 75.070 116.900 98.69500 13.751325 
Valid N (listwise) 8 
2 CZN1 LATZ 5 82.820 137.040 104.19800 20.031539 
CZN1LAT2 5 87.460 118.450 101.71600 14.998488 
CZN1LAT3 5 62.680 124.650 101.10000 23.119135 
Valid N (listwise) 5 
3 CZN1LAT1 8 79.720 147.890 100.43875 21.863879 
CZN 1 LAT2 8 81.270 140.140 100.24500 18.457282 
CZN1LAT3 8 78.170 118.450 94.82250 11.317041 
Valid N (listwise) 8 
4 CZN1LAT1 6 90.560 114.350 101.24000 9.417036 
CZNILAT2 6 82.820 101.410 92.37167 7.677967 
CZN1LAT3 6 98.310 116.900 104.50667 7.131958 
Valid N (listwise) 6 
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DTO TASK -AUDITORY TARGET Ni LATENCY AT Pz (msec) 
GRP N Minimum Maximum Mean Std. Deviation 
0 PZN1LAT1 14 75.070 130.850 99.52786 16.455814 
PZN 1 LAT2 14 76.920 121.550 94.45714 11.947278 
PZN1LAT3 14 67.320 115.350 94.21357 13.692724 
Valid N (Iistwise) 14 
1 PZN1LAT1 8 82.820 112.250 92.69250 9.328752 
PZN1LAT2 8 76.620 130.850 106.44500 18.972200 
PZN 1 LAT3 8 75.070 120.000 99.08250 14.557185 
Valid N (listwise) 8 
2 PZN 1 LAT1 5 82.820 135.490 104.50800 19.192847 
PZN1LAT2 5 85.920 116.900 100.47800 15.399023 
PZN 1 LAT3 5 61.130 124.650 101.09800 24.034889 
Valid N (listwise) 5 
3 PZN1LAT1 8 76.620 149.440 100.63375 23.025490 
PZN 1 LAT2 8 79.720 138.590 97.53500 19.083016 
PZN1LAT3 8 78.170 118.450 94.43625 11.971805 
Valid N (Iistwise) 8 
4 PZN1LAT1 6 85.920 118.450 101.41000 11.634898 
PZN 1 LAT2 6 81.270 102.960 91.33833 8.471150 
PZN 1 LAT3 6 98.310 116.900 104.24833 8.221179 
Valid N (listwise) 6 
DTO TASK -AUDITORY TARGET Ni LATENCY AT P3 (msec) 
GRP N Minimum Maximum Mean Std. Deviation 
0 P3N1LAT1 14 73.520 130.850 101.18857 16.328027 
P3N1LAT2 14 79.720 120.000 94.32500 11.508874 
P3N1LAT3 14 67.320 116.900 94.99071 14.014365 
Valid N (listwise) 14 
1 P3N1LAT1 8 79.720 109.150 90.95000 9.021732 
P3N 1 LAT2 8 73.520 138.850 106.67000 22.120351 
P3N1LAT3 8 70.420 120.000 97.72750 14.928900 
Valid N (listwise) 8 
2 P3N1LAT1 5 81.270 138.590 104.81800 20.997230 
P3N1LAT2 5 84.370 120.000 101.10000 17.229288 
P3N1LAT3 5 59.580 127.750 103.26800 26.232270 
Valid N (listwise) 5 
3 P3N 1 LAT1 8 76.620 150.990 100.05250 23.430864 
P3N1LAT2 8 81.270 140.140 97.92250 18.843204 
P3N1LAT3 8 76.620 118.450 95.40375 12.324021 
Valid N (listwise) 8 
4 P3N 1 LAT1 6 85.920 120.000 102.18333 12.915235 
P3N1LAT2 6 81.270 102.960 91.33833 9.385690 
P3N 1 LAT3 6 95.210 116.900 102.95833 8.020674 
Valid N (Iistwise) 6 
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DTO TASK -AUDITORY TARGET NI LATENCY AT P4 (msec) 
GRP N Minimum Maximum Mean Std. Deviation 
0 P4N 1 LATZ 14 70.420 132.390 99.52714 17.946168 
P4N 1 LAT2 14 78.170 120.000 93.77143 12.281638 
P4N1LAT3 14 64.230 116.900 94.65857 14.829755 
Valid N (listwise) 14 
1 P4N1LAT1 8 85.920 113.800 94.24125 8.682428 
P4N 1 LAT2 8 75.070 134.590 106.91250 20.139862 
P4N 1 LAT3 8 70.420 121.550 99.85750 16.625430 
Valid N (listwise) 8 
2 P4N1LAT1 5 81.270 133.940 100.78800 19.917430 
P4N1LAT2 5 84.370 116.900 99.55000 16.224568 
P4N 1 LAT3 5 62.680 124.650 102.02800 23.535155 
Valid N (listwise) 5 
3 P4N1LAT1 8 73.520 147.890 100.05250 23.562045 
P4N 1 LAT2 8 79.720 140.140 98.69625 19.662118 
P4N 1 LAT3 8 76.620 118.450 94.43500 11.943936 
Valid N (listwise) 8 
4 P4N1LAT1 6 89.010 115.350 100.63333 10.030248 
P4N1LAT2 6 79.720 104.510 91.85500 9.964563 
P4N1LAT3 6 99.860 120.000 106.05667 7.525346 
Valid N (listwise) 6 
DTO TASK -AUDITORY TARGET Ni AMPLITUDE AT Cz (µV) 
GRP N Minimum Maximum Mean Std. Deviation 
0 CZN1AMP1 14 -11.009 -3.528 -6.98200 2.263188 
CZN1AMP2 14 -11.866 -1.450 -7.96693 2.396309 
CZN1AMP3 14 -10.746 -1.971 -6.40857 2.407173 
Valid N (listwise) 14 
1 CZN1AMP1 8 -20.300 -6.328 -11.35600 4.560370 
CZN1AMP2 8 -22.277 -1.280 -9.50113 6.448957 
CZN1AMP3 8 -19.860 -3.208 -11.04300 5.150849 
Valid N (listwise) 8 
2 CZN1AMP1 5 -8.860 -4.090 -6.19680 2.295504 
CZNIAMP2 5 -10.178 -2.873 -5.67080 2.782814 
CZN1AMP3 5 -9.796 -6.029 -7.58480 1.596843 
Valid N (listwise) 5 
3 CZNIAMPI 8 -10.092 -2.677 -6.48850 2.466550 
CZN1AMP2 8 -11.346 -3.968 -7.16738 2.911760 
CZNIAMP3 8 -11.343 -2.825 -7.05238 3.010606 
Valid N (listwise) 8 
4 CZN1AMP1 6 -14.051 -2.865 -8.08600 3.727461 
CZN1AMP2 6 -11.492 -2.381 -6.81200 3.239164 
CZN1AMP3 6 -10.480 -2.649 -6.06950 2.947425 
Valid N (listwise) 6 
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DTO TASK -AUDITORY TARGET Ni AMPLITUDE AT Pz (µV) 
GRP N Minimum Maximum Mean Std. Deviation 
0 PZN1AMP1 14 -7.256 -1.263 -4.36279 1.911589 
PZN1AMP2 14 -7.881 -. 890 -4.94857 2.086153 
PZN 1 AM P3 14 -7.454 . 224 -3.87050 2.207436 
Valid N (listwise) 14 
1 PZN1AMP1 8 -11.961 -2.774 -6.28038 2.959313 
PZN1AMP2 8 -14.475 -. 905 -5.95850 4.574659 
PZN1AMP3 8 -14.990 -. 600 -7.26975 4.701727 
Valid N (Iistwise) 8 
2 PZN1AMP1 5 -6.131 -2.686 -3.99260 1.459307 
PZN1AMP2 5 -8.218 -1.892 -3.72900 2.738383 
PZN1AMP3 5 -6.691 -3.406 -5.03420 1.306939 
Valid N (Iistwise) 5 
3 PZN1AMP1 8 -5.423 -. 205 -3.11725 1.723347 
PZN 1 AMP2 8 -7.391 -. 802 -3.88600 2.122055 
PZN1AMP3 8 -7.757 -. 543 -3.69388 2.618482 
Valid N (listwise) 8 
4 PZN1AMP1 6 -9.162 -2.126 -4.80817 2.533156 
PZN1AMP2 6 -6.048 -. 114 -3.71650 2.269752 
PZN1AMP3 6 -8.942 -1.081 -3.83033 3.014622 
Valid N (listwise) 6 
DTO TASK -AUDITORY TARGET Ni AMPLITUDE AT P3 (µV) 
GRP N Minimum Maximum Mean Std. Deviation 
0 P3N1AMP1 14 -6.997 . 
233 -3.40779 2.365119 
P3N1AMP2 14 -7.623 -. 470 -3.73514 1.829555 
P3N1AMP3 14 -5.999 -. 979 -3.38979 1.754397 
Valid N (listwise) 14 
1 P3N1AMP1 8 -11.648 -2.708 -5.25775 2.949189 
P3N1AMP2 8 -13.314 -1.611 -5.40038 3.972466 
P3N1AMP3 8 -12.430 -1.075 -6.22200 4.007746 
Valid N (listwise) 8 
2 P3N1AMP1 5 -5.817 -1.658 -3.06280 1.657345 
P3N1AMP2 5 -6.470 -1.633 -3.47080 1.920234 
P3N1AMP3 5 -5.621 -2.567 -4.00540 1.236638 
Valid N (listwise) 5 
3 P3N1AMP1 8 -5.125 1.958 -1.94163 2.077810 
P3N1AMP2 8 -5.556 . 483 -2.53663 1.836978 
P3N1AMP3 8 -7.456 . 
769 -2.74563 2.683175 
Valid N (listwise) 8 
4 P3N1AMP1 6 -8.291 -1.693 -3.97650 2.392427 
P3N 1 AM P2 6 -5.771 . 
257 -3.17817 2.156757 
P3N1AMP3 6 -7.212 . 
369 -2.63083 2.645408 
Valid N (listwise) 6 
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DTO TASK -AUDITORY TARGET Nl AMPLITUDE AT P4 (µV) 
GRP N Minimum Maximum Mean Std. Deviation 
0 P4N1AMP1 14 -5.277 -. 094 -3.01421 1.536683 
P4N1AMP2 14 -7.546 -1.131 -4.17957 2.039438 
P4N1AMP3 14 -6.006 -. 524 -3.20100 1.774645 
Valid N (listwise) 14 
1 P4N1AMP1 8 -9.179 -1.277 -4.12925 2.442205 
P4N1AMP2 8 -10.659 -. 978 -4.40150 3.416167 
P4N1AMP3 8 -13.980 . 126 -6.23550 4.499873 
Valid N (listwise) 8 
2 P4N1AMP1 5 -5.493 -. 477 -2.76420 1.975366 
P4N1AMP2 5 -5.224 -1.285 -2.57480 1.601823 
P4N1AMP3 5 -4.859 -1.840 -3.79240 1.238084 
Valid N (listwise) 5 
3 P4N1AMP1 8 -4.038 -. 245 -2.65513 1.539818 
P4N1AMP2 8 -6.056 . 205 -3.32438 1.876917 
P4N1AMP3 8 -6.140 . 
163 -2.72350 2.391192 
Valid N (listwise) 8 
4 P4N1AMP1 6 -5.840 -. 987 -3.05133 1.884258 
P4N1AMP2 6 -4.764 -. 829 -2.64400 1.470427 
P4N1AMP3 6 -6.290 . 226 -2.65033 
2.346735 
Valid N (listwise) 6 
DTO TASK -AUDITORY TARGET N2 LATENCY 
AT Cz (msec) 
GRP N Minimum Maximum Mean Std. Deviation 
0 CZN2LAT1 14 181.970 243.940 213.17071 20.216157 
CZN2LAT2 14 183.520 231.550 208.97500 14.221278 
CZN2LAT3 14 181.970 237.750 207.42429 17.131640 
Valid N (listwise) 14 
1 CZN2LAT1 8 181.970 310.560 246.26375 43.313262 
CZN2LAT2 8 203.660 295.070 246.07375 33.670582 
CZN2LAT3 8 217.610 310.560 259.11125 39.374704 
Valid N (listwise) 8 
2 CZN2LAT1 5 185.070 273.380 226.90200 33.301216 
CZN2LAT2 5 181.970 251.690 228.76200 26.978794 
CZN2LAT3 5 160.280 278.030 235.26800 45.231742 
Valid N (listwise) 5 
3 CZN2LAT1 8 181.970 295.070 227.09375 41.716103 
CZN2LAT2 8 180.420 270.280 221.09125 32.347674 
CZN2LAT3 8 183.520 278.030 241.23250 36.838981 
Valid N (listwise) 8 
4 CZN2LAT1 6 202.110 284.230 232.06667 28.715456 
CZN2LAT2 6 222.250 282.680 247.04333 25.889328 
CZN2LAT3 6 203.660 290.420 235.68000 29.423061 
Valid N (Iistwise) 6 
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DTO TASK -AUDITORY TARGET N2 LATENCY AT Pz (msec) 
GRP N Minimum Maximum Mean Std. Deviation 
0 PZN2LAT1 14 181.970 240.850 213.17857 20.705535 
PZN2LAT2 14 183.520 236.200 209.19571 15.091599 
PZN2LAT3 14 180.420 240.850 207.75000 18.328998 
Valid N (listwise) 14 
1 PZN2LAT1 8 177.320 313.660 247.42875 45.417743 
PZN2LAT2 8 205.210 295.070 246.65375 33.163942 
PZN2LAT3 8 216.060 313.660 259.29875 40.873809 
Valid N (listwise) 8 
2 PZN2LAT1 5 183.520 276.480 225.97200 35.527248 
PZN2LAT2 5 181.970 253.240 228.76200 27.332537 
PZN2LAT3 5 160.280 278.030 236.19800 45.738604 
Valid N (listwise) 5 
3 PZN2LAT1 8 183.520 293.520 227.48125 41.006953 
PZN2LAT2 8 180.420 270.280 222.44625 31.821446 
PZN2LAT3 8 185.070 273.380 240.65250 36.242835 
Valid N (listwise) 8 
4 PZN2LAT1 6 203.660 287.320 234.90500 29.919257 
PZN2LAT2 6 222.250 285.770 248.96667 27.660912 
PZN2LAT3 6 203.660 291.170 235.54500 30.344693 
Valid N (listwise) 6 
DTO TASK -AUDITORY TARGET N2 LATENCY AT P3 (msec) 
GRP N Minimum Maximum Mean Std. Deviation 
0 P3N2LAT1 14 183.520 242.390 212.84643 19.181967 
P3N2LAT2 14 181.270 236.200 208.48143 15.585235 
P3N2LAT3 14 178.870 240.850 208.30929 18.100078 
Valid N (listwise) 14 
1 P3N2LAT1 8 180.420 313.660 248.97875 44.463505 
P3N2LAT2 8 206.760 298.170 246.26750 33.178527 
P3N2LAT3 8 216.060 312.110 259.43625 40.374606 
Valid N (listwise) 8 
2 P3N2LAT1 5 183.520 278.030 224.11200 36.309533 
P3N2LAT2 5 183.520 259.440 229.07200 27.945049 
P3N2LAT3 5 158.730 274.930 236.81800 46.617555 
Valid N (listwise) 5 
3 P3N2LAT1 8 183.520 290.420 228.34375 41.990820 
P3N2LAT2 8 181.970 267.180 222.63875 30.592829 
P3N2LAT3 8 185.070 274.930 240.26500 35.924395 
Valid N (listwise) 8 
4 P3N2LAT1 6 203.660 282.680 234.38833 27.146750 
P3N2LAT2 6 220.700 287.320 247.59167 29.892236 
P3N2LAT3 6 208.310 295.070 236.97000 31.090945 
Valid N (listwise) 6 
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DTO TASK -AUDITORY TARGET N2 LATENCY AT P4 (msec) 
GRP N Minimum Maximum Mean Std. Deviation 
0 P4N2LAT1 14 180.420 242.390 213.84286 21.170971 
P4N2LAT2 14 183.520 233.100 208.31071 14.508029 
P4N2LAT3 14 180.420 237.750 207.97714 17.499732 
Valid N (listwise) 14 
1 P4N2LAT1 8 175.770 315.210 246.26625 45.653126 
P4N2LAT2 8 208.310 295.070 246.26500 33.342167 
P4N2LAT3 8 217.610 374.930 272.51750 57.997990 
Valid N (listwise) 8 
2 P4N2LAT1 5 181.970 274.930 225.97200 35.442727 
P4N2LAT2 5 180.420 259.440 227.83200 29.040764 
P4N2LAT3 5 161.830 278.030 236.81800 45.284826 
Valid N (listwise) 5 
3 P4N2LAT1 8 185.070 290.120 227.88750 39.487825 
P4N2LAT2 8 180.420 270.280 222.25250 32.508038 
P4N2LAT3 8 185.070 274.930 240.65125 36.870649 
Valid N (listwise) 8 
4 P4N2LAT1 6 205.210 285.770 235.93833 29.303191 
P4N2LAT2 6 223.800 290.420 249.22500 29.397726 
P4N2LAT3 6 206.760 295.070 236.71167 31.166788 
Valid N (listwise) 6 
DTO TASK -AUDITORY TARGET N2 AMPLITUDE AT Cz (µV) 
GRP N Minimum Maximum Mean Std. Deviation 
0 CZN2AMP1 14 -12.760 . 799 -4.96900 4.328360 
CZN2AMP2 14 -14.391 2.202 -5.37043 4.670992 
CZN2AMP3 14 -9.435 3.467 -2.80586 3.941365 
Valid N (Iistwise) 14 
1 CZN2AMP1 8 -21.082 6.034 -7.44550 8.279784 
CZN2AMP2 8 -14.117 -1.082 -7.70025 4.975112 
CZN2AMP3 8 -17.667 -1.249 -6.05263 5.147024 
Valid N (listwise) 8 
2 CZN2AMP1 5 -10.384 -2.107 -4.75540 3.313051 
CZN2AMP2 5 -8.598 3.123 -3.39340 4.931221 
CZN2AMP3 5 -7.454 -2.161 -4.61580 1.935549 
Valid N (listwise) 5 
3 CZN2AMP1 8 -12.584 . 235 -5.16287 4.939996 
CZN2AMP2 8 -14.230 1.023 -4.58438 6.312403 
CZN2AMP3 8 -13.200 2.287 -4.54625 5.053442 
Valid N (listwise) 8 
4 CZN2AMP1 6 -8.731 3.837 -3.31350 4.298893 
CZN2AMP2 6 -6.770 -. 632 -4.07817 2.093189 
CZN2AMP3 6 -3.451 2.936 -. 40267 2.487317 
Valid N (listwise) 6 
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DTO TASK -AUDITORY TARGET N2 AMPLITUDE AT Pz (µV) 
GRP N Minimum Maximum Mean Std. Deviation 
0 PZN2AMP1 14 -9.847 2.513 -2.27529 3.822535 
PZN2AMP2 14 -9.394 1.550 -3.49836 2.975468 
PZN2AMP3 14 -6.074 4.315 -1.37743 2.905237 
Valid N (listwise) 14 
1 PZN2AMP1 8 -8.681 1.687 -2.18337 3.171617 
PZN2AMP2 8 -7.888 . 740 -2.71800 2.825423 
PZN2AMP3 8 -10.620 12.237 -. 47062 6.378654 
Valid N (Iistwise) 8 
2 PZN2AMP1 5 -5.057 -. 415 -2.72100 1.868515 
PZN2AMP2 5 -4.823 3.752 -1.50220 3.181756 
PZN2AMP3 5 -3.948 . 828 -2.17780 1.879784 
Valid N (listwise) 5 
3 PZN2AMP1 8 -9.794 3.369 -2.81875 4.581188 
PZN2AMP2 8 -7.826 2.712 -1.63200 4.482123 
PZN2AMP3 8 -7.801 2.107 -2.02825 3.448342 
Valid N (listwise) 8 
4 PZN2AMP1 6 -5.646 3.714 -1.34783 3.266494 
PZN2AMP2 6 -4.002 -. 535 -2.72700 1.386505 
PZN2AMP3 6 -4.486 1.957 -. 37033 2.403595 
Valid N (listwise) 6 
DTO TASK -AUDITORY TARGET N2 AMPLITUDE AT P3 (µV) 
GRP N Minimum Maximum Mean Std. Deviation 
0 P3N2AMP1 14 -8.558 2.195 -2.10729 3.256332 
P3N2AMP2 14 -8.762 2.847 -1.96407 3.126851 
P3N2AMP3 14 -5.119 4.949 -1.21314 2.983015 
Valid N (listwise) 14 
1 P3N2AMP1 8 -3.810 7.138 . 39038 3.620135 
P3N2AMP2 8 -8.677 . 799 -2.13675 3.029946 
P3N2AMP3 8 -11.363 8.055 -1.23675 5.309773 
Valid N (listwise) 8 
2 P3N2AMP1 5 -5.342 -. 571 -2.30900 1.939400 
P3N2AMP2 5 -6.574 2.666 -2.91480 3.738636 
P3N2AMP3 5 -5.245 . 809 -1.92700 2.262055 
Valid N (listwise) 5 
3 P3N2AMP1 8 -10.916 1.660 -2.81400 4.806302 
P3N2AMP2 8 -7.385 2.423 -1.57900 3.418118 
P3N2AMP3 8 -6.615 2.814 -1.52375 3.011599 
Valid N (listwise) 8 
4 P3N2AMP1 6 -6.235 -1.576 -2.77783 1.773974 
P3N2AMP2 6 -4.916 1.596 -2.15883 2.568355 
P3N2AMP3 6 -6.831 . 831 -1.32217 2.925320 
Valid N (listwise) 6 
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DTO TASK -AUDITORY TARGET N2 AMPLITUDE AT P4 (µV) 
GRP N Minimum Maximum Mean Std. Deviation 
0 P4N2AMP1 14 -7.225 1.221 -2.27014 2.798181 
P4N2AMP2 14 -8.622 1.272 -2.75150 2.904844 
P4N2AMP3 14 -5.74 2.19 -1.4450 2.01043 
Valid N (listwise) 14 
1 P4N2AMP1 8 -8.322 1.979 -1.92275 2.959570 
P4N2AMP2 8 -4.410 1.033 -1.85275 2.048992 
P4N2AMP3 8 -12.13 1.23 -3.0948 5.23939 
Valid N (listwise) 8 
2 P4N2AMP1 5 -3.772 -. 677 -2.32340 1.346165 
P4N2AMP2 5 -3.695 -. 259 -2.08560 1.242730 
P4N2AMP3 5 -3.66 -1.47 -2.0704 . 91778 
Valid N (listwise) 5 
3 P4N2AMP1 8 -9.544 3.242 -2.04525 3.990540 
P4N2AMP2 8 -4.620 2.764 -1.32238 3.109528 
P4N2AMP3 8 -6.44 1.03 -1.8116 2.42463 
Valid N (listwise) 8 
4 P4N2AMP1 6 -3.854 3.325 -1.36467 2.577496 
P4N2AMP2 6 -4.002 2.831 -1.55067 2.482461 
P4N2AMP3 6 -4.08 2.86 -. 3758 2.48886 
Valid N (listwise) 6 
DTO TASK -AUDITORY TARGET P3b LATENCY AT Cz (msec) 
GRP N Minimum Maximum Mean Std. Deviation 
0 CZP3VRL1 14 273.880 384.930 337.49143 36.801930 
CZP3VRL2 14 285.770 394.230 335.35286 34.026707 
CZP3VRL3 14 285.770 378.730 331.25714 33.066881 
Valid N (listwise) 14 
1 CZP3VRL1 8 301.270 419.010 364.50875 33.916024 
CZP3VRL2 8 353.940 411.270 375.43875 21.651075 
CZP3VRL3 8 340.000 420.560 380.08625 27.270587 
Valid N (listwise) 8 
2 CZP3VRL1 5 313.660 364.790 341.55000 22.531913 
CZP3VRL2 5 278.030 391.130 351.15400 46.185492 
CZP3VRL3 5 349.300 412.820 383.07200 26.573351 
Valid N (listwise) 5 
3 CZP3VRL1 8 313.660 380.280 346.00375 22.625722 
CZP3VRL2 8 321.410 419.010 364.40000 31.703923 
CZP3VRL3 8 343.100 415.520 374.03625 30.953535 
Valid N (listwise) 8 
4 CZP3VRL1 6 260.990 415.920 356.27000 61.339122 
CZP3VRL2 6 298.170 415.920 362.98333 50.465193 
CZP3VRL3 6 267.180 417.460 354.71500 62.792899 
Valid N (listwise) 6 
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DTO TASK -AUDITORY TARGET P3b LATENCY AT Pz (msec) 
GRP N Minimum Maximum Mean Std. Deviation 
0 PZP3VRL1 14 273.380 388.030 338.00929 37.498653 
PZP3VRL2 14 285.770 392.680 334.98786 34.663925 
PZP3VRL3 14 282.680 380.280 332.14286 33.347695 
Valid N (Iistwise) 14 
1 PZP3VRL1 8 307.460 419.010 365.94875 32.145449 
PZP3VRL2 8 350.850 411.270 374.47125 21.923696 
PZP3VRL3 8 341.550 420.560 381.05500 26.421545 
Valid N (listwise) 8 
2 PZP3VRL1 5 316.760 366.340 341.86000 20.447991 
PZP3VRL2 5 333.800 391.130 371.46400 21.925619 
PZP3VRL3 5 347.750 414.370 383.69200 27.352662 
Valid N (listwise) 5 
3 PZP3VRL1 8 315.210 380.280 346.77875 21.909407 
PZP3VRL2 8 321.410 417.460 363.43125 31.635565 
PZP3VRL3 8 343.100 417.460 374.27875 31.862319 
Valid N (listwise) 8 
4 PZP3VRL1 6 260.990 414.370 355.49500 61.552088 
PZP3VRL2 6 298.170 415.920 364.53167 50.359170 
PZP3VRL3 6 265.630 415.920 354.20000 63.272371 
Valid N (listwise) 6 
DTO TASK -AUDITORY TARGET P3b LATENCY AT P3 (msec) 
GRP N Minimum Maximum Mean Std. Deviation 
0 P3P3VRL1 14 279.580 384.930 338.79071 36.935617 
P3P3VRL2 14 287.320 395.770 335.57214 34.791034 
P3P3VRL3 14 287.320 380.280 332.58500 32.816761 
Valid N (listwise) 14 
1 P3P3VRL1 8 296.620 420.560 363.82000 34.976511 
P3P3VRL2 8 352.390 414.370 376.02125 21.925109 
P3P3VRL3 8 346.200 422.110 381.63625 26.518065 
Valid N (listwise) 8 
2 P3P3VRL1 5 315.210 364.790 341.33000 21.799280 
P3P3VRL2 5 274.930 394.230 353.94400 49.079303 
P3P3VRL3 5 350.850 417.460 386.47800 27.141785 
Valid N (listwise) 5 
3 P3P3VRL1 8 313.660 381.830 346.58375 22.355708 
P3P3VRL2 8 322.660 412.820 362.17750 30.011155 
P3P3VRL3 8 346.200 415.920 376.30500 28.639771 
Valid N (listwise) 8 
4 P3P3VRL1 6 260.990 414.370 354.20333 61.218941 
P3P3VRL2 6 299.720 417.760 362.51500 50.293476 
P3P3VRL3 6 268.730 419.010 356.26500 63.341212 
Valid N (listwise) 6 
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DTO TASK -AUDITORY TARGET P3b LATENCY AT P4 (msec) 
GRP N Minimum Maximum Mean Std. Deviation 
0 P4P3VRL1 14 271.830 394.080 339.10500 40.225650 
P4P3VRL2 14 287.320 389.580 336.23714 34.455444 
P4P3VRL3 14 288.870 378.730 332.91786 32.195696 
Valid N (listwise) 14 
1 P4P3VRL1 8 305.920 415.920 366.53250 32.492023 
P4P3VRL2 8 350.850 411.270 375.44000 21.137841 
P4P3VRL3 8 344.650 420.560 382.02375 25.809958 
Valid N (listwise) 8 
2 P4P3VRL1 5 315.210 364.790 341.86000 21.562783 
P4P3VRL2 5 273.380 392.680 351.94400 49.320992 
P4P3VRL3 5 347.750 414.370 384.31200 27.813954 
Valid N (Iistwise) 5 
3 P4P3VRL1 8 316.760 381.830 347.55250 21.994981 
P4P3VRL2 8 321.410 417.460 364.02500 31.650412 
P4P3VRL3 8 340.000 415.920 373.50375 32.244234 
Valid N (Iistwise) 8 
4 P4P3VRL1 6 264.080 414.370 355.75167 60.844194 
P4P3VRL2 6 298.170 412.820 362.60833 48.719632 
P4P3VRL3 6 271.830 417.460 355.74833 61.896750 
Valid N (listwise) 6 
DTO TASK -AUDITORY TARGET P3b AMPLITUDE AT Cz (µV) 
GRP N Minimum Maximum Mean Std. Deviation 
0 CZP3VRA1 14 -. 563 23.036 6.15336 5.659067 
CZP3VRA2 14 -2.711 27.830 6.86307 7.083483 
CZP3VRA3 14 -1.288 23.210 7.42357 6.198633 
Valid N (listwise) 14 
1 CZP3VRA1 8 . 072 8.566 3.49050 2.962093 
CZP3VRA2 8 -6.027 4.099 . 22100 3.482032 
CZP3VRA3 8 
. 520 7.710 3.58063 2.415808 
Valid N (Iistwise) 8 
2 CZP3VRA1 5 . 446 12.238 3.93300 4.892286 
CZP3VRA2 5 2.441 14.651 7.04460 4.540356 
CZP3VRA3 5 . 425 9.781 5.39720 3.490983 
Valid N (listwise) 5 
3 CZP3VRA1 8 -3.387 17.012 6.10013 7.165664 
CZP3VRA2 8 -4.407 17.177 4.23387 7.591038 
CZP3VRA3 8 . 842 12.371 6.69800 4.105376 
Valid N (listwise) 8 
4 CZP3VRA1 6 -5.990 9.822 4.39750 5.743348 
CZP3VRA2 6 -. 535 10.354 3.35283 3.898285 
CZP3VRA3 6 2.945 9.645 4.81333 2.432401 
Valid N (Iistwise) 6 
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DTO TASK -AUDITORY TARGET P3b AMPLITUDE AT Pz (µV) 
GRP N Minimum Maximum Mean Std. Deviation 
0 PZP3VRA1 14 . 665 20.519 8.16743 5.548558 
PZP3VRA2 14 1.410 26.650 8.15007 6.294439 
PZP3VRA3 14 1.594 22.310 8.27400 5.837864 
Valid N (listwise) 14 
1 PZP3VRA1 8 1.731 13.909 7.53150 3.892210 
PZP3VRA2 8 -1.968 11.350 5.91388 4.485525 
PZP3VRA3 8 4.935 16.257 8.98750 3.615256 
Valid N (listwise) 8 
2 PZP3VRA1 5 2.988 10.905 6.50380 3.339167 
PZP3VRA2 5 4.496 15.698 8.82580 4.683574 
PZP3VRA3 5 1.532 12.891 8.59080 4.447902 
Valid N (listwise) 5 
3 PZP3VRA1 8 1.447 18.236 8.34125 5.950633 
PZP3VRA2 8 -1.061 21.816 8.72738 7.344974 
PZP3VRA3 8 4.431 16.089 9.92387 3.692464 
Valid N (Iistwise) 8 
4 PZP3VRA1 6 1.939 11.473 7.02150 3.184620 
PZP3VRA2 6 -. 765 9.846 4.93317 3.566756 
PZP3VRA3 6 2.319 16.572 7.94483 5.143375 
Valid N (listwise) 6 
DTO TASK -AUDITORY TARGET P3b AMPLITUDE AT P3 (µV) 
GRP N Minimum Maximum Mean Std. Deviation 
0 P3P3VRA1 14 1.508 16.122 7.55571 4.606749 
P3P3VRA2 14 2.674 20.310 7.15064 4.653011 
P3P3VRA3 14 1.575 19.320 7.55850 4.955022 
Valid N (listwise) 14 
1 P3P3VRA1 8 1.330 10.563 6.95600 3.068856 
P3P3VRA2 8 -. 988 10.580 4.89350 4.189603 
P3P3VRA3 8 3.894 13.076 7.27512 3.094758 
Valid N (listwise) 8 
2 P3P3VRA1 5 2.821 8.504 5.67840 2.484660 
P3P3VRA2 5 2.735 14.661 6.74860 4.602837 
P3P3VRA3 5 2.095 11.562 7.03180 4.218986 
Valid N (listwise) 5 
3 P3P3VRA1 8 -. 359 15.091 6.95663 5.007294 
P3P3VRA2 8 
. 
975 16.031 7.26650 5.212411 
P3P3VRA3 8 4.116 12.913 8.52575 3.444891 
Valid N (listwise) 8 
4 P3P3VRA1 6 -. 770 8.552 5.30800 3.290515 
P3P3VRA2 6 . 072 6.973 4.07850 2.348200 
P3P3VRA3 6 1.232 13.130 6.16217 4.282227 
Valid N (listwise) 6 
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DTO TASK -AUDITORY TARGET P3b AMPLITUDE AT P4 (µV) 
GRP N Minimum Maximum Mean Std. Deviation 
0 P4P3VRA1 14 -1.033 18.904 7.31643 5.279972 
P4P3VRA2 14 1.879 27.830 7.58379 6.629985 
P4P3VRA3 14 1.628 19.460 7.28136 4.901159 
Valid N (listwise) 14 
1 P4P3VRA1 8 1.236 13.417 6.39213 3.516420 
P4P3VRA2 8 -. 259 10.910 4.87100 3.199416 
P4P3VRA3 8 4.101 15.591 7.67650 3.910860 
Valid N (listwise) 8 
2 P4P3VRA1 5 1.809 11.351 6.23600 4.224580 
P4P3VRA2 5 3.476 12.025 7.49120 3.790935 
P4P3VRA3 5 . 856 15.621 7.43760 5.954939 
Valid N (listwise) 5 
3 P4P3VRA1 8 . 975 14.231 7.57612 4.602647 
P4P3VRA2 8 1.908 17.988 8.16362 5.304144 
P4P3VRA3 8 6.267 12.789 8.66738 2.257176 
Valid N (listwise) 8 
4 P4P3VRA1 6 -. 265 10.744 5.12883 3.653221 
P4P3VRA2 6 1.196 7.518 3.95633 2.132115 
P4P3VRA3 6 1.021 13.287 6.30867 4.751920 
Valid N (listwise) 6 
DTO TASK -VISUAL TARGET Ni LATENCY AT Cz (ursec) 
GRP N Minimum Maximum Mean Std. Deviation 
0 CZN1LAT1 14 67.320 101.410 86.35786 9.204567 
CZN1LAT2 14 78.170 107.610 90.01214 11.232115 
CZN1LAT3 14 75.070 110.700 92.11357 12.182812 
Valid N (listwise) 14 
1 CZN1LAT1 8 84.350 138.590 97.14500 17.367214 
CZN1LAT2 8 84.370 124.650 101.03375 14.233360 
CZN 1 LAT3 8 85.920 120.000 99.85875 12.000900 
Valid N (listwise) 8 
2 CZN1LAT1 5 87.460 120.000 97.06800 13.074529 
CZN 1 LAT2 5 82.820 106.060 91.49400 9.073835 
CZNILAT3 5 67.320 126.200 93.35200 21.508658 
Valid N (listwise) 5 
3 CZN1 LAT1 8 71.970 130.850 98.69750 18.587051 
CZN1 LAT2 8 85.920 118.450 99.85875 11.110049 
CZN1LAT3 8 78.170 109.150 96.76000 10.074864 
Valid N (listwise) 8 
4 CZNILAT1 6 79.720 110.700 94.43500 13.024110 
CZN1LAT2 6 82.820 118.450 92.62667 12.913214 
CZN1LAT3 6 65.770 102.960 88.23833 15.425070 
Valid N (listwise) 6 
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DTO TASK -VISUAL TARGET Ni LATENCY AT Pz (msec) 
GRP N Minimum Maximum Mean Std. Deviation 
0 PZN1LAT1 14 68.870 102.960 85.25143 10.397218 
PZN1LAT2 14 76.620 109.150 91.22857 11.525009 
PZN1LAT3 14 76.620 110.700 92.44429 11.924445 
Valid N (listwise) 14 
1 PZN1LAT1 8 81.270 141.690 97.52250 18.487905 
PZN 1 LAT2 8 85.920 123.100 99.85875 14.224367 
PZN 1 LAT3 8 87.460 123.100 101.40750 13.096003 
Valid N (listwise) 8 
2 PZN1LAT1 5 82.820 121.550 96.76000 14.738811 
PZN 1 LAT2 5 82.820 107.610 91.49600 10.135474 
PZN 1 LAT3 5 67.320 124.650 93.66200 21.272760 
Valid N (Iistwise) 5 
3 PZN1LAT1 8 68.870 132.390 99.66375 19.035681 
PZN1LAT2 8 89.010 120.000 101.79500 10.759059 
PZN1LAT3 8 75.070 109.150 96.56625 10.456819 
Valid N (Iistwise) 8 
4 PZNILAT1 6 79.720 113.800 94.17833 13.278624 
PZN1LAT2 6 81.270 116.900 93.40167 12.136344 
PZN1LAT3 6 65.770 101.410 87.72167 14.907735 
Valid N (listwise) 6 
DTO TASK -VISUAL TARGET Ni LATENCY AT P3 (ursec) 
GRP N Minimum Maximum Mean Std. Deviation 
0 P3N1 LAT1 14 68.870 106.060 85.58286 12.398095 
P3N1LAT2 14 75.070 107.610 91.45071 11.779750 
P3N1LAT3 14 78.170 110.700 92.11286 11.782209 
Valid N (listwise) 14 
1 P3N1LAT1 8 81.270 144.790 99.47250 19.522626 
P3N1LAT2 8 85.920 126.200 100.05250 14.917475 
P3N1LAT3 8 84.370 126.200 102.18250 14.126896 
Valid N (listwise) 8 
2 P3N 1 LATZ 5 78.170 123.100 95.83000 16.491772 
P3N 1 LAT2 5 85.920 104.510 92.11400 8.270990 
P3N 1 LAT3 5 68.870 123.100 92.11200 20.467122 
Valid N (listwise) 5 
3 P3N 1 lAT1 8 70.420 135.490 101.98875 19.959494 
P3N1LAT2 8 90.560 121.550 102.37625 10.005074 
P3N1LAT3 8 73.520 110.700 98.50375 12.099725 
Valid N (listwise) 8 
4 P3N 1 LAT1 6 85.920 113.800 97.53667 11.581956 
P3N1LAT2 6 79.720 120.000 93.40333 14.077475 
P3N1LAT3 6 65.770 102.960 88.23833 16.566182 
Valid N (listwise) 6 
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DTO TASK - VISUAL TARGET Ni LATENCY AT P4 (ursec) 
GRP N Minimum Maximum Mean Std. Deviation 
0 P4N 1 LATZ 14 61.130 102.960 84.36643 12.468466 
P4N 1 LAT2 14 78.170 110.700 91.89143 12.012846 
P4N 1 LAT3 14 76.620 110.700 92.22357 12.384193 
Valid N (listwise) 14 
1 P4N1LAT1 8 81.270 143.240 98.69750 19.381473 
P4N 1 LAT2 8 89.010 124.650 101.98875 12.988715 
P4N 1 LAT3 8 89.010 126.200 101.79375 13.976088 
Valid N (Iistwise) 8 
2 P4N1LAT1 5 78.170 120.000 94.59000 15.438881 
P4N1LAT2 5 82.820 107.610 92.11800 9.860607 
P4N1LAT3 5 68.870 124.650 94.59200 21.289585 
Valid N (listwise) 5 
3 P4N1LAT1 8 70.420 135.490 98.88875 19.821228 
P4N 1 LAT2 8 87.460 120.000 102.18125 11.505506 
P4N1LAT3 8 73.520 112.250 96.17875 11.503353 
Valid N (listwise) 8 
4 P4N1LAT1 6 76.620 109.150 91.85333 12.056173 
P4N 1 LAT2 6 75.070 115.350 91.59333 13.133869 
P4N 1 LAT3 6 67.320 101.410 87.98000 14.189755 
Valid N (listwise) 6 
DTO TASK - VISUAL TARGET N1 AMPLITUDE AT Cz (µV) 
GRP N Minimum Maximum Mean Std. Deviation 
0 CZN1AMP1 14 -7.489 1.869 -4.34236 2.613222 
CZN1AMP2 14 -9.493 -1.519 -5.20986 2.126954 
CZN1AMP3 14 -10.771 . 266 -5.33129 3.356348 
Valid N (listwise) 14 
1 CZN1AMP1 8 -16.777 -2.623 -9.67450 5.196609 
CZN1AMP2 8 -12.989 -2.186 -8.11913 4.421748 
CZN1AMP3 8 -11.962 -5.990 -8.92725 2.396904 
Valid N (listwise) 8 
2 CZN1AMP1 5 -11.325 -3.219 -5.97320 3.285559 
CZN1AMP2 5 -8.849 -2.795 -4.72760 2.367593 
CZN1AMP3 5 -6.831 -2.828 -4.76760 1.553348 
Valid N (Iistwise) 5 
3 CZN1AMP1 8 -14.307 -2.207 -7.43000 4.425505 
CZN1AMP2 8 -9.537 -2.801 -6.58625 2.458846 
CZN1AMP3 8 -10.128 -1.750 -6.41950 3.186864 
Valid N (Iistwise) 8 
4 CZN1AMP1 6 -12.989 -3.712 -6.94867 3.507770 
CZN1AMP2 6 -10.362 -. 848 -5.05383 3.509958 
CZN 1 AM PS 6 -9.989 . 197 -6.02950 3.525438 
Valid N (listwise) 6 
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DTO TASK - VISUAL TARGET Ni AMPLITUDE AT Pz (MV) 
GRP N Minimum Maximum Mean Std. Deviation 
0 PZN1AMP1 14 -6.203 -. 244 -3.42836 1.543023 
PZN 1 AM P2 14 -7.501 -. 008 -3.88614 2.126576 
PZN 1 AM P3 14 -9.850 1.503 -3.89800 3.416468 
Valid N (listwise) 14 
1 PZN1AMP1 8 -13.760 -. 920 -6.95025 4.571443 
PZN1AMP2 8 -9.165 -. 524 -4.72875 3.795354 
PZN1AMP3 8 -9.185 -2.210 -5.50350 2.420886 
Valid N (Iistwise) 8 
2 PZN1AMP1 5 -9.488 . 083 -3.87900 3.527956 
PZN1AMP2 5 -6.617 -1.289 -3.38040 2.128494 
PZN1AMP3 5 -3.441 -1.287 -2.49940 . 983045 
Valid N (listwise) 5 
3 PZN 1 AM P1 8 -8.035 -. 888 -4.18600 2.273386 
PZN1AMP2 8 -8.135 -1.643 -3.77163 2.239963 
PZN1AMP3 8 -7.825 -1.463 -4.31075 2.144694 
Valid N (listwise) 8 
4 PZN1AMP1 6 -9.079 -. 419 -4.44250 3.302210 
PZN1AMP2 6 -10.597 -1.345 -4.06783 3.524477 
PZN1AMP3 6 -6.207 -2.333 -4.37867 1.544298 
Valid N (listwise) 6 
DTO TASK - VISUAL TARGET Ni AMPLITUDE AT P3 (µV) 
GRP N Minimum Maximum Mean Std. Deviation 
0 P3N1AMP1 14 -5.010 . 
131 -2.58800 1.275201 
P3N1AMP2 14 -5.873 . 019 -3.31421 1.852756 
P3N1AMP3 14 -10.030 . 
687 -3.36186 2.991860 
Valid N (listwise) 14 
1 P3N1AMP1 8 -12.940 -. 955 -5.81163 4.483227 
P3111 AMP2 8 -8.340 -. 294 -4.10087 3.251767 
P3N1AMP3 8 -9.370 -2.415 -5.74450 2.512866 
Valid N (listwise) 8 
2 P3N1AMP1 5 -9.513 -. 642 -3.19940 3.665283 
P3N 1 AMP2 5 -5.987 -. 078 -2.66220 2.250250 
P3N1AMP3 5 -4.498 -. 748 -2.28440 1.669150 
Valid N (listwise) 5 
3 P3N1AMP1 8 -5.119 -1.356 -3.10600 1.294485 
P3N1AMP2 8 -7.868 -1.338 -3.18488 2.050662 
P3N1AMP3 8 -6.702 -1.264 -3.48100 2.020982 
Valid N (listwise) 8 
4 P3N1AMP1 6 -8.340 . 073 -3.85083 3.303860 
P3N1AMP2 6 -9.036 -. 605 -3.28700 3.046480 
P3N1AMP3 6 -6.239 -1.127 -3.38267 1.862436 
Valid N (Iistwise) 6 
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DTO TASK - VISUAL TARGET Nl AMPLITUDE AT P4 (µV) 
GRP N Minimum Maximum Mean Std. Deviation 
0 P4N1AMP1 14 -5.574 -. 371 -2.62121 1.534399 
P4N1AMP2 14 -6.142 -. 060 -3.07350 1.904504 
P4N1AMP3 14 -10.070 2.477 -3.37686 3.211881 
Valid N (listwise) 14 
1 P4N1AMP1 8 -8.807 -. 616 -4.52912 3.361141 
P4N1AMP2 8 -8.249 -. 813 -3.34538 2.888166 
P4N1AMP3 8 -9.370 -. 840 -4.87213 2.501705 
Valid N (listwise) 8 
2 P4N1AMP1 5 -8.191 . 584 -3.20280 3.214282 
P4N1AMP2 5 -3.690 -. 552 -2.41000 1.237312 
P4N1AMP3 5 -4.032 -. 825 -1.79420 1.371151 
Valid N (listwise) 5 
3 P4N1AMP1 8 -5.921 -. 177 -3.43063 1.918089 
P4N1AMP2 8 -6.233 -. 540 -2.44163 2.033464 
P4N1AMP3 8 -6.765 -. 035 -3.42638 2.725697 
Valid N (listwise) 8 
4 P4N1AMP1 6 -6.263 . 906 -2.93083 2.597747 
P4N1AMP2 6 -7.570 . 
001 -2.68533 2.831146 
P4N1AMP3 6 -6.308 -1.060 -3.33417 1.923814 
Valid N (listwise) 6 
DTO TASK -VISUAL TARGET N2 LATENCY AT 
Cz (ursec) 
GRP N Minimum Maximum Mean Std. Deviation 
0 CZN2LAT1 14 319.860 392.680 349.62714 19.816152 
CZN2LAT2 14 313.660 383.380 348.52143 16.871674 
CZN2LAT3 14 312.110 372.540 347.74643 16.798389 
Valid N (listwise) 14 
1 CZN2LAT1 8 326.060 397.320 351.81375 22.125806 
CZN2LAT2 8 329.150 394.230 363.23875 18.575580 
CZN2LAT3 8 335.350 388.030 356.51750 18.648342 
Valid N (listwise) 8 
2 CZN2LAT1 5 305.920 454.650 360.76200 56.337528 
CZN2LAT2 5 333.800 364.790 347.74600 13.771357 
CZN2LAT3 5 340.000 366.340 350.22600 11.204288 
Valid N (Iistwise) 5 
3 CZN2LAT1 8 324.510 473.240 382.60750 49.534203 
CZN2LAT2 8 302.820 471.610 383.76000 49.444053 
CZN2LAT3 8 313.660 446.900 387.25250 40.417799 
Valid N (listwise) 8 
4 CZN2LAT1 6 333.800 381.830 364.78833 16.629265 
CZN2LAT2 6 346.200 363.240 354.97667 7.243661 
CZN2LAT3 6 315.210 381.830 355.23333 23.463192 
Valid N (listwise) 6 
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DTO TASK -VISUAL TARGET N2 LATENCY AT Pz (msec) 
GRP N Minimum Maximum Mean Std. Deviation 
0 PZN2LAT1 14 318.130 391.130 350.75429 19.317295 
PZN2LAT2 14 315.210 384.930 349.19286 16.987098 
PZN2LAT3 14 309.010 372.540 348.52143 17.035887 
Valid N (listwise) 14 
1 PZN2LAT1 8 324.510 391.130 351.81500 20.519654 
PZN2LAT2 8 330.700 388.030 360.33375 17.162270 
PZN2LAT3 8 338.450 384.390 357.36000 16.471866 
Valid N (listwise) 8 
2 PZN2LAT1 5 309.010 456.200 362.31000 55.987191 
PZN2LAT2 5 333.800 364.790 347.12600 12.663208 
PZN2LAT3 5 340.000 370.990 351.15600 12.654086 
Valid N (listwise) 5 
3 PZN2LAT1 8 327.610 473.240 384.34875 48.569265 
PZN2LAT2 8 307.470 471.690 383.57500 48.382642 
PZN2LAT3 8 313.660 448.450 387.83375 40.852078 
Valid N (listwise) 8 
4 PZN2LAT1 6 335.350 380.280 364.78833 15.616564 
PZN2LAT2 6 343.100 364.790 353.94500 9.032831 
PZN2LAT3 6 316.760 380.280 354.20167 22.137625 
Valid N (listwise) 6 
DTO TASK -VISUAL TARGET N2 LATENCY AT P3 (msec) 
GRP N Minimum Maximum Mean Std. Deviation 
0 P3N2LAT1 14 313.660 391.130 352.17357 19.398371 
P3N2LAT2 14 316.760 384.930 350.29214 16.290459 
P3N2LAT3 14 305.920 375.630 349.18571 17.752194 
Valid N (listwise) 14 
1 P3N2LAT1 8 322.960 392.680 351.81500 21.387361 
P3N2LAT2 8 330.700 392.680 360.91625 17.917540 
P3N2LAT3 8 338.450 386.480 359.36625 17.547800 
Valid N (listwise) 8 
2 P3N2LAT1 5 315.210 456.200 364.17000 54.211063 
P3N2LAT2 5 333.800 367.890 349.29600 13.684134 
P3N2LAT3 5 341.550 375.630 353.94400 14.490103 
Valid N (listwise) 5 
3 P3N2LAT1 8 327.610 473.240 383.96125 48.576286 
P3N2LAT2 8 305.920 470.140 383.96375 47.987202 
P3N2LAT3 8 316.760 446.900 387.83375 39.154016 
Valid N (listwise) 8 
4 P3N2LAT1 6 344.650 380.280 367.11500 12.189019 
P3N2LAT2 6 346.200 369.440 355.75333 10.248949 
P3N2LAT3 6 318.310 380.280 355.23500 21.787528 
Valid N (listwise) 6 
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DTO TASK - VISUAL TARGET N2 LATENCY AT P4 (msec) 
GRP N Minimum Maximum Mean Std. Deviation 
0 P4N2LAT1 14 319.860 391.830 353.10857 20.319037 
P4N2LAT2 14 316.760 384.930 351.06643 16.685430 
P4N2LAT3 14 307.460 372.540 350.18000 17.567790 
Valid N (listwise) 14 
1 P4N2LAT1 8 322.960 391.130 351.81500 20.982443 
P4N2LAT2 8 332.250 392.680 362.07750 18.083454 
P4N2LAT3 8 336.900 386.480 357.02875 17.050884 
Valid N (listwise) 8 
2 P4N2LAT1 5 310.560 453.100 362.31000 54.288563 
P4N2LAT2 5 333.800 363.240 348.05600 11.920870 
P4N2LAT3 5 340.000 378.730 353.32400 15.280651 
Valid N (listwise) 5 
3 P4N2LAT1 8 327.610 477.890 386.67375 48.791216 
P4N2LAT2 8 310.560 477.890 384.73750 48.941478 
P4N2LAT3 8 316.760 446.900 387.83375 39.951939 
Valid N (listwise) 8 
4 P4N2LAT1 6 343.100 386.480 367.37167 14.288886 
P4N2LAT2 6 346.200 366.340 356.01167 9.068225 
P4N2LAT3 6 315.210 383.380 355.49333 23.497155 
Valid N (Iistwise) 6 
DTO TASK - VISUAL TARGET N2 AMPLITUDE AT Cz (µV) 
GRP N Minimum Maximum Mean Std. Deviation 
0 CZN2AMP1 14 -8.332 1.063 -3.48079 2.913330 
CZN2AMP2 14 -10.733 5.201 -1.62050 4.186659 
CZN2AMP3 14 -8.071 2.620 -2.78721 2.956726 
Valid N (listwise) 14 
1 CZN2AMP1 8 -9.408 -. 623 -5.69763 3.270288 
CZN2AMP2 8 -6.223 -. 865 -4.16638 1.997078 
CZN2AMP3 8 -16.910 3.380 -5.14463 6.252526 
Valid N (listwise) 8 
2 CZN2AMP1 5 -7.068 . 348 -3.13760 2.848231 
CZN2AMP2 5 -5.130 . 300 -2.38220 2.467882 
CZN2AMP3 5 -5.606 . 589 -2.31600 2.604285 
Valid N (listwise) 5 
3 CZN2AMP1 8 -8.431 -1.682 -3.79600 2.365185 
CZN2AMP2 8 -5.926 3.576 -1.75325 2.914676 
CZN2AMP3 8 -10.624 4.511 -2.15813 5.123972 
Valid N (listwise) 8 
4 CZN2AMP1 6 -10.651 -. 084 -4.47883 3.779999 
CZN2AMP2 6 -9.304 1.956 -2.54433 4.467022 
CZN2AMP3 6 -6.024 1.998 -1.47483 3.384802 
Valid N (listwise) 6 
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DTO TASK - VISUAL TARGET N2 AMPLITUDE AT Pz (µV) 
GRP N Minimum Maximum Mean Std. Deviation 
0 PZN2AMP1 14 -10.046 -. 918 -3.97714 2.692823 
PZN2AMP2 14 -7.221 2.902 -2.11586 2.906844 
PZN2AMP3 14 -6.930 . 550 -3.63743 1.862697 
Valid N (listwise) 14 
1 PZN2AMP1 8 -14.158 . 090 -6.47212 4.733071 
PZN2AMP2 8 -7.874 2.252 -3.04738 3.359115 
PZN2AMP3 8 -17.490 6.030 -5.51938 7.427862 
Valid N (listwise) 8 
2 PZN2AMP1 5 -4.527 . 434 -2.00760 2.248416 
PZN2AMP2 5 -5.910 1.316 -2.63780 2.634164 
PZN2AMP3 5 -4.931 2.521 -1.44020 3.086848 
Valid N (listwise) 5 
3 PZN2AMP1 8 -6.460 . 
396 -2.22750 2.183529 
PZN2AMP2 8 -6.267 1.268 -2.10400 2.343451 
PZN2AMP3 8 -10.189 1.414 -3.19963 3.979515 
Valid N (listwise) 8 
4 PZN2AMP1 6 -8.288 -. 759 -4.52500 2.871634 
PZN2AMP2 6 -8.489 2.728 -2.61983 4.046413 
PZN2AMP3 6 -4.934 1.623 -1.40583 2.505416 
Valid N (listwise) 6 
DTO TASK - VISUAL TARGET N2 AMPLITUDE AT P3 (µV) 
GRP N Minimum Maximum Mean Std. Deviation 
0 P3N2AMP1 13 -9.060 -. 145 -4.01985 3.080990 
P3N2AMP2 14 -7.476 2.358 -2.00936 3.192676 
P3N2AMP3 14 -11.700 . 
360 -3.53564 2.876948 
Valid N (listwise) 13 
1 P3N2AMP1 8 -14.281 . 855 -6.00638 5.217243 
P3N2AMP2 8 -9.474 1.538 -3.81562 3.984490 
P3N2AMP3 8 -13.200 5.090 -4.11538 5.710038 
Valid N (listwise) 8 
2 P3N2AMP1 5 -6.080 -. 766 -2.69720 2.072113 
P3N2AMP2 5 -4.222 1.357 -1.83720 2.316706 
P3N2AMP3 5 -4.586 1.628 -1.69900 2.853741 
Valid N (listwise) 5 
3 P3N2AMP1 8 -5.009 . 077 -2.11100 1.675683 
P3N2AMP2 8 -7.201 . 375 -2.69888 3.003058 
P3N2AMP3 8 -10.044 1.239 -3.33200 4.145643 
Valid N (listwise) 8 
4 P3N2AMP1 6 -9.474 . 496 -4.88167 3.444312 
P3N2AMP2 6 -9.160 2.099 -3.16067 4.004459 
P3N2AMP3 6 -4.114 1.979 -1.31217 2.613464 
Valid N (listwise) 6 
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DTO TASK - VISUAL TARGET N2 AMPLITUDE AT P4 (µV) 
GRP N Minimum Maximum Mean Std. Deviation 
0 P4N2AMP1 14 -12.722 -. 569 -4.19764 3.659505 
P4N2AMP2 14 -6.307 2.866 -2.01893 3.149975 
P4N2AMP3 14 -7.350 -. 120 -3.43900 2.245693 
Valid N (listwise) 14 
1 P4N2AMP1 8 -12.923 -1.207 -5.87575 3.932742 
P4N2AMP2 8 -7.288 1.803 -3.33112 3.786759 
P4N2AMP3 8 -16.650 2.500 -5.61488 6.115863 
Valid N (Iistwise) 8 
2 P4N2AMP1 5 -3.296 -. 261 -1.84380 1.134449 
P4N2AMP2 5 -4.211 2.023 -1.22580 2.461127 
P4N2AMP3 5 -4.174 3.185 -1.07520 3.080070 
Valid N (Iistwise) 5 
3 P4N2AMP1 8 -7.147 1.638 -2.42650 2.404396 
P4N2AMP2 8 -7.237 1.316 -2.15713 2.556317 
P4N2AMP3 8 -8.325 1.051 -3.04025 3.225157 
Valid N (listwise) 8 
4 P4N2AMP1 6 -7.355 . 152 -3.92750 2.901215 
P4N2AMP2 6 -5.175 1.179 -1.81867 2.566646 
P4N2AMP3 6 -4.583 1.416 -1.37417 2.410314 
Valid N (listwise) 6 
DTO TASK -VISUAL TARGET P6 LATENCY AT Cz (msec) 
GRP N Minimum Maximum Mean Std. Deviation 
0 CZP3VVL1 14 533.660 625.070 579.47643 27.820022 
CZP3VVL2 14 527.460 604.930 571.07357 26.604307 
CZP3VVL3 14 524.370 611.130 575.60357 28.659856 
Valid N (listwise) 14 
1 CZP3VVL1 8 524.370 648.310 567.55125 36.629638 
CZP3VVL2 8 474.790 652.960 575.68625 58.331684 
CZP3VVL3 8 556.900 649.860 588.66250 31.773635 
Valid N (listwise) 8 
2 CZP3VVL1 - 5 552.250 595.630 581.99960 18.047728 
CZP3VVL2 5 560.000 623.520 588.25800 28.989503 
CZP3VVL3 5 575.490 642.110 596.56200 26.532518 
Valid N (listwise) 5 
3 CZP3VVL1 8 484.080 603.380 566.76500 37.088438 
CZP3VVL2 8 560.000 646.760 596.85375 29.794764 
CZP3VVL3 8 570.850 674.650 610.15875 37.447991 
Valid N (listwise) 8 
4 CZP3VVL1 6 549.150 688.590 606.21833 50.626462 
CZP3VVL2 6 561.550 704.080 614.48333 52.284550 
CZP3VVL3 6 561.550 705.630 608.02833 54.905842 
Valid N (listwise) 6 
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DTO TASK -VISUAL TARGET P6 LATENCY AT Pz (msec) 
GRP N Minimum Maximum Mean Std. Deviation 
0 PZP3VVL1 14 533.660 621.970 580.25214 28.583879 
PZP3VVL2 14 525.920 603.380 569.96071 26.826169 
PZP3VVL3 14 525.920 611.130 575.79643 28.226311 
Valid N (Iistwise) 14 
1 PZP3VVL1 8 527.460 649.860 568.90750 37.384324 
PZP3VVL2 8 494.440 652.960 577.56375 54.094260 
PZP3VVL3 8 553.800 649.860 587.88875 32.212574 
Valid N (listwise) 8 
2 PZP3VVL1 5 555.350 597.180 583.23800 17.217362 
PZP3VVL2 5 558.450 623.520 587.88800 28.943543 
PZP3VVL3 5 578.590 642.110 597.18200 26.085143 
Valid N (listwise) 5 
3 PZP3VVL1 8 485.630 603.380 566.83375 36.819131 
PZP3VVL2 8 560.000 646.760 607.06000 29.845779 
PZP3VVL3 8 569.300 674.650 609.38375 37.480173 
Valid N (listwise) 8 
4 PZP3VVL1 6 546.060 687.040 605.96167 51.622340 
PZP3VVL2 6 558.450 704.080 613.70833 53.206533 
PZP3VVL3 6 560.000 704.080 608.02833 54.174955 
Valid N (listwise) 6 
DTO TASK -VISUAL TARGET P6 LATENCY AT P3 (msec) 
GRP N Minimum Maximum Mean Std. Deviation 
0 P3P3VVL1 14 533.660 620.420 580.47357 28.217777 
P3P3VVL2 14 527.460 601.830 570.06929 26.375590 
P3P3VVL3 14 525.920 609.580 576.48143 28.380349 
Valid N (listwise) 14 
1 P3P3VVL1 8 530.560 651.410 570.45750 37.061666 
P3P3VVL2 8 479.440 649.860 575.49250 56.415658 
P3P3VVL3 8 564.650 648.310 589.05125 30.626467 
Valid N (listwise) 8 
2 P3P3VVL1 5 558.450 594.080 581.69000 14.616576 
P3P3VVL2 5 558.450 637.460 593.46400 35.354519 
P3P3VVL3 5 575.490 652.960 599.04200 31.014349 
Valid N (listwise) 5 
3 P3P3VVL1 8 485.630 608.030 567.55250 37.013610 
P3P3VVL2 8 560.000 645.210 606.47875 29.835043 
P3P3VVL3 8 570.850 673.100 607.84750 38.322838 
Valid N (listwise) 8 
4 P3P3VVL1 6 542.960 687.040 605.96167 52.398023 
P3P3VVL2 6 558.450 708.730 614.30000 54.832977 
P3P3VVL3 6 555.350 705.630 608.28667 54.725537 
Valid N (listwise) 6 
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DTO TASK - VISUAL TARGET P6 LATENCY AT P4 (ursec) 
GRP N Minimum Maximum Mean Std. Deviation 
0 P4P3VVL1 14 530.560 621.970 581.69071 28.632856 
P4P3VVL2 14 524.370 604.930 570.27786 26.808428 
P4P3VVL3 14 525.920 612.680 575.82500 27.562440 
Valid N (listwise) 14 
1 P4P3VVL1 8 530.560 646.760 569.29375 35.446784 
P4P3VVL2 8 482.540 649.860 576.85000 55.726910 
P4P3VVL3 8 556.900 648.310 589.24250 31.777220 
Valid N (Iistwise) 8 
2 P4P3VVL1 5 555.350 601.830 584.47800 18.377800 
P4P3VVL2 5 560.000 626.620 589.43800 28.922784 
P4P3VVL3 5 575.490 651.410 599.33200 30.275649 
Valid N (listwise) 5 
3 P4P3VVL1 8 484.080 603.380 568.64375 37.669040 
P4P3VVL2 8 589.440 645.210 617.51750 24.779409 
P4P3VVL3 8 570.850 674.650 608.45250 38.860563 
Valid N (listwise) 8 
4 P4P3VVL1 6 544.510 688.590 605.18833 52.451040 
P4P3VVL2 6 555.350 700.990 612.93500 53.017748 
P4P3VVL3 6 560.000 704.080 608.80333 53.098252 
Valid N (listwise) 6 
DTO TASK - VISUAL TARGET P6 AMPLITUDE AT Cz (µV) 
GRP N Minimum Maximum Mean Std. Deviation 
0 CZP3VVA1 14 3.559 29.510 13.07014 7.889199 
CZP3VVA2 14 . 
871 31.130 14.46443 7.697335 
CZP3VVA3 14 -. 517 28.950 13.50779 9.251935 
Valid N (listwise) 14 
1 CZP3VVA1 8 5.688 27.490 13.47788 7.268231 
CZP3VVA2 8 1.297 15.447 9.72725 4.669292 
CZP3VVA3 8 4.167 25.320 10.89613 7.058629 
Valid N (Iistwise) 8- 
2 CZP3VVA1 5 2.743 15.775 9.87120 4.847371 
CZP3VVA2 5 1.086 19.924 13.05680 7.509420 
CZP3VVA3 5 . 464 23.081 11.78940 8.011487 
Valid N (listwise) 5 
3 CZP3VVA1 8 -3.771 18.680 9.52388 7.347490 
CZP3VVA2 8 . 576 
20.580 11.15650 6.317044 
CZP3VVA3 8 2.401 16.036 10.38850 4.544446 
Valid N (listwise) 8 
4 CZP3VVA1 6 2.069 18.598 8.96367 6.366239 
CZP3VVA2 6 -2.698 15.372 8.15133 7.683010 
CZP3VVA3 6 2.272 16.041 7.61600 5.907202 
Valid N (listwise) 6 
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DTO TASK - VISUAL TARGET P6 AMPLITUDE AT Pz (µV) 
GRP N Minimum Maximum Mean Std. Deviation 
0 PZP3VVA1 14 4.245 25.600 13.55564 7.185507 
PZP3VVA2 14 1.977 27.730 14.54529 6.887859 
PZP3VVA3 14 -. 887 24.300 14.30779 8.244013 
Valid N (listwise) 14 
1 PZP3VVA1 8 5.771 26.350 14.50475 7.510394 
PZP3VVA2 8 5.877 22.531 13.79825 5.383346 
PZP3VVA3 8 7.987 27.190 13.03738 6.451864 
Valid N (listwise) 8 
2 PZP3VVA1 5 1.273 17.529 11.09980 6.180410 
PZP3VVA2 5 3.885 21.718 14.86080 6.649746 
PZP3VVA3 5 6.638 23.150 13.27140 6.301107 
Valid N (listwise) 5 
3 PZP3VVA1 8 1.321 21.432 11.04125 7.641760 
PZP3VVA2 8 -2.611 22.530 12.78613 8.222231 
PZP3VVA3 8 2.518 20.429 12.26138 5.579809 
Valid N (Iistwise) 8 
4 PZP3VVA1 6 6.497 16.905 10.16400 3.948533 
PZP3VVA2 6 -. 832 16.975 10.64333 7.500362 
PZP3VVA3 6 5.425 13.219 8.32250 2.946681 
Valid N (listwise) 6 
DTO TASK - VISUAL TARGET P6 AMPLITUDE AT P3 (µV) 
GRP N Minimum Maximum Mean Std. Deviation 
0 P3P3VVA1 14 3.899 20.340 10.96093 5.556634 
P3P3VVA2 14 . 
553 23.470 12.89743 5.532485 
P3P3VVA3 14 2.926 20.510 12.28000 6.096006 
Valid N (listwise) 14 
1 P3P3VVA1 8 3.377 22.360 11.51900 5.972835 
P3P3VVA2 8 4.321 20.833 11.77725 5.947104 
P3P3VVA3 8 5.875 23.780 11.31200 6.191789 
Valid N (listwise) 8 
2 P3P3VVA1 5 -1.786 15.093 8.36440 6.361487 
P3P3VVA2 5 5.875 16.334 13.12440 4.218469 
P3P3VVA3 5 5.580 18.816 10.88280 5.170298 
Valid N (Iistwise) 5 
3 P3P3VVA1 8 . 106 19.202 8.74588 6.929879 
P3P3VVA2 8 -6.610 18.480 9.20813 8.012801 
P3P3VVA3 8 2.262 16.854 9.22100 4.960472 
Valid N (listwise) 8 
4 P3P3VVA1 6 4.557 12.439 7.86300 3.001233 
P3P3VVA2 6 -2.212 14.782 8.22533 6.418041 
P3P3VVA3 6 3.881 11.870 7.32283 2.870141 
Valid N (listwise) 6 
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DTO TASK - VISUAL TARGET P6 AMPLITUDE AT P4 (µV) 
GRP N Minimum Maximum Mean Std. Deviation 
0 P4P3VVA1 14 1.929 595.630 53.60064 156.149864 
P4P3VVA2 14 2.225 27.450 13.02543 6.436875 
P4P3VVA3 14 -3.979 40.960 14.82664 10.644290 
Valid N (Iistwise) 14 
1 P4P3VVA1 8 5.607 19.250 11.11200 5.467895 
P4P3VVA2 8 5.082 20.187 10.66700 5.134430 
P4P3VVA3 8 7.517 24.890 11.42988 5.876280 
Valid N (listwise) 8 
2 P4P3VVA1 5 3.401 17.382 9.02580 5.420638 
P4P3VVA2 5 5.501 19.414 12.56660 4.997590 
P4P3VVA3 5 5.431 18.129 11.02880 4.959708 
Valid N (listwise) 5 
3 P4P3VVA1 8 . 690 18.647 
8.71663 6.771234 
P4P3VVA2 8 -. 278 19.420 8.73225 6.926685 
P4P3VVA3 8 4.832 16.414 11.20088 3.755283 
Valid N (listwise) 8 
4 P4P3VVA1 6 5.661 12.846 8.22600 2.675131 
P4P3VVA2 6 -. 723 14.101 8.70917 5.897529 
P4P3VVA3 6 4.741 10.878 7.33283 2.639166 
Valid N (listwise) 6 1 -1 
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APPENDIX V: ERP waveforms averaged sweep data 
Figure 3.1 MMN averaged sweep data 
mean minimum 
DDR set 1 68 60 
DDR set 2 69 51 
DDV set 1 74 61 
DDV set 2 61 49 
DIR set 1 66 54 
DIR set 2 65 46 
DIV set 1 73 55 
DIV set 2 61 54 
FIR set 1 67 54 
FIR set 2 57 55 
FIV set 1 69 54 
FIV set 2 62 51 
Figure 3.2 MMN averaged sweep data 
mean minimum 
DDR set 1 75 60 
DDR set 2 65 51 
DDR set 3 128 113 
DIR set 1 61 56 
DIR set 2 64 46 
DIR set 3 123 100 
FIR set 1 69 54 
FIR set 2 59 60 
FIR set 3 115 64 
Figures 4.5a and 4.5 b session 1 MMN averaged sweep data 
mean minimum 
Controls 117 61 
PGS group 128 114 
FSG group 122 74 
FS group 124 77 
Pain group 126 83 
Figures 4.6a and 4.6 b session 1 P3b avers ed sweep data 
mean minimum 
Controls 40 24 
PGS group 36 25 
FSG group 39 32 
FS group 38 24 
Pain group 41 36 
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Figures 4.7a and 4.7 b -session 1 P3a averaged sweep data 
mean minimum 
Controls 41 25 
PGS group 39 35 
FSG group 41 34 
FS group 40 33 
Pain group 40 30 
Figures 4.8a and 4.8 b -session 1 DTO task auditory target avers 
mean minimum 
Controls 43 38 
PGS group 38 29 
FSG group 41 35 
FS group 41 28 
Pain group 42 36 
Figures 4.9a and 4.9 b -session 1 DTO task visual target avers e 
mean minimum 
Controls 22 18 
PGS group 20 17 
FSG group 22 17 
FS group 22 14 
Pain group' 21 16 
Figures 5.6a and 5.6 b -session 3 MMN averaged sweep data 
mean minimum 
Controls 103 75 
PGS group 108 83 
FSG group 91 49 
FS group 113 60 
Pain group 108 72 
Figures 5.7a and 5.7 b -session 3 P3b averaged sweep data 
mean minimum 
Controls 37 27 
PGS group 36 15 
FSG group 39 29 
FS group 36 27 
Pain group 40 29 
iged sweep data 
d sweep data 
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Figures 5.8a and 5.. 8 b -session 3 P3a averaged sweep data 
mean minimum 
Controls 37 25 
PGS group 41 30 
FSG group 38 30 
FS group 36 20 
Pain group 39 28 
Figures 5.9a and 5.9 b -session 3 DTO task auditory target aver. 
mean minimum 
Controls 38 23 
PGS group 39 25 
FSG group 41 37 
FS group 34 21 
Pain group 40 31 
Figures 5.10a and 5.10 -session 3 DTO tas k visual target avers 
mean minimum 
Controls 24 18 
PGS group 23 18 
FSG group 25 20 
FS group 21 13 
Pain group 23 17 
iged sweep data 
ed sweep data 
Figures 6.9a, 6.9b, 6.9c, 6.9d and 6.9e -MMN averaged sweep data 
mean minimum 
Controls session 1 117 61 
Controls session 2 113 56 
Controls session 3 104 75 
PGS session 1 128 114 
PGS session 2 125 100 
PGS session 3 108 83 
FSG session 1 119 74 
FSG session 2 117 80 
FSG session 3 88 49 
FS session 1 121 77 
FS session 2 125 90 
FS session 3 113 60 
Pain session 1 126 83 
Pain session 2 121 90 
Pain session 3 108 72 
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Figures 6.10a, 6.10b, 6.10c, 6.10d and 6.10e -P3b averaged sweep data 
mean minimum 
Controls session 1 40 24 
Controls session 2 41 35 
Controls session 3 37 27 
PGS session 1 36 25 
PGS session 2 40 32 
PGS session 3 36 15 
FSG session 1 44 41 
FSG session 2 33 21 
FSG session 3 41 40 
FS session 1 38 29 
FS session 2 37 29 
FS session 3 37 27 
Pain session 1 41 36 
Pain session 2 39 33 
Pain session 3 40 29 
Figures 6.11a, 6.11b, 6.11c, 6.11d and 6.1le -P3a averaged sweep data 
mean minimum 
Controls session 1 41 25 
Controls session 2 39 23 
Controls session 3 37 25 
PGS session 1 39 35 
PGS session 2 41 31 
PGS session 3 40 30 
FSG session 1 41 34 
FSG session 2 38 34 
FSG session 3 38 31 
FS session 1 40 33 
FS session 2 37 26 
FS session 3 37 20 
Pain session 1 40 30 
Pain session 2 38 30 
Pain session 3 39 28 
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Figures 6.12a, 6.12b, 6.12c, 6.12d and 6.12e -DTO task auditory target averaged 
sweep data 
mean minimum 
Controls session 1 43 38 
Controls session 2 40 23 
Controls session 3 38 23 
PGS session 1 38 29 
PGS session 2 36 15 
PGS session 3 38 25 
FSG session 1 42 39 
FSG session 2 36 33 
FSG session 3 41 37 
FS session 1 41 28 
FS session 2 36 21 
FS session 3 33 21 
Pain session 1 42 36 
Pain session 2 40 30 
Pain session 3 40 31 
Figures 6.13a, 6.13b, 6.13c, 6.13d and 6.13e -DTO task visual target averaged 
sweep data 
mean minimum 
Controls session 1 22 18 
Controls session 2 24 19 
Controls session 3 24 18 
PGS session 1 20 17 
PGS session 2 20 15 
PGS session 3 23 18 
FSG session 1 23 23 
FSG session 2 21 16 
FSG session 3 25 20 
FS session 1 22 14 
FS session 2 22 16 
FS session 3 21 13 
Pain session 1 21 16 
Pain session 2 21 13 
Pain session 3 23 17 
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